Variant ID,Case ID,Type,Effect,c.DNA,HGVS/Amino acid,Legacy/Amino Acid,Domain,Location in gene,Variant,Protein Change,FIX:C %,FIX:Ag %,Type I/II,Inhibitors,Severity,Comments,Reference,Reporting Centre
1102,4676,Point,,,,,,3'UTR ,c.*1159A>G,,3,,,NO,Moderate,,Johnsen et al (2017),United States
1102,4677,Point,,,,,,3'UTR ,c.*1159A>G,,<1,,,NO,Severe,,Johnsen et al (2017),United States
1102,4679,Point,,,,,,3'UTR ,c.*1159A>G,,<1,,,NO,Severe,,Johnsen et al (2017),United States
1102,4680,Point,,,,,,3'UTR ,c.*1159A>G,,<1,,,NO,Severe,,Johnsen et al (2017),United States
1102,2887,Point,,,,,,3'UTR ,c.*1159A>G,,<1,-,-,,Severe,-,Centre B30 (unpublished),
1102,2888,Point,,,,,,3'UTR ,c.*1159A>G,,<1,0.6,-,,Severe,-,Centre B30 (unpublished),
1102,2889,Point,,,,,,3'UTR ,c.*1159A>G,,1,-,-,,Moderate,-,Centre B30 (unpublished),
1102,2890,Point,,,,,,3'UTR ,c.*1159A>G,,2,-,-,,Moderate,-,Centre B30 (unpublished),
1102,2891,Point,,,,,,3'UTR ,c.*1159A>G,,4,-,-,,Moderate,-,Centre B30 (unpublished),
1102,2892,Point,,,,,,3'UTR ,c.*1159A>G,,1,10,II,,Moderate,-,Centre B30 (unpublished),
1102,2893,Point,,,,,,3'UTR ,c.*1159A>G,,-,-,-,,,-,Centre B8 (unpublished),
1102,2896,Point,,,,,,3'UTR ,c.*1159A>G,,2,-,-,,Moderate,-,Centre B36 (unpublished),
1102,2897,Point,,,,,,3'UTR ,c.*1159A>G,,<1,-,-,,Severe,-,Centre B13 (unpublished),
1102,2898,Point,,,,,,3'UTR ,c.*1159A>G,,1,-,-,,Moderate,-,Centre B13 (unpublished),
1102,2895,Point,,,,,,3'UTR ,c.*1159A>G,,4.5,-,-,,Moderate,-,Liu et al (2000),China
1102,2899,Point,,,,,,3'UTR ,c.*1159A>G,,-,-,-,,Moderate,-,Belvini et al (2005),Italy
1102,2900,Point,,,,,,3'UTR ,c.*1159A>G,,<1,-,-,,Severe,-,Awidi et al (2011),Jordan
1102,2882,Point,,,,,,3'UTR ,c.*1159A>G,,<1,<1,-,,Severe,-,Chen et al (1995),United States
1102,2883,Point,,,,,,3'UTR ,c.*1159A>G,,2,<1,I,,Moderate,-,Vielhaber et al (1993),United States
1102,2884,Point,,,,,,3'UTR ,c.*1159A>G,,3,<1,I,,Moderate,-,Vielhaber et al (1993),United States
1102,2885,Point,,,,,,3'UTR ,c.*1159A>G,,1.3,<1,I,,Moderate,-,Vielhaber et al (1993),United States
1102,2886,Point,,,,,,3'UTR ,c.*1159A>G,,-,-,-,,Severe,-,Vielhaber et al (1993),United States
1102,2894,Point,,,,,,3'UTR ,c.*1159A>G,,-,-,-,,,-,Ketterling et al (1999B),United States
1102,4678,Point,,,,,,3'UTR ,c.*1159A>G,,1.4,,,,Moderate,,Johnsen et al (2017),United States
1103,2902,Point,,,,,,polyA ,c.*1370A>G,,<1,-,-,,Severe,-,Awidi et al (2011),Jordan
1103,2901,Point,,,,,,polyA ,c.*1370A>G,,33.4,-,-,,Mild,-,Li et al (2000),United States
802,2903,Point,NA,,,,-,UTR 3',c.*1478T>C,N/A,1,-,-,,Moderate,-,Centre B36 (unpublished),
802,3422,Point,NA,,,,-,UTR 3',c.*1478T>C,N/A,-,-,-,,,-,Jayandharan et al (2003),India
1148,3391,Point,NA,-822,,,-,UTR 5',c.-822A>G,,-,-,-,,,-,Rai and Winship (1996),United Kingdom
1,2,Point,NA,-55,,,-,UTR 5',c.-55G>A,N/A,<1,-,-,,Severe,-,Wulff et al (1999),Germany
1,1,Point,NA,-55,,,-,UTR 5',c.-55G>A,N/A,3,-,-,,Moderate,-,Morgan et al (1997),United Kingdom
1,3,Point,NA,-55,,,-,UTR 5',c.-55G>A,N/A,<1,-,-,,Severe,-,Heit et al (1999),United States
3,6,Point,NA,-55,,,-,UTR 5',c.-55G>T,N/A,<1,-,-,,Severe,-,Centre B13 (unpublished),
3,4,Point,NA,-55,,,-,UTR 5',c.-55G>T,N/A,0.9,-,-,,Severe,-,Belvini et al (2005),Italy
2,5,Point,NA,-55,,,-,UTR 5',c.-55G>C,N/A,<1,<1,-,,Severe,-,Crossley et al (1992),United Kingdom
4,8,Point,NA,-53,,,-,UTR 5',c.-53A>G,N/A,-,-,-,,,-,Centre B39 (unpublished),
5,9,Point,NA,-52,,,-,UTR 5',c.-52C>G,N/A,-,-,-,,,-,Centre B39 (unpublished),
6,10,Point,NA,-52,,,-,UTR 5',c.-52C>T,N/A,2,-,-,,Moderate,-,Ketterling et al (1995),United States
7,11,Point,NA,-50,,,-,UTR 5',c.-50T>G,N/A,-,-,-,,,-,Centre B13 (unpublished),
7,12,Point,NA,-50,,,-,UTR 5',c.-50T>G,N/A,-,-,-,,,-,Centre B13 (unpublished),
7,13,Point,NA,-50,,,-,UTR 5',c.-50T>G,N/A,0 to 10,0 to 10,-,,Mild,Leiden Mutation,Reijnen et al (1993),Netherlands
8,3822,Point,NA,-49,,,-,UTR 5',c.-49T>A,N/A,2.5,,,NO,Moderate,,Johnsen et al (2017),United States
8,14,Point,NA,-49,,,-,UTR 5',c.-49T>A,N/A,0 to 36,0 to 36,-,,Mild,-,Centre B23 (unpublished),
8,15,Point,NA,-49,,,-,UTR 5',c.-49T>A,N/A,3.5,-,-,,Moderate,-,Wulff et al (2001),Germany
8,16,Point,NA,-49,,,-,UTR 5',c.-49T>A,N/A,0 to 60,0 to 60,-,,Mild,Leiden Mutation,Reitsma et al (1988),Netherlands
9,20,Point,NA,-49,,,-,UTR 5',c.-49T>C,N/A,18 to 50,-,-,,Mild,-,Centre B25 (unpublished),
9,17,Point,NA,-49,,,-,UTR 5',c.-49T>C,N/A,7 to 20,-,-,,Mild,-,Ghanem et al (1993),France
9,18,Point,NA,-49,,,-,UTR 5',c.-49T>C,N/A,26,-,-,,Mild,-,Belvini et al (2005),Italy
9,3821,Point,NA,-49,,,-,UTR 5',c.-49T>C,N/A,8,,,,Mild,,Johnsen et al (2017),United States
10,22,Point,NA,-48,,,-,UTR 5',c.-48G>C,N/A,-,<25,-,,,-,Centre B25 (unpublished),
10,21,Point,NA,-48,,,-,UTR 5',c.-48G>C,N/A,3,-,-,,Moderate,Leiden Mutation,Ketterling et al (1995),United States
11,3516,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,6,-,-,NO,Mild,Leiden Mutation,Radic et al (2013),Argentina
11,43,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,20,25,I,NO,Mild,Leiden Mutation,Attali et al (1999),France
11,3823,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,1,,,NO,Moderate,,Johnsen et al (2017),United States
11,3824,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,14,,,NO,Mild,,Johnsen et al (2017),United States
11,3825,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,10,,,NO,Mild,,Johnsen et al (2017),United States
11,3826,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,14,,,NO,Mild,,Johnsen et al (2017),United States
11,3827,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,2,,,NO,Moderate,,Johnsen et al (2017),United States
11,3828,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,4,,,NO,Moderate,,Johnsen et al (2017),United States
11,3829,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,10,,,NO,Mild,,Johnsen et al (2017),United States
11,3707,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,-,-,-,NO,Mild,-,Miller et al (2012),United States
11,3830,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,27,,,NO,Mild,,Johnsen et al (2017),United States
11,49,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,-,-,-,,,-,Centre B39 (unpublished),
11,50,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,-,-,-,,,-,Centre B39 (unpublished),
11,33,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,18 to 60,-,-,,Mild,-,Centre B30 (unpublished),
11,36,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,10 to 65,-,-,,Mild,Leiden Mutation,Centre B47 (unpublished),
11,38,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,28,-,-,,Mild,-,Centre B30 (unpublished),
11,39,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,15,-,-,,Mild,-,Centre B30 (unpublished),
11,41,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,1,-,-,,Moderate,-,Centre B30 (unpublished),
11,42,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,35,35,I,,Mild,Leiden Mutation,Centre B38 (unpublished),
11,44,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,2,-,-,,Moderate,-,Centre B20 (unpublished),
11,45,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,1,-,-,,Moderate,-,Centre B21 (unpublished),
11,46,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,-,-,-,,,-,Centre B21 (unpublished),
11,47,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,-,-,-,,,-,Centre B21 (unpublished),
11,48,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,7,-,-,,Mild,-,Centre B38 (unpublished),
11,51,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,52,50,I,,Mild,-,Centre B25 (unpublished),
11,40,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,3 to 26,-,-,,Mild,Leiden Mutation,Wilton et al (1997),Canada
11,25,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,-,-,-,,,-,Poon et al (1993),Canada
11,27,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,7,4,I,,Mild,Leiden Mutation,Tartary et al (1993),France
11,26,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,1 to norm,-,-,,Mild,-,Ghanem et al (1993),France
11,32,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,-,-,-,,,-,Saad et al (1994),United Kingdom
11,31,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,30,-,-,,Mild,-,Saad et al (1994),United Kingdom
11,29,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,10 to 64,-,-,,Mild,Leiden Mutation,Morgan et al (1995),United Kingdom
11,28,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,30,-,-,,Mild,Leiden Mutation,Stowell et al (1993),United Kingdom
11,23,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,13 to 70,-,-,,Mild,Leiden Mutation,Crossley et al (1990),United Kingdom
11,35,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,2.5,-,-,,Moderate,Leiden Mutation,Coyle et al (1994),United States
11,30,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,9,8,I,,Mild,-,Bottema et al (1993),United States
11,24,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,10,13,I,,Mild,Leiden Mutation,Hirosawa et al (1990),United States
11,3763,Point,NA,-35,,,-,UTR 5',c.-35G>A,N/A,44,,,,Mild,18 cases in 10 families: mean FIX:C given (range 30-76),Jenkins et al (2008),Ireland
12,54,Point,NA,-35,,,-,UTR 5',c.-35G>C,N/A,6,-,-,,Mild,-,Centre B13 (unpublished),
12,55,Point,NA,-35,,,-,UTR 5',c.-35G>C,N/A,<1,<1,-,,Severe,-,Centre B25 (unpublished),
12,56,Point,NA,-35,,,-,UTR 5',c.-35G>C,N/A,1,-,-,,Moderate,-,Centre B25 (unpublished),
12,37,Point,NA,-35,,,-,UTR 5',c.-35G>C,N/A,0 to 25,-,-,,Mild,Leiden Mutation,Nguyen et al (1995),France
12,52,Point,NA,-35,,,-,UTR 5',c.-35G>C,N/A,1 to 30,1 to 30,-,,Mild,Leiden Mutation,Gispert et al (1989),France
12,53,Point,NA,-35,,,-,UTR 5',c.-35G>C,N/A,16,-,-,,Mild,Leiden Mutation,Ljung et al (2001),Sweden
13,57,Point,NA,-34,,,-,UTR 5',c.-34A>G,N/A,15,-,-,,Mild,-,Saad et al (1994),United Kingdom
13,58,Point,NA,-34,,,-,UTR 5',c.-34A>G,N/A,7,-,-,,Mild,-,Saad et al (1994),United Kingdom
14,59,Point,NA,-34,,,-,UTR 5',c.-34A>T,N/A,3,-,-,,Moderate,Leiden Mutation,Picketts et al (1992),Canada
14,61,Point,NA,-34,,,-,UTR 5',c.-34A>T,N/A,4.5,-,-,,Moderate,-,Belvini et al (2005),Italy
15,3447,Point,NA,-24,,,-,UTR 5',c.-24T>A,N/A,5.5,-,-,NO,Moderate,Leiden Mutation,Balraj et al (2012),Malaysia
15,3448,Point,NA,-24,,,-,UTR 5',c.-24T>A,N/A,4,-,-,NO,Moderate,Leiden Mutation,Balraj et al (2012),Malaysia
15,3831,Point,NA,-24,,,-,UTR 5',c.-24T>A,N/A,6,,,NO,Mild,,Johnsen et al (2017),United States
15,63,Point,NA,-24,,,-,UTR 5',c.-24T>A,N/A,0 to 8,-,-,,Mild,Leiden Mutation,Nielsen et al (1995),Denmark
15,62,Point,NA,-24,,,-,UTR 5',c.-24T>A,N/A,0 to 37,-,-,,Mild,Leiden Mutation,Freedenberg et al (1991),United States
16,64,Point,NA,-23,,,-,UTR 5',c.-23T>C,N/A,-,-,-,,,-,Wulff et al (2001),Germany
18,67,Point,NA,-22,,,-,UTR 5',c -22T>C,N/A,2,-,-,,Moderate,-,Centre B30 (unpublished),
18,69,Point,NA,-22,,,-,UTR 5',c -22T>C,N/A,-,-,-,,,-,Centre B13 (unpublished),
18,66,Point,NA,-22,,,-,UTR 5',c -22T>C,N/A,0 to 60,0 to 60,-,,Mild,Leiden Mutation,Royle et al (1991),New Zealand
18,68,Point,NA,-22,,,-,UTR 5',c -22T>C,N/A,1,-,-,,Moderate,-,Montejo et al (1999),Spain
18,3773,Point,NA,-22,,,-,UTR 5',c -22T>C,N/A,1.5,-,-,,Moderate,-,Montejo et al (1999),Spain
19,70,Point,NA,-21,,,-,UTR 5',c -21C>G,N/A,-,-,-,,,Leiden Mutation,Wulff et al (2001),Germany
23,71,Point,NA,-18,,,-,UTR 5',c.-18A>G,N/A,1,-,-,,Moderate,-,Centre B30 (unpublished),
1162,81,Point,NA,-17,,,-,UTR 5',c.-17A>C,,-,-,-,,,-,Wulff et al (2001),Germany
20,3833,Point,NA,-17,,,-,UTR 5',c.-17A>G,N/A,3,,,NO,Moderate,,Johnsen et al (2017),United States
20,3834,Point,NA,-17,,,-,UTR 5',c.-17A>G,N/A,34,,,NO,Mild,,Johnsen et al (2017),United States
20,3835,Point,NA,-17,,,-,UTR 5',c.-17A>G,N/A,1.2,,,NO,Moderate,,Johnsen et al (2017),United States
20,3836,Point,NA,-17,,,-,UTR 5',c.-17A>G,N/A,6.7,,,NO,Mild,,Johnsen et al (2017),United States
20,3837,Point,NA,-17,,,-,UTR 5',c.-17A>G,N/A,3,,,NO,Moderate,,Johnsen et al (2017),United States
20,73,Point,NA,-17,,,-,UTR 5',c.-17A>G,N/A,<1,-,-,,Severe,-,Centre B23 (unpublished),
20,78,Point,NA,-17,,,-,UTR 5',c.-17A>G,N/A,1.5 to 2,-,-,,Moderate,-,Centre B6 (unpublished),
20,79,Point,NA,-17,,,-,UTR 5',c.-17A>G,N/A,3 to 51,-,-,,Mild,-,Centre B30 (unpublished),
20,83,Point,NA,-17,,,-,UTR 5',c.-17A>G,N/A,6 to 35,-,-,,Mild,-,Centre B38 (unpublished),
20,84,Point,NA,-17,,,-,UTR 5',c.-17A>G,N/A,-,-,-,,,-,Centre B21 (unpublished),
20,77,Point,NA,-17,,,-,UTR 5',c.-17A>G,N/A,12 to norm,-,-,,Mild,-,Ghanem et al (1993),France
20,74,Point,NA,-17,,,-,UTR 5',c.-17A>G,N/A,0 to 60,0 to 60,-,,Mild,Leiden Mutation,Reitsma et al (1989),Netherlands
20,82,Point,NA,-17,,,-,UTR 5',c.-17A>G,N/A,<1,<1,-,,Severe,Leiden Mutation,Ljung et al (2001),Sweden
20,76,Point,NA,-17,,,-,UTR 5',c.-17A>G,N/A,3 to 35,-,-,,Mild,Leiden Mutation,Crossley et al (1989),United Kingdom
20,75,Point,NA,-17,,,-,UTR 5',c.-17A>G,N/A,32,-,-,,Mild,-,Koeberl et al (1989),United States
20,3832,Point,NA,-17,,,-,UTR 5',c.-17A>G,N/A,49,,,,Mild,,Johnsen et al (2017),United States
24,85,Point,NA,-5,,,-,UTR 5',c.-5A>G,N/A,-,105,-,,Mild,Leiden Mutation,Centre B38 (unpublished),
220006,86,Point,Missense,8,3,-44,Signal Peptide,Exon 1,c.8G>A,p.(Arg3His),<1,<1,-,,Severe,-,Ludwig et al (1992A),Germany
26,87,Point,Missense,19,7,-40,Signal Peptide,Exon 1,c.19A>T,p.(Ile7Phe),<1,<1,-,,Severe,-,Centre B8 (unpublished),
26,3428,Point,Missense,19,7,-40,Signal Peptide,Exon 1,c.19A>T,p.(Ile7Phe),<1,<1,-,,Severe,Also has p.Arg384* causative mutation,Poon et al (1993),Canada
26,89,Point,Missense,19,7,-40,Signal Peptide,Exon 1,c.19A>T,p.(Ile7Phe),-,-,-,,,-,Wulff et al (2001),Germany
26,88,Point,Missense,19,7,-40,Signal Peptide,Exon 1,c.19A>T,p.(Ile7Phe),30,-,-,,Mild,-,Montejo et al (1999),Spain
28,93,Point,Missense,50,17,-30,Signal Peptide,Exon 1,c.50T>A,p.(Ile17Asn),2,<1,I,,Moderate,-,Green et al (1993),United Kingdom
28,91,Point,Missense,50,17,-30,Signal Peptide,Exon 1,c.50T>A,p.(Ile17Asn),<1,<1,-,,Severe,-,Chen et al (1995),United States
28,92,Point,Missense,50,17,-30,Signal Peptide,Exon 1,c.50T>A,p.(Ile17Asn),1,-,-,,Moderate,-,Thorland et al (1995),United States
29,94,Point,Missense,53,18,-29,Signal Peptide,Exon 1,c.53G>T,p.(Cys18Phe),2,-,-,,Moderate,-,Centre B36 (unpublished),
33,98,Point,Nonsense,59,20,-27,Signal Peptide,Exon 1,c.59T>A,p.(Leu20*),<1,-,-,,Severe,-,Costa et al (2000),France
34,99,Point,Missense,59,20,-27,Signal Peptide,Exon 1,c.59T>C,p.(Leu20Ser),-,-,-,,Severe,-,Liu et al (2000),China
34,100,Point,Missense,59,20,-27,Signal Peptide,Exon 1,c.59T>C,p.(Leu20Ser),0,-,-,,Severe,-,Belvini et al (2005),Italy
36,103,Point,Nonsense,61,21,-26,Signal Peptide,Exon 1,c.61G>T,p.(Gly21*),<1,-,-,,Severe,-,Centre B21 (unpublished),
37,104,Point,Missense,62,21,-26,Signal Peptide,Exon 1,c.62G>T,p.(Gly21Val),40,-,-,,Mild,-,Centre B30 (unpublished),
38,105,Point,Nonsense,64,22,-25,Signal Peptide,Exon 1,c.64T>G,p.(Tyr22*),<1,<1,-,,Severe,-,"Quadros et al, (2009)",India
39,106,Point,Nonsense,66,22,-25,Signal Peptide,Exon 1,c.66T>A,p.(Tyr22*),<1,-,-,,Severe,-,Centre B25 (unpublished),
40,3839,Point,Missense,68,23,-24,Signal Peptide,Exon 1,c.68T>C,p.(Leu23Pro),<1,,,YES,Severe,,Johnsen et al (2017),United States
40,3838,Point,Missense,68,23,-24,Signal Peptide,Exon 1,c.68T>C,p.(Leu23Pro),1,,,NO,Moderate,,Johnsen et al (2017),United States
40,107,Point,Missense,68,23,-24,Signal Peptide,Exon 1,c.68T>C,p.(Leu23Pro),<1,<1,-,,Severe,-,Centre B13 (unpublished),
41,108,Point,Missense,71,24,-23,Signal Peptide,Exon 1,c.71T>C,p.(Leu24Pro),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
42,3840,Point,Missense,77,26,-21,Signal Peptide,Exon 1,c.77C>A,p.(Ala26Asp),4,,,NO,Moderate,,Johnsen et al (2017),United States
42,109,Point,Missense,77,26,-21,Signal Peptide,Exon 1,c.77C>A,p.(Ala26Asp),2,2,I,,Moderate,-,Centre B24 (unpublished),
42,3841,Point,Missense,77,26,-21,Signal Peptide,Exon 1,c.77C>A,p.(Ala26Asp),3,,,,Moderate,,Johnsen et al (2017),United States
43,3654,Point,Missense,82,28,-19,Signal Peptide,Exon 1,c.82T>C,p.(Cys28Arg),-,-,-,NO,Moderate,-,Miller et al (2012),United States
43,3842,Point,Missense,82,28,-19,Signal Peptide,Exon 1,c.82T>C,p.(Cys28Arg),3,,,NO,Moderate,,Johnsen et al (2017),United States
43,110,Point,Missense,82,28,-19,Signal Peptide,Exon 1,c.82T>C,p.(Cys28Arg),4,4,I,,Moderate,-,Wulff et al (1999),Germany
43,111,Point,Missense,82,28,-19,Signal Peptide,Exon 1,c.82T>C,p.(Cys28Arg),4,-,-,,Moderate,-,Belvini et al (2005),Italy
43,114,Point,Missense,82,28,-19,Signal Peptide,Exon 1,c.82T>C,p.(Cys28Arg),20,-,-,,Mild,-,Bottema et al (1991),United States
44,113,Point,Missense,82,28,-19,Signal Peptide,Exon 1,c.82T>G,p.(Cys28Gly),-,-,-,,Severe,-,Liu et al (2000),China
46,124,Point,Missense,83,28,-19,Signal Peptide,Exon 1,c.83G>A,p.(Cys28Tyr),<1,-,-,NO,Severe,-,Bicocchi et al (2006),Italy
46,115,Point,Missense,83,28,-19,Signal Peptide,Exon 1,c.83G>A,p.(Cys28Tyr),-,-,-,,,-,Centre B21 (unpublished),
46,117,Point,Missense,83,28,-19,Signal Peptide,Exon 1,c.83G>A,p.(Cys28Tyr),1,-,-,,Moderate,-,Centre B36 (unpublished),
46,118,Point,Missense,83,28,-19,Signal Peptide,Exon 1,c.83G>A,p.(Cys28Tyr),-,-,-,,,-,Centre B38 (unpublished),
46,119,Point,Missense,83,28,-19,Signal Peptide,Exon 1,c.83G>A,p.(Cys28Tyr),1,-,-,,Moderate,-,Centre B36 (unpublished),
46,120,Point,Missense,83,28,-19,Signal Peptide,Exon 1,c.83G>A,p.(Cys28Tyr),1,-,-,,Moderate,-,Centre B36 (unpublished),
46,123,Point,Missense,83,28,-19,Signal Peptide,Exon 1,c.83G>A,p.(Cys28Tyr),5,-,-,,Moderate,-,Centre B35 (unpublished),
46,116,Point,Missense,83,28,-19,Signal Peptide,Exon 1,c.83G>A,p.(Cys28Tyr),-,-,-,,Severe,-,Belvini et al (2005),Italy
46,121,Point,Missense,83,28,-19,Signal Peptide,Exon 1,c.83G>A,p.(Cys28Tyr),3.9,-,-,,Moderate,-,Onay et al (2003),Turkey
50,126,Point,Nonsense,84,28,-19,Signal Peptide,Exon 1,c.84T>A,p.(Cys28*),<1,-,-,,Severe,-,Elmahmoudi et al (2011),Tunisia
49,125,Point,Missense,84,28,-19,Signal Peptide,Exon 1,c.84T>G,p.(Cys28Trp),<1,<1,-,,Severe,-,Nielsen et al (1995),Denmark
51,3843,Point,Missense,86,29,-18,Pro-Peptide,Exon 1,c.86C>T,p.(Thr29Ile),16,,,NO,Mild,,Johnsen et al (2017),United States
51,127,Point,Missense,86,29,-18,Pro-Peptide,Exon 1,c.86C>T,p.(Thr29Ile),<1,-,-,,Severe,-,Centre B20 (unpublished),
52,3702,Point,Silent,87,29,-18,Pro-Peptide,Exon 1,c.87A>G,p.(Thr29Thr),-,-,-,NO,Mild,-,Miller et al (2012),United States
52,130,Point,Silent,87,29,-18,Pro-Peptide,Exon 1,c.87A>G,p.(Thr29Thr),-,-,-,,,-,Centre B30 (unpublished),
52,131,Point,Silent,87,29,-18,Pro-Peptide,Exon 1,c.87A>G,p.(Thr29Thr),10,-,-,,Mild,-,Centre B44 (unpublished),
52,132,Point,Silent,87,29,-18,Pro-Peptide,Exon 1,c.87A>G,p.(Thr29Thr),-,4,-,,,-,Centre B38 (unpublished),
52,128,Point,Silent,87,29,-18,Pro-Peptide,Exon 1,c.87A>G,p.(Thr29Thr),<1,-,-,,Severe,-,Belvini et al (2005),Italy
52,129,Point,Silent,87,29,-18,Pro-Peptide,Exon 1,c.87A>G,p.(Thr29Thr),1,-,-,,Moderate,-,Saad et al (1994),United Kingdom
961,3198,Point,Splice,88,,,-,Intron 1,c.88+5G>T,N/A,1,1,I,,Moderate,-,David et al (1998),Portugal
961,3199,Point,Splice,88,,,-,Intron 1,c.88+5G>T,N/A,<1,-,-,,Severe,-,Montejo et al (1999),Spain
961,3775,Point,Splice,88,,,-,Intron 1,c.88+5G>T,N/A,4,-,-,,Moderate,-,Montejo et al (1999),Spain
955,3180,Point,Splice,88,,,-,Intron 1,c.88+1G>A,N/A,-,-,-,,,-,Centre B39 (unpublished),
955,3179,Point,Splice,88,,,-,Intron 1,c.88+1G>A,N/A,<1,<1,-,,Severe,-,Centre B38 (unpublished),
956,3182,Point,Splice,88,,,-,Intron 1,c.88+1G>T,N/A,<1,-,-,,Severe,-,Centre B30 (unpublished),
956,3181,Point,Splice,88,,,-,Intron 1,c.88+1G>T,N/A,4,-,-,,Moderate,-,Saad et al (1994),United Kingdom
957,3184,Point,Splice,88,,,-,Intron 1,c.88+2T>C,N/A,<1,-,-,,Severe,-,Centre B38 (unpublished),
957,3183,Point,Splice,88,,,-,Intron 1,c.88+2T>C,N/A,-,-,-,,,-,Montejo et al (1999),Spain
958,3185,Point,Splice,88,,,-,Intron 1,c.88+2T>G,N/A,<1,-,-,,Severe,-,Ketterling et al (1999A),United States
959,3188,Point,Splice,88,,,-,Intron 1,c.88+5G>A,N/A,-,-,-,,,-,Centre B17 (unpublished),
959,3187,Point,Splice,88,,,-,Intron 1,c.88+5G>A,N/A,5,-,-,,Moderate,-,Meireles et al (2017),Brazil
959,3189,Point,Splice,88,,,-,Intron 1,c.88+5G>A,N/A,<1,<1,-,,Severe,-,Wulff et al (1999),Germany
959,3190,Point,Splice,88,,,-,Intron 1,c.88+5G>A,N/A,8.4,-,-,,Mild,-,Belvini et al (2005),Italy
959,3186,Point,Splice,88,,,-,Intron 1,c.88+5G>A,N/A,3,2,I,,Moderate,-,Green et al (1991),United Kingdom
960,3197,Point,Splice,88,,,-,Intron 1,c.88+5G>C,N/A,-,-,-,,Moderate,-,Jenkins et al (2008),Ireland
960,3192,Point,Splice,88,,,-,Intron 1,c.88+5G>C,N/A,<1,-,-,,Severe,-,Belvini et al (2005),Italy
960,3195,Point,Splice,88,,,-,Intron 1,c.88+5G>C,N/A,3.8,-,-,,Moderate,-,Ketterling et al (1999A),United States
1085,3553,Point,Splice,88,,,-,Intron 1,c.88+5G>C,N/A,-,-,-,NO,Moderate,-,Yu et al (2012),China
1085,3193,Point,Splice,88,,,-,Intron 1,c.88+5G>C,N/A,11,-,-,,Mild,-,Centre B30 (unpublished),
1085,3194,Point,Splice,88,,,-,Intron 1,c.88+5G>C,N/A,-,-,-,,,-,Centre B17 (unpublished),
53,3484,Point,Missense,88,30,-17,Pro-Peptide,Exon 1,c.88G>A,p.(Val30Ile),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
53,138,Point,Missense,88,30,-17,Pro-Peptide,Exon 1,c.88G>A,p.(Val30Ile),-,-,-,,,-,Centre B39 (unpublished),
53,136,Point,Missense,88,30,-17,Pro-Peptide,Exon 1,c.88G>A,p.(Val30Ile),-,-,-,,,-,Wulff et al (2001),Germany
53,139,Point,Missense,88,30,-17,Pro-Peptide,Exon 1,c.88G>A,p.(Val30Ile),-,-,-,,,-,Nawaz et al (2008),Pakistan
53,140,Point,Missense,88,30,-17,Pro-Peptide,Exon 1,c.88G>A,p.(Val30Ile),-,-,-,,,-,Nawaz et al (2008),Pakistan
53,141,Point,Missense,88,30,-17,Pro-Peptide,Exon 1,c.88G>A,p.(Val30Ile),-,-,-,,,-,Nawaz et al (2008),Pakistan
53,135,Point,Missense,88,30,-17,Pro-Peptide,Exon 1,c.88G>A,p.(Val30Ile),<1,-,-,,Severe,-,Montejo et al (1999),Spain
53,137,Point,Missense,88,30,-17,Pro-Peptide,Exon 1,c.88G>A,p.(Val30Ile),<1,-,-,,Severe,-,Vidal et al (2000),Spain
53,134,Point,Missense,88,30,-17,Pro-Peptide,Exon 1,c.88G>A,p.(Val30Ile),<1,2,II,,Severe,-,Bottema et al (1991),United States
53,3774,Point,Missense,88,30,-17,Pro-Peptide,Exon 1,c.88G>A,p.(Val30Ile),<1,-,-,,Severe,-,Montejo et al (1999),Spain
54,142,Point,Missense,88,30,-17,Pro-Peptide,Exon 1,c.88G>C,p.(Val30Leu),<1,-,-,,Severe,-,Centre B30 (unpublished),
1215,4794,Point,Splice,89,,,,Intron 1,c.89-3C>A,,22,,,NO,Mild,,Johnsen et al (2017),United States
962,3201,Point,Splice,89,,,-,Intron 1,c.89-1G>A,N/A,<1,-,-,,Severe,-,Centre B11 (unpublished),
962,3200,Point,Splice,89,,,-,Intron 1,c.89-1G>A,N/A,<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
963,3202,Point,Splice,89,,,-,Intron 1,c.89-1G>C,N/A,-,-,-,,,-,Centre B3 (unpublished),
964,4644,Point,Splice,89,,,-,Intron 1,c.89-1G>T,N/A,<1,,,NO,Severe,,Johnsen et al (2017),United States
964,3203,Point,Splice,89,,,-,Intron 1,c.89-1G>T,N/A,<1,-,-,,Severe,-,Ghanem et al (1993),France
965,3204,Point,Splice,89,,,-,Intron 1,c.89-6T>G,N/A,-,-,-,,Severe,-,Belvini et al (2005),Italy
965,143,Point,Splice,89,,,-,Intron 1,c.89-6T>G,N/A,<1,-,-,,Severe,-,Kwon et al (2008),South Korea
965,3205,Point,Splice,89,,,-,Intron 1,c.89-6T>G,N/A,-,-,-,,,-,Bottema et al (1991),United States
1059,3523,Point,Nonsense,103,35,-12,Pro-Peptide,Exon 2,c.103G>T,p.(Glu35*),<1,-,-,YES,Severe,-,Radic et al (2013),Argentina
57,145,Point,Missense,107,36,-11,Pro-Peptide,Exon 2,c.107A>C,p.(Asn36Thr),-,-,-,,,-,Centre B39 (unpublished),
58,146,Point,Missense,109,37,-10,Pro-Peptide,Exon 2,c.109G>A,p.(Ala37Thr),-,-,-,,,-,Oldenburg et al (1997),Germany
58,147,Point,Missense,109,37,-10,Pro-Peptide,Exon 2,c.109G>A,p.(Ala37Thr),-,-,-,,,-,Chu et al (1996),United States
60,149,Point,Missense,110,37,-10,Pro-Peptide,Exon 2,c.110C>A,p.(Ala37Asp),-,-,-,,Severe,-,Belvini et al (2005),Italy
59,148,Point,Missense,110,37,-10,Pro-Peptide,Exon 2,c.110C>T,p.(Ala37Val),-,-,-,,,-,Oldenburg et al (1997),Germany
59,150,Point,Missense,110,37,-10,Pro-Peptide,Exon 2,c.110C>T,p.(Ala37Val),-,-,-,,,-,Oldenburg et al (1997),Germany
62,151,Point,Missense,112,38,-9,Pro-Peptide,Exon 2,c.112A>C,p.(Asn38His),<1,<1,I,,Severe,-,"Quadros et al, (2009)",India
62,152,Point,Missense,112,38,-9,Pro-Peptide,Exon 2,c.112A>C,p.(Asn38His),<1,-,I,,Severe,-,Ghosh et al (2009),India
1165,4732,Point,Missense,122,41,-6,Pro-Peptide,Exon 2,c.122T>G,p.(Leu41Arg),30,,,NO,Mild,,Johnsen et al (2017),United States
65,3485,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
65,3556,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,NO,Moderate,-,Yu et al (2012),China
65,3555,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,NO,Severe,-,Yu et al (2012),China
65,3554,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,NO,Severe,-,Yu et al (2012),China
65,3557,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,NO,Moderate,-,Yu et al (2012),China
65,197,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),3,41,II,NO,Moderate,-,Attali et al (1999),France
65,166,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,20,II,NO,Severe,-,Bicocchi et al (2006),Italy
65,3848,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,,,NO,Severe,,Johnsen et al (2017),United States
65,3655,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,NO,Severe,-,Miller et al (2012),United States
65,3844,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),2,,,NO,Moderate,,Johnsen et al (2017),United States
65,3846,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),2,,,NO,Moderate,,Johnsen et al (2017),United States
65,3847,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),1,,,NO,Moderate,,Johnsen et al (2017),United States
65,199,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,,,-,Centre B39 (unpublished),
65,180,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,-,-,,Severe,-,Centre B39 (unpublished),
65,190,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,,,-,Centre B39 (unpublished),
65,209,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,,,-,Centre B39 (unpublished),
65,204,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,,,-,Centre B21 (unpublished),
65,193,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),1,28,II,,Moderate,-,Centre B14 (unpublished),
65,210,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),2,-,-,,Moderate,-,Centre B36 (unpublished),
65,198,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,,,-,Centre B24 (unpublished),
65,177,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,,,-,Centre B30 (unpublished),
65,181,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,,,-,Centre B17 (unpublished),
65,182,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),2,-,-,,Moderate,-,Centre B13 (unpublished),
65,192,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),1,52,II,,Moderate,-,Centre B14 (unpublished),
65,186,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),1.5,-,-,,Moderate,-,Centre B13 (unpublished),
65,188,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,37,II,,Severe,-,Centre B38 (unpublished),
65,215,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),4,36,II,,Moderate,-,Centre B27 (unpublished),
65,211,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,-,-,,Severe,-,Centre B13 (unpublished),
65,205,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,-,-,,Severe,-,Centre B9 (unpublished),
65,178,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,,,-,Meireles et al (2017),Brazil
65,202,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,,,-,Liu et al (2000),China
65,195,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,-,-,,Severe,-,Costa et al (2000),France
65,167,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,28,II,,Severe,-,Ghanem et al (1993),France
65,175,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,-,-,,Severe,-,Ghanem et al (1993),France
65,179,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,,,-,Costa et al (2000),France
65,189,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,-,-,,Severe,-,Costa et al (2000),France
65,194,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,38,II,,Severe,-,Costa et al (2000),France
65,200,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,,,-,Wulff et al (2001),Germany
65,207,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,,,-,Wulff et al (2001),Germany
65,208,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,,,-,Wulff et al (2001),Germany
65,156,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,-,-,,Severe,-,Knobloch et al (1993),Germany
65,157,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,40,II,,Severe,-,Knobloch et al (1993),Germany
65,169,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),1.5,-,-,,Moderate,-,Knobloch et al (1993),Germany
65,170,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,-,-,,Severe,-,Ivaskevicius et al (2001),Germany
65,173,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,-,-,,Severe,-,Ivaskevicius et al (2001),Germany
65,174,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),1,-,-,,Moderate,-,Knobloch et al (1993),Germany
65,203,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,-,-,,Severe,-,Mahajan et al (2004),India
65,212,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),1.3,-,-,,Moderate,-,Mukherjee et al (2004),India
65,185,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),1,-,-,,Moderate,-,Belvini et al (2005),Italy
65,172,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,,,-,Nawaz et al (2008),Pakistan
65,171,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,,,-,Nawaz et al (2008),Pakistan
65,196,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),6,-,-,,Mild,-,Montejo et al (1999),Spain
65,191,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,-,-,,Severe,-,Montejo et al (1999),Spain
65,184,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,,,-,Ljung et al (2001),Sweden
65,165,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),2,-,-,,Moderate,-,Ljung et al (2001),Sweden
65,213,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),3.2,-,-,,Moderate,-,Elmahmoudi et al (2011),Tunisia
65,164,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),4,-,-,,Moderate,-,Saad et al (1994),United Kingdom
65,163,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
65,162,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),2,-,-,,Moderate,-,Saad et al (1994),United Kingdom
65,161,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),1,30,II,,Moderate,-,Green et al (1990),United Kingdom
65,160,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),2,27,II,,Moderate,-,Green et al (1990),United Kingdom
65,159,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),2 to 3,36,-,,Moderate,-,Green et al (1990),United Kingdom
65,158,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,26 to 34,II,,Severe,-,Green et al (1989),United Kingdom
65,168,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),4,9,II,,Moderate,-,Bottema et al (1991),United States
65,187,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),-,-,-,,,-,Heit et al (1998),United States
65,183,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),1,37,II,,Moderate,-,Weinmann et al (1998),United States
65,176,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),3,20,II,,Moderate,-,Gostout et al (1993),United States
65,3845,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,,,,Severe,,Johnsen et al (2017),United States
65,201,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,-,-,,Severe,-,Ketterling et al (1999B),United States
65,3750,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),4,,,,Moderate,,Green et al (1992),United Kingdom
65,3751,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),2,,,,Moderate,,Green et al (1992),United Kingdom
65,3752,Point,Missense,127,43,-4,Pro-Peptide,Exon 2,c.127C>T,p.(Arg43Trp),<1,,,,Severe,,Green et al (1992),United Kingdom
68,3486,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
68,3558,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,NO,Severe,-,Yu et al (2012),China
68,3562,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,NO,Mild,-,Yu et al (2012),China
68,3561,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,NO,Mild,-,Yu et al (2012),China
68,3560,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,NO,Moderate,-,Yu et al (2012),China
68,3559,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,NO,Severe,-,Yu et al (2012),China
68,271,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,44,II,NO,Severe,-,Attali et al (1999),France
68,227,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,15 to 53,II,NO,Severe,-,Bicocchi et al (2006),Italy
68,3445,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,NO,Severe,-,Balraj et al (2012),Malaysia
68,3849,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
68,3862,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
68,3861,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
68,3860,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),1,,,NO,Moderate,,Johnsen et al (2017),United States
68,3656,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,NO,Severe,-,Miller et al (2012),United States
68,3859,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
68,3865,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
68,3853,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
68,3856,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
68,3855,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
68,3854,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
68,3858,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
68,3851,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
68,3863,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
68,3864,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),1,,,NO,Moderate,,Johnsen et al (2017),United States
68,278,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,,,-,Centre B39 (unpublished),
68,238,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,49,II,,Severe,-,Centre B41 (unpublished),
68,283,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Centre B25 (unpublished),
68,281,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,12,II,,Severe,-,Centre B38 (unpublished),
68,277,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),2,-,-,,Moderate,-,Centre B20 (unpublished),
68,246,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Centre B6 (unpublished),
68,229,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,,,-,Centre B12 (unpublished),
68,270,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Centre B13 (unpublished),
68,253,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,,,-,Centre B30 (unpublished),
68,255,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,55,II,,Severe,-,Centre B30 (unpublished),
68,257,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),4,-,-,,Moderate,-,Centre B30 (unpublished),
68,258,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Centre B30 (unpublished),
68,259,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,40 to 57,II,,Severe,-,Centre B30 (unpublished),
68,263,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),1,-,-,,Moderate,-,Centre B13 (unpublished),
68,266,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,37,II,,Severe,-,Centre B38 (unpublished),
68,280,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),1,-,-,,Moderate,-,Centre B36 (unpublished),
68,286,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Centre B5 (unpublished),
68,284,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,,,-,Centre B20 (unpublished),
68,256,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),3,-,-,,Moderate,-,Meireles et al (2017),Brazil
68,239,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),2,15,II,,Moderate,-,Poon et al (1993),Canada
68,274,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,,,-,Liu et al (2000),China
68,276,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,,,-,Liu et al (2000),China
68,273,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,,,-,Liu et al (2000),China
68,221,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),1,82,II,,Moderate,Patient tested at Hong Kong,Chan et al (1991),China
68,220,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),4,93,II,,Moderate,Patient tested at Hong Kong,Chan et al (1991),China
68,275,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,,,-,Liu et al (2000),China
68,247,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),18,-,-,,Mild,-,Tartary et al (1993),France
68,224,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,40,II,,Severe,-,de la Salle et al (1993B),France
68,245,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Ghanem et al (1993),France
68,264,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Costa et al (2000),France
68,260,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,52,II,,Severe,-,Wulff et al (2001),Germany
68,261,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,48,II,,Severe,-,Wulff et al (1999),Germany
68,268,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,52,II,,Severe,-,Wulff et al (1999),Germany
68,304,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Wulff et al (2001),Germany
68,223,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Knobloch et al (1993),Germany
68,219,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Knobloch et al (1993),Germany
68,234,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Jayandharan et al (2005),India
68,216,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Belvini et al (2005),Italy
68,222,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,46,II,,Severe,-,Sugimoto et al (1989),Japan
68,290,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Awidi et al (2011),Jordan
68,231,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),2,-,-,,Moderate,-,Van de Water et al (1996),New Zealand
68,269,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),3,-,-,,Moderate,-,Montejo et al (1999),Spain
68,267,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Montejo et al (1999),Spain
68,240,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,55,II,,Severe,-,Lin and Shen (1993),Taiwan
68,230,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,38,II,,Severe,-,Lin et al (1991),Taiwan
68,291,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Elmahmoudi et al (2011),Tunisia
68,289,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),2,-,-,,Moderate,-,Onay et al (2003),Turkey
68,244,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),2,-,-,,Moderate,-,Saad et al (1994),United Kingdom
68,243,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,,,-,Saad et al (1994),United Kingdom
68,287,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Enayat et al (2004),United Kingdom
68,288,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),1.8,-,-,,Moderate,-,Enayat et al (2004),United Kingdom
68,292,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,89,II,,Severe,-,Bentley et al (1986),United Kingdom
68,242,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
68,228,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),1,45,II,,Moderate,-,Green et al (1989),United Kingdom
68,226,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),1,48,II,,Moderate,-,Green et al (1989),United Kingdom
68,225,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),4,80,II,,Moderate,-,Liddell et al (1989),United Kingdom
68,241,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,,,-,Saad et al (1994),United Kingdom
68,252,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
68,237,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,37,II,,Severe,-,Bottema et al (1991),United States
68,236,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,41,II,,Severe,-,Thompson et al (1992A),United States
68,235,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,65,II,,Severe,-,Thompson et al (1992A),United States
68,232,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),2,40,II,,Moderate,-,Thompson et al (1992A),United States
68,233,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,,,-,Thompson et al (1992A),United States
68,217,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,98,II,,Severe,-,Ware et al (1989),United States
68,251,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),2.6,49,II,,Moderate,-,Gostout et al (1993),United States
68,3857,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),2,,,,Moderate,,Johnsen et al (2017),United States
68,272,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Bottema et al (1990A),United States
68,250,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),-,-,-,,Severe,-,Bottema et al (1993),United States
68,249,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),1,26,II,,Moderate,-,Gostout et al (1993),United States
68,248,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),3,38,II,,Moderate,-,Bottema et al (1993),United States
68,3850,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,,,,Severe,,Johnsen et al (2017),United States
68,265,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,-,-,,Severe,-,Heit et al (1998),United States
68,3852,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),<1,,,,Severe,,Johnsen et al (2017),United States
68,254,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>A,p.(Arg43Gln),2,-,-,,Moderate,-,Thorland et al (1995),United States
69,3866,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>T,p.(Arg43Leu),<1,,,YES,Severe,,Johnsen et al (2017),United States
69,307,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>T,p.(Arg43Leu),-,-,-,,,-,Centre B39 (unpublished),
69,308,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>T,p.(Arg43Leu),-,-,-,,,-,Centre B20 (unpublished),
69,301,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>T,p.(Arg43Leu),3,-,-,,Moderate,-,Meireles et al (2017),Brazil
69,297,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>T,p.(Arg43Leu),2,52,II,,Moderate,-,Ghanem et al (1993),France
69,298,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>T,p.(Arg43Leu),3,-,-,,Moderate,-,Ghanem et al (1993),France
69,293,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>T,p.(Arg43Leu),<1,-,-,,Severe,-,Knobloch et al (1993),Germany
69,294,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>T,p.(Arg43Leu),<1,45,II,,Severe,-,Knobloch et al (1993),Germany
69,295,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>T,p.(Arg43Leu),<1,49,II,,Severe,-,Knobloch et al (1993),Germany
69,299,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>T,p.(Arg43Leu),<1,-,-,,Severe,-,Wulff et al (1995),Germany
69,300,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>T,p.(Arg43Leu),<1,-,-,,Severe,-,Wulff et al (1995),Germany
69,305,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>T,p.(Arg43Leu),-,-,-,,,-,Wulff et al (2001),Germany
69,306,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>T,p.(Arg43Leu),-,-,-,,,-,Wulff et al (2001),Germany
69,302,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>T,p.(Arg43Leu),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
69,303,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>T,p.(Arg43Leu),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
69,296,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>T,p.(Arg43Leu),<1,27,II,,Severe,-,Koeberl et al (1990B),United States
69,3795,Point,Missense,128,43,-4,Pro-Peptide,Exon 2,c.128G>T,p.(Arg43Leu),1,-,-,,Moderate,-,Onay et al (2003),Turkey
1166,4733,Point,Missense,133,45,-2,Pro-Peptide,Exon 2,c.133A>G,p.(Lys45Glu),4.3,,,NO,Moderate,,Johnsen et al (2017),United States
71,310,Point,Missense,135,45,-2,Pro-Peptide,Exon 2,c.135G>C,p.(Lys45Asn),<1,-,-,,Severe,-,Belvini et al (2005),Italy
72,311,Point,Missense,135,45,-2,Pro-Peptide,Exon 2,c.135G>T,p.(Lys45Asn),<1,37,II,,Severe,-,Thompson et al (1992A),United States
73,312,Point,Missense,137,46,-1,Pro-Peptide,Exon 2,c.137G>A,p.(Arg46Lys),-,-,-,,,-,Centre B39 (unpublished),
73,313,Point,Missense,137,46,-1,Pro-Peptide,Exon 2,c.137G>A,p.(Arg46Lys),-,-,-,,,-,Centre B39 (unpublished),
73,314,Point,Missense,137,46,-1,Pro-Peptide,Exon 2,c.137G>A,p.(Arg46Lys),-,-,-,,,-,Centre B39 (unpublished),
73,3867,Point,Missense,137,46,-1,Pro-Peptide,Exon 2,c.137G>A,p.(Arg46Lys),2,,,,Moderate,,Johnsen et al (2017),United States
1167,4734,Point,Missense,137,46,-1,Pro-Peptide,Exon 2,c.137G>T,p.(Arg46Met),<1,,,NO,Severe,,Johnsen et al (2017),United States
74,316,Point,Missense,137,46,-1,Pro-Peptide,Exon 2,c.137G>C,p.(Arg46Thr),<1,-,-,,Severe,-,Centre B13 (unpublished),
74,315,Point,Missense,137,46,-1,Pro-Peptide,Exon 2,c.137G>C,p.(Arg46Thr),<1,-,-,,Severe,-,Heit et al (1998),United States
75,3868,Point,Missense,138,46,-1,Pro-Peptide,Exon 2,c.138G>T,p.(Arg46Ser),<1,,,NO,Severe,,Johnsen et al (2017),United States
75,317,Point,Missense,138,46,-1,Pro-Peptide,Exon 2,c.138G>T,p.(Arg46Ser),2,65,II,,Moderate,-,Wulff et al (1999),Germany
76,318,Point,Missense,138,46,-1,Pro-Peptide,Exon 2,c.138G>C,p.(Arg46Ser),<1,80,II,,Severe,actually c.138G>Y as case only sequenced at protein level,Diuguid et al (1986),United States
77,3869,Point,Missense,142,48,2,Gla,Exon 2,c.142A>G,p.(Asn48Asp),5,,,NO,Moderate,,Johnsen et al (2017),United States
77,3870,Point,Missense,142,48,2,Gla,Exon 2,c.142A>G,p.(Asn48Asp),4.7,,,NO,Moderate,,Johnsen et al (2017),United States
77,3871,Point,Missense,142,48,2,Gla,Exon 2,c.142A>G,p.(Asn48Asp),5,,,NO,Moderate,,Johnsen et al (2017),United States
77,3872,Point,Missense,142,48,2,Gla,Exon 2,c.142A>G,p.(Asn48Asp),4,,,NO,Moderate,,Johnsen et al (2017),United States
77,3873,Point,Missense,142,48,2,Gla,Exon 2,c.142A>G,p.(Asn48Asp),<1,,,NO,Severe,,Johnsen et al (2017),United States
77,3874,Point,Missense,142,48,2,Gla,Exon 2,c.142A>G,p.(Asn48Asp),<1,,,NO,Severe,,Johnsen et al (2017),United States
77,3875,Point,Missense,142,48,2,Gla,Exon 2,c.142A>G,p.(Asn48Asp),3,,,NO,Moderate,,Johnsen et al (2017),United States
77,319,Point,Missense,142,48,2,Gla,Exon 2,c.142A>G,p.(Asn48Asp),6,-,-,,Mild,-,Koeberl et al (1990B),United States
77,3876,Point,Missense,142,48,2,Gla,Exon 2,c.142A>G,p.(Asn48Asp),3,,,,Moderate,,Johnsen et al (2017),United States
78,320,Point,Missense,142,48,2,Gla,Exon 2,c.142A>T,p.(Asn48Tyr),4,60,II,,Moderate,-,Costa et al (2000),France
80,322,Point,Missense,143,48,2,Gla,Exon 2,c.143A>T,p.(Asn48Ile),1,60,II,,Moderate,-,Poon et al (1993),Canada
81,323,Point,Missense,145,49,3,Gla,Exon 2,c.145T>C,p.(Ser49Pro),5,44,II,,Moderate,-,Montejo et al (1999),Spain
81,3776,Point,Missense,145,49,3,Gla,Exon 2,c.145T>C,p.(Ser49Pro),4,41,II,,Moderate,-,Montejo et al (1999),Spain
82,324,Point,Nonsense,146,49,3,Gla,Exon 2,c.146C>G,p.(Ser49*),<1,-,-,YES,Severe,-,Centre B9 (unpublished),
84,327,Point,Missense,148,50,4,Gla,Exon 2,c.148G>A,p.(Gly50Ser),20,-,-,,Mild,-,Centre B30 (unpublished),
84,328,Point,Missense,148,50,4,Gla,Exon 2,c.148G>A,p.(Gly50Ser),17,-,-,,Mild,-,Centre B30 (unpublished),
84,329,Point,Missense,148,50,4,Gla,Exon 2,c.148G>A,p.(Gly50Ser),11,-,-,,Mild,-,Centre B30 (unpublished),
84,330,Point,Missense,148,50,4,Gla,Exon 2,c.148G>A,p.(Gly50Ser),-,-,-,,,-,Centre B20 (unpublished),
84,331,Point,Missense,148,50,4,Gla,Exon 2,c.148G>A,p.(Gly50Ser),23,-,-,,Mild,-,Van de Water et al (1996),New Zealand
84,326,Point,Missense,148,50,4,Gla,Exon 2,c.148G>A,p.(Gly50Ser),20,-,-,,Mild,-,Saad et al (1994),United Kingdom
1116,3877,Point,Missense,149,50,4,Gla,Exon 2,c.149G>A,p.(Gly50Asp),17,,,NO,Mild,,Johnsen et al (2017),United States
1116,332,Point,Missense,149,50,4,Gla,Exon 2,c.149G>A,p.(Gly50Asp),-,-,-,,,-,Centre B19 (unpublished),
85,333,Point,Missense,151,51,5,Gla,Exon 2,c.151A>G,p.(Lys51Glu),4,121,II,,Moderate,-,Centre B30 (unpublished),
1136,334,Point,Silent,153,51,5,Gla,Exon 2,c.153A>G,p.(Lys51Lys),7,-,-,,Mild,-,Koeberl et al (1990B),United States
87,338,Point,Missense,155,52,6,Gla,Exon 2,c.155T>C,p.(Leu52Ser),-,-,-,,,-,Centre B39 (unpublished),
87,336,Point,Missense,155,52,6,Gla,Exon 2,c.155T>C,p.(Leu52Ser),<1,-,-,,Severe,-,Belvini et al (2005),Italy
87,3796,Point,Missense,155,52,6,Gla,Exon 2,c.155T>C,p.(Leu52Ser),2,-,-,,Moderate,-,Onay et al (2003),Turkey
1168,4735,Point,Missense,157,53,7,Gla,Exon 2,c.157G>C,p.(Glu53Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
88,3878,Point,Missense,157,53,7,Gla,Exon 2,c.157G>A,p.(Glu53Lys),<1,,,NO,Severe,,Johnsen et al (2017),United States
88,339,Point,Missense,157,53,7,Gla,Exon 2,c.157G>A,p.(Glu53Lys),<1,-,-,,Severe,-,Costa et al (2000),France
89,340,Point,Missense,158,53,7,Gla,Exon 2,c.158A>C,p.(Glu53Ala),5,5,I,,Moderate,-,Winship and Dragon (1991),United Kingdom
90,341,Point,Missense,158,53,7,Gla,Exon 2,c.158A>G,p.(Glu53Gly),2,-,-,,Moderate,-,Belvini et al (2005),Italy
91,342,Point,Missense,158,53,7,Gla,Exon 2,c.158A>T,p.(Glu53Val),<1,-,-,,Severe,-,Centre B30 (unpublished),
91,343,Point,Missense,158,53,7,Gla,Exon 2,c.158A>T,p.(Glu53Val),<1,-,-,,Severe,-,Wulff et al (1999),Germany
1050,3641,Point,Missense,160,54,8,Gla,Exon 2,c.160G>C,p.(Glu54Gln),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
92,344,Point,Missense,160,54,8,Gla,Exon 2,c.160G>A,p.(Glu54Lys),2,-,-,,Moderate,-,Centre B13 (unpublished),
93,345,Point,Missense,161,54,8,Gla,Exon 2,c.161A>C,p.(Glu54Ala),4,-,-,,Moderate,-,Saad et al (1994),United Kingdom
94,346,Point,Missense,161,54,8,Gla,Exon 2,c.161A>G,p.(Glu54Gly),2,45,II,,Moderate,-,Bottema et al (1991),United States
95,3563,Point,Missense,162,54,8,Gla,Exon 2,c.162G>C,p.(Glu54Asp),-,-,-,NO,Severe,-,Yu et al (2012),China
95,348,Point,Missense,162,54,8,Gla,Exon 2,c.162G>C,p.(Glu54Asp),<1,100,II,,Severe,-,Wulff et al (1999),Germany
95,347,Point,Missense,162,54,8,Gla,Exon 2,c.162G>C,p.(Glu54Asp),<1,-,-,,Severe,-,Jayandharan et al (2005),India
95,3815,Point,Missense,162,54,8,Gla,Exon 2,c.162G>C,p.(Glu54Asp),,,,,,,Wulff et al (2001),Germany
96,354,Point,Missense,163,55,9,Gla,Exon 2,c.163T>A,p.(Phe55Ile),21,-,-,NO,Mild,-,Attali et al (1999),France
96,361,Point,Missense,163,55,9,Gla,Exon 2,c.163T>A,p.(Phe55Ile),15,68,II,NO,Mild,-,Bicocchi et al (2006),Italy
96,356,Point,Missense,163,55,9,Gla,Exon 2,c.163T>A,p.(Phe55Ile),-,-,-,,,-,Centre B39 (unpublished),
96,350,Point,Missense,163,55,9,Gla,Exon 2,c.163T>A,p.(Phe55Ile),13,-,-,,Mild,-,Centre B30 (unpublished),
96,351,Point,Missense,163,55,9,Gla,Exon 2,c.163T>A,p.(Phe55Ile),25,-,-,,Mild,-,Centre B30 (unpublished),
96,353,Point,Missense,163,55,9,Gla,Exon 2,c.163T>A,p.(Phe55Ile),5,-,-,,Moderate,-,Centre B13 (unpublished),
96,358,Point,Missense,163,55,9,Gla,Exon 2,c.163T>A,p.(Phe55Ile),20,-,-,,Mild,-,Centre B36 (unpublished),
96,359,Point,Missense,163,55,9,Gla,Exon 2,c.163T>A,p.(Phe55Ile),8,-,-,,Mild,-,Centre B13 (unpublished),
96,360,Point,Missense,163,55,9,Gla,Exon 2,c.163T>A,p.(Phe55Ile),8,-,-,,Mild,-,Centre B13 (unpublished),
96,363,Point,Missense,163,55,9,Gla,Exon 2,c.163T>A,p.(Phe55Ile),4,82,II,,Moderate,-,Centre B20 (unpublished),
96,352,Point,Missense,163,55,9,Gla,Exon 2,c.163T>A,p.(Phe55Ile),12,-,-,,Mild,-,Costa et al (2000),France
96,362,Point,Missense,163,55,9,Gla,Exon 2,c.163T>A,p.(Phe55Ile),10,-,-,,Mild,-,Belvini et al (2005),Italy
96,349,Point,Missense,163,55,9,Gla,Exon 2,c.163T>A,p.(Phe55Ile),14,118,II,,Mild,-,Saad et al (1994),United Kingdom
98,366,Point,Missense,164,55,9,Gla,Exon 2,c.164T>G,p.(Phe55Cys),10,-,-,,Mild,-,Meireles et al (2017),Brazil
98,365,Point,Missense,164,55,9,Gla,Exon 2,c.164T>G,p.(Phe55Cys),<1,-,-,,Severe,-,Montejo et al (1999),Spain
97,3879,Point,Missense,164,55,9,Gla,Exon 2,c.164T>C,p.(Phe55Ser),2.6,,,NO,Moderate,,Johnsen et al (2017),United States
97,364,Point,Missense,164,55,9,Gla,Exon 2,c.164T>C,p.(Phe55Ser),<1,-,-,,Severe,-,Ketterling et al (1999B),United States
100,4549,Point,Nonsense,169,57,11,Gla,Exon 2,c.169C>T,p.(Gln57*),<1,,,NO,Severe,,Johnsen et al (2017),United States
100,368,Point,Nonsense,169,57,11,Gla,Exon 2,c.169C>T,p.(Gln57*),-,-,-,,,-,Saad et al (1994),
100,369,Point,Nonsense,169,57,11,Gla,Exon 2,c.169C>T,p.(Gln57*),<1,0.2,-,,Severe,-,Winship and Dragon (1991),United Kingdom
99,367,Point,Missense,169,57,11,Gla,Exon 2,c.169C>G,p.(Gln57Glu),-,-,-,,,-,Centre B39 (unpublished),
101,3880,Point,Missense,172,58,12,Gla,Exon 2,c.172G>A,p.(Gly58Arg),1.73,,,NO,Moderate,,Johnsen et al (2017),United States
101,370,Point,Missense,172,58,12,Gla,Exon 2,c.172G>A,p.(Gly58Arg),<1,48,II,,Severe,-,Centre B41 (unpublished),
101,371,Point,Missense,172,58,12,Gla,Exon 2,c.172G>A,p.(Gly58Arg),13,44,II,,Mild,-,Gostout et al (1993),United States
1037,3377,Point,Missense,172,58,12,Gla,Exon 2,c.172G>C,p.(Gly58Arg),<1,-,I,,Severe,-,Kwon et al (2008),South Korea
103,3883,Point,Missense,173,58,12,Gla,Exon 2,c.173G>C,p.(Gly58Ala),2,,,NO,Moderate,,Johnsen et al (2017),United States
103,379,Point,Missense,173,58,12,Gla,Exon 2,c.173G>C,p.(Gly58Ala),3,97,II,,Moderate,Patient tested at Hong Kong,Chan et al (1991),China
103,378,Point,Missense,173,58,12,Gla,Exon 2,c.173G>C,p.(Gly58Ala),2,-,-,,Moderate,-,Belvini et al (2005),Italy
102,375,Point,Missense,173,58,12,Gla,Exon 2,c.173G>A,p.(Gly58Glu),1,104,II,NO,Moderate,-,Attali et al (1999),France
102,3881,Point,Missense,173,58,12,Gla,Exon 2,c.173G>A,p.(Gly58Glu),<1,,,NO,Severe,,Johnsen et al (2017),United States
102,3882,Point,Missense,173,58,12,Gla,Exon 2,c.173G>A,p.(Gly58Glu),2,,,NO,Moderate,,Johnsen et al (2017),United States
102,374,Point,Missense,173,58,12,Gla,Exon 2,c.173G>A,p.(Gly58Glu),-,-,-,,,-,Centre B30 (unpublished),
102,373,Point,Missense,173,58,12,Gla,Exon 2,c.173G>A,p.(Gly58Glu),25,-,-,,Mild,-,Costa et al (2000),France
102,377,Point,Missense,173,58,12,Gla,Exon 2,c.173G>A,p.(Gly58Glu),-,-,-,,Mild,-,Belvini et al (2005),Italy
102,372,Point,Missense,173,58,12,Gla,Exon 2,c.173G>A,p.(Gly58Glu),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
104,381,Point,Missense,173,58,12,Gla,Exon 2,c.173G>T,p.(Gly58Val),<1,-,-,,Severe,-,Jayandharan et al (2005),India
1095,3657,Point,Missense,178,60,14,Gla,Exon 2,c.178C>T,p.(Leu60Phe),-,-,-,NO,Mild,-,Miller et al (2012),United States
106,383,Point,Missense,179,60,14,Gla,Exon 2,c.179T>C,p.(Leu60Pro),6,-,-,,Mild,-,Centre B10 (unpublished),
107,384,Point,Nonsense,184,62,16,Gla,Exon 2,c.184A>T,p.(Arg62*),<1,-,-,,Severe,-,Niceta et al (2006),Italy
109,389,Point,Missense,187,63,17,Gla,Exon 2,c.187G>C,p.(Glu63Gln),-,-,-,,,-,Centre B19 (unpublished),
108,387,Point,Missense,187,63,17,Gla,Exon 2,c.187G>A,p.(Glu63Lys),-,-,-,,,-,Centre B2 (unpublished),
108,388,Point,Missense,187,63,17,Gla,Exon 2,c.187G>A,p.(Glu63Lys),1,32,II,,Moderate,-,Centre B14 (unpublished),
108,385,Point,Missense,187,63,17,Gla,Exon 2,c.187G>A,p.(Glu63Lys),<1,-,-,,Severe,-,Ghanem et al (1993),France
108,386,Point,Missense,187,63,17,Gla,Exon 2,c.187G>A,p.(Glu63Lys),1,58,II,,Moderate,-,Tartary et al (1993),France
110,390,Point,Missense,188,63,17,Gla,Exon 2,c.188A>C,p.(Glu63Ala),-,-,-,,,-,Centre B8 (unpublished),
111,3564,Point,Missense,188,63,17,Gla,Exon 2,c.188A>G,p.(Glu63Gly),-,-,-,NO,Severe,-,Yu et al (2012),China
111,391,Point,Missense,188,63,17,Gla,Exon 2,c.188A>G,p.(Glu63Gly),<1,-,-,,Severe,-,Centre B24 (unpublished),
112,392,Point,Missense,188,63,17,Gla,Exon 2,c.188A>T,p.(Glu63Val),<1,-,-,,Severe,-,Jayandharan et al (2005),India
1169,4736,Point,Missense,189,63,17,Gla,Exon 2,c.189A>C,p.(Glu63Asp),<1,,,NO,Severe,,Johnsen et al (2017),United States
113,399,Point,Missense,190,64,18,Gla,Exon 2,c.190T>C,p.(Cys64Arg),-,-,-,,,-,Centre B39 (unpublished),
113,393,Point,Missense,190,64,18,Gla,Exon 2,c.190T>C,p.(Cys64Arg),<1,100,II,,Severe,-,Centre B27 (unpublished),
113,395,Point,Missense,190,64,18,Gla,Exon 2,c.190T>C,p.(Cys64Arg),-,-,-,,,-,Centre B21 (unpublished),
113,396,Point,Missense,190,64,18,Gla,Exon 2,c.190T>C,p.(Cys64Arg),<1,-,-,,Severe,-,Centre B9 (unpublished),
113,397,Point,Missense,190,64,18,Gla,Exon 2,c.190T>C,p.(Cys64Arg),<1,-,-,,Severe,-,Centre B21 (unpublished),
113,398,Point,Missense,190,64,18,Gla,Exon 2,c.190T>C,p.(Cys64Arg),1,-,-,,Moderate,-,Centre B21 (unpublished),
113,394,Point,Missense,190,64,18,Gla,Exon 2,c.190T>C,p.(Cys64Arg),2,-,-,,Moderate,-,Wulff et al (2001),Germany
113,401,Point,Missense,190,64,18,Gla,Exon 2,c.190T>C,p.(Cys64Arg),<1,-,-,,Severe,-,Ludwig et al (1992A),Germany
113,400,Point,Missense,190,64,18,Gla,Exon 2,c.190T>C,p.(Cys64Arg),<1,-,-,,Severe,-,Enayat et al (2004),United Kingdom
1170,4737,Point,Missense,191,64,18,Gla,Exon 2,c.191G>T,p.(Cys64Phe),<1,,,NO,Severe,,Johnsen et al (2017),United States
114,402,Point,Missense,191,64,18,Gla,Exon 2,c.191G>A,p.(Cys64Tyr),3,27,II,,Moderate,-,Tartary et al (1993),France
114,404,Point,Missense,191,64,18,Gla,Exon 2,c.191G>A,p.(Cys64Tyr),<1,-,-,,Severe,-,Mahajan et al (2004),India
114,403,Point,Missense,191,64,18,Gla,Exon 2,c.191G>A,p.(Cys64Tyr),<1,-,-,,Severe,-,Bottema et al (1991),United States
1117,3884,Point,Missense,196,66,20,Gla,Exon 2,c.196G>A,p.(Glu66Lys),30,,,NO,Mild,,Johnsen et al (2017),United States
1117,405,Point,Missense,196,66,20,Gla,Exon 2,c.196G>A,p.(Glu66Lys),30,-,-,,Mild,-,Centre B25 (unpublished),
115,406,Point,Missense,197,66,20,Gla,Exon 2,c.197A>T,p.(Glu66Val),-,-,-,,Moderate,-,Wulff et al (1995),Germany
116,3885,Point,Missense,199,67,21,Gla,Exon 2,c.199G>A,p.(Glu67Lys),<1,,,NO,Severe,,Johnsen et al (2017),United States
116,408,Point,Missense,199,67,21,Gla,Exon 2,c.199G>A,p.(Glu67Lys),<1,52,II,,Severe,-,Hamaguchi et al (1991),Japan
116,407,Point,Missense,199,67,21,Gla,Exon 2,c.199G>A,p.(Glu67Lys),1,-,-,,Moderate,-,Sommer et al (1995),United States
119,414,Point,Missense,205,69,23,Gla,Exon 2,c.205T>C,p.(Cys69Arg),<1,20,II,NO,Severe,-,Bicocchi et al (2006),Italy
119,413,Point,Missense,205,69,23,Gla,Exon 2,c.205T>C,p.(Cys69Arg),-,-,-,,,-,Centre B39 (unpublished),
119,412,Point,Missense,205,69,23,Gla,Exon 2,c.205T>C,p.(Cys69Arg),<1,-,-,,Severe,-,Wulff et al (2001),Germany
119,3378,Point,Missense,205,69,23,Gla,Exon 2,c.205T>C,p.(Cys69Arg),-,-,-,,Severe,-,Belvini et al (2005),Italy
119,411,Point,Missense,205,69,23,Gla,Exon 2,c.205T>C,p.(Cys69Arg),<1,35,II,,Severe,-,Lin et al (1991),Taiwan
1040,3565,Point,Missense,205,69,23,Gla,Exon 2,c.205T>G,p.(Cys69Gly),-,-,-,NO,Severe,-,Yu et al (2012),China
1040,3432,Point,Missense,205,69,23,Gla,Exon 2,c.205T>G,p.(Cys69Gly),<1,-,-,,Severe,-,Jayandharan et al (2009),India
120,3566,Point,Missense,206,69,23,Gla,Exon 2,c.206G>A,p.(Cys69Tyr),-,-,-,NO,Severe,-,Yu et al (2012),China
120,3636,Point,Missense,206,69,23,Gla,Exon 2,c.206G>A,p.(Cys69Tyr),-,-,-,NO,Severe,-,Yu et al (2012),China
120,3637,Point,Missense,206,69,23,Gla,Exon 2,c.206G>A,p.(Cys69Tyr),-,-,-,NO,Severe,-,Yu et al (2012),China
120,418,Point,Missense,206,69,23,Gla,Exon 2,c.206G>A,p.(Cys69Tyr),-,-,-,,,-,Centre B39 (unpublished),
120,419,Point,Missense,206,69,23,Gla,Exon 2,c.206G>A,p.(Cys69Tyr),<1,-,-,,Severe,-,Centre B39 (unpublished),
120,416,Point,Missense,206,69,23,Gla,Exon 2,c.206G>A,p.(Cys69Tyr),<1,45,II,,Severe,-,Centre B20 (unpublished),
120,417,Point,Missense,206,69,23,Gla,Exon 2,c.206G>A,p.(Cys69Tyr),-,-,-,,,-,Centre B17 (unpublished),
120,420,Point,Missense,206,69,23,Gla,Exon 2,c.206G>A,p.(Cys69Tyr),-,-,-,,Severe,-,Jenkins et al (2008),Ireland
120,415,Point,Missense,206,69,23,Gla,Exon 2,c.206G>A,p.(Cys69Tyr),<1,19,II,,Severe,-,Winship & Dragon (1991),United Kingdom
1206,4783,Point,Nonsense,207,69,23,Gla,Exon 2,c.207T>A,p.(Cys69*),<1,,,,Severe,,Johnsen et al (2017),United States
1171,4738,Point,Missense,208,70,24,Gla,Exon 2,c.208A>C,p.(Ser70Arg),28,,,NO,Mild,,Johnsen et al (2017),United States
122,425,Point,Missense,212,71,25,Gla,Exon 2,c.212T>G,p.(Phe71Cys),10,-,-,,Mild,-,Belvini et al (2005),Italy
121,3658,Point,Missense,212,71,25,Gla,Exon 2,c.212T>C,p.(Phe71Ser),-,-,-,NO,,-,Miller et al (2012),United States
121,3886,Point,Missense,212,71,25,Gla,Exon 2,c.212T>C,p.(Phe71Ser),8.6,,,NO,Mild,,Johnsen et al (2017),United States
121,3887,Point,Missense,212,71,25,Gla,Exon 2,c.212T>C,p.(Phe71Ser),7,,,NO,Mild,,Johnsen et al (2017),United States
121,423,Point,Missense,212,71,25,Gla,Exon 2,c.212T>C,p.(Phe71Ser),-,-,-,,,-,Centre B39 (unpublished),
121,424,Point,Missense,212,71,25,Gla,Exon 2,c.212T>C,p.(Phe71Ser),5,25,II,,Moderate,-,Centre B38 (unpublished),
121,421,Point,Missense,212,71,25,Gla,Exon 2,c.212T>C,p.(Phe71Ser),2,32,II,,Moderate,-,Ludwig et al (1992A),Germany
121,422,Point,Missense,212,71,25,Gla,Exon 2,c.212T>C,p.(Phe71Ser),-,-,-,,Severe,-,Wulff et al (1995),Germany
124,430,Point,Nonsense,214,72,26,Gla,Exon 2,c.214G>T,p.(Glu72*),<1,-,-,,Severe,-,Centre B11 (unpublished),
124,431,Point,Nonsense,214,72,26,Gla,Exon 2,c.214G>T,p.(Glu72*),<1,-,-,,Severe,-,Centre B13 (unpublished),
124,432,Point,Nonsense,214,72,26,Gla,Exon 2,c.214G>T,p.(Glu72*),<1,-,-,,Severe,-,Elmahmoudi et al (2011),Tunisia
123,428,Point,Missense,214,72,26,Gla,Exon 2,c.214G>C,p.(Glu72Gln),-,-,-,,Severe,-,Liu et al (2000),China
123,429,Point,Missense,214,72,26,Gla,Exon 2,c.214G>C,p.(Glu72Gln),<1,42,II,,Severe,-,Tartary et al (1993),France
123,426,Point,Missense,214,72,26,Gla,Exon 2,c.214G>C,p.(Glu72Gln),-,-,-,,,-,Wulff et al (2001),Germany
123,427,Point,Missense,214,72,26,Gla,Exon 2,c.214G>C,p.(Glu72Gln),<1,-,-,,Severe,-,Ivaskevicius et al (2001),Germany
125,433,Point,Missense,215,72,26,Gla,Exon 2,c.215A>G,p.(Glu72Gly),-,-,-,,Severe,-,Liu et al (2000),China
127,435,Point,Nonsense,217,73,27,Gla,Exon 2,c.217G>T,p.(Glu73*),-,-,-,,Severe,-,Liu et al (2000),China
126,434,Point,Missense,217,73,27,Gla,Exon 2,c.217G>A,p.(Glu73Lys),<1,30,II,,Severe,-,Chen et al (1989b),United States
128,436,Point,Missense,218,73,27,Gla,Exon 2,c.218A>C,p.(Glu73Ala),7,-,-,NO,Mild,-,Attali et al (1999),France
129,438,Point,Missense,218,73,27,Gla,Exon 2,c.218A>T,p.(Glu73Val),-,-,-,,,-,Centre B18 (unpublished),
129,437,Point,Missense,218,73,27,Gla,Exon 2,c.218A>T,p.(Glu73Val),<1,3,II,,Severe,-,Wang et al (1990),United States
130,3567,Point,Missense,219,73,27,Gla,Exon 2,c.219A>C,p.(Glu73Asp),-,-,-,NO,Severe,-,Yu et al (2012),China
130,440,Point,Missense,219,73,27,Gla,Exon 2,c.219A>C,p.(Glu73Asp),1,-,-,,Moderate,-,Centre B30 (unpublished),
130,439,Point,Missense,219,73,27,Gla,Exon 2,c.219A>C,p.(Glu73Asp),<1,90,II,,Severe,-,Nielsen et al (1995),Denmark
131,441,Point,Missense,219,73,27,Gla,Exon 2,c.219A>T,p.(Glu73Asp),<1,-,-,,Severe,-,Centre B20 (unpublished),
131,442,Point,Missense,219,73,27,Gla,Exon 2,c.219A>T,p.(Glu73Asp),<1,-,-,,Severe,-,Costa et al (2000),France
132,477,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,YES,Severe,-,Centre B30 (unpublished),
132,3521,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,YES,Severe,-,Radic et al (2013),Argentina
132,482,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,YES,Severe,-,Wulff et al (1995),Germany
132,484,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,<1,-,YES,Severe,-,Green et al (1991),Sweden
132,485,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,<1,-,YES,Severe,-,Ljung et al (2001),Sweden
132,446,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,<0.1,-,YES,Severe,-,Green et al (1989),United Kingdom
132,475,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,YES,Severe,-,Saad et al (1994),United Kingdom
132,460,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,<1,-,YES,Severe,-,Thompson et al (1992A),United States
132,4570,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,YES,Severe,,Johnsen et al (2017),United States
132,4565,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,YES,Severe,,Johnsen et al (2017),United States
132,4558,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,YES,Severe,,Johnsen et al (2017),United States
132,4553,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,YES,Severe,,Johnsen et al (2017),United States
132,4552,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,YES,Severe,,Johnsen et al (2017),United States
132,4551,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,YES,Severe,,Johnsen et al (2017),United States
132,4550,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,YES,Severe,,Johnsen et al (2017),United States
132,3522,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
132,3569,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),-,-,-,NO,Severe,-,Yu et al (2012),China
132,3568,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),-,-,-,NO,Severe,-,Yu et al (2012),China
132,493,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,<1,-,NO,Severe,-,Attali et al (1999),France
132,3443,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),1.8,-,-,NO,Moderate,-,Balraj et al (2012),Malaysia
132,3437,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,NO,Severe,-,Balraj et al (2012),Malaysia
132,4554,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,NO,Severe,,Johnsen et al (2017),United States
132,4572,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,NO,Severe,,Johnsen et al (2017),United States
132,4571,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,NO,Severe,,Johnsen et al (2017),United States
132,4569,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,NO,Severe,,Johnsen et al (2017),United States
132,4568,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,NO,Severe,,Johnsen et al (2017),United States
132,4567,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,NO,Severe,,Johnsen et al (2017),United States
132,4566,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,NO,Severe,,Johnsen et al (2017),United States
132,4564,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,NO,Severe,,Johnsen et al (2017),United States
132,4563,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),1,,,NO,Moderate,,Johnsen et al (2017),United States
132,4562,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,NO,Severe,,Johnsen et al (2017),United States
132,4560,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,NO,Severe,,Johnsen et al (2017),United States
132,4561,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,NO,Severe,,Johnsen et al (2017),United States
132,4559,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,NO,Severe,,Johnsen et al (2017),United States
132,4557,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,NO,Severe,,Johnsen et al (2017),United States
132,4556,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,NO,Severe,,Johnsen et al (2017),United States
132,4555,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,,,NO,Severe,,Johnsen et al (2017),United States
132,499,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),-,-,-,,,-,Centre B39 (unpublished),
132,504,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),-,-,-,,,-,Centre B39 (unpublished),
132,503,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),-,-,-,,,-,Centre B39 (unpublished),
132,463,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,<1,-,,Severe,-,Centre B7 (unpublished),
132,476,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Centre B12 (unpublished),
132,478,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),-,-,-,,,-,Centre B30 (unpublished),
132,479,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Centre B30 (unpublished),
132,487,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,<1,-,,Severe,-,Centre B35 (unpublished),
132,488,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Centre B9 (unpublished),
132,490,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Centre B13 (unpublished),
132,491,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),-,-,-,,,-,Centre B38 (unpublished),
132,480,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Centre B11 (unpublished),
132,495,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,<1,-,,Severe,-,Centre B38 (unpublished),
132,500,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,<1,-,,Severe,-,Centre B25 (unpublished),
132,501,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),-,-,-,,,-,Centre B21 (unpublished),
132,502,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Centre B38 (unpublished),
132,505,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),1,-,-,,Moderate,-,Centre B36 (unpublished),
132,507,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Centre B5 (unpublished),
132,481,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Meireles et al (2017),Brazil
132,497,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),-,-,-,,Severe,-,Liu et al (2000),China
132,498,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),-,-,-,,Severe,-,Liu et al (2000),China
132,496,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),-,-,-,,Severe,-,Liu et al (2000),China
132,466,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,<1,-,,Severe,-,Tartary et al (1993),France
132,465,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Costa et al (2000),France
132,467,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Wulff et al (1995),Germany
132,468,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Wulff et al (1995),Germany
132,462,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Wulff et al (1995),Germany
132,461,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Knobloch et al (1993),Germany
132,492,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),-,-,-,,,-,Wulff et al (2001),Germany
132,457,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Ivaskevicius et al (2001),Germany
132,451,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,<1,-,,Severe,-,Knobloch et al (1993),Germany
132,469,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Wulff et al (1995),Germany
132,483,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Mahajan et al (2004),India
132,508,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Mahajan et al (2004),India
132,509,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Mahajan et al (2004),India
132,456,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Jayandharan et al (2005),India
132,459,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),0,-,-,,Severe,-,Belvini et al (2005),Italy
132,449,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),-,-,-,,,-,Nawaz et al (2008),Pakistan
132,450,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
132,489,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Montejo et al (1999),Spain
132,455,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,<1,-,,Severe,-,Lin et al (1991),Taiwan
132,454,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,<1,-,,Severe,-,Lin et al (1991),Taiwan
132,458,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),-,-,-,,,-,Saad et al (1994),United Kingdom
132,464,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
132,453,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,<1,-,,Severe,-,Green et al (1992),United Kingdom
132,452,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Green et al (1992),United Kingdom
132,448,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),1,-,-,,Moderate,-,Green et al (1990),United Kingdom
132,447,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,2,II,,Severe,-,Montandon et al (1989),United Kingdom
132,494,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Li et al (2000),United States
132,474,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),1.9,<1,I,,Moderate,-,Gostout et al (1993),United States
132,473,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),1.6,<1,I,,Moderate,-,Bottema et al (1993),United States
132,472,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),-,-,-,,Severe,-,Bottema et al (1993),United States
132,471,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),-,-,-,,Severe,-,Bottema et al (1993),United States
132,470,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,<1,-,,Severe,-,Gostout et al (1993),United States
132,444,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,<1,-,,Severe,-,Koeberl et al (1990A),United States
132,445,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,7,II,,Severe,-,Koeberl et al (1990A),United States
132,486,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,<1,-,,Severe,-,Weinmann et al (1998),United States
132,3777,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),<1,-,-,,Severe,-,Montejo et al (1999),Spain
132,3807,Point,Nonsense,223,75,29,Gla,Exon 2,c.223C>T,p.(Arg75*),,,,,,,Vidal et al (2000),Spain
1172,4739,Point,Missense,223,75,29,Gla,Exon 2,c.223C>G,p.(Arg75Gly),9,,,,Mild,,Johnsen et al (2017),United States
133,3659,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),-,-,-,NO,Mild,-,Miller et al (2012),United States
133,3888,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),29,,,NO,Mild,,Johnsen et al (2017),United States
133,3890,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),23,,,NO,Mild,,Johnsen et al (2017),United States
133,3892,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),33,,,NO,Mild,,Johnsen et al (2017),United States
133,3893,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),20,,,NO,Mild,,Johnsen et al (2017),United States
133,3894,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),17,,,NO,Mild,,Johnsen et al (2017),United States
133,3895,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),24,,,NO,Mild,,Johnsen et al (2017),United States
133,3896,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),45,,,NO,Mild,,Johnsen et al (2017),United States
133,3897,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),46,,,NO,Mild,,Johnsen et al (2017),United States
133,3898,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),53,,,NO,Mild,,Johnsen et al (2017),United States
133,3900,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),20,,,NO,Mild,,Johnsen et al (2017),United States
133,518,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),-,-,-,,,-,Centre B30 (unpublished),
133,520,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),29,-,-,,Mild,-,Centre B30 (unpublished),
133,521,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),35,-,-,,Mild,-,Centre B30 (unpublished),
133,522,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),31,-,-,,Mild,-,Centre B11 (unpublished),
133,523,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),47,-,-,,Mild,-,Centre B30 (unpublished),
133,524,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),33,-,-,,Mild,-,Centre B30 (unpublished),
133,513,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),19,-,-,,Mild,-,Ghanem et al (1993),France
133,526,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),20,-,-,,Mild,-,Belvini et al (2005),Italy
133,514,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),18,-,-,,Mild,-,Van de Water et al (1996),New Zealand
133,519,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),25,-,-,,Mild,-,Van de Water et al (1996),New Zealand
133,516,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),-,-,-,,,-,Saad et al (1994),United Kingdom
133,510,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),37,-,-,,Mild,-,Koeberl et al (1990B),United States
133,511,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),30,-,-,,Mild,-,Koeberl et al (1989),United States
133,512,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),20,70,II,,Mild,-,Chen et al (1991a),United States
133,515,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),10,77,II,,Mild,-,Thompson and Chen (1992),United States
133,517,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),18,51,II,,Mild,-,Bottema et al (1993),United States
133,3889,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),16,,,,Mild,,Johnsen et al (2017),United States
133,3891,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),20,,,,Mild,,Johnsen et al (2017),United States
133,3899,Point,Missense,224,75,29,Gla,Exon 2,c.224G>A,p.(Arg75Gln),21,,,,Mild,,Johnsen et al (2017),United States
134,527,Point,Missense,224,75,29,Gla,Exon 2,c.224G>C,p.(Arg75Pro),1,-,-,,Moderate,-,Thorland et al (1995),United States
136,531,Point,Nonsense,226,76,30,Gla,Exon 2,c.226G>T,p.(Glu76*),<1,-,-,,Severe,-,Wulff et al (1995),Germany
1041,3452,Point,Missense,226,76,30,Gla,Exon 2,c.226G>C,p.(Glu76Gln),-,-,-,NO,Moderate,-,Belvini et al (2005),Italy
135,3901,Point,Missense,226,76,30,Gla,Exon 2,c.226G>A,p.(Glu76Lys),<1,,,NO,Severe,,Johnsen et al (2017),United States
135,529,Point,Missense,226,76,30,Gla,Exon 2,c.226G>A,p.(Glu76Lys),<1,-,-,,Severe,-,Centre B13 (unpublished),
135,530,Point,Missense,226,76,30,Gla,Exon 2,c.226G>A,p.(Glu76Lys),-,-,-,,Moderate,-,Belvini et al (2005),Italy
135,528,Point,Missense,226,76,30,Gla,Exon 2,c.226G>A,p.(Glu76Lys),1,-,-,,Moderate,-,Ketterling et al (1993A),United States
137,3570,Point,Missense,228,76,30,Gla,Exon 2,c.228A>C,p.(Glu76Asp),-,-,-,NO,Moderate,-,Yu et al (2012),China
137,532,Point,Missense,228,76,30,Gla,Exon 2,c.228A>C,p.(Glu76Asp),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
139,534,Point,Missense,233,78,32,Gla,Exon 2,c.233T>C,p.(Phe78Ser),5,-,-,,Moderate,-,Centre B30 (unpublished),
141,3450,Point,Missense,235,79,33,Gla,Exon 2,c.235G>C,p.(Glu79Gln),0,-,-,NO,Severe,-,Belvini et al (2005),Italy
140,535,Point,Missense,235,79,33,Gla,Exon 2,c.235G>A,p.(Glu79Lys),-,-,-,,,-,Centre B39 (unpublished),
140,538,Point,Missense,235,79,33,Gla,Exon 2,c.235G>A,p.(Glu79Lys),-,-,-,,Severe,-,Belvini et al (2005),Italy
140,539,Point,Missense,235,79,33,Gla,Exon 2,c.235G>A,p.(Glu79Lys),-,-,-,,Severe,-,Belvini et al (2005),Italy
140,537,Point,Missense,235,79,33,Gla,Exon 2,c.235G>A,p.(Glu79Lys),<1,-,-,,Severe,-,Enayat et al (2004),United Kingdom
144,3571,Point,Missense,236,79,33,Gla,Exon 2,c.236A>C,p.(Glu79Ala),-,-,-,NO,Moderate,-,Yu et al (2012),China
144,3902,Point,Missense,236,79,33,Gla,Exon 2,c.236A>C,p.(Glu79Ala),<1,,,NO,Severe,,Johnsen et al (2017),United States
144,543,Point,Missense,236,79,33,Gla,Exon 2,c.236A>C,p.(Glu79Ala),5.57,-,-,,Moderate,-,Liu et al (2000),China
145,544,Point,Missense,236,79,33,Gla,Exon 2,c.236A>G,p.(Glu79Gly),1,-,-,,Moderate,-,Centre B39 (unpublished),
1173,4740,Point,Missense,236,79,33,Gla,Exon 2,c.236A>T,p.(Glu79Val),3,,,NO,Moderate,,Johnsen et al (2017),United States
146,546,Point,Missense,237,79,33,Gla,Exon 2,c.237A>C,p.(Glu79Asp),-,-,-,,,-,Centre B39 (unpublished),
146,545,Point,Missense,237,79,33,Gla,Exon 2,c.237A>C,p.(Glu79Asp),4,-,-,,Moderate,-,Koeberl et al (1989),United States
147,547,Point,Missense,250,84,38,Gla,Exon 2,c.250A>G,p.(Thr84Ala),-,-,-,,,-,Centre B39 (unpublished),
148,548,Point,Missense,251,84,38,Gla,Exon 2,c.251C>G,p.(Thr84Arg),<1,-,-,,Severe,-,Centre B23 (unpublished),
149,550,Point,Missense,251,84,38,Gla,Exon 2,c.251C>T,p.(Thr84Ile),10,-,-,,Mild,-,Centre B30 (unpublished),
149,551,Point,Missense,251,84,38,Gla,Exon 2,c.251C>T,p.(Thr84Ile),16,40,II,,Mild,-,Centre B38 (unpublished),
149,3379,Point,Missense,251,84,38,Gla,Exon 2,c.251C>T,p.(Thr84Ile),7.9,-,-,,Mild,-,Belvini et al (2005),Italy
149,549,Point,Missense,251,84,38,Gla,Exon 2,c.251C>T,p.(Thr84Ile),7,-,-,,Mild,-,Saad et al (1994),United Kingdom
1144,3234,Point,Splice,252,,,,Intron 2,c.252+1G>C,,<1,-,-,,Severe,-,Montejo et al (1999),Spain
1144,3235,Point,Splice,252,,,,Intron 2,c.252+1G>C,,<1,-,-,,Severe,-,Ketterling et al (1999A),United States
1144,3778,Point,Splice,252,,,,Intron 2,c.252+1G>C,,<1,-,-,,Severe,-,Montejo et al (1999),Spain
966,3206,Point,Splice,252,,,-,Intron 2,c.252+4A>G,N/A,<1,-,-,,Severe,-,Jayandharan et al (2005),India
967,4647,Point,Splice,252,,,-,Intron 2,c.252+5G>A,N/A,<1,,,NO,Severe,,Johnsen et al (2017),United States
967,3209,Point,Splice,252,,,-,Intron 2,c.252+5G>A,N/A,-,-,-,,,-,Centre B30 (unpublished),
967,3210,Point,Splice,252,,,-,Intron 2,c.252+5G>A,N/A,<1,<7,-,,Severe,-,Centre B38 (unpublished),
967,3212,Point,Splice,252,,,-,Intron 2,c.252+5G>A,N/A,10,-,-,,Mild,-,Centre B36 (unpublished),
967,3214,Point,Splice,252,,,-,Intron 2,c.252+5G>A,N/A,-,-,-,,,-,Centre B13 (unpublished),
967,3207,Point,Splice,252,,,-,Intron 2,c.252+5G>A,N/A,<1,-,-,,Severe,-,Ghanem et al (1993),France
967,3213,Point,Splice,252,,,-,Intron 2,c.252+5G>A,N/A,-,-,-,,,-,Jayandharan et al (2005),India
967,3215,Point,Splice,252,,,-,Intron 2,c.252+5G>A,N/A,0,-,-,,Severe,-,Belvini et al (2005),Italy
967,3208,Point,Splice,252,,,-,Intron 2,c.252+5G>A,N/A,1,-,-,,Moderate,-,Van de Water et al (1996),New Zealand
968,3216,Point,Splice,252,,,-,Intron 2,c.252+5G>C,N/A,1.5,-,-,,Moderate,-,Belvini et al (2005),Italy
969,3217,Point,Splice,252,,,-,Intron 2,c.252+5G>T,N/A,<1,-,-,,Severe,-,Belvini et al (2005),Italy
970,3219,Point,Splice,252,,,-,Intron 2,c.252+6T>C,N/A,-,-,-,,,-,Centre B21 (unpublished),
970,3218,Point,Splice,252,,,-,Intron 2,c.252+6T>C,N/A,<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
970,3220,Point,Splice,252,,,-,Intron 2,c.252+6T>C,N/A,1,1,I,,Moderate,-,Bottema et al (1990C),United States
971,3221,Point,Splice,252,,,-,Intron 2,c.252+86C>G,N/A,<1,<1,-,,Severe,-,Bottema et al (1991),United States
978,3433,Point,Splice,252,,,-,Intron 2,c.252+1G>A,N/A,<1,-,-,NO,Severe,-,Balraj et al (2012),Malaysia
978,3233,Point,Splice,252,,,-,Intron 2,c.252+1G>A,N/A,<1,-,-,,Severe,-,Centre B11 (unpublished),
979,4646,Point,Splice,252,,,-,Intron 2,c.252+3G>C,N/A,<1,,,NO,Severe,,Johnsen et al (2017),United States
979,3236,Point,Splice,252,,,-,Intron 2,c.252+3G>C,N/A,2,-,-,,Moderate,-,Nielsen et al (1995),Denmark
979,3237,Point,Splice,252,,,-,Intron 2,c.252+3G>C,N/A,-,-,-,,,-,Nielsen et al (1995),Denmark
1057,3536,Point,Splice,252,,,-,Intron 2,c.252+2T>C,N/A,<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
1057,4645,Point,Splice,252,,,-,Intron 2,c.252+2T>C,N/A,<1,,,NO,Severe,,Johnsen et al (2017),United States
1056,3537,Point,Splice,252,,,-,Intron 2,c.252+2T>G,N/A,<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
1121,3231,Point,Splice,253,,,,Intron 2,c.253-25A>T,,-,-,-,,,-,Centre B30 (unpublished),
972,3223,Point,Splice,253,,,-,Intron 2,c.253-1G>A,N/A,<1,-,-,,Severe,-,Centre B30 (unpublished),
972,3222,Point,Splice,253,,,-,Intron 2,c.253-1G>A,N/A,<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
973,3224,Point,Splice,253,,,-,Intron 2,c.253-1G>C,N/A,-,-,-,,,-,Wulff et al (1995),Germany
973,3225,Point,Splice,253,,,-,Intron 2,c.253-1G>C,N/A,5,-,-,,Moderate,-,Ketterling et al (1993A),United States
974,3226,Point,Splice,253,,,-,Intron 2,c.253-10T>G,N/A,<1,-,-,,Severe,-,Jayandharan et al (2005),India
975,3518,Point,Splice,253,,,-,Intron 2,c.253-2A>G,N/A,<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
975,3227,Point,Splice,253,,,-,Intron 2,c.253-2A>G,N/A,<1,<1,-,,Severe,-,Centre B30 (unpublished),
976,3704,Point,Splice,253,,,-,Intron 2,c.253-25A>G,N/A,-,-,-,NO,Severe,-,Miller et al (2012),United States
976,4648,Point,Splice,253,,,-,Intron 2,c.253-25A>G,N/A,<1,,,NO,Severe,,Johnsen et al (2017),United States
976,4649,Point,Splice,253,,,-,Intron 2,c.253-25A>G,N/A,<1,,,NO,Severe,,Johnsen et al (2017),United States
976,3230,Point,Splice,253,,,-,Intron 2,c.253-25A>G,N/A,-,-,-,,,-,Centre B39 (unpublished),
976,3228,Point,Splice,253,,,-,Intron 2,c.253-25A>G,N/A,1,-,-,,Moderate,-,David et al (1998),Portugal
976,3229,Point,Splice,253,,,-,Intron 2,c.253-25A>G,N/A,<1,-,-,,Severe,-,Ketterling et al (1999A),United States
977,3232,Point,Splice,253,,,-,Intron 2,c.253-3T>G,N/A,2,-,-,,Moderate,-,Ketterling et al (1999A),United States
151,554,Point,Missense,259,87,41,Gla,Exon 3,c.259T>G,p.(Phe87Val),15,34,II,NO,Mild,-,Attali et al (1999),France
797,559,Point,Missense,260,87,41,Gla,Exon 3,c.260T>G,p.(Phe87Cys),<1,-,-,NO,Severe,-,Bicocchi et al (2006),Italy
797,555,Point,Missense,260,87,41,Gla,Exon 3,c.260T>G,p.(Phe87Cys),-,-,-,,,-,Centre B36 (unpublished),
797,556,Point,Missense,260,87,41,Gla,Exon 3,c.260T>G,p.(Phe87Cys),<1,-,-,,Severe,-,Centre B36 (unpublished),
797,557,Point,Missense,260,87,41,Gla,Exon 3,c.260T>G,p.(Phe87Cys),<1,-,-,,Severe,-,Centre B36 (unpublished),
797,558,Point,Missense,260,87,41,Gla,Exon 3,c.260T>G,p.(Phe87Cys),1.5,-,-,,Moderate,-,Centre B36 (unpublished),
797,2877,Point,Missense,260,87,41,Gla,Exon 3,c.260T>G,p.(Phe87Cys),-,-,-,,Moderate,-,Belvini et al (2005),Italy
152,560,Point,Missense,262,88,42,Gla,Exon 3,c.262T>C,p.(Trp88Arg),<1,-,-,,Severe,-,Mahajan et al (2007),India
153,562,Point,Nonsense,263,88,42,Gla,Exon 3,c.263G>A,p.(Trp88*),<1,-,-,,Severe,-,Centre B38 (unpublished),
153,561,Point,Nonsense,263,88,42,Gla,Exon 3,c.263G>A,p.(Trp88*),<1,<1,-,,Severe,-,Costa et al (2000),France
153,563,Point,Nonsense,263,88,42,Gla,Exon 3,c.263G>A,p.(Trp88*),2,-,-,,Moderate,-,Saad et al (1994),United Kingdom
155,565,Point,Nonsense,265,89,43,Gla,Exon 3,c.265A>T,p.(Lys89*),-,-,-,,,-,Centre B39 (unpublished),
154,564,Point,Missense,265,89,43,Gla,Exon 3,c.265A>G,p.(Lys89Glu),14,96,II,,Mild,-,Centre B27 (unpublished),
156,3572,Point,Nonsense,268,90,44,Gla,Exon 3,c.268C>T,p.(Gln90*),-,-,-,NO,Moderate,-,Yu et al (2012),China
156,4573,Point,Nonsense,268,90,44,Gla,Exon 3,c.268C>T,p.(Gln90*),<1,,,NO,Severe,,Johnsen et al (2017),United States
156,4574,Point,Nonsense,268,90,44,Gla,Exon 3,c.268C>T,p.(Gln90*),<1,,,NO,Severe,,Johnsen et al (2017),United States
156,566,Point,Nonsense,268,90,44,Gla,Exon 3,c.268C>T,p.(Gln90*),<1,-,-,,Severe,-,Ljung et al (2001),Sweden
157,3903,Point,Missense,271,91,45,Gla,Exon 3,c.271T>A,p.(Tyr91Asn),18,,,NO,Mild,,Johnsen et al (2017),United States
157,568,Point,Missense,271,91,45,Gla,Exon 3,c.271T>A,p.(Tyr91Asn),<1,-,I,,Severe,-,Ghosh et al (2009),India
157,567,Point,Missense,271,91,45,Gla,Exon 3,c.271T>A,p.(Tyr91Asn),9,-,-,,Mild,-,Saad et al (1994),United Kingdom
158,569,Point,Missense,271,91,45,Gla,Exon 3,c.271T>G,p.(Tyr91Asp),9,59,II,,Mild,-,Gostout et al (1993),United States
159,571,Point,Missense,272,91,45,Gla,Exon 3,c.272A>G,p.(Tyr91Cys),-,-,-,,,-,Centre B39 (unpublished),
159,570,Point,Missense,272,91,45,Gla,Exon 3,c.272A>G,p.(Tyr91Cys),-,-,-,,Moderate,-,Wulff et al (1995),Germany
159,572,Point,Missense,272,91,45,Gla,Exon 3,c.272A>G,p.(Tyr91Cys),-,-,-,,Moderate,-,Li et al (2000),United States
160,573,Point,Missense,275,92,46,Gla,Exon 3,c.275T>C,p.(Val92Ala),-,-,-,,,-,Liu et al (2000),China
1216,4795,Point,Splice,277,,,,Intron 3,c.277+1G>C,,<1,,,NO,Severe,,Johnsen et al (2017),United States
980,3238,Point,Splice,277,,,-,Intron 3,c.277+1G>A,N/A,-,-,-,,,-,Centre B17 (unpublished),
980,3239,Point,Splice,277,,,-,Intron 3,c.277+1G>A,N/A,<1,-,-,,Severe,-,Centre B9 (unpublished),
981,3240,Point,Splice,277,,,-,Intron 3,c.277+1G>T,N/A,-,-,-,,,-,Centre B39 (unpublished),
982,3243,Point,Splice,277,,,-,Intron 3,c.277+2T>C,N/A,<1,<1,-,,Severe,-,Centre B23 (unpublished),
982,3241,Point,Splice,277,,,-,Intron 3,c.277+2T>C,N/A,3 to 13,-,-,,Mild,-,Ghanem et al (1993),France
982,3242,Point,Splice,277,,,-,Intron 3,c.277+2T>C,N/A,1,28,II,,Moderate,-,Costa et al (2000),France
983,3244,Point,Splice,277,,,-,Intron 3,c.277+2T>G,N/A,0.5,0.4,I,,Severe,-,Centre B47 (unpublished),
984,3449,Point,Splice,277,,,-,Intron 3,c.277+4A>G,N/A,-,-,-,NO,Moderate,-,Belvini et al (2005),Italy
984,3246,Point,Splice,277,,,-,Intron 3,c.277+4A>G,N/A,<1,-,-,,Severe,-,Wulff et al (2001),Germany
984,3245,Point,Splice,277,,,-,Intron 3,c.277+4A>G,N/A,-,<1,-,,,-,Montejo et al (1999),Spain
985,3473,Point,Splice,277,,,-,Intron 3,c.277+5G>A,N/A,1.78,-,-,NO,Moderate,-,Balraj et al (2012),Malaysia
985,3249,Point,Splice,277,,,-,Intron 3,c.277+5G>A,N/A,<1,-,-,,Severe,-,Centre B21 (unpublished),
985,3247,Point,Splice,277,,,-,Intron 3,c.277+5G>A,N/A,2,2,I,,Moderate,-,Wulff et al (1999),Germany
985,3250,Point,Splice,277,,,-,Intron 3,c.277+5G>A,N/A,1,-,-,,Moderate,-,Saad et al (1994),United Kingdom
986,3251,Point,Splice,277,,,-,Intron 3,c.277+5G>C,N/A,5,-,-,,Moderate,-,Caglayan et al (1997),Turkey
161,3660,Point,Missense,277,93,47,EGF1,Exon 3,c.277G>A,p.(Asp93Asn),-,-,-,NO,Severe,-,Miller et al (2012),United States
161,3904,Point,Missense,277,93,47,EGF1,Exon 3,c.277G>A,p.(Asp93Asn),<1,,,NO,Severe,,Johnsen et al (2017),United States
161,577,Point,Missense,277,93,47,EGF1,Exon 3,c.277G>A,p.(Asp93Asn),<1,-,-,,Severe,-,Centre B39 (unpublished),
161,576,Point,Missense,277,93,47,EGF1,Exon 3,c.277G>A,p.(Asp93Asn),<1,<1,-,,Severe,-,Wulff et al (1999),Germany
161,575,Point,Missense,277,93,47,EGF1,Exon 3,c.277G>A,p.(Asp93Asn),<1,<1,-,,Severe,-,Saad et al (1994),United Kingdom
161,574,Point,Missense,277,93,47,EGF1,Exon 3,c.277G>A,p.(Asp93Asn),-,-,-,,Moderate,-,Li et al (2000),United States
162,578,Point,Missense,277,93,47,EGF1,Exon 3,c.277G>C,p.(Asp93HIs),<1,-,-,,Severe,-,Mahajan et al (2007),India
163,3705,Point,Splice,278,,,-,Intron 3,c.278-3A>G,N/A,-,-,-,NO,Severe,-,Miller et al (2012),United States
163,579,Point,Splice,278,,,-,Intron 3,c.278-3A>G,N/A,<1,-,-,,Severe,-,Kwon et al (2008),South Korea
163,3262,Point,Splice,278,,,-,Intron 3,c.278-3A>G,N/A,<1,-,-,,Severe,-,Vidal et al (2000),Spain
163,3261,Point,Splice,278,,,-,Intron 3,c.278-3A>G,N/A,<1,-,-,,Severe,-,Ketterling et al (1999A),United States
163,3263,Point,Splice,278,,,-,Intron 3,c.278-3A>G,N/A,<1,27,II,,Severe,-,Ketterling et al (1993A),United States
163,3431,Point,Splice,278,,,-,Intron 3,c.278-3A>G,N/A,-,-,-,,Severe,<1% of functional F9 transcripts produced experimentally ,Rogaev et al (2009),United States
163,4653,Point,Splice,278,,,-,Intron 3,c.278-3A>G,N/A,<1,,,,Severe,,Johnsen et al (2017),United States
987,3252,Point,Splice,278,,,-,Intron 3,c.278-1G>A,N/A,-,-,-,,,-,Centre B2 (unpublished),
987,3253,Point,Splice,278,,,-,Intron 3,c.278-1G>A,N/A,3,-,-,,Moderate,-,Koeberl et al (1990B),United States
988,3254,Point,Splice,278,,,-,Intron 3,c.278-1G>C,N/A,<1,<1,-,,Severe,-,Ljung et al (2001),Sweden
989,4650,Point,Splice,278,,,-,Intron 3,c.278-1G>T,N/A,3,,,NO,Moderate,,Johnsen et al (2017),United States
989,3255,Point,Splice,278,,,-,Intron 3,c.278-1G>T,N/A,-,-,-,,Severe,-,Jenkins et al (2008),Ireland
989,3256,Point,Splice,278,,,-,Intron 3,c.278-1G>T,N/A,<1,-,-,,Severe,-,Ketterling et al (1999A),United States
990,3257,Point,Splice,278,,,-,Intron 3,c.278-12C>G,N/A,<1,-,-,,Severe,-,Belvini et al (2005),Italy
991,4651,Point,Splice,278,,,-,Intron 3,c.278-13A>G,N/A,<1,,,NO,Severe,,Johnsen et al (2017),United States
991,3259,Point,Splice,278,,,-,Intron 3,c.278-13A>G,N/A,1 to 5,<30,-,,Moderate,-,Centre B38 (unpublished),
991,3258,Point,Splice,278,,,-,Intron 3,c.278-13A>G,N/A,-,-,-,,Severe,-,Jenkins et al (2008),Ireland
992,3573,Point,Splice,278,,,-,Intron 3,c.278-2A>T,N/A,-,-,-,NO,Severe,-,Yu et al (2012),China
992,4652,Point,Splice,278,,,-,Intron 3,c.278-2A>T,N/A,<1,,,NO,Severe,,Johnsen et al (2017),United States
992,3260,Point,Splice,278,,,-,Intron 3,c.278-2A>T,N/A,<1,-,-,,Severe,-,Centre B30 (unpublished),
164,580,Point,Missense,278,93,47,EGF1,Exon 4,c.278A>G,p.(Asp93Gly),24,-,-,,Mild,-,Centre B35 (unpublished),
164,581,Point,Missense,278,93,47,EGF1,Exon 4,c.278A>G,p.(Asp93Gly),10,100,II,,Mild,-,Davis et al (1987),United States
1174,4741,Point,Missense,278,93,47,EGF1,Exon 4,c.278A>T,p.(Asp93Val),4,,,NO,Moderate,,Johnsen et al (2017),United States
165,582,Point,Missense,279,93,47,EGF1,Exon 4,c.279T>A,p.(Asp93Glu),1,90,II,,Moderate,-,Winship and Dragon (1991),United Kingdom
165,583,Point,Missense,279,93,47,EGF1,Exon 4,c.279T>A,p.(Asp93Glu),14,80,II,,Mild,-,Bottema et al (1990C),United States
166,584,Point,Missense,280,94,48,EGF1,Exon 4,c.280G>A,p.(Gly94Arg),25,89,II,NO,Mild,-,Attali et al (1999),France
166,585,Point,Missense,280,94,48,EGF1,Exon 4,c.280G>A,p.(Gly94Arg),28,70,II,NO,Mild,-,Attali et al (1999),France
166,3905,Point,Missense,280,94,48,EGF1,Exon 4,c.280G>A,p.(Gly94Arg),32,,,NO,Mild,,Johnsen et al (2017),United States
166,586,Point,Missense,280,94,48,EGF1,Exon 4,c.280G>A,p.(Gly94Arg),28,101,II,,Mild,-,Lin et al (1991),Taiwan
167,588,Point,Missense,281,94,48,EGF1,Exon 4,c.281G>T,p.(Gly94Val),-,-,-,,,-,Centre B39 (unpublished),
167,587,Point,Missense,281,94,48,EGF1,Exon 4,c.281G>T,p.(Gly94Val),19,108,II,,Mild,-,Green et al (1991),United Kingdom
1123,589,Point,Missense,283,95,49,EGF1,Exon 4,c.283G>T,p.(Asp95Tyr),18,-,-,,Mild,-,Costa et al (2000),France
169,591,Point,Missense,284,95,49,EGF1,Exon 4,c.284A>G,p.(Asp95Gly),4,-,-,,Moderate,-,Thorland et al (1995),United States
170,592,Point,Missense,284,95,49,EGF1,Exon 4,c.284A>T,p.(Asp95Val),-,-,-,,,-,Liu et al (2000),China
171,593,Point,Nonsense,286,96,50,EGF1,Exon 4,c.286C>T,p.(Gln96*),<1,-,-,,Severe,-,Centre B12 (unpublished),
171,594,Point,Nonsense,286,96,50,EGF1,Exon 4,c.286C>T,p.(Gln96*),<1,-,-,,Severe,-,Costa et al (2000),France
171,595,Point,Nonsense,286,96,50,EGF1,Exon 4,c.286C>T,p.(Gln96*),-,-,-,,Severe,-,Belvini et al (2005),Italy
172,596,Point,Missense,286,96,50,EGF1,Exon 4,c.286C>G,p.(Gln96Glu),<1,<1,-,,Severe,-,"Quadros et al, (2009)",India
173,597,Point,Missense,287,96,50,EGF1,Exon 4,c.287A>C,p.(Gln96Pro),<1,114,II,,Severe,-,Lozier et al (1990),United States
174,598,Point,Missense,288,96,50,EGF1,Exon 4,c.288G>C,p.(Gln96His),-,-,-,,,-,Centre B30 (unpublished),
174,600,Point,Missense,288,96,50,EGF1,Exon 4,c.288G>C,p.(Gln96His),24,-,-,,Mild,-,Saad et al (1994),United Kingdom
175,599,Point,Missense,288,96,50,EGF1,Exon 4,c.288G>T,p.(Gln96His),15,-,-,,Mild,-,Centre B20 (unpublished),
177,602,Point,Missense,289,97,51,EGF1,Exon 4,c.289T>C,p.(Cys97Arg),42,-,-,,Mild,-,Centre B30 (unpublished),
177,601,Point,Missense,289,97,51,EGF1,Exon 4,c.289T>C,p.(Cys97Arg),<1,2,II,,Severe,-,Costa et al (2000),France
178,603,Point,Missense,289,97,51,EGF1,Exon 4,c.289T>A,p.(Cys97Ser),-,-,-,,,-,Montejo et al (1999),Spain
179,604,Point,Missense,290,97,51,EGF1,Exon 4,c.290G>A,p.(Cys97Tyr),<1,-,-,,Severe,-,Centre B13 (unpublished),
180,606,Point,Missense,291,97,51,EGF1,Exon 4,c.291T>G,p.(Cys97Trp),<1,5,II,NO,Severe,-,Attali et al (1999),France
180,607,Point,Missense,291,97,51,EGF1,Exon 4,c.291T>G,p.(Cys97Trp),<1,<10,-,NO,Severe,-,Attali et al (1999),France
180,608,Point,Missense,291,97,51,EGF1,Exon 4,c.291T>G,p.(Cys97Trp),1,5,II,NO,Moderate,-,Attali et al (1999),France
180,609,Point,Missense,291,97,51,EGF1,Exon 4,c.291T>G,p.(Cys97Trp),-,-,-,,,-,Centre B13 (unpublished),
180,605,Point,Missense,291,97,51,EGF1,Exon 4,c.291T>G,p.(Cys97Trp),<1,<1,-,,Severe,-,Ghanem et al (1993),France
180,610,Point,Missense,291,97,51,EGF1,Exon 4,c.291T>G,p.(Cys97Trp),30,-,-,,Mild,-,Saad et al (1994),United Kingdom
181,612,Point,Nonsense,292,98,52,EGF1,Exon 4,c.292G>T,p.(Glu98*),-,-,-,,,-,Centre B39 (unpublished),
181,611,Point,Nonsense,292,98,52,EGF1,Exon 4,c.292G>T,p.(Glu98*),<1,-,-,,Severe,-,Knobloch et al (1993),Germany
181,613,Point,Nonsense,292,98,52,EGF1,Exon 4,c.292G>T,p.(Glu98*),<1,20,II,,Severe,-,Bottema et al (1991),United States
183,3662,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),-,-,-,NO,Mild,-,Miller et al (2012),United States
183,3908,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),7,,,NO,Mild,,Johnsen et al (2017),United States
183,3909,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),8,,,NO,Mild,,Johnsen et al (2017),United States
183,3911,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),10,,,NO,Mild,,Johnsen et al (2017),United States
183,3913,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),2,,,NO,Moderate,,Johnsen et al (2017),United States
183,3914,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),9,,,NO,Mild,,Johnsen et al (2017),United States
183,3917,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),9,,,NO,Mild,,Johnsen et al (2017),United States
183,3918,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),5,,,NO,Moderate,,Johnsen et al (2017),United States
183,3919,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),8,,,NO,Mild,,Johnsen et al (2017),United States
183,3920,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),6,,,NO,Mild,,Johnsen et al (2017),United States
183,3921,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),6,,,NO,Mild,,Johnsen et al (2017),United States
183,3922,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),8,,,NO,Mild,,Johnsen et al (2017),United States
183,617,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),8,53,II,,Mild,-,Centre B14 (unpublished),
183,615,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),10 to 12,49,II,,Mild,-,Green et al (1989),United Kingdom
183,616,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),10,<30,-,,Mild,-,Chen et al (1991a),United States
183,618,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),6,-,-,,Mild,-,Li et al (2000),United States
183,619,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),6,-,-,,Mild,-,Li et al (2000),United States
183,620,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),-,-,-,,Severe,-,Li et al (2000),United States
183,621,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),11,58,II,,Mild,-,Spitzer et al (1990),United States
183,3906,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),5.1,,,,Mild,,Johnsen et al (2017),United States
183,3907,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),5.1,,,,Mild,,Johnsen et al (2017),United States
183,3910,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),11,,,,Mild,,Johnsen et al (2017),United States
183,3912,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),11,,,,Mild,,Johnsen et al (2017),United States
183,3915,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),11,,,,Mild,,Johnsen et al (2017),United States
183,3916,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>G,p.(Pro101Ala),9,,,,Mild,,Johnsen et al (2017),United States
184,622,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>T,p.(Pro101Ser),12,52,II,,Mild,-,Green et al (1991),United Kingdom
182,3661,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>A,p.(Pro101Thr),-,-,-,NO,Mild,-,Miller et al (2012),United States
182,614,Point,Missense,301,101,55,EGF1,Exon 4,c.301C>A,p.(Pro101Thr),13,95,II,,Mild,-,Centre B24 (unpublished),
186,624,Point,Missense,302,101,55,EGF1,Exon 4,c.302C>G,p.(Pro101Arg),22,-,-,,Mild,-,Montejo et al (1999),Spain
185,623,Point,Missense,302,101,55,EGF1,Exon 4,c.302C>A,p.(Pro101Gln),6,34,II,,Mild,-,Ketterling et al (1993A),United States
187,625,Point,Missense,302,101,55,EGF1,Exon 4,c.302C>T,p.(Pro101Leu),26,-,-,,Mild,-,Green et al (1991),United Kingdom
189,3663,Point,Missense,304,102,56,EGF1,Exon 4,c.304T>C,p.(Cys102Arg),-,-,-,NO,Severe,-,Miller et al (2012),United States
189,629,Point,Missense,304,102,56,EGF1,Exon 4,c.304T>C,p.(Cys102Arg),<1,-,-,,Severe,-,Centre B21 (unpublished),
189,630,Point,Missense,304,102,56,EGF1,Exon 4,c.304T>C,p.(Cys102Arg),<1,-,-,,Severe,-,Centre B30 (unpublished),
189,632,Point,Missense,304,102,56,EGF1,Exon 4,c.304T>C,p.(Cys102Arg),1.3,-,-,,Moderate,-,Centre B5 (unpublished),
189,631,Point,Missense,304,102,56,EGF1,Exon 4,c.304T>C,p.(Cys102Arg),<1,-,-,,Severe,-,Mukherjee et al (2004),India
189,634,Point,Missense,304,102,56,EGF1,Exon 4,c.304T>C,p.(Cys102Arg),<1,-,-,,Severe,-,Jayandharan et al (2003),India
189,628,Point,Missense,304,102,56,EGF1,Exon 4,c.304T>C,p.(Cys102Arg),<1,-,-,,Severe,-,Alkan et al (1991),Switzerland
189,633,Point,Missense,304,102,56,EGF1,Exon 4,c.304T>C,p.(Cys102Arg),<1,-,-,,Severe,-,Enayat et al (2004),United Kingdom
188,627,Point,Missense,304,102,56,EGF1,Exon 4,c.304T>A,p.(Cys102Ser),-,-,-,,,-,Centre B39 (unpublished),
188,626,Point,Missense,304,102,56,EGF1,Exon 4,c.304T>A,p.(Cys102Ser),1,2,II,,Moderate,-,Tartary et al (1993),France
1051,3638,Point,Missense,305,102,56,EGF1,Exon 4,c.305G>T,p.(Cys102Phe),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
191,639,Point,Missense,305,102,56,EGF1,Exon 4,c.305G>C,p.(Cys102Ser),<1,<1,-,,Severe,-,Ludwig et al (1991),Germany
190,3574,Point,Missense,305,102,56,EGF1,Exon 4,c.305G>A,p.(Cys102Tyr),-,-,-,NO,Moderate,-,Yu et al (2012),China
190,3635,Point,Missense,305,102,56,EGF1,Exon 4,c.305G>A,p.(Cys102Tyr),-,-,-,NO,Moderate,-,Yu et al (2012),China
190,636,Point,Missense,305,102,56,EGF1,Exon 4,c.305G>A,p.(Cys102Tyr),<1,<1,-,,Severe,-,Centre B15 (unpublished),
190,638,Point,Missense,305,102,56,EGF1,Exon 4,c.305G>A,p.(Cys102Tyr),-,-,-,,Severe,-,Liu et al (2000),China
190,637,Point,Missense,305,102,56,EGF1,Exon 4,c.305G>A,p.(Cys102Tyr),-,-,-,,Severe,-,Jenkins et al (2008),Ireland
190,635,Point,Missense,305,102,56,EGF1,Exon 4,c.305G>A,p.(Cys102Tyr),1,2,II,,Moderate,-,Koeberl et al (1990B),United States
192,640,Point,Nonsense,308,103,57,EGF1,Exon 4,c.308T>A,p.(Leu103*),-,-,-,,Severe,-,Belvini et al (2005),Italy
193,641,Point,Missense,312,104,58,EGF1,Exon 4,c.312T>G,p.(Asn104Lys),10,-,-,,Mild,-,Centre B30 (unpublished),
193,3923,Point,Missense,312,104,58,EGF1,Exon 4,c.312T>G,p.(Asn104Lys),5,,,,Moderate,,Johnsen et al (2017),United States
194,642,Point,Missense,313,105,59,EGF1,Exon 4,c.313G>A,p.(Gly105Ser),18,-,-,,Mild,-,Saad et al (1994),United Kingdom
1124,643,Point,Missense,314,105,59,EGF1,Exon 4,c.314G>A,p.(Gly105Asp),20,60,II,,Mild,-,Costa et al (2000),France
195,3924,Point,Missense,314,105,59,EGF1,Exon 4,c.314G>T,p.(Gly105Val),2,,,NO,Moderate,,Johnsen et al (2017),United States
195,644,Point,Missense,314,105,59,EGF1,Exon 4,c.314G>T,p.(Gly105Val),2,-,-,,Moderate,-,Bottema et al (1991),United States
197,3666,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>C,p.(Gly106Arg),-,-,-,NO,Severe,-,Miller et al (2012),United States
197,716,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>C,p.(Gly106Arg),<1,6,II,,Severe,-,Bottema et al (1991),United States
198,717,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>T,p.(Gly106Cys),<1,-,-,,Severe,-,Centre B30 (unpublished),
198,718,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>T,p.(Gly106Cys),<1,-,-,,Severe,-,Elmahmoudi et al (2011),Tunisia
196,3489,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),11,-,-,NO,Mild,-,Radic et al (2013),Argentina
196,3664,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),-,-,-,NO,Moderate,-,Miller et al (2012),United States
196,3665,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),-,-,-,NO,Mild,-,Miller et al (2012),United States
196,3925,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),15,,,NO,Mild,,Johnsen et al (2017),United States
196,3926,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),18,,,NO,Mild,,Johnsen et al (2017),United States
196,3927,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),3,,,NO,Moderate,,Johnsen et al (2017),United States
196,3929,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),6,,,NO,Mild,,Johnsen et al (2017),United States
196,3930,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),14.77,,,NO,Mild,,Johnsen et al (2017),United States
196,3932,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),18,,,NO,Mild,,Johnsen et al (2017),United States
196,3934,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),18,,,NO,Mild,,Johnsen et al (2017),United States
196,3935,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),21,,,NO,Mild,,Johnsen et al (2017),United States
196,3936,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),10,,,NO,Mild,,Johnsen et al (2017),United States
196,3937,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),15,,,NO,Mild,,Johnsen et al (2017),United States
196,3938,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),13,,,NO,Mild,,Johnsen et al (2017),United States
196,3939,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),10,,,NO,Mild,,Johnsen et al (2017),United States
196,3940,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),7,,,NO,Mild,,Johnsen et al (2017),United States
196,3941,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),10,,,NO,Mild,,Johnsen et al (2017),United States
196,3942,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),8,,,NO,Mild,,Johnsen et al (2017),United States
196,3943,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),11,,,NO,Mild,,Johnsen et al (2017),United States
196,3944,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),12,,,NO,Mild,,Johnsen et al (2017),United States
196,3945,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),15,,,NO,Mild,,Johnsen et al (2017),United States
196,3946,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),15,,,NO,Mild,,Johnsen et al (2017),United States
196,3947,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),9,,,NO,Mild,,Johnsen et al (2017),United States
196,3948,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),11.5,,,NO,Mild,,Johnsen et al (2017),United States
196,3950,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),15,,,NO,Mild,,Johnsen et al (2017),United States
196,3951,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),13,,,NO,Mild,,Johnsen et al (2017),United States
196,3953,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),20,,,NO,Mild,,Johnsen et al (2017),United States
196,3954,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),8,,,NO,Mild,,Johnsen et al (2017),United States
196,3955,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),11,,,NO,Mild,,Johnsen et al (2017),United States
196,3956,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),25,,,NO,Mild,,Johnsen et al (2017),United States
196,3957,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),15,,,NO,Mild,,Johnsen et al (2017),United States
196,3958,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),4,,,NO,Moderate,,Johnsen et al (2017),United States
196,3959,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),8,,,NO,Mild,,Johnsen et al (2017),United States
196,3960,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),8,,,NO,Mild,,Johnsen et al (2017),United States
196,3961,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),8,,,NO,Mild,,Johnsen et al (2017),United States
196,3962,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),17,,,NO,Mild,,Johnsen et al (2017),United States
196,3963,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),15,,,NO,Mild,,Johnsen et al (2017),United States
196,3964,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),8,,,NO,Mild,,Johnsen et al (2017),United States
196,3965,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),15,,,NO,Mild,,Johnsen et al (2017),United States
196,3966,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),30,,,NO,Mild,,Johnsen et al (2017),United States
196,3968,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),11,,,NO,Mild,,Johnsen et al (2017),United States
196,3969,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),25,,,NO,Mild,,Johnsen et al (2017),United States
196,3971,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),19,,,NO,Mild,,Johnsen et al (2017),United States
196,3972,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),7,,,NO,Mild,,Johnsen et al (2017),United States
196,3974,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),12,,,NO,Mild,,Johnsen et al (2017),United States
196,3975,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),13,,,NO,Mild,,Johnsen et al (2017),United States
196,3976,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),8,,,NO,Mild,,Johnsen et al (2017),United States
196,3977,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),7,,,NO,Mild,,Johnsen et al (2017),United States
196,3979,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),8,,,NO,Mild,,Johnsen et al (2017),United States
196,3980,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),13,,,NO,Mild,,Johnsen et al (2017),United States
196,3981,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),13,,,NO,Mild,,Johnsen et al (2017),United States
196,3982,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),15,,,NO,Mild,,Johnsen et al (2017),United States
196,3983,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),8,,,NO,Mild,,Johnsen et al (2017),United States
196,3984,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),13,,,NO,Mild,,Johnsen et al (2017),United States
196,3985,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),13,,,NO,Mild,,Johnsen et al (2017),United States
196,3986,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),7,,,NO,Mild,,Johnsen et al (2017),United States
196,3987,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),11,,,NO,Mild,,Johnsen et al (2017),United States
196,3989,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),14,,,NO,Mild,,Johnsen et al (2017),United States
196,3990,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),8,,,NO,Mild,,Johnsen et al (2017),United States
196,3991,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),14,,,NO,Mild,,Johnsen et al (2017),United States
196,3992,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),10,,,NO,Mild,,Johnsen et al (2017),United States
196,3993,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),17,,,NO,Mild,,Johnsen et al (2017),United States
196,3994,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),6,,,NO,Mild,,Johnsen et al (2017),United States
196,3995,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),9,,,NO,Mild,,Johnsen et al (2017),United States
196,3996,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),10,,,NO,Mild,,Johnsen et al (2017),United States
196,3997,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),7,,,NO,Mild,,Johnsen et al (2017),United States
196,3999,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),11,,,NO,Mild,,Johnsen et al (2017),United States
196,4000,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),12,,,NO,Mild,,Johnsen et al (2017),United States
196,4001,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),13,,,NO,Mild,,Johnsen et al (2017),United States
196,709,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),-,-,-,,,-,Centre B39 (unpublished),
196,647,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),13,34,II,,Mild,-,Centre B26 (unpublished),
196,649,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),17,22,I,,Mild,-,Centre B26 (unpublished),
196,684,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),31,-,-,,Mild,-,Centre B30 (unpublished),
196,685,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),-,-,-,,,-,Centre B30 (unpublished),
196,686,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),76,72,I,,Mild,-,Centre B30 (unpublished),
196,687,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),36,-,-,,Mild,-,Centre B30 (unpublished),
196,688,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),8,-,-,,Mild,-,Centre B30 (unpublished),
196,689,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),14,-,-,,Mild,-,Centre B30 (unpublished),
196,690,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),20,-,-,,Mild,-,Centre B30 (unpublished),
196,691,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),-,-,-,,,-,Centre B30 (unpublished),
196,693,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),7,-,-,,Mild,-,Centre B30 (unpublished),
196,694,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),21,-,-,,Mild,-,Centre B30 (unpublished),
196,695,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),-,-,-,,,-,Centre B30 (unpublished),
196,697,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),17,21,I,,Mild,-,Centre B20 (unpublished),
196,699,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),12,-,-,,Mild,-,Centre B30 (unpublished),
196,700,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),11,-,-,,Mild,-,Centre B13 (unpublished),
196,702,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),10,27,II,,Mild,-,Centre B38 (unpublished),
196,703,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),6,28,II,,Mild,-,Centre B38 (unpublished),
196,704,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),10,10,I,,Mild,-,Centre B13 (unpublished),
196,705,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),20,-,-,,Mild,-,Centre B25 (unpublished),
196,706,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),<1,-,-,,Severe,-,Centre B36 (unpublished),
196,707,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),-,-,-,,,-,Centre B38 (unpublished),
196,708,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),11,4,I,,Mild,-,Centre B38 (unpublished),
196,710,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),15,-,-,,Mild,-,Centre B36 (unpublished),
196,711,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),7,-,-,,Mild,-,Centre B36 (unpublished),
196,715,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),20,-,-,,Mild,-,Centre B38 (unpublished),
196,3457,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),-,-,-,,,-,Centre B30 (unpublished),
196,672,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),9,31,II,,Mild,-,Poon et al (1993),Canada
196,673,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),13,30,II,,Mild,-,Poon et al (1993),Canada
196,674,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),17,21,I,,Mild,-,Tartary et al (1993),France
196,714,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),-,-,-,,Mild,-,Belvini et al (2005),Italy
196,648,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),12,31,II,,Mild,-,Poort et al (1989),Netherlands
196,650,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),10,-,-,,Mild,-,Green et al (1990),United Kingdom
196,655,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),10,28,II,,Mild,-,Winship and Dragon (1991),United Kingdom
196,679,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),6,-,-,,Mild,-,Saad et al (1994),United Kingdom
196,680,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),9,-,-,,Mild,-,Saad et al (1994),United Kingdom
196,681,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),17,-,-,,Mild,-,Saad et al (1994),United Kingdom
196,682,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),13,-,-,,Mild,-,Saad et al (1994),United Kingdom
196,645,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),14,-,-,,Mild,-,Denton et al (1988),United States
196,646,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),10,11,I,,Mild,-,Koeberl et al (1990B),United States
196,651,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),11,19,II,,Mild,-,Chen et al (1989b),United States
196,652,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),10,18,II,,Mild,-,Chen et al (1991a),United States
196,653,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),17,30,II,,Mild,-,Chen et al (1989b),United States
196,654,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),15,54,II,,Mild,-,Chen et al (1991a),United States
196,656,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),14,35,II,,Mild,-,Koeberl et al (1989),United States
196,657,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),16,41,II,,Mild,-,Koeberl et al (1989),United States
196,658,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),13,30,II,,Mild,-,Thompson and Chen (1992),United States
196,659,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),17,-,-,,Mild,-,Ketterling et al (1991B),United States
196,660,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),12,32,II,,Mild,-,Ketterling et al (1991B),United States
196,661,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),5,-,-,,Moderate,-,Ketterling et al (1991B),United States
196,662,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),10,-,-,,Mild,-,Ketterling et al (1991B),United States
196,663,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),15,-,-,,Mild,-,Ketterling et al (1991B),United States
196,664,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),22,23,I,,Mild,-,Ketterling et al (1991B),United States
196,665,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),9,20,II,,Mild,-,Ketterling et al (1991B),United States
196,666,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),15,20,I,,Mild,-,Ketterling et al (1991B),United States
196,667,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),16,-,-,,Mild,-,Ketterling et al (1991B),United States
196,668,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),9,-,-,,Mild,-,Ketterling et al (1991B),United States
196,669,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),11,31,II,,Mild,-,Thompson et al (1992A),United States
196,670,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),15,30,II,,Mild,-,Thompson et al (1992A),United States
196,675,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),25,32,I,,Mild,-,Bottema et al (1993),United States
196,676,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),7,33,II,,Mild,-,Bottema et al (1993),United States
196,677,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),7,23.5,II,,Mild,-,Bottema et al (1993),United States
196,678,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),8,26,II,,Mild,-,Bottema et al (1993),United States
196,692,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),8,-,-,,Mild,-,Thorland et al (1995),United States
196,696,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),-,-,-,,,-,Weinmann et al (1998),United States
196,698,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),6,-,-,,Mild,-,Weinmann et al (1998),United States
196,701,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),-,-,-,,,-,Heit et al (1998),United States
196,3928,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),5.1,,,,Mild,,Johnsen et al (2017),United States
196,3931,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),12,,,,Mild,,Johnsen et al (2017),United States
196,3933,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),10,,,,Mild,,Johnsen et al (2017),United States
196,3949,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),8,,,,Mild,,Johnsen et al (2017),United States
196,3952,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),10,,,,Mild,,Johnsen et al (2017),United States
196,3967,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),16,,,,Mild,,Johnsen et al (2017),United States
196,3970,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),3,,,,Moderate,,Johnsen et al (2017),United States
196,3973,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),13,,,,Mild,,Johnsen et al (2017),United States
196,3978,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),14,,,,Mild,,Johnsen et al (2017),United States
196,3988,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),17,,,,Mild,,Johnsen et al (2017),United States
196,3998,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),10,,,,Mild,,Johnsen et al (2017),United States
196,3764,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),12,,,,Mild,5 cases in 4 families (FIX:C range 10-16),Jenkins et al (2008),Ireland
196,3733,Point,Missense,316,106,60,EGF1,Exon 4,c.316G>A,p.(Gly106Ser),,,,,,,Denton et al (1988),United States
199,3667,Point,Missense,317,106,60,EGF1,Exon 4,c.317G>A,p.(Gly106Asp),-,-,-,NO,Severe,-,Miller et al (2012),United States
199,4002,Point,Missense,317,106,60,EGF1,Exon 4,c.317G>A,p.(Gly106Asp),<1,,,NO,Severe,,Johnsen et al (2017),United States
199,720,Point,Missense,317,106,60,EGF1,Exon 4,c.317G>A,p.(Gly106Asp),3,-,-,,Moderate,-,Onay et al (2003),Turkey
199,719,Point,Missense,317,106,60,EGF1,Exon 4,c.317G>A,p.(Gly106Asp),1,2,II,,Moderate,-,Koeberl et al (1990B),United States
203,727,Point,Missense,323,108,62,EGF1,Exon 4,c.323G>T,p.(Cys108Phe),-,-,-,,Severe,-,Belvini et al (2005),Italy
202,726,Point,Missense,323,108,62,EGF1,Exon 4,c.323G>C,p.(Cys108Ser),<1,-,-,,Severe,-,Montejo et al (1999),Spain
201,725,Point,Missense,323,108,62,EGF1,Exon 4,c.323G>A,p.(Cys108Tyr),-,-,-,,,-,Centre B39 (unpublished),
201,723,Point,Missense,323,108,62,EGF1,Exon 4,c.323G>A,p.(Cys108Tyr),-,-,-,,,-,Haris et al (1994),United Kingdom
201,724,Point,Missense,323,108,62,EGF1,Exon 4,c.323G>A,p.(Cys108Tyr),1,-,-,,Moderate,-,Thorland et al (1995),United States
204,4575,Point,Nonsense,324,108,62,EGF1,Exon 4,c.324C>A,p.(Cys108*),<1,,,NO,Severe,,Johnsen et al (2017),United States
204,728,Point,Nonsense,324,108,62,EGF1,Exon 4,c.324C>A,p.(Cys108*),-,-,-,,,-,Montejo et al (1999),Spain
205,729,Point,Missense,324,108,62,EGF1,Exon 4,c.324C>G,p.(Cys108Trp),0,-,-,,Severe,-,Belvini et al (2005),Italy
206,730,Point,Missense,328,110,64,EGF1,Exon 4,c.328G>A,p.(Asp110Asn),3,117,II,,Moderate,-,Winship and Dragon (1991),United Kingdom
207,4003,Point,Missense,328,110,64,EGF1,Exon 4,c.328G>T,p.(Asp110Tyr),6,,,NO,Mild,,Johnsen et al (2017),United States
207,731,Point,Missense,328,110,64,EGF1,Exon 4,c.328G>T,p.(Asp110Tyr),-,-,-,,,-,Liu et al (2000),China
208,732,Point,Missense,329,110,64,EGF1,Exon 4,c.329A>G,p.(Asp110Gly),8,87,II,,Mild,-,Green et al (1989),United Kingdom
209,733,Point,Missense,330,110,64,EGF1,Exon 4,c.330T>G,p.(Asp110Glu),12,46,II,,Mild,-,Tartary et al (1993),France
210,734,Point,Missense,335,112,66,EGF1,Exon 4,c.335T>A,p.(Ile112Asn),26,-,-,,Mild,-,Enayat et al (2004),United Kingdom
212,738,Point,Missense,335,112,66,EGF1,Exon 4,c.335T>G,p.(Ile112Ser),-,-,-,,,-,Montejo et al (1999),Spain
211,735,Point,Missense,335,112,66,EGF1,Exon 4,c.335T>C,p.(Ile112Thr),5,-,-,,Moderate,-,Centre B7 (unpublished),
211,736,Point,Missense,335,112,66,EGF1,Exon 4,c.335T>C,p.(Ile112Thr),30,-,-,,Mild,-,Ghanem et al (1993),France
211,737,Point,Missense,335,112,66,EGF1,Exon 4,c.335T>C,p.(Ile112Thr),20,91,II,,Mild,-,Tartary et al (1993),France
213,739,Point,Missense,339,113,67,EGF1,Exon 4,c.339T>A,p.(Asn113Lys),12,-,-,,Mild,-,Caglayan et al (1997),Turkey
1069,3488,Point,Missense,340,114,68,EGF1,Exon 4,c.340T>C,p.(Ser114Pro),-,-,-,NO,Moderate,-,Yu et al (2012),China
1134,4004,Point,Missense,343,115,69,EGF1,Exon 4,c.343T>A,p.(Tyr115Asn),<1,,,NO,Severe,,Johnsen et al (2017),United States
1134,740,Point,Missense,343,115,69,EGF1,Exon 4,c.343T>A,p.(Tyr115Asn),<1,-,-,,Severe,-,Ketterling et al (1999B),United States
1175,4742,Point,Missense,343,115,69,EGF1,Exon 4,c.343T>C,p.(Tyr115His),5,,,NO,Moderate,,Johnsen et al (2017),United States
1175,4743,Point,Missense,343,115,69,EGF1,Exon 4,c.343T>C,p.(Tyr115His),6,,,,Mild,,Johnsen et al (2017),United States
214,3490,Point,Missense,344,115,69,EGF1,Exon 4,c.344A>G,p.(Tyr115Cys),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
214,3575,Point,Missense,344,115,69,EGF1,Exon 4,c.344A>G,p.(Tyr115Cys),-,-,-,NO,Severe,-,Yu et al (2012),China
214,747,Point,Missense,344,115,69,EGF1,Exon 4,c.344A>G,p.(Tyr115Cys),<1,-,-,,Severe,-,Centre B13 (unpublished),
214,743,Point,Missense,344,115,69,EGF1,Exon 4,c.344A>G,p.(Tyr115Cys),<1,-,-,,Severe,-,Ghanem et al (1993),France
214,741,Point,Missense,344,115,69,EGF1,Exon 4,c.344A>G,p.(Tyr115Cys),<1,-,-,,Severe,-,Knobloch et al (1993),Germany
214,742,Point,Missense,344,115,69,EGF1,Exon 4,c.344A>G,p.(Tyr115Cys),<1,-,-,,Severe,-,Knobloch et al (1993),Germany
214,745,Point,Missense,344,115,69,EGF1,Exon 4,c.344A>G,p.(Tyr115Cys),-,-,-,,Severe,-,Wulff et al (1995),Germany
214,744,Point,Missense,344,115,69,EGF1,Exon 4,c.344A>G,p.(Tyr115Cys),-,-,-,,,-,Saad et al (1994),United Kingdom
214,746,Point,Missense,344,115,69,EGF1,Exon 4,c.344A>G,p.(Tyr115Cys),-,-,-,,,-,Heit et al (1998),United States
214,3772,Point,Missense,344,115,69,EGF1,Exon 4,c.344A>G,p.(Tyr115Cys),,,,,,,Li et al (2000),United States
216,750,Point,Missense,349,117,71,EGF1,Exon 4,c.349T>C,p.(Cys117Arg),<1,-,-,,Severe,-,Jayandharan et al (2005),India
215,748,Point,Missense,349,117,71,EGF1,Exon 4,c.349T>A,p.(Cys117Ser),-,-,-,,,-,Centre B8 (unpublished),
215,749,Point,Missense,349,117,71,EGF1,Exon 4,c.349T>A,p.(Cys117Ser),<1,-,-,,Severe,-,Nielsen et al (1995),Denmark
219,754,Point,Missense,350,117,71,EGF1,Exon 4,c.350G>T,p.(Cys117Phe),<1,-,-,,Severe,-,Jayandharan et al (2005),India
219,755,Point,Missense,350,117,71,EGF1,Exon 4,c.350G>T,p.(Cys117Phe),<1,-,-,,Severe,-,Jayandharan et al (2005),India
218,753,Point,Missense,350,117,71,EGF1,Exon 4,c.350G>C,p.(Cys117Ser),-,-,-,,,-,Saad et al (1994),United Kingdom
217,752,Point,Missense,350,117,71,EGF1,Exon 4,c.350G>A,p.(Cys117Tyr),<1,<1,-,NO,Severe,-,Attali et al (1999),France
217,751,Point,Missense,350,117,71,EGF1,Exon 4,c.350G>A,p.(Cys117Tyr),-,-,-,,Severe,-,Belvini et al (2005),Italy
221,757,Point,Missense,351,117,71,EGF1,Exon 4,c.351T>G,p.(Cys117Trp),<1,-,-,,Severe,-,Centre B13 (unpublished),
220,756,Point,Nonsense,352,118,72,EGF1,Exon 4,c.352T>A,p.(Trp118Arg),6,-,-,,Mild,-,Saad et al (1994),United Kingdom
222,758,Point,Missense,352,118,72,EGF1,Exon 4,c.352T>A,p.(Trp118Arg),-,-,-,,,-,Saad et al (1994),United Kingdom
223,4576,Point,Nonsense,353,118,72,EGF1,Exon 4,c.353G>A,p.(Trp118*),<1,,,NO,Severe,,Johnsen et al (2017),United States
223,4577,Point,Nonsense,353,118,72,EGF1,Exon 4,c.353G>A,p.(Trp118*),<1,,,NO,Severe,,Johnsen et al (2017),United States
223,761,Point,Nonsense,353,118,72,EGF1,Exon 4,c.353G>A,p.(Trp118*),-,-,-,,,-,Centre B42 (unpublished),
223,762,Point,Nonsense,353,118,72,EGF1,Exon 4,c.353G>A,p.(Trp118*),<1,-,-,,Severe,-,Centre B25 (unpublished),
223,763,Point,Nonsense,353,118,72,EGF1,Exon 4,c.353G>A,p.(Trp118*),<1,-,-,,Severe,-,Ghanem et al (1993),France
223,764,Point,Nonsense,353,118,72,EGF1,Exon 4,c.353G>A,p.(Trp118*),<1,-,-,,Severe,-,Onay et al (2003),Turkey
223,759,Point,Nonsense,353,118,72,EGF1,Exon 4,c.353G>A,p.(Trp118*),<1,-,-,,Severe,-,Li et al (2000),United States
223,760,Point,Nonsense,353,118,72,EGF1,Exon 4,c.353G>A,p.(Trp118*),1,-,-,,Moderate,-,Thorland et al (1995),United States
224,765,Point,Missense,355,119,73,EGF1,Exon 4,c.355T>C,p.(Cys119Arg),1,1,I,,Moderate,-,David et al (1998),Portugal
226,767,Point,Missense,356,119,73,EGF1,Exon 4,c.356G>T,p.(Cys119Phe),<1,-,-,,Severe,-,Wulff et al (1995),Germany
225,4005,Point,Missense,356,119,73,EGF1,Exon 4,c.356G>A,p.(Cys119Tyr),<1,,,NO,Severe,,Johnsen et al (2017),United States
225,4006,Point,Missense,356,119,73,EGF1,Exon 4,c.356G>A,p.(Cys119Tyr),<1,,,NO,Severe,,Johnsen et al (2017),United States
225,768,Point,Missense,356,119,73,EGF1,Exon 4,c.356G>A,p.(Cys119Tyr),<1,1,II,,Severe,-,Centre B18 (unpublished),
225,766,Point,Missense,356,119,73,EGF1,Exon 4,c.356G>A,p.(Cys119Tyr),<1,2,II,,Severe,-,Weinmann et al (1998),United States
228,4578,Point,Nonsense,357,119,73,EGF1,Exon 4,c.357T>A,p.(Cys119*),<1,,,NO,Severe,,Johnsen et al (2017),United States
228,769,Point,Nonsense,357,119,73,EGF1,Exon 4,c.357T>A,p.(Cys119*),<1,-,-,,Severe,-,Ghanem et al (1993),France
229,770,Point,Missense,364,122,76,EGF1,Exon 4,c.364G>A,p.(Gly122Arg),14,-,-,,Mild,-,Centre B30 (unpublished),
230,771,Point,Missense,365,122,76,EGF1,Exon 4,c.365G>T,p.(Gly122Val),6,12,II,,Mild,-,Saad et al (1994),United Kingdom
230,3765,Point,Missense,365,122,76,EGF1,Exon 4,c.365G>T,p.(Gly122Val),4,,,,Moderate,,Jenkins et al (2008),Ireland
232,778,Point,Missense,368,123,77,EGF1,Exon 4,c.368T>G,p.(Phe123Cys),19,83,II,,Mild,-,Ljung et al (2001),Sweden
232,774,Point,Missense,368,123,77,EGF1,Exon 4,c.368T>G,p.(Phe123Cys),-,-,-,,,-,Saad et al (1994),United Kingdom
232,775,Point,Missense,368,123,77,EGF1,Exon 4,c.368T>G,p.(Phe123Cys),<1,-,-,,Severe,-,Enayat et al (2004),United Kingdom
232,776,Point,Missense,368,123,77,EGF1,Exon 4,c.368T>G,p.(Phe123Cys),<1,-,-,,Severe,-,Enayat et al (2004),United Kingdom
231,4007,Point,Missense,368,123,77,EGF1,Exon 4,c.368T>C,p.(Phe123Ser),8,,,NO,Mild,,Johnsen et al (2017),United States
231,4008,Point,Missense,368,123,77,EGF1,Exon 4,c.368T>C,p.(Phe123Ser),13.5,,,NO,Mild,,Johnsen et al (2017),United States
231,4009,Point,Missense,368,123,77,EGF1,Exon 4,c.368T>C,p.(Phe123Ser),10,,,NO,Mild,,Johnsen et al (2017),United States
231,773,Point,Missense,368,123,77,EGF1,Exon 4,c.368T>C,p.(Phe123Ser),14,54,II,,Mild,-,Centre B38 (unpublished),
231,772,Point,Missense,368,123,77,EGF1,Exon 4,c.368T>C,p.(Phe123Ser),10,-,-,,Mild,-,Weinmann et al (1998),United States
231,777,Point,Missense,368,123,77,EGF1,Exon 4,c.368T>C,p.(Phe123Ser),12,66,II,,Mild,-,Chen et al (1995),United States
235,4010,Point,Missense,370,124,78,EGF1,Exon 4,c.370G>A,p.(Glu124Lys),4,,,NO,Moderate,,Johnsen et al (2017),United States
235,779,Point,Missense,370,124,78,EGF1,Exon 4,c.370G>A,p.(Glu124Lys),<1,84,II,,Severe,-,Bertina et al (1978),Netherlands
235,780,Point,Missense,370,124,78,EGF1,Exon 4,c.370G>A,p.(Glu124Lys),0.1,-,-,,Severe,-,Onay et al (2003),Turkey
1119,4011,Point,Missense,373,125,79,EGF1,Exon 4,c.373G>A,p.(Gly125Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
1119,4012,Point,Missense,373,125,79,EGF1,Exon 4,c.373G>A,p.(Gly125Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
1119,782,Point,Missense,373,125,79,EGF1,Exon 4,c.373G>A,p.(Gly125Arg),<1,-,-,,Severe,-,Centre B30 (unpublished),
1119,781,Point,Missense,373,125,79,EGF1,Exon 4,c.373G>A,p.(Gly125Arg),<1,<1,-,,Severe,-,Costa et al (2000),France
1142,783,Point,Missense,374,125,79,EGF1,Exon 4,c.374G>A,p.(Gly125Glu),-,-,-,,,-,Montejo et al (1999),Spain
236,784,Point,Missense,374,125,79,EGF1,Exon 4,c.374G>T,p.(Gly125Val),-,-,-,,,-,Montejo et al (1999),Spain
237,785,Point,Missense,382,128,82,EGF1,Exon 4,c.382T>C,p.(Cys128Arg),-,-,-,,,-,Centre B43 (unpublished),
238,3436,Point,Missense,383,128,82,EGF1,Exon 4,c.383G>C,p.(Cys128Ser),-,-,-,,Severe,-,Belvini et al (2005),Italy
239,786,Point,Missense,383,128,82,EGF1,Exon 4,c.383G>A,p.(Cys128Tyr),2,-,-,,Moderate,-,Wulff et al (2001),Germany
239,787,Point,Missense,383,128,82,EGF1,Exon 4,c.383G>A,p.(Cys128Tyr),<1,-,-,,Severe,-,Li et al (2000),United States
1207,4784,Point,Nonsense,385,129,83,EGF1,Exon 4,c.385G>T,p.(Glu129*),<1,,,NO,Severe,,Johnsen et al (2017),United States
240,789,Point,Missense,385,129,83,EGF1,Exon 4,c.385G>A,p.(Glu129Lys),<1,<10,-,,Severe,-,Centre B14 (unpublished),
1176,4744,Point,Missense,386,129,83,EGF1,Exon 4,c.386A>G,p.(Glu129Gly),12,,,NO,Mild,,Johnsen et al (2017),United States
1208,4785,Point,Nonsense,389,130,84,EGF2,Exon 4,c.389T>G,p.(Leu130*),<1,,,NO,Severe,,Johnsen et al (2017),United States
1217,4796,Point,Splice,391,,,,Intron 4,c.391+4A>G,,53,,,NO,Mild,,Johnsen et al (2017),United States
998,3270,Point,Splice,391,,,-,Intron 4,c.391+2T>C,N/A,8,-,-,,Mild,-,Centre B30 (unpublished),
998,3271,Point,Splice,391,,,-,Intron 4,c.391+2T>C,N/A,8,-,-,,Mild,-,Centre B30 (unpublished),
998,2948,Point,Splice,391,,,-,Intron 4,c.391+2T>C,N/A,20,-,-,,Mild,-,Elmahmoudi et al (2011),Tunisia
994,3264,Point,Splice,391,,,-,Intron 4,c.391+1G>A,N/A,1,-,-,,Moderate,-,Centre B35 (unpublished),
995,3265,Point,Splice,391,,,-,Intron 4,c.391+1G>C,N/A,-,-,-,,,-,Centre B30 (unpublished),
995,3266,Point,Splice,391,,,-,Intron 4,c.391+1G>C,N/A,-,-,-,,Severe,-,Ketterling et al (1999A),United States
997,3269,Point,Splice,391,,,-,Intron 4,c.391+2T>A,N/A,-,-,-,,,-,Centre B30 (unpublished),
999,3272,Point,Splice,391,,,-,Intron 4,c.391+5G>A,N/A,5,-,-,,Moderate,-,Centre B30 (unpublished),
999,3274,Point,Splice,391,,,-,Intron 4,c.391+5G>A,N/A,-,-,-,,,-,Centre B10 (unpublished),
999,3273,Point,Splice,391,,,-,Intron 4,c.391+5G>A,N/A,-,-,-,,,-,Ketterling et al (1999A),United States
1000,3278,Point,Splice,391,,,-,Intron 4,c.391+7A>G,N/A,4,-,-,,Moderate,-,Saad et al (1994),
1000,3279,Point,Splice,391,,,-,Intron 4,c.391+7A>G,N/A,<1,-,-,,Severe,-,Centre B35 (unpublished),
1000,3280,Point,Splice,391,,,-,Intron 4,c.391+7A>G,N/A,<1,<1,-,,Severe,-,Centre B13 (unpublished),
1000,3281,Point,Splice,391,,,-,Intron 4,c.391+7A>G,N/A,<1,-,-,,Severe,-,Centre B36 (unpublished),
1000,3277,Point,Splice,391,,,-,Intron 4,c.391+7A>G,N/A,<1,-,-,,Severe,-,Ghanem et al (1993),France
1000,3275,Point,Splice,391,,,-,Intron 4,c.391+7A>G,N/A,2,3,II,,Moderate,-,Koeberl et al (1990B),United States
1000,3276,Point,Splice,391,,,-,Intron 4,c.391+7A>G,N/A,<1,<1,-,,Severe,-,Bottema et al (1991),United States
242,788,Point,Splice,391,,,-,Intron 4,c.391+1G>T,N/A,<1,-,-,NO,Severe,-,Belvini et al (2005),Italy
242,1326,Point,Splice,391,,,-,Intron 4,c.391+1G>T,N/A,<1,-,-,NO,Severe,-,Belvini et al (2005),Italy
242,791,Point,Splice,391,,,-,Intron 4,c.391+1G>T,N/A,<1,-,-,,Severe,-,Kwon et al (2008),South Korea
1002,3285,Point,Splice,392,,,-,Intron 4,c.392-2A>G,N/A,<1,-,-,,Severe,-,Ketterling et al (1999A),United States
1002,3288,Point,Splice,392,,,-,Intron 4,c.392-2A>G,N/A,3,3,I,,Moderate,-,Koeberl et al (1990B),United States
1002,4654,Point,Splice,392,,,-,Intron 4,c.392-2A>G,N/A,<1,,,,Severe,,Johnsen et al (2017),United States
1002,3762,Point,Splice,392,,,-,Intron 4,c.392-2A>G,N/A,,,,,,,Heit et al (1998),United States
1001,3706,Point,Splice,392,,,-,Intron 4,c.392-1G>C,N/A,-,-,-,NO,Severe,-,Miller et al (2012),United States
1001,3284,Point,Splice,392,,,-,Intron 4,c.392-1G>C,N/A,<1,<1,-,,Severe,-,Green et al (1991),United Kingdom
1001,3282,Point,Splice,392,,,-,Intron 4,c.392-1G>C,N/A,3,-,-,,Moderate,-,Ketterling et al (1999A),United States
1001,3283,Point,Splice,392,,,-,Intron 4,c.392-1G>C,N/A,-,-,-,,,-,Ketterling et al (1999A),United States
1003,3286,Point,Splice,392,,,-,Intron 4,c.392-2A>T,N/A,<1,-,-,,Severe,-,Ketterling et al (1999A),United States
1004,3287,Point,Splice,392,,,-,Intron 4,c.392-2A>C,N/A,3,4,I,,Moderate,-,Bowen et al (1993),United Kingdom
1006,3289,Point,Splice,392,,,-,Intron 4,c.392-22C>G,N/A,9,-,-,,Mild,-,Centre B30 (unpublished),
1007,3290,Point,Splice,392,,,-,Intron 4,c.392-4T>C,N/A,<1,-,-,,Severe,-,Wulff et al (2001),Germany
1008,3291,Point,Splice,392,,,-,Intron 4,c.392-569C>A,N/A,<1,-,-,,Severe,-,Centre B38 (unpublished),
1009,3292,Point,Splice,392,,,-,Intron 4,c.392-8T>G,N/A,5 to 6,-,-,,Moderate,-,Centre B13 (unpublished),
1010,3293,Point,Splice,392,,,-,Intron 4,c.392-9T>G,N/A,-,-,-,,,-,Montejo et al (1999),Spain
1178,4746,Point,Missense,392,131,85,EGF2,Exon 5,c.392A>C,p.(Asp131Ala),29,,,NO,Mild,,Johnsen et al (2017),United States
1177,4745,Point,Missense,392,131,85,EGF2,Exon 5,c.392A>T,p.(Asp131Val),15,,,,Mild,,Johnsen et al (2017),United States
244,806,Point,Missense,400,134,88,EGF2,Exon 5,c.400T>C,p.(Cys134Arg),<1,-,-,NO,Severe,-,Belvini et al (2005),Italy
244,799,Point,Missense,400,134,88,EGF2,Exon 5,c.400T>C,p.(Cys134Arg),-,-,-,,,-,Centre B2 (unpublished),
244,798,Point,Missense,400,134,88,EGF2,Exon 5,c.400T>C,p.(Cys134Arg),<1,24,II,,Severe,-,Wulff et al (1999),Germany
244,801,Point,Missense,400,134,88,EGF2,Exon 5,c.400T>C,p.(Cys134Arg),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
1112,802,Point,Missense,400,134,88,EGF2,Exon 5,c.400T>G,p.(Cys134Gly),<1,-,-,,Severe,-,Centre B13 (unpublished),
1112,803,Point,Missense,400,134,88,EGF2,Exon 5,c.400T>G,p.(Cys134Gly),<1,14,II,,Severe,-,Centre B25 (unpublished),
245,807,Point,Missense,401,134,88,EGF2,Exon 5,c.401G>T,p.(Cys134Phe),-,-,-,,,-,Jaloma-Cruz et al (2000),Mexico
1046,3446,Point,Missense,401,134,88,EGF2,Exon 5,c.401G>C,p.(Cys134Ser),-,-,-,NO,Severe,-,Belvini et al (2005),Italy
1046,805,Point,Missense,401,134,88,EGF2,Exon 5,c.401G>C,p.(Cys134Ser),<1,-,-,,Severe,-,Centre B39 (unpublished),
1046,804,Point,Missense,401,134,88,EGF2,Exon 5,c.401G>C,p.(Cys134Ser),<1,-,-,,Severe,-,Centre B23 (unpublished),
1111,795,Point,Missense,401,134,88,EGF2,Exon 5,c.401G>A,p.(Cys134Tyr),-,-,-,,,-,Centre B17 (unpublished),
1111,797,Point,Missense,401,134,88,EGF2,Exon 5,c.401G>A,p.(Cys134Tyr),<1,-,-,,Severe,-,Centre B24 (unpublished),
1111,793,Point,Missense,401,134,88,EGF2,Exon 5,c.401G>A,p.(Cys134Tyr),<1,9,II,,Severe,-,Tartary et al (1993),France
1111,796,Point,Missense,401,134,88,EGF2,Exon 5,c.401G>A,p.(Cys134Tyr),1,-,-,,Moderate,-,Jaloma-Cruz et al (2000),Mexico
1111,794,Point,Missense,401,134,88,EGF2,Exon 5,c.401G>A,p.(Cys134Tyr),<1,-,-,,Severe,-,Van de Water et al (1996),New Zealand
1111,808,Point,Missense,401,134,88,EGF2,Exon 5,c.401G>A,p.(Cys134Tyr),-,-,-,,,-,Onay et al (2003),Turkey
247,812,Point,Missense,407,136,90,EGF2,Exon 5,c.407T>C,p.(Ile136Thr),-,-,-,,,-,Centre B30 (unpublished),
247,811,Point,Missense,407,136,90,EGF2,Exon 5,c.407T>C,p.(Ile136Thr),-,-,-,,Mild,-,Wulff et al (1995),Germany
247,810,Point,Missense,407,136,90,EGF2,Exon 5,c.407T>C,p.(Ile136Thr),15,-,-,,Mild,-,Saad et al (1994),United Kingdom
1139,823,Point,Missense,412,138,92,EGF2,Exon 5,c.412A>G,p.(Asn138Asp),-,-,-,,,-,Wulff et al (2001),Germany
1139,824,Point,Missense,412,138,92,EGF2,Exon 5,c.412A>G,p.(Asn138Asp),<1,-,-,,Severe,-,Mahajan et al (2004),India
1139,825,Point,Missense,412,138,92,EGF2,Exon 5,c.412A>G,p.(Asn138Asp),<1,-,-,,Severe,-,Mahajan et al (2004),India
248,814,Point,Missense,412,138,92,EGF2,Exon 5,c.412A>C,p.(Asn138His),5,57,II,NO,Moderate,-,Attali et al (1999),France
248,813,Point,Missense,412,138,92,EGF2,Exon 5,c.412A>C,p.(Asn138His),-,-,-,,,-,Centre B6 (unpublished),
248,816,Point,Missense,412,138,92,EGF2,Exon 5,c.412A>C,p.(Asn138His),<1,-,-,,Severe,-,Centre B36 (unpublished),
248,818,Point,Missense,412,138,92,EGF2,Exon 5,c.412A>C,p.(Asn138His),<1,-,-,,Severe,-,Centre B36 (unpublished),
248,819,Point,Missense,412,138,92,EGF2,Exon 5,c.412A>C,p.(Asn138His),7,-,-,,Mild,-,Centre B36 (unpublished),
248,821,Point,Missense,412,138,92,EGF2,Exon 5,c.412A>C,p.(Asn138His),5,-,-,,Moderate,-,Centre B25 (unpublished),
248,822,Point,Missense,412,138,92,EGF2,Exon 5,c.412A>C,p.(Asn138His),2,-,-,,Moderate,-,Centre B25 (unpublished),
248,820,Point,Missense,412,138,92,EGF2,Exon 5,c.412A>C,p.(Asn138His),12,-,-,,Mild,-,Belvini et al (2005),Italy
248,828,Point,Missense,412,138,92,EGF2,Exon 5,c.412A>C,p.(Asn138His),2,66,II,,Moderate,-,Nishimura et al (1993),Japan
251,3576,Point,Missense,413,138,92,EGF2,Exon 5,c.413A>G,p.(Asn138Ser),-,-,-,NO,Severe,-,Yu et al (2012),China
251,4013,Point,Missense,413,138,92,EGF2,Exon 5,c.413A>G,p.(Asn138Ser),2,,,NO,Moderate,,Johnsen et al (2017),United States
251,829,Point,Missense,413,138,92,EGF2,Exon 5,c.413A>G,p.(Asn138Ser),-,-,-,,Moderate,-,Liu et al (2000),China
252,832,Point,Missense,414,138,92,EGF2,Exon 5,c.414T>A,p.(Asn138Lys),<1,-,-,NO,Severe,-,Attali et al (1999),France
252,830,Point,Missense,414,138,92,EGF2,Exon 5,c.414T>A,p.(Asn138Lys),2,-,-,,Moderate,-,Ghanem et al (1993),France
252,831,Point,Missense,414,138,92,EGF2,Exon 5,c.414T>A,p.(Asn138Lys),<1,86,II,,Severe,-,Tartary et al (1993),France
252,833,Point,Missense,414,138,92,EGF2,Exon 5,c.414T>A,p.(Asn138Lys),<1,-,-,,Severe,-,Ghanem et al (1993),France
253,3474,Point,Missense,415,139,93,EGF2,Exon 5,c.415G>A,p.(Gly139Ser),<1,-,-,NO,Severe,-,Balraj et al (2012),Malaysia
253,3475,Point,Missense,415,139,93,EGF2,Exon 5,c.415G>A,p.(Gly139Ser),<1,-,-,NO,Severe,-,Balraj et al (2012),Malaysia
253,3476,Point,Missense,415,139,93,EGF2,Exon 5,c.415G>A,p.(Gly139Ser),1.5,-,-,NO,Moderate,-,Balraj et al (2012),Malaysia
253,834,Point,Missense,415,139,93,EGF2,Exon 5,c.415G>A,p.(Gly139Ser),1,37,II,,Moderate,-,Centre B14 (unpublished),
253,836,Point,Missense,415,139,93,EGF2,Exon 5,c.415G>A,p.(Gly139Ser),2,30,II,,Moderate,-,Centre B38 (unpublished),
253,837,Point,Missense,415,139,93,EGF2,Exon 5,c.415G>A,p.(Gly139Ser),<1,-,-,,Severe,-,Centre B13 (unpublished),
253,839,Point,Missense,415,139,93,EGF2,Exon 5,c.415G>A,p.(Gly139Ser),<1,-,-,,Severe,-,Belvini et al (2005),Italy
253,835,Point,Missense,415,139,93,EGF2,Exon 5,c.415G>A,p.(Gly139Ser),6,-,-,,Mild,-,Montejo et al (1999),Spain
253,840,Point,Missense,415,139,93,EGF2,Exon 5,c.415G>A,p.(Gly139Ser),3,22,II,,Moderate,-,Ketterling et al (1993A),United States
254,3577,Point,Missense,416,139,93,EGF2,Exon 5,c.416G>A,p.(Gly139Asp),-,-,-,NO,Severe,-,Yu et al (2012),China
254,841,Point,Missense,416,139,93,EGF2,Exon 5,c.416G>A,p.(Gly139Asp),2,30,II,,Moderate,-,Nielsen et al (1992),Denmark
254,842,Point,Missense,416,139,93,EGF2,Exon 5,c.416G>A,p.(Gly139Asp),-,-,-,,Severe,-,Wulff et al (1995),Germany
254,843,Point,Missense,416,139,93,EGF2,Exon 5,c.416G>A,p.(Gly139Asp),-,-,-,,,-,Wulff et al (2001),Germany
254,4014,Point,Missense,416,139,93,EGF2,Exon 5,c.416G>A,p.(Gly139Asp),<1,,,,Severe,,Johnsen et al (2017),United States
255,3668,Point,Missense,420,140,94,EGF2,Exon 5,c.420A>T,p.(Arg140Ser),-,-,-,NO,Moderate,-,Miller et al (2012),United States
255,844,Point,Missense,420,140,94,EGF2,Exon 5,c.420A>T,p.(Arg140Ser),1,84,II,,Moderate,-,Bottema et al (1991),United States
256,847,Point,Missense,421,141,95,EGF2,Exon 5,c.421T>C,p.(Cys141Arg),<1,-,-,NO,Severe,-,Bicocchi et al (2006),Italy
256,848,Point,Missense,421,141,95,EGF2,Exon 5,c.421T>C,p.(Cys141Arg),-,-,-,,,-,Centre B17 (unpublished),
256,846,Point,Missense,421,141,95,EGF2,Exon 5,c.421T>C,p.(Cys141Arg),0.9,-,-,,Severe,-,Belvini et al (2005),Italy
257,849,Point,Missense,421,141,95,EGF2,Exon 5,c.421T>A,p.(Cys141Ser),<1,-,-,,Severe,-,Centre B21 (unpublished),
260,857,Point,Missense,422,141,95,EGF2,Exon 5,c.422G>T,p.(Cys141Phe),-,-,-,,,-,Centre B2 (unpublished),
259,856,Point,Missense,422,141,95,EGF2,Exon 5,c.422G>C,p.(Cys141Ser),<1,-,-,,Severe,-,Centre B13 (unpublished),
258,3491,Point,Missense,422,141,95,EGF2,Exon 5,c.422G>A,p.(Cys141Tyr),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
258,4015,Point,Missense,422,141,95,EGF2,Exon 5,c.422G>A,p.(Cys141Tyr),<1,,,NO,Severe,,Johnsen et al (2017),United States
258,853,Point,Missense,422,141,95,EGF2,Exon 5,c.422G>A,p.(Cys141Tyr),<1,-,-,,Severe,-,Mukherjee et al (2004),India
258,855,Point,Missense,422,141,95,EGF2,Exon 5,c.422G>A,p.(Cys141Tyr),<1,-,-,,Severe,-,Mukherjee et al (2004),India
258,854,Point,Missense,422,141,95,EGF2,Exon 5,c.422G>A,p.(Cys141Tyr),-,-,-,,,-,Nawaz et al (2008),Pakistan
258,850,Point,Missense,422,141,95,EGF2,Exon 5,c.422G>A,p.(Cys141Tyr),5,-,-,,Moderate,-,Bottema et al (1991),United States
258,851,Point,Missense,422,141,95,EGF2,Exon 5,c.422G>A,p.(Cys141Tyr),<1,6,II,,Severe,-,Bottema et al (1991),United States
258,852,Point,Missense,422,141,95,EGF2,Exon 5,c.422G>A,p.(Cys141Tyr),<1,-,-,,Severe,-,Ketterling et al (1999B),United States
261,862,Point,Nonsense,423,141,95,EGF2,Exon 5,c.423C>A,p.(Cys141*),3.5,-,-,,Moderate,-,Centre B30 (unpublished),
261,863,Point,Nonsense,423,141,95,EGF2,Exon 5,c.423C>A,p.(Cys141*),-,-,-,,,-,Centre B42 (unpublished),
261,864,Point,Nonsense,423,141,95,EGF2,Exon 5,c.423C>A,p.(Cys141*),<1,<10,-,,Severe,-,Centre B14 (unpublished),
261,858,Point,Nonsense,423,141,95,EGF2,Exon 5,c.423C>A,p.(Cys141*),<1,-,-,,Severe,-,Tam et al (1991),Canada
261,861,Point,Nonsense,423,141,95,EGF2,Exon 5,c.423C>A,p.(Cys141*),0.9,-,-,,Severe,-,Belvini et al (2005),Italy
261,860,Point,Nonsense,423,141,95,EGF2,Exon 5,c.423C>A,p.(Cys141*),-,-,-,,,-,Saad et al (1994),United Kingdom
261,859,Point,Nonsense,423,141,95,EGF2,Exon 5,c.423C>A,p.(Cys141*),3,-,-,,Moderate,-,Gostout et al (1993),United States
262,869,Point,Missense,423,141,95,EGF2,Exon 5,c.423C>G,p.(Cys141Trp),<1,<5,-,NO,Severe,-,Attali et al (1999),France
262,868,Point,Missense,423,141,95,EGF2,Exon 5,c.423C>G,p.(Cys141Trp),2,-,-,,Moderate,-,Centre B24 (unpublished),
262,867,Point,Missense,423,141,95,EGF2,Exon 5,c.423C>G,p.(Cys141Trp),<1,2,II,,Severe,-,Nielsen et al (1992),Denmark
262,870,Point,Missense,423,141,95,EGF2,Exon 5,c.423C>G,p.(Cys141Trp),-,-,-,,Severe,-,Jenkins et al (2008),Ireland
262,866,Point,Missense,423,141,95,EGF2,Exon 5,c.423C>G,p.(Cys141Trp),<1,-,-,,Severe,-,Ljung et al (2001),Sweden
265,872,Point,Nonsense,424,142,96,EGF2,Exon 5,c.424G>T,p.(Glu142*),-,-,-,,Severe,-,Belvini et al (2005),Italy
264,871,Point,Missense,424,142,96,EGF2,Exon 5,c.424G>A,p.(Glu142Lys),<1,-,-,,Severe,-,Enayat et al (2004),United Kingdom
267,4579,Point,Nonsense,427,143,97,EGF2,Exon 5,c.427C>T,p.(Gln143*),4,,,NO,Moderate,,Johnsen et al (2017),United States
267,874,Point,Nonsense,427,143,97,EGF2,Exon 5,c.427C>T,p.(Gln143*),-,-,-,,Severe,-,Li et al (2000),United States
266,3578,Point,Missense,427,143,97,EGF2,Exon 5,c.427C>G,p.(Gln143Glu),-,-,-,NO,Severe,-,Yu et al (2012),China
266,877,Point,Missense,427,143,97,EGF2,Exon 5,c.427C>G,p.(Gln143Glu),<1,<1,-,,Severe,-,Tartary et al (1993),France
266,878,Point,Missense,427,143,97,EGF2,Exon 5,c.427C>G,p.(Gln143Glu),2,-,-,,Moderate,-,Belvini et al (2005),Italy
268,876,Point,Missense,427,143,97,EGF2,Exon 5,c.427C>A,p.(Gln143Lys),-,-,-,,Severe,-,Belvini et al (2005),Italy
268,875,Point,Missense,427,143,97,EGF2,Exon 5,c.427C>A,p.(Gln143Lys),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
271,880,Point,Missense,428,143,97,EGF2,Exon 5,c.428A>G,p.(Gln143Arg),<1,<1,-,,Severe,-,"Quadros et al, (2009)",India
271,881,Point,Missense,428,143,97,EGF2,Exon 5,c.428A>G,p.(Gln143Arg),<1,-,I,,Severe,-,Ghosh et al (2009),India
270,879,Point,Missense,428,143,97,EGF2,Exon 5,c.428A>C,p.(Gln143Pro),-,-,-,,,-,Centre B18 (unpublished),
273,883,Point,Missense,433,145,99,EGF2,Exon 5,c.433T>C,p.(Cys145Arg),<1,-,-,,Severe,-,Koeberl et al (1990B),United States
1179,4747,Point,Missense,433,145,99,EGF2,Exon 5,c.433T>G,p.(Cys145Gly),1,,,,Moderate,,Johnsen et al (2017),United States
274,3579,Point,Missense,434,145,99,EGF2,Exon 5,c.434G>A,p.(Cys145Tyr),-,-,-,NO,Severe,-,Yu et al (2012),China
274,4016,Point,Missense,434,145,99,EGF2,Exon 5,c.434G>A,p.(Cys145Tyr),2,,,NO,Moderate,,Johnsen et al (2017),United States
274,884,Point,Missense,434,145,99,EGF2,Exon 5,c.434G>A,p.(Cys145Tyr),1,-,-,,Moderate,-,Centre B14 (unpublished),
274,886,Point,Missense,434,145,99,EGF2,Exon 5,c.434G>A,p.(Cys145Tyr),-,-,-,,,-,Centre B9 (unpublished),
274,887,Point,Missense,434,145,99,EGF2,Exon 5,c.434G>A,p.(Cys145Tyr),<1,-,-,,Severe,-,Centre B37 (unpublished),
274,885,Point,Missense,434,145,99,EGF2,Exon 5,c.434G>A,p.(Cys145Tyr),-,-,-,,,-,Nawaz et al (2008),Pakistan
276,889,Point,Nonsense,454,152,106,EGF2,Exon 5,c.454A>T,p.(Lys152*),<1,-,-,,Severe,-,Jayandharan et al (2003),India
733,2664,Point,Missense,457,153,107,EGF2,Exon 5,c.457G>A,p.(Val153Met),-,-,-,,Mild,-,Belvini et al (2005),Italy
278,896,Point,Missense,458,153,107,EGF2,Exon 5,c.458T>C,p.(Val153Ala),20,120,II,,Mild,-,Chen et al (1991a),United States
277,4667,Point,Silent,459,153,107,EGF2,Exon 5,c.459G>A,p.(Val153Val),35,,,NO,Mild,,Johnsen et al (2017),United States
277,4668,Point,Silent,459,153,107,EGF2,Exon 5,c.459G>A,p.(Val153Val),10,,,NO,Mild,,Johnsen et al (2017),United States
277,4669,Point,Silent,459,153,107,EGF2,Exon 5,c.459G>A,p.(Val153Val),18,,,NO,Mild,,Johnsen et al (2017),United States
277,894,Point,Silent,459,153,107,EGF2,Exon 5,c.459G>A,p.(Val153Val),12,20,II,,Mild,-,Centre B38 (unpublished),
277,892,Point,Silent,459,153,107,EGF2,Exon 5,c.459G>A,p.(Val153Val),18,-,-,,Mild,-,Ljung et al (2001),Sweden
277,893,Point,Silent,459,153,107,EGF2,Exon 5,c.459G>A,p.(Val153Val),17,-,-,,Mild,-,Ljung et al (2001),Sweden
277,890,Point,Silent,459,153,107,EGF2,Exon 5,c.459G>A,p.(Val153Val),20,24,I,,Mild,-,Green et al (1991),United Kingdom
277,891,Point,Silent,459,153,107,EGF2,Exon 5,c.459G>A,p.(Val153Val),15,24,II,,Mild,-,Green et al (1991),United Kingdom
277,895,Point,Silent,459,153,107,EGF2,Exon 5,c.459G>A,p.(Val153Val),21,14,I,,Mild,-,Green et al (1991),United Kingdom
281,902,Point,Missense,464,155,109,EGF2,Exon 5,c.464G>T,p.(Cys155Phe),<1,-,-,,Severe,-,Centre B18 (unpublished),
281,904,Point,Missense,464,155,109,EGF2,Exon 5,c.464G>T,p.(Cys155Phe),<1,-,-,,Severe,-,Centre B13 (unpublished),
281,906,Point,Missense,464,155,109,EGF2,Exon 5,c.464G>T,p.(Cys155Phe),2,-,-,,Moderate,-,Centre B8 (unpublished),
281,903,Point,Missense,464,155,109,EGF2,Exon 5,c.464G>T,p.(Cys155Phe),<1,4,II,,Severe,-,Wulff et al (1999),Germany
281,905,Point,Missense,464,155,109,EGF2,Exon 5,c.464G>T,p.(Cys155Phe),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
281,907,Point,Missense,464,155,109,EGF2,Exon 5,c.464G>T,p.(Cys155Phe),-,-,-,,,-,Heit et al (1998),United States
281,4017,Point,Missense,464,155,109,EGF2,Exon 5,c.464G>T,p.(Cys155Phe),<1,,,,Severe,,Johnsen et al (2017),United States
280,4018,Point,Missense,464,155,109,EGF2,Exon 5,c.464G>C,p.(Cys155Ser),<1,,,NO,Severe,,Johnsen et al (2017),United States
280,4019,Point,Missense,464,155,109,EGF2,Exon 5,c.464G>C,p.(Cys155Ser),<1,,,NO,Severe,,Johnsen et al (2017),United States
280,899,Point,Missense,464,155,109,EGF2,Exon 5,c.464G>C,p.(Cys155Ser),<1,-,-,,Severe,-,Centre B37 (unpublished),
280,900,Point,Missense,464,155,109,EGF2,Exon 5,c.464G>C,p.(Cys155Ser),<1,-,-,,Severe,-,Belvini et al (2005),Italy
279,897,Point,Missense,464,155,109,EGF2,Exon 5,c.464G>A,p.(Cys155Tyr),<1,<1,-,NO,Severe,-,Attali et al (1999),France
279,898,Point,Missense,464,155,109,EGF2,Exon 5,c.464G>A,p.(Cys155Tyr),-,-,-,,,-,Centre B39 (unpublished),
282,910,Point,Missense,466,156,110,EGF2,Exon 5,c.466T>C,p.(Ser156Pro),<1,<1,-,,Severe,-,Wulff et al (1999),Germany
282,911,Point,Missense,466,156,110,EGF2,Exon 5,c.466T>C,p.(Ser156Pro),-,-,-,,,-,Wulff et al (2001),Germany
282,908,Point,Missense,466,156,110,EGF2,Exon 5,c.466T>C,p.(Ser156Pro),<1,-,-,,Severe,-,Elmahmoudi et al (2011),Tunisia
282,909,Point,Missense,466,156,110,EGF2,Exon 5,c.466T>C,p.(Ser156Pro),7,<1,I,,Mild,-,Bottema et al (1991),United States
282,4020,Point,Missense,466,156,110,EGF2,Exon 5,c.466T>C,p.(Ser156Pro),<1,,,,Severe,,Johnsen et al (2017),United States
282,3816,Point,Missense,466,156,110,EGF2,Exon 5,c.466T>C,p.(Ser156Pro),,,,,,,Wulff et al (2001),Germany
1110,913,Point,Missense,469,157,111,EGF2,Exon 5,c.469T>C,p.(Cys157Arg),<1,-,-,,Severe,-,Centre B39 (unpublished),
1110,914,Point,Missense,469,157,111,EGF2,Exon 5,c.469T>C,p.(Cys157Arg),<1,-,-,,Severe,-,Centre B9 (unpublished),
1110,912,Point,Missense,469,157,111,EGF2,Exon 5,c.469T>C,p.(Cys157Arg),<1,-,-,,Severe,-,Wulff et al (2001),Germany
1110,915,Point,Missense,469,157,111,EGF2,Exon 5,c.469T>C,p.(Cys157Arg),<1,<1,-,,Severe,-,Lin and Shen (1993),Taiwan
284,923,Point,Missense,470,157,111,EGF2,Exon 5,c.470G>C,p.(Cys157Ser),<6,-,-,,,-,Jaloma-Cruz et al (2000),Mexico
284,922,Point,Missense,470,157,111,EGF2,Exon 5,c.470G>C,p.(Cys157Ser),<1,-,-,,Severe,-,Bowen et al (1993),United Kingdom
283,4021,Point,Missense,470,157,111,EGF2,Exon 5,c.470G>A,p.(Cys157Tyr),<1,,,NO,Severe,,Johnsen et al (2017),United States
283,4022,Point,Missense,470,157,111,EGF2,Exon 5,c.470G>A,p.(Cys157Tyr),<1,,,NO,Severe,,Johnsen et al (2017),United States
283,920,Point,Missense,470,157,111,EGF2,Exon 5,c.470G>A,p.(Cys157Tyr),<1,-,-,,Severe,-,Centre B21 (unpublished),
283,921,Point,Missense,470,157,111,EGF2,Exon 5,c.470G>A,p.(Cys157Tyr),<1,-,-,,Severe,-,Centre B38 (unpublished),
283,917,Point,Missense,470,157,111,EGF2,Exon 5,c.470G>A,p.(Cys157Tyr),<1,-,-,,Severe,-,Drost et al (2000),China
283,919,Point,Missense,470,157,111,EGF2,Exon 5,c.470G>A,p.(Cys157Tyr),<1,-,-,,Severe,-,Drost et al (2000),China
283,918,Point,Missense,470,157,111,EGF2,Exon 5,c.470G>A,p.(Cys157Tyr),<1,-,-,,Severe,-,Jayandharan et al (2005),India
283,916,Point,Missense,470,157,111,EGF2,Exon 5,c.470G>A,p.(Cys157Tyr),1.8,-,-,,Moderate,-,Jaloma-Cruz et al (2000),Mexico
285,924,Point,Nonsense,471,157,111,EGF2,Exon 5,c.471T>A,p.(Cys157*),-,-,-,,Severe,-,Belvini et al (2005),Italy
287,929,Point,Nonsense,478,160,114,EGF2,Exon 5,c.478G>T,p.(Gly160*),<1,-,-,,Severe,-,Belvini et al (2005),Italy
286,925,Point,Missense,478,160,114,EGF2,Exon 5,c.478G>A,p.(Gly160Arg),-,-,-,,,-,Centre B42 (unpublished),
286,926,Point,Missense,478,160,114,EGF2,Exon 5,c.478G>A,p.(Gly160Arg),-,-,-,,,-,Wulff et al (2001),Germany
286,927,Point,Missense,478,160,114,EGF2,Exon 5,c.478G>A,p.(Gly160Arg),<1,-,-,,Severe,-,Mukherjee et al (2004),India
286,4023,Point,Missense,478,160,114,EGF2,Exon 5,c.478G>A,p.(Gly160Arg),<1,,,,Severe,,Johnsen et al (2017),United States
1132,4024,Point,Missense,478,160,114,EGF2,Exon 5,c.478G>C,p.(Gly160Arg),3,,,NO,Moderate,,Johnsen et al (2017),United States
1132,4025,Point,Missense,478,160,114,EGF2,Exon 5,c.478G>C,p.(Gly160Arg),2,,,NO,Moderate,,Johnsen et al (2017),United States
1132,4026,Point,Missense,478,160,114,EGF2,Exon 5,c.478G>C,p.(Gly160Arg),3,,,NO,Moderate,,Johnsen et al (2017),United States
1132,4027,Point,Missense,478,160,114,EGF2,Exon 5,c.478G>C,p.(Gly160Arg),1,,,NO,Moderate,,Johnsen et al (2017),United States
1132,928,Point,Missense,478,160,114,EGF2,Exon 5,c.478G>C,p.(Gly160Arg),-,-,-,,Severe,-,Jenkins et al (2008),Ireland
290,4028,Point,Missense,479,160,114,EGF2,Exon 5,c.479G>C,p.(Gly160Ala),3,,,NO,Moderate,,Johnsen et al (2017),United States
290,4029,Point,Missense,479,160,114,EGF2,Exon 5,c.479G>C,p.(Gly160Ala),4.3,,,NO,Moderate,,Johnsen et al (2017),United States
290,938,Point,Missense,479,160,114,EGF2,Exon 5,c.479G>C,p.(Gly160Ala),13,5,I,,Mild,-,Tam et al (1991),Canada
290,939,Point,Missense,479,160,114,EGF2,Exon 5,c.479G>C,p.(Gly160Ala),5,4,I,,Moderate,-,Winship and Dragon (1991),United Kingdom
289,937,Point,Missense,479,160,114,EGF2,Exon 5,c.479G>A,p.(Gly160Glu),-,-,-,,,-,Centre B39 (unpublished),
289,933,Point,Missense,479,160,114,EGF2,Exon 5,c.479G>A,p.(Gly160Glu),4,-,-,,Moderate,-,Centre B11 (unpublished),
289,934,Point,Missense,479,160,114,EGF2,Exon 5,c.479G>A,p.(Gly160Glu),4,-,-,,Moderate,-,Centre B11 (unpublished),
289,935,Point,Missense,479,160,114,EGF2,Exon 5,c.479G>A,p.(Gly160Glu),7,8,I,,Mild,-,Centre B38 (unpublished),
289,931,Point,Missense,479,160,114,EGF2,Exon 5,c.479G>A,p.(Gly160Glu),-,-,-,,Mild,-,Wulff et al (1995),Germany
289,932,Point,Missense,479,160,114,EGF2,Exon 5,c.479G>A,p.(Gly160Glu),-,-,-,,Mild,-,Wulff et al (1995),Germany
289,936,Point,Missense,479,160,114,EGF2,Exon 5,c.479G>A,p.(Gly160Glu),-,-,-,,,-,Wulff et al (2001),Germany
291,4030,Point,Missense,479,160,114,EGF2,Exon 5,c.479G>T,p.(Gly160Val),<1,,,NO,Severe,,Johnsen et al (2017),United States
291,940,Point,Missense,479,160,114,EGF2,Exon 5,c.479G>T,p.(Gly160Val),<1,2,II,,Severe,-,Centre B38 (unpublished),
291,941,Point,Missense,479,160,114,EGF2,Exon 5,c.479G>T,p.(Gly160Val),1,-,-,,Moderate,-,Mukherjee et al (2004),India
293,4031,Point,Missense,482,161,115,EGF2,Exon 5,c.482A>G,p.(Tyr161Cys),<1,,,NO,Severe,,Johnsen et al (2017),United States
293,947,Point,Missense,482,161,115,EGF2,Exon 5,c.482A>G,p.(Tyr161Cys),-,-,-,,,-,Centre B39 (unpublished),
293,943,Point,Missense,482,161,115,EGF2,Exon 5,c.482A>G,p.(Tyr161Cys),<1,-,-,,Severe,-,Centre B23 (unpublished),
293,945,Point,Missense,482,161,115,EGF2,Exon 5,c.482A>G,p.(Tyr161Cys),-,-,-,,,-,Centre B13 (unpublished),
293,946,Point,Missense,482,161,115,EGF2,Exon 5,c.482A>G,p.(Tyr161Cys),3.8,-,-,,Moderate,-,Liu et al (2000),China
293,944,Point,Missense,482,161,115,EGF2,Exon 5,c.482A>G,p.(Tyr161Cys),2,1,I,,Moderate,-,Saad et al (1994),United Kingdom
294,4580,Point,Nonsense,483,161,115,EGF2,Exon 5,c.483T>A,p.(Tyr161*),<1,,,NO,Severe,,Johnsen et al (2017),United States
294,948,Point,Nonsense,483,161,115,EGF2,Exon 5,c.483T>A,p.(Tyr161*),<1,-,-,,Severe,-,Centre B38 (unpublished),
297,4586,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,,,YES,Severe,,Johnsen et al (2017),United States
297,3580,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),-,-,-,NO,Severe,-,Yu et al (2012),China
297,3695,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),-,-,-,NO,Severe,-,Miller et al (2012),United States
297,4581,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,,,NO,Severe,,Johnsen et al (2017),United States
297,4582,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,,,NO,Severe,,Johnsen et al (2017),United States
297,4583,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,,,NO,Severe,,Johnsen et al (2017),United States
297,4584,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,,,NO,Severe,,Johnsen et al (2017),United States
297,4585,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,,,NO,Severe,,Johnsen et al (2017),United States
297,4587,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,,,NO,Severe,,Johnsen et al (2017),United States
297,967,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,-,-,,Severe,-,Centre B39 (unpublished),
297,970,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),-,-,-,,,-,Centre B39 (unpublished),
297,962,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,<1,-,,Severe,-,Centre B38 (unpublished),
297,963,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),-,-,-,,,-,Centre B19 (unpublished),
297,964,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,-,-,,Severe,-,Centre B9 (unpublished),
297,966,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,<1,-,,Severe,-,Centre B38 (unpublished),
297,968,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,-,-,,Severe,-,Centre B38 (unpublished),
297,969,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,-,-,,Severe,-,Centre B38 (unpublished),
297,960,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,<1,-,,Severe,-,Nielsen et al (1992),Denmark
297,973,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,-,-,,Severe,-,Mahajan et al (2007),India
297,971,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),-,-,-,,Severe,-,Belvini et al (2005),Italy
297,959,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),1,-,-,,Moderate,-,Van de Water et al (1996),New Zealand
297,965,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,<1,-,,Severe,-,Ljung et al (2001),Sweden
297,956,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,<1,-,,Severe,-,Lin and Shen (1993),Taiwan
297,954,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,<0.1,-,,Severe,Also has p.His303Tyr Neutral,Montandon et al (1990A),United Kingdom
297,957,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
297,958,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,0.4,-,,Severe,-,Saad et al (1994),United Kingdom
297,955,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),<1,3,II,,Severe,-,Bottema et al (1991),United States
297,961,Point,Nonsense,484,162,116,EGF2,Exon 5,c.484C>T,p.(Arg162*),1,-,-,,Moderate,-,Thorland et al (1995),United States
296,3703,Point,Silent,484,162,116,EGF2,Exon 5,c.484C>A,p.(Arg162Arg),-,-,-,NO,Mild,-,Miller et al (2012),United States
296,4671,Point,Silent,484,162,116,EGF2,Exon 5,c.484C>A,p.(Arg162Arg),16.45,,,NO,Mild,,Johnsen et al (2017),United States
296,951,Point,Silent,484,162,116,EGF2,Exon 5,c.484C>A,p.(Arg162Arg),4,5,I,,Moderate,-,Centre B39 (unpublished),
296,952,Point,Silent,484,162,116,EGF2,Exon 5,c.484C>A,p.(Arg162Arg),6,7,I,,Mild,-,Wulff et al (2001),Germany
296,953,Point,Silent,484,162,116,EGF2,Exon 5,c.484C>A,p.(Arg162Arg),3,-,-,,Moderate,-,Jayandharan et al (2005),India
296,950,Point,Silent,484,162,116,EGF2,Exon 5,c.484C>A,p.(Arg162Arg),5,5,I,,Moderate,-,Saad et al (1994),United Kingdom
296,4670,Point,Silent,484,162,116,EGF2,Exon 5,c.484C>A,p.(Arg162Arg),6,,,,Mild,,Johnsen et al (2017),United States
298,974,Point,Missense,487,163,117,EGF2,Exon 5,c.487C>T,p.(Leu163Phe),<1,-,-,,Severe,-,Belvini et al (2005),Italy
299,975,Point,Missense,491,164,118,EGF2,Exon 5,c.491C>T,p.(Ala164Val),25,-,-,,Mild,-,Centre B25 (unpublished),
300,976,Point,Missense,496,166,120,EGF2,Exon 5,c.496A>T,p.(Asn166Tyr),<1,0.4,-,,Severe,-,Green et al (1989),United Kingdom
302,4588,Point,Nonsense,499,167,121,EGF2,Exon 5,c.499C>T,p.(Gln167*),<1,,,NO,Severe,,Johnsen et al (2017),United States
302,978,Point,Nonsense,499,167,121,EGF2,Exon 5,c.499C>T,p.(Gln167*),<1,<1,-,,Severe,-,Centre B38 (unpublished),
303,979,Point,Missense,501,167,121,EGF2,Exon 5,c.501G>T,p.(Gln167His),-,-,-,,Mild,-,Wulff et al (1995),Germany
303,981,Point,Missense,501,167,121,EGF2,Exon 5,c.501G>T,p.(Gln167His),-,-,-,,Mild,-,Wulff et al (1995),Germany
303,982,Point,Missense,501,167,121,EGF2,Exon 5,c.501G>T,p.(Gln167His),-,-,-,,,-,Wulff et al (1995),Germany
303,980,Point,Missense,501,167,121,EGF2,Exon 5,c.501G>T,p.(Gln167His),18,-,-,,Mild,-,Van de Water et al (1996),New Zealand
305,4032,Point,Missense,505,169,123,EGF2,Exon 5,c.505T>C,p.(Ser169Pro),<1,,,NO,Severe,,Johnsen et al (2017),United States
305,4033,Point,Missense,505,169,123,EGF2,Exon 5,c.505T>C,p.(Ser169Pro),<1,,,NO,Severe,,Johnsen et al (2017),United States
305,984,Point,Missense,505,169,123,EGF2,Exon 5,c.505T>C,p.(Ser169Pro),<1,-,-,,Severe,-,Centre B37 (unpublished),
305,985,Point,Missense,505,169,123,EGF2,Exon 5,c.505T>C,p.(Ser169Pro),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
306,986,Point,Missense,506,169,123,EGF2,Exon 5,c.506C>G,p.(Ser169Cys),15,-,-,,Mild,-,Vidal et al (2000),Spain
307,987,Point,Missense,507,170,124,EGF2,Exon 5,c.507C>T,p.(Cys170Phe),<1,-,-,,Severe,-,Wulff et al (2001),Germany
308,4034,Point,Missense,508,170,124,EGF2,Exon 5,c.508T>C,p.(Cys170Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
308,988,Point,Missense,508,170,124,EGF2,Exon 5,c.508T>C,p.(Cys170Arg),-,-,-,,,-,Centre B18 (unpublished),
308,989,Point,Missense,508,170,124,EGF2,Exon 5,c.508T>C,p.(Cys170Arg),0,-,-,,Severe,-,Belvini et al (2005),Italy
310,997,Point,Missense,509,170,124,EGF2,Exon 5,c.509G>T,p.(Cys170Phe),-,-,-,,,-,Centre B18 (unpublished),
311,998,Point,Missense,509,170,124,EGF2,Exon 5,c.509G>C,p.(Cys170Ser),<1,-,-,,Severe,-,Li et al (2000),United States
309,4035,Point,Missense,509,170,124,EGF2,Exon 5,c.509G>A,p.(Cys170Tyr),<1,,,NO,Severe,,Johnsen et al (2017),United States
309,992,Point,Missense,509,170,124,EGF2,Exon 5,c.509G>A,p.(Cys170Tyr),<1,-,-,,Severe,-,Centre B30 (unpublished),
309,994,Point,Missense,509,170,124,EGF2,Exon 5,c.509G>A,p.(Cys170Tyr),-,-,-,,,-,Liu et al (2000),China
309,993,Point,Missense,509,170,124,EGF2,Exon 5,c.509G>A,p.(Cys170Tyr),<1,-,-,,Severe,-,Mahajan et al (2004),India
309,995,Point,Missense,509,170,124,EGF2,Exon 5,c.509G>A,p.(Cys170Tyr),<1,-,-,,Severe,-,Belvini et al (2005),Italy
309,991,Point,Missense,509,170,124,EGF2,Exon 5,c.509G>A,p.(Cys170Tyr),2,-,-,,Moderate,-,Bottema et al (1991),United States
312,999,Point,Missense,517,173,127,Linker,Exon 5,c.517G>A,p.(Ala173Thr),-,-,-,,,-,Centre B32 (unpublished),
313,4036,Point,Missense,518,173,127,Linker,Exon 5,c.518C>T,p.(Ala173Val),<1,,,NO,Severe,,Johnsen et al (2017),United States
313,1001,Point,Missense,518,173,127,Linker,Exon 5,c.518C>T,p.(Ala173Val),<1,<10,-,,Severe,-,Centre B14 (unpublished),
313,1000,Point,Missense,518,173,127,Linker,Exon 5,c.518C>T,p.(Ala173Val),<1,<1,-,,Severe,-,Lin and Shen (1993),Taiwan
314,4672,Point,Silent,519,173,127,Linker,Exon 5,c.519A>C,p.(Ala173Ala),5,,,NO,Moderate,,Johnsen et al (2017),United States
314,1002,Point,Silent,519,173,127,Linker,Exon 5,c.519A>C,p.(Ala173Ala),-,-,-,,,-,Centre B18 (unpublished),
314,1003,Point,Silent,519,173,127,Linker,Exon 5,c.519A>C,p.(Ala173Ala),2,-,-,,Moderate,-,Centre B38 (unpublished),
315,1005,Point,Silent,519,173,127,Linker,Exon 5,c.519A>G,p.(Ala173Ala),-,-,-,,,-,Centre B39 (unpublished),
315,1008,Point,Silent,519,173,127,Linker,Exon 5,c.519A>G,p.(Ala173Ala),-,-,-,,,-,Centre B39 (unpublished),
315,1004,Point,Silent,519,173,127,Linker,Exon 5,c.519A>G,p.(Ala173Ala),-,-,-,,,-,Centre B18 (unpublished),
315,1007,Point,Silent,519,173,127,Linker,Exon 5,c.519A>G,p.(Ala173Ala),-,-,-,,,-,Centre B21 (unpublished),
315,1006,Point,Silent,519,173,127,Linker,Exon 5,c.519A>G,p.(Ala173Ala),-,-,-,,,-,Wulff et al (2001),Germany
316,1009,Point,Silent,519,173,127,Linker,Exon 5,c.519A>T,p.(Ala173Ala),-,-,-,,,-,Centre B18 (unpublished),
1012,3300,Point,Splice,520,,,-,Intron 5,c.520+1G>T,N/A,<1,-,-,,Severe,-,Centre B24 (unpublished),
1012,3298,Point,Splice,520,,,-,Intron 5,c.520+1G>T,N/A,<1,-,-,,Severe,-,Ludwig et al (1992A),Germany
1012,1014,Point,Splice,520,,,-,Intron 5,c.520+1G>T,N/A,0.4,-,-,,Severe,-,Kwon et al (2008),South Korea
1012,3299,Point,Splice,520,,,-,Intron 5,c.520+1G>T,N/A,<1,<1,-,,Severe,conference  abstract,Thompson et al (1992B),United States
1012,3301,Point,Splice,520,,,-,Intron 5,c.520+1G>T,N/A,-,-,-,,Severe,-,Ketterling et al (1999A),United States
1013,4655,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,5.1,,,NO,Mild,,Johnsen et al (2017),United States
1013,3326,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,-,-,-,,,-,Centre B30 (unpublished),
1013,3327,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,5,-,-,,Moderate,-,Centre B30 (unpublished),
1013,3316,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,6,-,-,,Mild,-,Centre B30 (unpublished),
1013,3317,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,6,-,-,,Mild,-,Centre B30 (unpublished),
1013,3318,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,-,-,-,,,-,Centre B30 (unpublished),
1013,3319,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,-,-,-,,,-,Centre B30 (unpublished),
1013,3320,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,5,6,I,,Moderate,-,Centre B30 (unpublished),
1013,3309,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,<1,10,II,,Severe,-,Centre B30 (unpublished),
1013,3321,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,9,-,-,,Mild,-,Centre B30 (unpublished),
1013,3322,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,8,-,-,,Mild,-,Centre B30 (unpublished),
1013,3323,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,9,-,-,,Mild,-,Centre B30 (unpublished),
1013,3324,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,12,4,I,,Mild,-,Centre B30 (unpublished),
1013,3305,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,5,5,I,,Moderate,-,Poon et al (1993),Canada
1013,1015,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,-,-,-,,Moderate,-,Belvini et al (2005),Italy
1013,3315,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,8,-,-,,Mild,-,Van de Water et al (1996),New Zealand
1013,3325,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,8,-,-,,Mild,-,Van de Water et al (1996),New Zealand
1013,3304,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,-,-,-,,,-,Saad et al (1994),United Kingdom
1013,3306,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,20,-,-,,Mild,-,Saad et al (1994),United Kingdom
1013,3307,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,4,-,-,,Moderate,-,Saad et al (1994),United Kingdom
1013,3308,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,6,-,-,,Mild,-,Saad et al (1994),United Kingdom
1013,3310,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,11,4,I,,Mild,-,Saad et al (1994),United Kingdom
1013,3311,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,3,-,-,,Moderate,-,Saad et al (1994),United Kingdom
1013,3312,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,3,6,II,,Moderate,-,Haris et al (1994),United Kingdom
1013,3313,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,5,-,-,,Moderate,-,Saad et al (1994),United Kingdom
1013,3314,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,2,6,II,,Moderate,-,Saad et al (1994),United Kingdom
1013,3302,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,10,-,-,,Mild,-,Koeberl et al (1990B),United States
1013,3303,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,10,-,-,,Mild,-,Koeberl et al (1990B),United States
1013,3328,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,3,-,-,,Moderate,-,Ketterling et al (1999A),United States
1013,3329,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,<1,-,-,,Severe,-,Li et al (2000),United States
1013,3330,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,3 to 15,-,-,,Mild,-,Ketterling et al (1999A),United States
1013,3331,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,3,-,-,,Moderate,-,Ketterling et al (1999A),United States
1013,3332,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,2,-,-,,Moderate,-,Ketterling et al (1999A),United States
1013,3333,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,2,-,-,,Moderate,-,Ketterling et al (1999A),United States
1013,3334,Point,Splice,520,,,-,Intron 5,c.520+13A>G,N/A,1 to 13,-,-,,Mild,-,Ketterling et al (1999A),United States
1011,3297,Point,Splice,520,,,-,Intron 5,c.520+1G>A,N/A,-,-,-,,,-,Centre B39 (unpublished),
1011,3294,Point,Splice,520,,,-,Intron 5,c.520+1G>A,N/A,1,-,-,,Moderate,-,Centre B30 (unpublished),
1011,3295,Point,Splice,520,,,-,Intron 5,c.520+1G>A,N/A,-,-,-,,,-,Wulff et al (2001),Germany
1011,3296,Point,Splice,520,,,-,Intron 5,c.520+1G>A,N/A,<1,-,-,,Severe,-,Mahajan et al (2004),India
1011,3345,Point,Splice,520,,,-,Intron 5,c.520+1G>A,N/A,-,-,-,,,-,Weinmann et al (1998),United States
1011,3346,Point,Splice,520,,,-,Intron 5,c.520+1G>A,N/A,<1,-,-,,Severe,-,Weinmann et al (1998),United States
1014,3336,Point,Splice,520,,,-,Intron 5,c.520+2T>A,N/A,-,-,-,,Severe,-,Gostout et al (1993),United States
1015,3338,Point,Splice,520,,,-,Intron 5,c.520+2T>C,N/A,<1,-,-,,Severe,-,Centre B11 (unpublished),
1015,3337,Point,Splice,520,,,-,Intron 5,c.520+2T>C,N/A,<1,-,-,,Severe,-,Ghanem et al (1993),France
1016,3339,Point,Splice,520,,,-,Intron 5,c.520+2T>G,N/A,<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
1017,3340,Point,Splice,520,,,-,Intron 5,c.520+4A>G,N/A,3,4,I,,Moderate,-,Centre B38 (unpublished),
319,1013,Point,Missense,520,174,128,Linker,Exon 5,c.520G>T,p.(Val174Leu),<1,-,-,,Severe,-,Centre B25 (unpublished),
319,4037,Point,Missense,520,174,128,Linker,Exon 5,c.520G>T,p.(Val174Leu),<1,,,,Severe,,Johnsen et al (2017),United States
318,1012,Point,Missense,520,174,128,Linker,Exon 5,c.520G>A,p.(Val174Met),<1,-,-,,Severe,-,Centre B38 (unpublished),
318,1011,Point,Missense,520,174,128,Linker,Exon 5,c.520G>A,p.(Val174Met),1,-,-,,Moderate,-,Bottema et al (1991),United States
1018,3341,Point,Splice,521,,,-,Intron 5,c.521-1G>C,N/A,<1,-,-,,Severe,-,Centre B9 (unpublished),
1019,4656,Point,Splice,521,,,-,Intron 5,c.521-2A>G,N/A,<1,,,NO,Severe,,Johnsen et al (2017),United States
1019,3342,Point,Splice,521,,,-,Intron 5,c.521-2A>G,N/A,1.5,-,-,,Moderate,-,Ketterling et al (1999A),United States
1020,3343,Point,Splice,521,,,-,Intron 5,c.521-3T>G,N/A,<1,-,-,,Severe,-,Centre B2 (unpublished),
322,1018,Point,Missense,529,177,131,Linker,Exon 6,c.529C>T,p.(Pro177Ser),-,-,-,,,-,Centre B39 (unpublished),
322,1016,Point,Missense,529,177,131,Linker,Exon 6,c.529C>T,p.(Pro177Ser),<1,<1,-,,Severe,-,Costa et al (2000),France
1115,1017,Point,Missense,530,177,131,Linker,Exon 6,c.530C>T,p.(Pro177Leu),-,-,-,,,-,Centre B18 (unpublished),
323,3581,Point,Missense,532,178,132,Linker,Exon 6,c.532T>C,p.(Cys178Arg),-,-,-,NO,Severe,-,Yu et al (2012),China
323,1022,Point,Missense,532,178,132,Linker,Exon 6,c.532T>C,p.(Cys178Arg),2,-,-,,Moderate,-,Centre B35 (unpublished),
323,1023,Point,Missense,532,178,132,Linker,Exon 6,c.532T>C,p.(Cys178Arg),<1,<10,-,,Severe,-,Centre B14 (unpublished),
323,1024,Point,Missense,532,178,132,Linker,Exon 6,c.532T>C,p.(Cys178Arg),<1,<10,-,,Severe,-,Centre B14 (unpublished),
323,1021,Point,Missense,532,178,132,Linker,Exon 6,c.532T>C,p.(Cys178Arg),<1,<1,-,,Severe,-,Nielsen et al (1995),Denmark
323,1028,Point,Missense,532,178,132,Linker,Exon 6,c.532T>C,p.(Cys178Arg),<1,<1,-,,Severe,-,Ghanem et al (1993),France
323,1026,Point,Missense,532,178,132,Linker,Exon 6,c.532T>C,p.(Cys178Arg),-,-,-,,,-,Mukherjee et al (2004),India
323,1025,Point,Missense,532,178,132,Linker,Exon 6,c.532T>C,p.(Cys178Arg),2,-,-,,Moderate,-,Montejo et al (1999),Spain
323,1019,Point,Missense,532,178,132,Linker,Exon 6,c.532T>C,p.(Cys178Arg),<1,<1,-,,Severe,-,Lin and Shen (1993),Taiwan
323,1020,Point,Missense,532,178,132,Linker,Exon 6,c.532T>C,p.(Cys178Arg),<1,<1,-,,Severe,-,Lin and Shen (1993),Taiwan
323,1027,Point,Missense,532,178,132,Linker,Exon 6,c.532T>C,p.(Cys178Arg),<1,-,-,,Severe,-,Enayat et al (2004),United Kingdom
1149,1029,Point,Missense,532,178,132,Linker,Exon 6,c.532T>G,p.(Cys178Gly),-,-,-,,,-,Saad et al (1994),United Kingdom
326,1038,Point,Missense,533,178,132,Linker,Exon 6,c.533G>T,p.(Cys178Phe),<1,-,-,,Severe,-,Centre B18 (unpublished),
326,1039,Point,Missense,533,178,132,Linker,Exon 6,c.533G>T,p.(Cys178Phe),<1,-,-,,Severe,-,Centre B21 (unpublished),
326,1040,Point,Missense,533,178,132,Linker,Exon 6,c.533G>T,p.(Cys178Phe),<1,<1,-,,Severe,-,Green et al (1991),United Kingdom
325,1037,Point,Missense,533,178,132,Linker,Exon 6,c.533G>C,p.(Cys178Ser),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
324,3492,Point,Missense,533,178,132,Linker,Exon 6,c.533G>A,p.(Cys178Tyr),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
324,1033,Point,Missense,533,178,132,Linker,Exon 6,c.533G>A,p.(Cys178Tyr),<1,<1,-,NO,Severe,-,Bicocchi et al (2006),Italy
324,4038,Point,Missense,533,178,132,Linker,Exon 6,c.533G>A,p.(Cys178Tyr),<1,,,NO,Severe,,Johnsen et al (2017),United States
324,4039,Point,Missense,533,178,132,Linker,Exon 6,c.533G>A,p.(Cys178Tyr),<1,,,NO,Severe,,Johnsen et al (2017),United States
324,1034,Point,Missense,533,178,132,Linker,Exon 6,c.533G>A,p.(Cys178Tyr),-,-,-,,,-,Centre B30 (unpublished),
324,1032,Point,Missense,533,178,132,Linker,Exon 6,c.533G>A,p.(Cys178Tyr),<1,-,-,,Severe,-,Tartary et al (1993),France
324,1036,Point,Missense,533,178,132,Linker,Exon 6,c.533G>A,p.(Cys178Tyr),1,-,-,,Moderate,-,Belvini et al (2005),Italy
324,1031,Point,Missense,533,178,132,Linker,Exon 6,c.533G>A,p.(Cys178Tyr),<1,<1,-,,Severe,-,Lin and Shen (1993),Taiwan
324,1030,Point,Missense,533,178,132,Linker,Exon 6,c.533G>A,p.(Cys178Tyr),<1,-,-,,Severe,-,Bottema et al (1991),United States
327,1041,Point,Missense,534,178,132,Linker,Exon 6,c.534T>G,p.(Cys178Trp),<1,-,-,,Severe,-,Wulff et al (1995),Germany
1060,3530,Point,Nonsense,535,179,133,Linker,Exon 6,c.535G>T,p.(Gly179*),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
328,1042,Point,Missense,535,179,133,Linker,Exon 6,c.535G>A,p.(Gly179Arg),4,4,I,,Moderate,-,Centre B41 (unpublished),
1154,1043,Point,Missense,536,179,133,Linker,Exon 6,c.536G>A,p.(Gly179Glu),<1,<1,-,,Severe,-,Tartary et al (1993),France
1070,3487,Point,Nonsense,551,184,138,Linker,Exon 6,c.551C>A,p.(Ser184*),-,-,-,NO,Severe,-,Yu et al (2012),China
1209,4786,Point,Nonsense,551,184,138,Serine Protease,Exon 6,c.551C>G,p.(Ser184*),<1,,,NO,Severe,,Johnsen et al (2017),United States
1210,4787,Point,Nonsense,553,185,139,Serine Protease,Exon 6,c.553C>T,p.(Gln185*),<1,,,NO,Severe,,Johnsen et al (2017),United States
334,3493,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),2.5,-,-,NO,Moderate,-,Radic et al (2013),Argentina
334,1092,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),1,43,II,NO,Moderate,-,Attali et al (1999),France
334,4042,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),1,,,NO,Moderate,,Johnsen et al (2017),United States
334,4041,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),3,,,NO,Moderate,,Johnsen et al (2017),United States
334,4040,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),<1,,,NO,Severe,,Johnsen et al (2017),United States
334,4046,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),1.66,,,NO,Moderate,,Johnsen et al (2017),United States
334,4043,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),4,,,NO,Moderate,,Johnsen et al (2017),United States
334,4045,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),4,,,NO,Moderate,,Johnsen et al (2017),United States
334,4047,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),<1,,,NO,Severe,,Johnsen et al (2017),United States
334,4044,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),3,,,NO,Moderate,,Johnsen et al (2017),United States
334,1098,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),-,-,-,,,-,Centre B39 (unpublished),
334,1081,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),2,-,-,,Moderate,-,Centre B39 (unpublished),
334,1097,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),-,-,-,,,-,Centre B39 (unpublished),
334,1103,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),5,-,-,,Moderate,-,Centre B36 (unpublished),
334,1102,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),4,-,-,,Moderate,-,Centre B36 (unpublished),
334,1101,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),3,-,-,,Moderate,-,Centre B36 (unpublished),
334,1099,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),2.6,-,-,,Moderate,-,Centre B36 (unpublished),
334,1078,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),<1,-,-,,Severe,-,Centre B12 (unpublished),
334,1068,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),3,-,-,,Moderate,-,Centre B30 (unpublished),
334,1087,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),2,18,II,,Moderate,-,Centre B38 (unpublished),
334,1091,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),<1,-,-,,Severe,-,Centre B30 (unpublished),
334,1071,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),<1,-,-,,Severe,-,Centre B18 (unpublished),
334,1086,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),4,-,-,,Moderate,-,Centre B14 (unpublished),
334,1085,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),2,38,II,,Moderate,-,Centre B14 (unpublished),
334,1082,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),2,-,-,,Moderate,-,Centre B13 (unpublished),
334,1075,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),-,-,-,,,-,Centre B30 (unpublished),
334,1076,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),4,-,-,,Moderate,-,Centre B30 (unpublished),
334,1096,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),2,-,-,,Moderate,-,Centre B36 (unpublished),
334,1084,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),1,17,II,,Moderate,-,Centre B38 (unpublished),
334,1066,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),3,-,-,,Moderate,-,Centre B30 (unpublished),
334,1064,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),<1,30,II,,Severe,-,Poon et al (1993),Canada
334,1093,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),-,-,-,,Severe,-,Liu et al (2000),China
334,1077,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),3,36,II,,Moderate,-,Costa et al (2000),France
334,1088,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),2,-,-,,Moderate,-,Wulff and Herrmann (1999),Germany
334,1059,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),16,-,-,,Mild,-,Knobloch et al (1993),Germany
334,1060,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),3,-,-,,Moderate,-,Knobloch et al (1993),Germany
334,1070,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),-,-,-,,Moderate,-,Wulff et al (1995),Germany
334,1080,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),-,-,-,,,-,Wulff et al (2001),Germany
334,1090,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),-,-,-,,,-,Wulff and Herrmann (1999),Germany
334,1067,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),2.5,-,-,,Moderate,-,Jayandharan et al (2005),India
334,1104,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),2.5,-,-,,Moderate,-,Mukherjee et al (2004),India
334,1056,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),2,-,-,,Moderate,-,Belvini et al (2005),Italy
334,1063,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),5,-,-,,Moderate,-,Van de Water et al (1996),New Zealand
334,1089,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),-,-,-,,,-,Montejo et al (1999),Spain
334,1094,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),<1,-,-,,Severe,-,Vidal et al (2000),Spain
334,1083,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),-,-,-,,,-,Montejo et al (1999),Spain
334,1079,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),3,-,-,,Moderate,-,Ljung et al (2001),Sweden
334,1065,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),3,32,II,,Moderate,-,Saad et al (1994),United Kingdom
334,1057,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),-,-,-,,,-,Saad et al (1994),United Kingdom
334,1055,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),2,-,-,,Moderate,-,Saad et al (1994),United Kingdom
334,1054,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),<1,13,II,,Severe,-,Saad et al (1994),United Kingdom
334,1050,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),<1,66,II,,Severe,-,Liddell et al (1989),United Kingdom
334,1053,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),3,54,II,,Moderate,-,Winship and Dragon (1991),United Kingdom
334,1052,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),2,43,II,,Moderate,-,Green et al (1990),United Kingdom
334,1051,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),1,-,-,,Moderate,-,Green et al (1990),United Kingdom
334,1069,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),<1,34,II,,Severe,-,Saad et al (1994),United Kingdom
334,1074,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),2,60,II,,Moderate,-,Chen et al (1995),United States
334,1058,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),2,40,II,,Moderate,-,Thompson and Chen (1992),United States
334,1062,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),3,52,II,,Moderate,-,Bottema et al (1993),United States
334,1061,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),3,52,II,,Moderate,-,Thompson and Chen (1994),United States
334,1105,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),-,-,-,,Mild,-,Li et al (2000),United States
334,1106,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),1,30,II,,Moderate,-,Toomey et al (1988),United States
334,1073,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),4,44,II,,Moderate,-,Chen et al (1995),United States
334,1072,Point,Missense,571,191,145,Linker,Exon 6,c.571C>T,p.(Arg191Cys),2,62,II,,Moderate,-,Chen et al (1995),United States
333,1049,Point,Missense,571,191,145,Linker,Exon 6,c.571C>A,p.(Arg191Ser),-,-,-,,,-,Nielsen et al (1995),Denmark
338,3584,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,-,-,NO,Moderate,-,Yu et al (2012),China
338,1150,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),4,-,-,NO,Moderate,-,Attali et al (1999),France
338,1151,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5,91,II,NO,Moderate,-,Attali et al (1999),France
338,1152,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),3,75,II,NO,Moderate,-,Attali et al (1999),France
338,1153,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),4,147,II,NO,Moderate,-,Attali et al (1999),France
338,1154,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),3,-,-,NO,Moderate,-,Attali et al (1999),France
338,1155,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),7,120,II,NO,Mild,-,Attali et al (1999),France
338,1156,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),4,80,II,NO,Moderate,-,Attali et al (1999),France
338,1157,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5,140,II,NO,Moderate,-,Attali et al (1999),France
338,1123,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),2,40 to 140,II,NO,Moderate,-,Bicocchi et al (2006),Italy
338,3669,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,-,-,NO,Moderate,-,Miller et al (2012),United States
338,3670,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,-,-,NO,Mild,-,Miller et al (2012),United States
338,4048,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5,,,NO,Moderate,,Johnsen et al (2017),United States
338,4051,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),2,,,NO,Moderate,,Johnsen et al (2017),United States
338,4052,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),3,,,NO,Moderate,,Johnsen et al (2017),United States
338,4053,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),3,,,NO,Moderate,,Johnsen et al (2017),United States
338,4055,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),<1,,,NO,Severe,,Johnsen et al (2017),United States
338,4056,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),3,,,NO,Moderate,,Johnsen et al (2017),United States
338,4057,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),3,,,NO,Moderate,,Johnsen et al (2017),United States
338,4058,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),3,,,NO,Moderate,,Johnsen et al (2017),United States
338,4059,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),4,,,NO,Moderate,,Johnsen et al (2017),United States
338,4060,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5,,,NO,Moderate,,Johnsen et al (2017),United States
338,4061,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),4,,,NO,Moderate,,Johnsen et al (2017),United States
338,4062,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),17.7,,,NO,Mild,,Johnsen et al (2017),United States
338,4063,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),4,,,NO,Moderate,,Johnsen et al (2017),United States
338,4064,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),7,,,NO,Mild,,Johnsen et al (2017),United States
338,4065,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),3,,,NO,Moderate,,Johnsen et al (2017),United States
338,4066,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),10,,,NO,Mild,,Johnsen et al (2017),United States
338,4067,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),4,,,NO,Moderate,,Johnsen et al (2017),United States
338,1159,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5,-,-,,Moderate,-,Centre B39 (unpublished),
338,1172,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,-,-,,,-,Centre B39 (unpublished),
338,1173,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,-,-,,,-,Centre B39 (unpublished),
338,1125,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),9,105,II,,Mild,-,Aguilar-Martinez et al (1994B),
338,1126,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),8,-,-,,Mild,-,Centre B6 (unpublished),
338,1127,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,-,-,,,-,Centre B8 (unpublished),
338,1132,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,-,-,,,-,Centre B31 (unpublished),
338,1134,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),3,-,-,,Moderate,-,Centre B30 (unpublished),
338,1135,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5,-,-,,Moderate,-,Centre B30 (unpublished),
338,1136,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5,-,-,,Moderate,-,Centre B30 (unpublished),
338,1138,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),7,-,-,,Mild,-,Centre B1 (unpublished),
338,1139,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5,-,-,,Moderate,-,Centre B13 (unpublished),
338,1140,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),3 to 4,-,-,,Moderate,-,Centre B13 (unpublished),
338,1142,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),4,-,-,,Moderate,-,Centre B13 (unpublished),
338,1146,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,105,-,,Mild,-,Centre B38 (unpublished),
338,1147,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),7,-,-,,Mild,-,Centre B13 (unpublished),
338,1148,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5,-,-,,Moderate,-,Centre B13 (unpublished),
338,1149,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,-,-,,,-,Centre B30 (unpublished),
338,1158,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),3,-,-,,Moderate,-,Centre B20 (unpublished),
338,1161,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5,-,-,,Moderate,-,Centre B36 (unpublished),
338,1162,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),<1,-,-,,Severe,-,Centre B36 (unpublished),
338,1163,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),4 to 5,-,-,,Moderate,-,Centre B13 (unpublished),
338,1164,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),3,-,-,,Moderate,-,Centre B13 (unpublished),
338,1165,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),7,-,-,,Mild,-,Centre B13 (unpublished),
338,1166,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),2,-,-,,Moderate,-,Centre B13 (unpublished),
338,1167,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),3 to 5,-,-,,Moderate,-,Centre B13 (unpublished),
338,1168,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5,-,-,,Moderate,-,Centre B13 (unpublished),
338,1169,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),6,-,-,,Mild,-,Centre B25 (unpublished),
338,1170,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),8,-,-,,Mild,-,Centre B25 (unpublished),
338,1171,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),22,-,-,,Mild,-,Centre B25 (unpublished),
338,1174,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,-,-,,,-,Centre B36 (unpublished),
338,1175,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),3,-,-,,Moderate,-,Centre B36 (unpublished),
338,1176,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),2.29,-,-,,Moderate,-,Centre B36 (unpublished),
338,1177,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),2.5,-,-,,Moderate,-,Centre B36 (unpublished),
338,1178,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5.5,-,-,,Moderate,-,Centre B36 (unpublished),
338,1179,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),19,-,-,,Mild,-,Centre B36 (unpublished),
338,1180,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),3.8,-,-,,Moderate,-,Centre B36 (unpublished),
338,1181,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,-,-,,,-,Centre B20 (unpublished),
338,1182,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5,-,-,,Moderate,-,Centre B25 (unpublished),
338,1184,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),10,80,II,,Mild,-,Centre B38 (unpublished),
338,1185,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,-,-,,,-,Centre B38 (unpublished),
338,1186,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),2.5,-,-,,Moderate,-,Centre B32 (unpublished),
338,1187,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),4.2,-,-,,Moderate,-,Centre B32 (unpublished),
338,1137,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),9,104,II,,Mild,-,Costa et al (2000),France
338,1143,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5,94,II,,Moderate,-,Costa et al (2000),France
338,1128,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,-,-,,Mild,-,Wulff et al (1995),Germany
338,1141,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),<1,-,-,,Severe,-,Wulff et al (2001),Germany
338,1144,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,-,-,,,-,Wulff and Herrmann (1999),Germany
338,1145,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),12,73,II,,Mild,-,Wulff and Herrmann (1999),Germany
338,1160,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,-,-,,,-,Wulff and Herrmann (1999),Germany
338,1114,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,-,-,,Mild,-,Belvini et al (2005),Italy
338,1115,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),4,100,II,,Moderate,-,Suehiro et al (1990),Japan
338,1117,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),3,-,-,,Moderate,-,Van de Water et al (1996),New Zealand
338,1133,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5,-,-,,Moderate,-,Van de Water et al (1996),New Zealand
338,1121,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),9,-,-,,Mild,-,David et al (1993),Portugal
338,1124,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),7,148,II,,Mild,-,Green et al (1991),Sweden
338,1120,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),1,60,II,,Moderate,-,Lin and Shen (1993),Taiwan
338,1109,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),4 to 11,91,-,,Mild,-,Green et al (1991),United Kingdom
338,1110,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),7,148,II,,Mild,-,Green et al (1991),United Kingdom
338,1111,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5 to 8,115,II,,Mild,-,Green et al (1991),United Kingdom
338,1112,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),7,110,II,,Mild,-,Green et al (1991),United Kingdom
338,1113,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,-,-,,,-,Green et al (1991),United Kingdom
338,1122,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),-,-,-,,,-,Saad et al (1994),United Kingdom
338,1131,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),7,-,-,,Mild,-,Saad et al (1994),United Kingdom
338,1107,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),7,160,II,,Mild,-,Diuguid et al (1989),United States
338,1108,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),4,-,-,,Moderate,-,Koeberl et al (1989),United States
338,1116,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),6,100,II,,Mild,-,Bottema et al (1990C),United States
338,1118,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),11,-,-,,Mild,-,Bottema et al (1991),United States
338,1119,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),4,-,-,,Moderate,-,Bottema et al (1991),United States
338,1129,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),11,100,II,,Mild,-,Chen et al (1995),United States
338,1130,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5,44,II,,Moderate,-,Bottema et al (1993),United States
338,1183,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),10,80,II,,Mild,-,Chen et al (1995),United States
338,1198,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),8,100,II,,Mild,-,Noyes et al (1983),United States
338,4049,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),3,,,,Moderate,,Johnsen et al (2017),United States
338,4050,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),2,,,,Moderate,,Johnsen et al (2017),United States
338,4054,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),8,,,,Mild,,Johnsen et al (2017),United States
338,3766,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),5,,,,Mild,,Jenkins et al (2008),Ireland
338,3761,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),,,,,,,Hamaguchi et al (1991),Japan
338,3740,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),7,148,II,,Mild,,Green et al (1990) ,United Kingdom
338,3738,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),6,115,II,,Mild,,Green et al (1990) ,United Kingdom
338,3739,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),7,110,II,,Mild,,Green et al (1990) ,United Kingdom
338,3736,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),4-11,91,II,,Mild,,Green et al (1990) ,United Kingdom
338,3737,Point,Missense,572,191,145,Linker,Exon 6,c.572G>A,p.(Arg191His),,,,,,,Green et al (1990) ,United Kingdom
340,1196,Point,Missense,572,191,145,Linker,Exon 6,c.572G>T,p.(Arg191Leu),3,-,-,,Moderate,-,Centre B11 (unpublished),
340,1200,Point,Missense,572,191,145,Linker,Exon 6,c.572G>T,p.(Arg191Leu),7,60,II,,Mild,-,Centre B21 (unpublished),
340,1201,Point,Missense,572,191,145,Linker,Exon 6,c.572G>T,p.(Arg191Leu),3.5,-,-,,Moderate,-,Belvini et al (2005),Italy
340,1195,Point,Missense,572,191,145,Linker,Exon 6,c.572G>T,p.(Arg191Leu),2,40,II,,Moderate,-,Chen et al (1995),United States
339,1188,Point,Missense,572,191,145,Linker,Exon 6,c.572G>C,p.(Arg191Pro),5,73,II,NO,Moderate,-,Attali et al (1999),France
339,1189,Point,Missense,572,191,145,Linker,Exon 6,c.572G>C,p.(Arg191Pro),-,-,-,,,-,Centre B39 (unpublished),
339,1193,Point,Missense,572,191,145,Linker,Exon 6,c.572G>C,p.(Arg191Pro),3,-,-,,Moderate,-,Centre B25 (unpublished),
339,1194,Point,Missense,572,191,145,Linker,Exon 6,c.572G>C,p.(Arg191Pro),9,-,-,,Mild,-,Centre B25 (unpublished),
339,1199,Point,Missense,572,191,145,Linker,Exon 6,c.572G>C,p.(Arg191Pro),36,-,-,,Mild,-,Centre B30 (unpublished),
339,1190,Point,Missense,572,191,145,Linker,Exon 6,c.572G>C,p.(Arg191Pro),3.7,-,-,,Moderate,-,Kwon et al (2008),South Korea
339,1191,Point,Missense,572,191,145,Linker,Exon 6,c.572G>C,p.(Arg191Pro),4,-,-,,Moderate,-,Kwon et al (2008),South Korea
341,1202,Point,Missense,574,192,146,Act-Peptide,Exon 6,c.574G>C,p.(Ala192Pro),6,-,-,,Mild,-,Centre B30 (unpublished),
341,1203,Point,Missense,574,192,146,Act-Peptide,Exon 6,c.574G>C,p.(Ala192Pro),6,-,-,,Mild,-,Centre B30 (unpublished),
343,1205,Point,Nonsense,603,201,155,Act-Peptide,Exon 6,c.603T>G,p.(Tyr201*),<1,<1,-,,Severe,-,Thompson and Chen (1994),United States
1180,4748,Point,Missense,613,205,159,Act-Peptide,Exon 6,c.613A>G,p.(Thr205Ala),33,,,NO,Mild,,Johnsen et al (2017),United States
345,1208,Point,Nonsense,622,208,162,Act-Peptide,Exon 6,c.622G>T,p.(Glu208*),<1,<2,-,,Severe,-,Centre B25 (unpublished),
345,1209,Point,Nonsense,622,208,162,Act-Peptide,Exon 6,c.622G>T,p.(Glu208*),<1,-,-,,Severe,-,Centre B37 (unpublished),
345,1210,Point,Nonsense,622,208,162,Act-Peptide,Exon 6,c.622G>T,p.(Glu208*),<1,-,-,,Severe,-,Belvini et al (2005),Italy
1072,3648,Point,Nonsense,646,216,170,Act-Peptide,Exon 6,c.646C>T,p.(Gln216*),-,-,-,NO,Severe,-,Yu et al (2012),China
1072,3808,Point,Nonsense,646,216,170,Act-Peptide,Exon 6,c.646C>T,p.(Gln216*),,,,,,,Yu et al (2012),China
347,3524,Point,Nonsense,655,219,173,Act-Peptide,Exon 6,c.655C>T,p.(Gln219*),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
347,4589,Point,Nonsense,655,219,173,Act-Peptide,Exon 6,c.655C>T,p.(Gln219*),<1,,,NO,Severe,,Johnsen et al (2017),United States
347,1212,Point,Nonsense,655,219,173,Act-Peptide,Exon 6,c.655C>T,p.(Gln219*),<1,-,-,,Severe,-,Koeberl et al (1989),United States
351,3586,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>G,p.(Arg226Gly),-,-,-,NO,Severe,-,Yu et al (2012),China
351,1216,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>G,p.(Arg226Gly),<1,64,II,,Severe,-,Aguilar-Martinez et al (1994B),
351,1219,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>G,p.(Arg226Gly),<1,85,II,,Severe,Also has p.Phe224Leu polymorphism,Ghanem et al (1993),France
351,1215,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>G,p.(Arg226Gly),<1,90,II,,Severe,-,Solera et al (1991),Spain
351,1217,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>G,p.(Arg226Gly),12.2,-,-,,Mild,-,Onay et al (2003),Turkey
351,1218,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>G,p.(Arg226Gly),-,-,-,,,-,Onay et al (2003),Turkey
352,3585,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),-,-,-,NO,Moderate,-,Yu et al (2012),China
352,3462,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,-,-,NO,Severe,-,Jayandharan et al (2009),India
352,4070,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,,,NO,Severe,,Johnsen et al (2017),United States
352,4069,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,,,NO,Severe,,Johnsen et al (2017),United States
352,4068,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,,,NO,Severe,,Johnsen et al (2017),United States
352,1256,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,-,-,,Severe,-,Centre B39 (unpublished),
352,1255,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),-,-,-,,,-,Centre B39 (unpublished),
352,1254,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,-,-,,Severe,-,Centre B39 (unpublished),
352,1247,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),1,-,-,,Moderate,-,Centre B35 (unpublished),
352,1250,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,-,-,,Severe,-,Centre B24 (unpublished),
352,1253,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,-,-,,Severe,-,Centre B21 (unpublished),
352,1259,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),0,-,-,,Severe,-,Centre B36 (unpublished),
352,1236,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,-,-,,Severe,-,Centre B18 (unpublished),
352,1239,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,-,-,,Severe,-,Centre B30 (unpublished),
352,1248,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,59,II,,Severe,-,Centre B14 (unpublished),
352,1251,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),-,-,-,,,-,Liu et al (2000),China
352,1252,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),-,-,-,,Severe,-,Liu et al (2000),China
352,1234,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),-,-,-,,,-,Nielsen et al (1995),Denmark
352,1233,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,-,-,,Severe,-,Nielsen et al (1995),Denmark
352,1227,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,-,-,,Severe,-,Ghanem et al (1993),France
352,1249,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,-,-,,Severe,-,Costa et al (2000),France
352,1232,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),2,-,-,,Moderate,-,Tartary et al (1993),France
352,1222,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,69,II,,Severe,-,Ludwig et al (1992A),Germany
352,1243,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,-,-,,Severe,-,Wulff et al (2001),Germany
352,1242,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,77,II,,Severe,-,Wulff et al (1999),Germany
352,1235,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),0.3,-,-,,Severe,-,Belvini et al (2005),Italy
352,1226,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,120,II,,Severe,-,Hamaguchi et al (1991),Japan
352,1261,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,100,II,,Severe,-,Suehiro et al (1989),Japan
352,1221,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,130,II,,Severe,-,Bertina et al (1990),Netherlands
352,1244,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),-,-,-,,,-,Nawaz et al (2008),Pakistan
352,1231,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),1.3,-,-,,Moderate,-,Kwon et al (2008),South Korea
352,1260,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,-,-,,Severe,-,Elmahmoudi et al (2011),Tunisia
352,1220,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,-,-,,Severe,-,Onay et al (2003),Turkey
352,1238,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),5,-,-,,Moderate,-,Saad et al (1994),United Kingdom
352,1223,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,-,-,,Severe,-,Demers et al (1990),United States
352,1224,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,74,II,,Severe,-,Driscoll et al (1989),United States
352,1228,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,50,II,,Severe,-,Thompson and Chen (1992),United States
352,1229,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,110,II,,Severe,-,Thompson and Chen (1992),United States
352,1230,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,45,II,,Severe,-,Ketterling et al (1993A),United States
352,1241,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,-,-,,Severe,-,Driscoll et al (1996),United States
352,1237,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),-,-,-,,Severe,-,Bottema et al (1993),United States
352,1225,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),<1,95,II,,Severe,-,Driscoll et al (1989),United States
352,3734,Point,Missense,676,226,180,Act-Peptide,Exon 6,c.676C>T,p.(Arg226Trp),,,,,,,Gostout et al (1993),United States
353,3494,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
353,3589,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),-,-,-,NO,Moderate,-,Yu et al (2012),China
353,3588,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),-,-,-,NO,Severe,-,Yu et al (2012),China
353,3587,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),-,-,-,NO,Severe,-,Yu et al (2012),China
353,4079,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
353,4077,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
353,4076,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
353,4075,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
353,4074,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
353,4072,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
353,4073,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
353,4071,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),5,,,NO,Moderate,,Johnsen et al (2017),United States
353,3672,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),-,-,-,NO,Severe,-,Miller et al (2012),United States
353,3671,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),-,-,-,NO,Mild,-,Miller et al (2012),United States
353,4080,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
353,1303,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Centre B39 (unpublished),
353,1283,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Centre B39 (unpublished),
353,1302,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),-,-,-,,,-,Centre B39 (unpublished),
353,1301,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),-,-,-,,,-,Centre B39 (unpublished),
353,1294,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),-,-,-,,,-,Centre B39 (unpublished),
353,1306,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Centre B25 (unpublished),
353,1305,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),2,-,-,,Moderate,-,Centre B13 (unpublished),
353,1279,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Centre B30 (unpublished),
353,1281,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),-,-,-,,,-,Centre B30 (unpublished),
353,1285,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,129,II,,Severe,-,Centre B14 (unpublished),
353,1299,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),1,-,-,,Moderate,-,Centre B36 (unpublished),
353,1288,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,100,II,,Severe,-,Centre B38 (unpublished),
353,1297,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Centre B36 (unpublished),
353,1296,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Centre B36 (unpublished),
353,1282,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Meireles et al (2017),Brazil
353,1268,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),2,120,II,,Moderate,-,Poon et al (1993),Canada
353,1292,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),-,-,-,,Severe,-,Liu et al (2000),China
353,1273,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Nielsen et al (1995),Denmark
353,1270,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Nielsen et al (1995),Denmark
353,1276,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Nielsen et al (1995),Denmark
353,1269,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,5,II,,Severe,-,Tartary et al (1993),France
353,1262,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,120,II,,Severe,-,Ghanem et al (1993),France
353,1295,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),-,-,-,,,-,Wulff and Herrmann (1999),Germany
353,1289,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),-,-,-,,,-,Wulff et al (2001),Germany
353,1286,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Ivaskevicius et al (2001),Germany
353,1284,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),-,-,-,,,-,Wulff et al (2001),Germany
353,1280,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Wulff et al (2001),Germany
353,1278,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),-,-,-,,,-,Wulff et al (1995),Germany
353,1277,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),-,-,-,,,-,Wulff et al (1995),Germany
353,1265,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Knobloch et al (1993),Germany
353,1264,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Knobloch et al (1993),Germany
353,1300,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Mahajan et al (2007),India
353,1272,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Jayandharan et al (2005),India
353,1271,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Jayandharan et al (2005),India
353,1275,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Belvini et al (2005),Italy
353,1291,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Jaloma-Cruz et al (2000),Mexico
353,1290,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),5,-,-,,Moderate,-,Jaloma-Cruz et al (2000),Mexico
353,1263,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,112,II,,Severe,-,Bertina et al (1990),Netherlands
353,1287,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,-,-,,Severe,-,Montejo et al (1999),Spain
353,1274,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),-,-,-,,,-,Onay et al (2003),Turkey
353,1307,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,120,II,,Severe,-,Huang et al (1989),United States
353,1267,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,100,II,,Severe,-,Thompson et al (1992A),United States
353,1266,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),3,100,II,,Moderate,-,Bottema et al (1990C),United States
353,4078,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),<1,,,,Severe,,Johnsen et al (2017),United States
353,1293,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>A,p.(Arg226Gln),-,-,-,,Severe,-,Li et al (2000),United States
355,4081,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>T,p.(Arg226Leu),<1,,,NO,Severe,,Johnsen et al (2017),United States
355,1310,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>T,p.(Arg226Leu),1,-,-,,Moderate,-,Van de Water et al (1996),New Zealand
355,1311,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>T,p.(Arg226Leu),<1,73,II,,Severe,-,Lin and Shen (1993),Taiwan
354,1309,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>C,p.(Arg226Pro),<1,-,-,,Severe,-,Centre B28 (unpublished),
354,1308,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>C,p.(Arg226Pro),-,-,-,,,-,Wulff and Herrmann (1999),Germany
354,3812,Point,Missense,677,226,180,Act-Peptide,Exon 6,c.677G>C,p.(Arg226Pro),<1,90,II,,Severe,-,Wulff et al (1999),Germany
1086,3590,Point,Missense,679,227,181,Serine Protease,Exon 6,c.679G>T,p.(Val227Phe),-,-,-,NO,Moderate,-,Yu et al (2012),China
1086,3592,Point,Missense,679,227,181,Serine Protease,Exon 6,c.679G>T,p.(Val227Phe),-,-,-,NO,Moderate,-,Yu et al (2012),China
1086,1313,Point,Missense,679,227,181,Serine Protease,Exon 6,c.679G>T,p.(Val227Phe),<1,117,II,,Severe,-,Wulff et al (1999),Germany
1086,1312,Point,Missense,679,227,181,Serine Protease,Exon 6,c.679G>T,p.(Val227Phe),<1,130,II,,Severe,-,Bertina et al (1990),Netherlands
357,1315,Point,Missense,680,227,181,Serine Protease,Exon 6,c.680T>C,p.(Val227Ala),<1,-,-,,Severe,-,Centre B13 (unpublished),
356,1314,Point,Missense,680,227,181,Serine Protease,Exon 6,c.680T>A,p.(Val227Asp),-,-,-,,,-,Wulff et al (1995),Germany
358,1316,Point,Missense,682,228,182,Serine Protease,Exon 6,c.682G>C,p.(Val228Leu),15,132,II,,Mild,-,Taylor et al (1990),Canada
358,1317,Point,Missense,682,228,182,Serine Protease,Exon 6,c.682G>C,p.(Val228Leu),4,-,-,,Moderate,-,Kwon et al (2008),South Korea
358,1318,Point,Missense,682,228,182,Serine Protease,Exon 6,c.682G>C,p.(Val228Leu),4 to 7,-,-,,Moderate,-,Haris et al (1994),United Kingdom
359,3591,Point,Missense,682,228,182,Serine Protease,Exon 6,c.682G>T,p.(Val228Phe),-,-,-,NO,Moderate,-,Yu et al (2012),China
359,1319,Point,Missense,682,228,182,Serine Protease,Exon 6,c.682G>T,p.(Val228Phe),<1,120,II,,Severe,-,Sakai et al (1989),Japan
360,1320,Point,Missense,683,228,182,Serine Protease,Exon 6,c.683T>C,p.(Val228Ala),23,100,II,,Mild,-,Maekawa et al (1993),Japan
361,1321,Point,Missense,683,228,182,Serine Protease,Exon 6,c.683T>G,p.(Val228Gly),2,72,II,,Moderate,-,Chen et al (1995),United States
362,4082,Point,Missense,685,229,183,Serine Protease,Exon 6,c.685G>A,p.(Gly229Ser),8,,,NO,Mild,,Johnsen et al (2017),United States
362,1322,Point,Missense,685,229,183,Serine Protease,Exon 6,c.685G>A,p.(Gly229Ser),-,-,-,,,-,Centre B21 (unpublished),
362,1325,Point,Missense,685,229,183,Serine Protease,Exon 6,c.685G>A,p.(Gly229Ser),-,-,-,,,-,Centre B36 (unpublished),
362,1323,Point,Missense,685,229,183,Serine Protease,Exon 6,c.685G>A,p.(Gly229Ser),13,-,-,,Mild,-,Nielsen et al (1995),Denmark
362,1324,Point,Missense,685,229,183,Serine Protease,Exon 6,c.685G>A,p.(Gly229Ser),<1,100,II,,Severe,conference  abstract,Thompson et al (1992B),United States
1181,4749,Point,Missense,686,229,183,Serine Protease,Exon 6,c.686G>T,p.(Gly229Val),<1,,,NO,Severe,,Johnsen et al (2017),United States
1182,4750,Point,Missense,688,230,184,Serine Protease,Exon 6,c.688G>C,p.(Gly230Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
1045,4083,Point,Missense,688,230,184,Serine Protease,Exon 6,c.688G>A,p.(Gly230Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
1045,4084,Point,Missense,688,230,184,Serine Protease,Exon 6,c.688G>A,p.(Gly230Arg),4,,,NO,Moderate,,Johnsen et al (2017),United States
1045,4085,Point,Missense,688,230,184,Serine Protease,Exon 6,c.688G>A,p.(Gly230Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
1045,1617,Point,Missense,688,230,184,Serine Protease,Exon 6,c.688G>A,p.(Gly230Arg),-,-,-,,Severe,-,Belvini et al (2005),Italy
363,4086,Point,Missense,689,230,184,Serine Protease,Exon 6,c.689G>C,p.(Gly230Ala),1,,,NO,Moderate,,Johnsen et al (2017),United States
363,4087,Point,Missense,689,230,184,Serine Protease,Exon 6,c.689G>C,p.(Gly230Ala),2,,,NO,Moderate,,Johnsen et al (2017),United States
363,1327,Point,Missense,689,230,184,Serine Protease,Exon 6,c.689G>C,p.(Gly230Ala),-,-,-,,Severe,-,Jenkins et al (2008),Ireland
1183,4751,Point,Missense,689,230,184,Serine Protease,Exon 6,c.689G>A,p.(Gly230Glu),<1,,,NO,Severe,,Johnsen et al (2017),United States
364,3477,Point,Missense,698,233,187,Serine Protease,Exon 6,c.698C>A,p.(Ala233Asp),<1,-,-,NO,Severe,-,Balraj et al (2012),Malaysia
364,3478,Point,Missense,698,233,187,Serine Protease,Exon 6,c.698C>A,p.(Ala233Asp),2.5,-,-,NO,Moderate,-,Balraj et al (2012),Malaysia
364,1329,Point,Missense,698,233,187,Serine Protease,Exon 6,c.698C>A,p.(Ala233Asp),<1,36,II,,Severe,-,Centre B22 (unpublished),
364,1330,Point,Missense,698,233,187,Serine Protease,Exon 6,c.698C>A,p.(Ala233Asp),<1,-,-,,Severe,-,Centre B6 (unpublished),
364,1328,Point,Missense,698,233,187,Serine Protease,Exon 6,c.698C>A,p.(Ala233Asp),<1,-,-,,Severe,-,Van de Water et al (1996),New Zealand
1211,4788,Point,Nonsense,700,234,188,Serine Protease,Exon 6,c.700A>T,p.(Lys234*),<1,,,NO,Severe,,Johnsen et al (2017),United States
365,1331,Point,Missense,706,236,190,Serine Protease,Exon 6,c.706G>T,p.(Gly236Cys),1,-,-,,Moderate,-,Saad et al (1994),United Kingdom
366,1345,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),<1,50,II,NO,Severe,-,Bicocchi et al (2006),Italy
366,1332,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),<1,-,-,,Severe,-,Centre B36 (unpublished),
366,1333,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),-,-,-,,,-,Centre B36 (unpublished),
366,1335,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),-,-,-,,,-,Centre B36 (unpublished),
366,1336,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),1.3,-,-,,Moderate,-,Centre B36 (unpublished),
366,1337,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),1.4,-,-,,Moderate,-,Centre B36 (unpublished),
366,1338,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),2,-,-,,Moderate,-,Centre B36 (unpublished),
366,1339,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),2,-,-,,Moderate,-,Centre B36 (unpublished),
366,1340,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),3,-,-,,Moderate,-,Centre B36 (unpublished),
366,1341,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),4,-,-,,Moderate,-,Centre B36 (unpublished),
366,1342,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),1.9,-,-,,Moderate,-,Centre B36 (unpublished),
366,1343,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),2,-,-,,Moderate,-,Centre B36 (unpublished),
366,1344,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),4,-,-,,Moderate,-,Centre B36 (unpublished),
366,1346,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),3,-,-,,Moderate,-,Centre B36 (unpublished),
366,1347,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),-,-,-,,,-,Centre B36 (unpublished),
366,1348,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),5,-,-,,Moderate,-,Centre B36 (unpublished),
366,1349,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),<1,-,-,,Severe,-,Centre B36 (unpublished),
366,1334,Point,Missense,707,236,190,Serine Protease,Exon 6,c.707G>A,p.(Gly236Asp),1,-,-,,Moderate,-,Belvini et al (2005),Italy
369,1350,Point,Missense,707,236,190,Serine Protease,Exon 6,c.706G>T,p.(Gly236Val),<1,-,-,,Severe,-,Centre B12 (unpublished),
369,1351,Point,Missense,707,236,190,Serine Protease,Exon 6,c.706G>T,p.(Gly236Val),<1,-,-,,Severe,-,Centre B13 (unpublished),
369,1352,Point,Missense,707,236,190,Serine Protease,Exon 6,c.706G>T,p.(Gly236Val),<1,36,II,,Severe,-,Kao et al (2011),
367,1357,Point,Nonsense,709,237,191,Serine Protease,Exon 6,c.709C>T,p.(Gln237*),<1,<1,-,YES,Severe,-,Matsushita et al (1990),Japan
367,1355,Point,Nonsense,709,237,191,Serine Protease,Exon 6,c.709C>T,p.(Gln237*),<1,4,II,,Severe,-,Centre B39 (unpublished),
367,1354,Point,Nonsense,709,237,191,Serine Protease,Exon 6,c.709C>T,p.(Gln237*),<1,5,II,,Severe,-,Aguilar-Martinez et al (1994B),
367,1356,Point,Nonsense,709,237,191,Serine Protease,Exon 6,c.709C>T,p.(Gln237*),<1,3,II,,Severe,-,Centre B38 (unpublished),
367,4590,Point,Nonsense,709,237,191,Serine Protease,Exon 6,c.709C>T,p.(Gln237*),<1,,,,Severe,,Johnsen et al (2017),United States
370,1353,Point,Missense,709,237,191,Serine Protease,Exon 6,c.709C>A,p.(Gln237Lys),<1,<0.1,-,YES,Severe,-,Chen et al (1991a),United States
371,1358,Point,Silent,711,237,191,Serine Protease,Exon 6,c.711A>G,p.(Gln237Gln),<1,<3,I,,Severe,-,Centre B24 (unpublished),
371,1359,Point,Silent,711,237,191,Serine Protease,Exon 6,c.711A>G,p.(Gln237Gln),3,2,I,,Moderate,-,Thompson et al (1992A),United States
372,1360,Point,Missense,712,238,192,Serine Protease,Exon 6,c.712T>G,p.(Phe238Val),2,<6,-,,Moderate,-,Lin and Shen (1993),Taiwan
373,1361,Point,Missense,715,239,193,Serine Protease,Exon 6,c.715C>T,p.(Pro239Ser),3,17,II,,Moderate,-,Wulff et al (1999),Germany
374,1362,Point,Missense,716,239,193,Serine Protease,Exon 6,c.716C>G,p.(Pro239Arg),<1,-,-,,Severe,-,Jayandharan et al (2003),India
1184,4752,Point,Missense,716,239,193,Serine Protease,Exon 6,c.716C>T,p.(Pro239Leu),<1,,,NO,Severe,,Johnsen et al (2017),United States
375,4088,Point,Missense,718,240,194,Serine Protease,Exon 6,c.718T>A,p.(Trp240Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
375,4089,Point,Missense,718,240,194,Serine Protease,Exon 6,c.718T>A,p.(Trp240Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
375,1363,Point,Missense,718,240,194,Serine Protease,Exon 6,c.718T>A,p.(Trp240Arg),<1,1,-,,Severe,-,Thompson et al (1992A),United States
376,1364,Point,Missense,718,240,194,Serine Protease,Exon 6,c.718T>C,p.(Trp240Arg),4,4,I,,Moderate,-,Thompson et al (1992A),United States
377,1371,Point,Nonsense,719,240,194,Serine Protease,Exon 6,c.719G>A,p.(Trp240*),<1,<0.1,-,YES,Severe,-,Green et al (1989),United Kingdom
377,4592,Point,Nonsense,719,240,194,Serine Protease,Exon 6,c.719G>A,p.(Trp240*),<1,,,YES,Severe,,Johnsen et al (2017),United States
377,4591,Point,Nonsense,719,240,194,Serine Protease,Exon 6,c.719G>A,p.(Trp240*),<1,,,NO,Severe,,Johnsen et al (2017),United States
377,1369,Point,Nonsense,719,240,194,Serine Protease,Exon 6,c.719G>A,p.(Trp240*),5,-,-,,Moderate,-,Centre B39 (unpublished),
377,1366,Point,Nonsense,719,240,194,Serine Protease,Exon 6,c.719G>A,p.(Trp240*),-,-,-,,,-,Nielsen et al (1995),Denmark
377,1372,Point,Nonsense,719,240,194,Serine Protease,Exon 6,c.719G>A,p.(Trp240*),<1,-,-,,Severe,-,Mukherjee et al (2004),India
377,1368,Point,Nonsense,719,240,194,Serine Protease,Exon 6,c.719G>A,p.(Trp240*),<1,<1,-,,Severe,-,Ljung et al (2001),Sweden
377,1365,Point,Nonsense,719,240,194,Serine Protease,Exon 6,c.719G>A,p.(Trp240*),-,-,-,,,-,Saad et al (1994),United Kingdom
377,1382,Point,Nonsense,719,240,194,Serine Protease,Exon 6,c.719G>A,p.(Trp240*),<1,2,II,,Severe,-,Saad et al (1994),United Kingdom
377,1367,Point,Nonsense,719,240,194,Serine Protease,Exon 6,c.719G>A,p.(Trp240*),3,7.8,II,,Moderate,-,Gostout et al (1993),United States
377,3755,Point,Nonsense,719,240,194,Serine Protease,Exon 6,c.719G>A,p.(Trp240*),<1,<1,,,Severe,,Green et al (1991),United Kingdom
378,3593,Point,Missense,719,240,194,Serine Protease,Exon 6,c.719G>T,p.(Trp240Leu),-,-,-,NO,Moderate,-,Yu et al (2012),China
378,1370,Point,Missense,719,240,194,Serine Protease,Exon 6,c.719G>T,p.(Trp240Leu),<1,-,-,,Severe,-,Centre B12 (unpublished),
378,1373,Point,Missense,719,240,194,Serine Protease,Exon 6,c.719G>T,p.(Trp240Leu),1,-,-,,Moderate,-,Centre B24 (unpublished),
381,3525,Point,Nonsense,720,240,194,Serine Protease,Exon 6,c.720G>A,p.(Trp240*),<1,-,-,YES,Severe,-,Radic et al (2013),Argentina
381,1377,Point,Nonsense,720,240,194,Serine Protease,Exon 6,c.720G>A,p.(Trp240*),<1,-,-,YES,Severe,-,Belvini et al (2005),Italy
381,3435,Point,Nonsense,720,240,194,Serine Protease,Exon 6,c.720G>A,p.(Trp240*),0.5,-,-,YES,Severe,-,Belvini et al (2005),Italy
381,1375,Point,Nonsense,720,240,194,Serine Protease,Exon 6,c.720G>A,p.(Trp240*),<1,-,-,,Severe,-,Centre B30 (unpublished),
381,1376,Point,Nonsense,720,240,194,Serine Protease,Exon 6,c.720G>A,p.(Trp240*),-,-,-,,,-,Centre B8 (unpublished),
381,1378,Point,Nonsense,720,240,194,Serine Protease,Exon 6,c.720G>A,p.(Trp240*),-,-,-,,Severe,-,Jenkins et al (2008),Ireland
381,1374,Point,Nonsense,720,240,194,Serine Protease,Exon 6,c.720G>A,p.(Trp240*),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
382,3463,Point,Missense,720,240,194,Serine Protease,Exon 6,c.720G>T,p.(Trp240Cys),<1,-,-,NO,Severe,-,Jayandharan et al (2009),India
382,1385,Point,Missense,720,240,194,Serine Protease,Exon 6,c.720G>T,p.(Trp240Cys),3,-,-,,Moderate,-,Centre B36 (unpublished),
382,1381,Point,Missense,720,240,194,Serine Protease,Exon 6,c.720G>T,p.(Trp240Cys),<1,-,-,,Severe,-,Jayandharan et al (2005),India
382,1383,Point,Missense,720,240,194,Serine Protease,Exon 6,c.720G>T,p.(Trp240Cys),6,-,-,,Mild,-,Ketterling et al (1999B),United States
382,1384,Point,Missense,720,240,194,Serine Protease,Exon 6,c.720G>T,p.(Trp240Cys),<1,<1,-,,Severe,conference  abstract,Thompson et al (1992B),United States
1044,1664,Point,Nonsense,721,241,195,Serine Protease,Exon 6,c.721C>T,p.(Gln241*),-,-,-,,Severe,-,Belvini et al (2005),Italy
385,1386,Point,Missense,721,241,195,Serine Protease,Exon 6,c.721C>A,p.(Gln241Lys),2,-,-,,Moderate,-,Centre B24 (unpublished),
385,1387,Point,Missense,721,241,195,Serine Protease,Exon 6,c.721C>A,p.(Gln241Lys),-,-,-,,,-,Onay et al (2003),Turkey
386,4090,Point,Missense,722,241,195,Serine Protease,Exon 6,c.722A>G,p.(Gln241Arg),2,,,NO,Moderate,,Johnsen et al (2017),United States
386,4091,Point,Missense,722,241,195,Serine Protease,Exon 6,c.722A>G,p.(Gln241Arg),1,,,NO,Moderate,,Johnsen et al (2017),United States
386,1388,Point,Missense,722,241,195,Serine Protease,Exon 6,c.722A>G,p.(Gln241Arg),<1,-,-,,Severe,-,Centre B18 (unpublished),
386,1390,Point,Missense,722,241,195,Serine Protease,Exon 6,c.722A>G,p.(Gln241Arg),<1,<1,-,,Severe,-,Centre B23 (unpublished),
1218,4797,Point,Splice,723,,,,Intron 6,c.723+2T>A,,<1,,,NO,Severe,,Johnsen et al (2017),United States
1109,4657,Point,Splice,723,,,,Intron 6,c.723+1G>A,N/A,<1,,,NO,Severe,,Johnsen et al (2017),United States
1109,4658,Point,Splice,723,,,,Intron 6,c.723+1G>A,N/A,<1,,,NO,Severe,,Johnsen et al (2017),United States
1109,4659,Point,Splice,723,,,,Intron 6,c.723+1G>A,N/A,<1,,,NO,Severe,,Johnsen et al (2017),United States
1109,4660,Point,Splice,723,,,,Intron 6,c.723+1G>A,N/A,<1,,,NO,Severe,,Johnsen et al (2017),United States
1109,3347,Point,Splice,723,,,,Intron 6,c.723+1G>A,N/A,-,-,-,,,-,Centre B2 (unpublished),
1109,3349,Point,Splice,723,,,,Intron 6,c.723+1G>A,N/A,<1,<1,-,,Severe,-,Centre B23 (unpublished),
1109,3344,Point,Splice,723,,,,Intron 6,c.723+1G>A,N/A,-,-,-,,,-,Nielsen et al (1995),Denmark
1109,3348,Point,Splice,723,,,,Intron 6,c.723+1G>A,N/A,2,-,-,,Moderate,-,Ketterling et al (1999A),United States
1021,3350,Point,Splice,723,,,-,Intron 6,c.723+1G>T,N/A,<1,0.3,-,,Severe,-,Rees et al (1985),United Kingdom
1022,3351,Point,Splice,723,,,-,Intron 6,c.723+18T>A,N/A,2,66,II,,Moderate,-,Centre B14 (unpublished),
1023,3353,Point,Splice,723,,,-,Intron 6,c.723+2T>C,N/A,<1,-,-,,Severe,-,Centre B30 (unpublished),
1023,3352,Point,Splice,723,,,-,Intron 6,c.723+2T>C,N/A,<1,-,-,,Severe,-,Costa et al (2000),France
1024,3354,Point,Splice,723,,,-,Intron 6,c.723+3A>T,N/A,-,-,-,,,-,Centre B39 (unpublished),
389,4673,Point,Silent,723,241,195,Serine Protease,Exon 6,c.723G>A,p.(Gln241Gln),2,,,NO,Moderate,,Johnsen et al (2017),United States
389,4674,Point,Silent,723,241,195,Serine Protease,Exon 6,c.723G>A,p.(Gln241Gln),2,,,NO,Moderate,,Johnsen et al (2017),United States
389,4675,Point,Silent,723,241,195,Serine Protease,Exon 6,c.723G>A,p.(Gln241Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
389,1392,Point,Silent,723,241,195,Serine Protease,Exon 6,c.723G>A,p.(Gln241Gln),2,2,I,,Moderate,-,Centre B38 (unpublished),
389,1395,Point,Silent,723,241,195,Serine Protease,Exon 6,c.723G>A,p.(Gln241Gln),-,-,-,,Severe,-,Wulff et al (1995),Germany
389,1391,Point,Silent,723,241,195,Serine Protease,Exon 6,c.723G>A,p.(Gln241Gln),<1,<1,-,,Severe,-,Chen et al (1995),United States
389,1393,Point,Silent,723,241,195,Serine Protease,Exon 6,c.723G>A,p.(Gln241Gln),<1,-,-,,Severe,-,Ketterling et al (1999B),United States
390,1394,Point,Missense,723,241,195,Serine Protease,Exon 6,c.723G>C,p.(Gln241His),<1,-,-,,Severe,-,Centre B9 (unpublished),
390,1396,Point,Missense,723,241,195,Serine Protease,Exon 6,c.723G>C,p.(Gln241His),<1,<1,-,,Severe,-,Montejo et al (1999),Spain
390,3779,Point,Missense,723,241,195,Serine Protease,Exon 6,c.723G>C,p.(Gln241His),<1,<1,-,,Severe,-,Montejo et al (1999),Spain
1185,4753,Point,Missense,723,241,195,Serine Protease,Exon 6,c.723G>T,p.(Gln241His),<1,,,NO,Severe,,Johnsen et al (2017),United States
1185,4754,Point,Missense,723,241,195,Serine Protease,Exon 6,c.723G>T,p.(Gln241His),<1,,,NO,Severe,,Johnsen et al (2017),United States
1025,3355,Point,Splice,724,,,-,Intron 6,c.724-1G>A,N/A,<1,-,-,,Severe,,Centre B4 (unpublished),
1025,3356,Point,Splice,724,,,-,Intron 6,c.724-1G>A,N/A,<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
1026,3357,Point,Splice,724,,,-,Intron 6,c.724-1G>C,N/A,21,19,I,,Mild,-,Poon et al (1993),Canada
1026,3358,Point,Splice,724,,,-,Intron 6,c.724-1G>C,N/A,<1,<1,-,,Severe,-,Bottema et al (1991),United States
1026,4661,Point,Splice,724,,,-,Intron 6,c.724-1G>C,N/A,<1,,,,Severe,,Johnsen et al (2017),United States
1027,3359,Point,Splice,724,,,-,Intron 6,c.724-1G>T,N/A,-,-,-,,Severe,-,Jenkins et al (2008),Ireland
1028,3360,Point,Splice,724,,,-,Intron 6,c.724-2A>G,N/A,1,-,-,,Moderate,-,Centre B5 (unpublished),
1028,3361,Point,Splice,724,,,-,Intron 6,c.724-2A>G,N/A,-,-,-,,Severe,-,Ketterling et al (1999A),United States
1029,3362,Point,Splice,724,,,-,Intron 6,c.724-2A>C,N/A,-,-,-,,Severe,-,Ketterling et al (1999A),United States
1160,3810,Point,Splice,724,,,,Intron 6,c.724-3C>G,N/A,,,,,,,Yu et al (2012),China
1160,3811,Point,Splice,724,,,,Intron 6,c.724-3C>G,N/A,,,,,,,Yu et al (2012),China
1075,3543,Point,Missense,724,242,196,Serine Protease,Exon 7,c.724G>A,p.(Val242Ile),-,-,-,NO,Moderate,-,Yu et al (2012),China
393,3718,Point,Missense,731,244,198,Serine Protease,Exon 7,c.731T>C,p.(Leu244Ser),<1,<1,,NO,Severe,,Bicocchi et al (2006),Italy
393,1399,Point,Missense,731,244,198,Serine Protease,Exon 7,c.731T>C,p.(Leu244Ser),5.6-12,-,I,,Mild,-,Ghosh et al (2009),India
393,1400,Point,Missense,731,244,198,Serine Protease,Exon 7,c.731T>C,p.(Leu244Ser),5.6-12,-,I,,Mild,-,Ghosh et al (2009),India
393,1397,Point,Missense,731,244,198,Serine Protease,Exon 7,c.731T>C,p.(Leu244Ser),<1,<1,-,,Severe,-,Ketterling et al (1993A),United States
394,1398,Point,Missense,731,244,198,Serine Protease,Exon 7,c.731T>G,p.(Leu244Trp),2,-,-,,Moderate,-,Saad et al (1994),United Kingdom
397,1402,Point,Missense,749,250,204,Serine Protease,Exon 7,c.749C>T,p.(Ala250Val),-,-,-,,,-,Centre B39 (unpublished),
399,1405,Point,Missense,754,252,206,Serine Protease,Exon 7,c.754T>C,p.(Cys252Arg),<1,-,-,,Severe,-,Knobloch et al (1993),Germany
399,1404,Point,Missense,754,252,206,Serine Protease,Exon 7,c.754T>C,p.(Cys252Arg),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
401,1413,Point,Missense,755,252,206,Serine Protease,Exon 7,c.755G>C,p.(Cys252Ser),<1,<1,-,,Severe,-,Taylor et al (1992),Canada
401,1412,Point,Missense,755,252,206,Serine Protease,Exon 7,c.755G>C,p.(Cys252Ser),-,-,-,,,-,Saad et al (1994),United Kingdom
400,1407,Point,Missense,755,252,206,Serine Protease,Exon 7,c.755G>A,p.(Cys252Tyr),2,-,-,,Moderate,-,Centre B30 (unpublished),
400,1408,Point,Missense,755,252,206,Serine Protease,Exon 7,c.755G>A,p.(Cys252Tyr),<1,-,-,,Severe,-,Centre B30 (unpublished),
400,1410,Point,Missense,755,252,206,Serine Protease,Exon 7,c.755G>A,p.(Cys252Tyr),1.8,-,-,,Moderate,-,Centre B25 (unpublished),
400,1414,Point,Missense,755,252,206,Serine Protease,Exon 7,c.755G>A,p.(Cys252Tyr),7.8,-,-,,Mild,-,Onay et al (2003),Turkey
400,1406,Point,Missense,755,252,206,Serine Protease,Exon 7,c.755G>A,p.(Cys252Tyr),2.5,-,-,,Moderate,-,Gostout et al (1993),United States
400,1409,Point,Missense,755,252,206,Serine Protease,Exon 7,c.755G>A,p.(Cys252Tyr),<1,1.5,II,,Severe,-,Li et al (2000),United States
400,1411,Point,Missense,755,252,206,Serine Protease,Exon 7,c.755G>A,p.(Cys252Tyr),<1,-,-,,Severe,-,Bottema et al (1991),United States
403,3594,Point,Nonsense,757,253,207,Serine Protease,Exon 7,c.757G>T,p.(Gly253*),-,-,-,NO,Moderate,-,Yu et al (2012),China
403,1418,Point,Nonsense,757,253,207,Serine Protease,Exon 7,c.757G>T,p.(Gly253*),<1,<1,-,,Severe,conference  abstract,Thompson et al (1992B),United States
1126,1415,Point,Missense,757,253,207,Serine Protease,Exon 7,c.757G>A,p.(Gly253Arg),1,-,-,,Moderate,-,David et al (1993),Portugal
1126,1416,Point,Missense,757,253,207,Serine Protease,Exon 7,c.757G>A,p.(Gly253Arg),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
404,1422,Point,Missense,758,253,207,Serine Protease,Exon 7,c.758G>A,p.(Gly253Glu),<1,-,-,,Severe,-,Centre B39 (unpublished),
404,1420,Point,Missense,758,253,207,Serine Protease,Exon 7,c.758G>A,p.(Gly253Glu),-,-,-,,,-,Centre B8 (unpublished),
404,1419,Point,Missense,758,253,207,Serine Protease,Exon 7,c.758G>A,p.(Gly253Glu),-,-,-,,,-,Wulff et al (1995),Germany
404,1421,Point,Missense,758,253,207,Serine Protease,Exon 7,c.758G>A,p.(Gly253Glu),<1,<1,-,,Severe,-,Wulff et al (1999),Germany
404,1417,Point,Missense,758,253,207,Serine Protease,Exon 7,c.758G>A,p.(Gly253Glu),-,-,-,,,-,Nawaz et al (2008),Pakistan
404,1425,Point,Missense,758,253,207,Serine Protease,Exon 7,c.758G>A,p.(Gly253Glu),<1,56,II,,Severe,-,Lin and Shen (1993),Taiwan
404,1423,Point,Missense,758,253,207,Serine Protease,Exon 7,c.758G>A,p.(Gly253Glu),<1,-,-,,Severe,-,Enayat et al (2004),United Kingdom
404,1424,Point,Missense,758,253,207,Serine Protease,Exon 7,c.758G>A,p.(Gly253Glu),<1,-,-,,Severe,-,Enayat et al (2004),United Kingdom
405,1426,Point,Missense,758,253,207,Serine Protease,Exon 7,c.758G>T,p.(Gly253Val),1,-,-,,Moderate,-,Centre B39 (unpublished),
405,1427,Point,Missense,758,253,207,Serine Protease,Exon 7,c.758G>T,p.(Gly253Val),-,-,-,,Severe,-,Liu et al (2000),China
1186,4755,Point,Missense,760,254,208,Serine Protease,Exon 7,c.760G>C,p.(Gly254Arg),1,,,NO,Moderate,,Johnsen et al (2017),United States
406,4092,Point,Missense,760,254,208,Serine Protease,Exon 7,c.760G>A,p.(Gly254Ser),<1,,,NO,Severe,,Johnsen et al (2017),United States
406,4093,Point,Missense,760,254,208,Serine Protease,Exon 7,c.760G>A,p.(Gly254Ser),<1,,,NO,Severe,,Johnsen et al (2017),United States
406,4094,Point,Missense,760,254,208,Serine Protease,Exon 7,c.760G>A,p.(Gly254Ser),1,,,NO,Moderate,,Johnsen et al (2017),United States
406,1428,Point,Missense,760,254,208,Serine Protease,Exon 7,c.760G>A,p.(Gly254Ser),1,-,-,,Moderate,-,Mukherjee et al (2004),India
1052,3542,Point,Missense,761,254,208,Serine Protease,Exon 7,c.761G>A,p.(Gly254Asp),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
1052,1430,Point,Missense,761,254,208,Serine Protease,Exon 7,c.761G>A,p.(Gly254Asp),6,<1,I,NO,Mild,-,Attali et al (1999),France
1052,1431,Point,Missense,761,254,208,Serine Protease,Exon 7,c.761G>A,p.(Gly254Asp),-,-,-,,,-,Centre B39 (unpublished),
1052,1429,Point,Missense,761,254,208,Serine Protease,Exon 7,c.761G>A,p.(Gly254Asp),-,1,-,,,-,Saad et al (1994),United Kingdom
407,4095,Point,Missense,761,254,208,Serine Protease,Exon 7,c.761G>T,p.(Gly254Val),1.9,,,NO,Moderate,,Johnsen et al (2017),United States
407,1432,Point,Missense,761,254,208,Serine Protease,Exon 7,c.761G>T,p.(Gly254Val),-,-,-,,Severe,-,Belvini et al (2005),Italy
408,1434,Point,Missense,767,256,210,Serine Protease,Exon 7,c.767T>C,p.(Ile256Thr),-,-,-,,,-,Centre B39 (unpublished),
408,1433,Point,Missense,767,256,210,Serine Protease,Exon 7,c.767T>C,p.(Ile256Thr),<1,-,-,,Severe,-,Awidi et al (2011),Jordan
410,1437,Point,Missense,769,257,211,Serine Protease,Exon 7,c.769G>A,p.(Val257Ile),<1,<1,-,,Severe,-,"Seita et al, 2009",Japan
410,3798,Point,Missense,769,257,211,Serine Protease,Exon 7,c.769G>A,p.(Val257Ile),,,,,,,Satoh et al (1993),Japan
409,1435,Point,Missense,769,257,211,Serine Protease,Exon 7,c.769G>T,p.(Val257Phe),7,-,-,,Mild,-,Centre B23 (unpublished),
409,1436,Point,Missense,769,257,211,Serine Protease,Exon 7,c.769G>T,p.(Val257Phe),4,-,-,,Moderate,-,Chen et al (1991a),United States
411,1438,Point,Missense,770,257,211,Serine Protease,Exon 7,c.770T>A,p.(Val257Asp),<1,<1,-,,Severe,-,Centre B38 (unpublished),
412,1439,Point,Missense,774,258,212,Serine Protease,Exon 7,c.774T>G,p.(Asn258Lys),20,-,-,,Mild,-,Nielsen et al (1995),Denmark
412,1440,Point,Missense,774,258,212,Serine Protease,Exon 7,c.774T>G,p.(Asn258Lys),-,-,-,,,-,Nielsen et al (1995),Denmark
412,1441,Point,Missense,774,258,212,Serine Protease,Exon 7,c.774T>G,p.(Asn258Lys),-,-,-,,,-,Nielsen et al (1995),Denmark
412,1442,Point,Missense,774,258,212,Serine Protease,Exon 7,c.774T>G,p.(Asn258Lys),-,-,-,,,-,Nielsen et al (1995),Denmark
412,1443,Point,Missense,774,258,212,Serine Protease,Exon 7,c.774T>G,p.(Asn258Lys),12,-,-,,Mild,-,Nielsen et al (1995),Denmark
413,1444,Point,Nonsense,775,259,213,Serine Protease,Exon 7,c.775G>T,p.(Glu259*),<1,<1,-,,Severe,-,Centre B23 (unpublished),
414,1445,Point,Missense,781,261,215,Serine Protease,Exon 7,c.781T>C,p.(Trp261Arg),4,-,-,,Moderate,-,Centre B21 (unpublished),
414,1448,Point,Missense,781,261,215,Serine Protease,Exon 7,c.781T>C,p.(Trp261Arg),3,-,-,,Moderate,-,Centre B30 (unpublished),
414,1449,Point,Missense,781,261,215,Serine Protease,Exon 7,c.781T>C,p.(Trp261Arg),-,-,-,,,-,Centre B30 (unpublished),
414,1447,Point,Missense,781,261,215,Serine Protease,Exon 7,c.781T>C,p.(Trp261Arg),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
414,1446,Point,Missense,781,261,215,Serine Protease,Exon 7,c.781T>C,p.(Trp261Arg),<1,<1,-,,Severe,-,Chen et al (1995),United States
414,1452,Point,Missense,781,261,215,Serine Protease,Exon 7,c.781T>C,p.(Trp261Arg),4,<1,I,,Moderate,-,Bottema et al (1990C),United States
415,1450,Point,Missense,781,261,215,Serine Protease,Exon 7,c.781T>G,p.(Trp261Gly),<1,-,-,,Severe,-,Centre B11 (unpublished),
415,1451,Point,Missense,781,261,215,Serine Protease,Exon 7,c.781T>G,p.(Trp261Gly),3,-,-,,Moderate,-,Centre B25 (unpublished),
417,1453,Point,Missense,782,261,215,Serine Protease,Exon 7,c.782G>A,p.(Trp261Leu),-,-,-,,,-,Centre B39 (unpublished),
417,1454,Point,Missense,782,261,215,Serine Protease,Exon 7,c.782G>A,p.(Trp261Leu),<1,0.1,-,,Severe,-,Chen et al (1991a),United States
418,4096,Point,Missense,783,261,215,Serine Protease,Exon 7,c.783G>T,p.(Trp261Cys),<1,,,NO,Severe,,Johnsen et al (2017),United States
418,4097,Point,Missense,783,261,215,Serine Protease,Exon 7,c.783G>T,p.(Trp261Cys),<1,,,NO,Severe,,Johnsen et al (2017),United States
418,1455,Point,Missense,783,261,215,Serine Protease,Exon 7,c.783G>T,p.(Trp261Cys),-,-,-,,,-,Centre B30 (unpublished),
418,1456,Point,Missense,783,261,215,Serine Protease,Exon 7,c.783G>T,p.(Trp261Cys),<1,<1,-,,Severe,-,Lin and Shen (1993),Taiwan
419,4098,Point,Missense,784,262,216,Serine Protease,Exon 7,c.784A>T,p.(Ile262Phe),<1,,,NO,Severe,,Johnsen et al (2017),United States
419,1457,Point,Missense,784,262,216,Serine Protease,Exon 7,c.784A>T,p.(Ile262Phe),<1,-,-,,Severe,-,Belvini et al (2005),Italy
420,4099,Point,Missense,785,262,216,Serine Protease,Exon 7,c.785T>C,p.(Ile262Thr),3,,,NO,Moderate,,Johnsen et al (2017),United States
420,1460,Point,Missense,785,262,216,Serine Protease,Exon 7,c.785T>C,p.(Ile262Thr),-,-,-,,,-,Centre B18 (unpublished),
420,1461,Point,Missense,785,262,216,Serine Protease,Exon 7,c.785T>C,p.(Ile262Thr),5.4,-,-,,Moderate,-,Mukherjee et al (2004),India
420,1462,Point,Missense,785,262,216,Serine Protease,Exon 7,c.785T>C,p.(Ile262Thr),4,-,-,,Moderate,-,Mukherjee et al (2004),India
420,1459,Point,Missense,785,262,216,Serine Protease,Exon 7,c.785T>C,p.(Ile262Thr),4,4,I,,Moderate,-,Green et al (1991),United Kingdom
420,1458,Point,Missense,785,262,216,Serine Protease,Exon 7,c.785T>C,p.(Ile262Thr),7,-,-,,Mild,-,Koeberl et al (1990B),United States
420,1463,Point,Missense,785,262,216,Serine Protease,Exon 7,c.785T>C,p.(Ile262Thr),4,-,-,,Moderate,-,Chen et al (1991a),United States
421,3673,Point,Missense,786,262,216,Serine Protease,Exon 7,c.786T>G,p.(Ile262Met),-,-,-,NO,Moderate,-,Miller et al (2012),United States
421,1464,Point,Missense,786,262,216,Serine Protease,Exon 7,c.786T>G,p.(Ile262Met),15,4,I,,Mild,-,Bottema et al (1991),United States
422,1465,Point,Missense,788,263,217,Serine Protease,Exon 7,c.788T>A,p.(Val263Glu),-,-,-,,Severe,-,Liu et al (2000),China
423,1466,Point,Missense,790,264,218,Serine Protease,Exon 7,c.790A>C,p.(Thr264Pro),<1,-,-,,Severe,-,Mahajan et al (2004),India
424,1467,Point,Missense,791,264,218,Serine Protease,Exon 7,c.791C>T,p.(Thr264Ile),-,-,-,,,-,Centre B39 (unpublished),
424,1468,Point,Missense,791,264,218,Serine Protease,Exon 7,c.791C>T,p.(Thr264Ile),2,-,-,,Moderate,-,Centre B13 (unpublished),
424,1469,Point,Missense,791,264,218,Serine Protease,Exon 7,c.791C>T,p.(Thr264Ile),3,-,-,,Moderate,-,Centre B30 (unpublished),
426,3714,Point,Missense,793,265,219,Serine Protease,Exon 7,c.793G>C,p.(Ala265Pro),<1,24,,NO,Severe,,Attali et al (1999),France
426,4100,Point,Missense,793,265,219,Serine Protease,Exon 7,c.793G>C,p.(Ala265Pro),<1,,,NO,Severe,,Johnsen et al (2017),United States
426,1472,Point,Missense,793,265,219,Serine Protease,Exon 7,c.793G>C,p.(Ala265Pro),<1,-,-,,Severe,-,Centre B12 (unpublished),
425,1470,Point,Missense,793,265,219,Serine Protease,Exon 7,c.793G>A,p.(Ala265Thr),-,-,-,,,-,Wulff and Herrmann (1999),Germany
425,1471,Point,Missense,793,265,219,Serine Protease,Exon 7,c.793G>A,p.(Ala265Thr),-,-,-,,Mild,-,Wulff et al (1995),Germany
427,1473,Point,Missense,794,265,219,Serine Protease,Exon 7,c.794C>A,p.(Ala265Asp),<1,-,-,,Severe,-,Jayandharan et al (2003),India
1187,4756,Point,Missense,796,266,220,Serine Protease,Exon 7,c.796G>C,p.(Ala266Pro),<1,,,NO,Severe,,Johnsen et al (2017),United States
428,3719,Point,Missense,796,266,220,Serine Protease,Exon 7,c.796G>A,p.(Ala266Thr),<1,,,NO,Severe,,Bicocchi et al (2006),Italy
428,4101,Point,Missense,796,266,220,Serine Protease,Exon 7,c.796G>A,p.(Ala266Thr),2,,,NO,Moderate,,Johnsen et al (2017),United States
428,4102,Point,Missense,796,266,220,Serine Protease,Exon 7,c.796G>A,p.(Ala266Thr),2.5,,,NO,Moderate,,Johnsen et al (2017),United States
428,1474,Point,Missense,796,266,220,Serine Protease,Exon 7,c.796G>A,p.(Ala266Thr),<1,-,-,,Severe,-,Belvini et al (2005),Italy
429,3496,Point,Missense,797,266,220,Serine Protease,Exon 7,c.797C>T,p.(Ala266Val),6.6,-,-,NO,Mild,-,Radic et al (2013),Argentina
429,4103,Point,Missense,797,266,220,Serine Protease,Exon 7,c.797C>T,p.(Ala266Val),3,,,NO,Moderate,,Johnsen et al (2017),United States
429,1476,Point,Missense,797,266,220,Serine Protease,Exon 7,c.797C>T,p.(Ala266Val),11,15,I,,Mild,-,Poon et al (1993),Canada
429,1475,Point,Missense,797,266,220,Serine Protease,Exon 7,c.797C>T,p.(Ala266Val),4,-,-,,Moderate,-,Koeberl et al (1990B),United States
429,1477,Point,Missense,797,266,220,Serine Protease,Exon 7,c.797C>T,p.(Ala266Val),<1,3,II,,Severe,-,Koeberl et al (1990B),United States
431,4104,Point,Missense,799,267,221,Serine Protease,Exon 7,c.799C>T,p.(His267Tyr),<1,,,NO,Severe,,Johnsen et al (2017),United States
431,1482,Point,Missense,799,267,221,Serine Protease,Exon 7,c.799C>T,p.(His267Tyr),<1,5,II,,Severe,-,Centre B38 (unpublished),
431,1483,Point,Missense,799,267,221,Serine Protease,Exon 7,c.799C>T,p.(His267Tyr),1,-,-,,Moderate,-,Ljung et al (2001),Sweden
432,1484,Point,Missense,800,267,221,Serine Protease,Exon 7,c.800A>G,p.(His267Arg),1,62,II,NO,Moderate,-,Attali et al (1999),France
432,1485,Point,Missense,800,267,221,Serine Protease,Exon 7,c.800A>G,p.(His267Arg),<1,-,-,,Severe,-,Jayandharan et al (2005),India
1188,4757,Point,Missense,800,267,221,Serine Protease,Exon 7,c.800A>T,p.(His267Leu),<1,,,NO,Severe,,Johnsen et al (2017),United States
1189,4758,Point,Missense,801,267,221,Serine Protease,Exon 7,c.801C>G,p.(His267Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
433,1486,Point,Missense,801,267,221,Serine Protease,Exon 7,c.801C>A,p.(His267Gln),<1,100,II,,Severe,-,Weinmann et al (1998),United States
435,1489,Point,Missense,802,268,222,Serine Protease,Exon 7,c.802T>C,p.(Cys268Arg),<1,-,-,,Severe,-,Centre B21 (unpublished),
435,1488,Point,Missense,802,268,222,Serine Protease,Exon 7,c.802T>C,p.(Cys268Arg),<1,-,-,,Severe,-,Belvini et al (2005),Italy
436,1490,Point,Missense,802,268,222,Serine Protease,Exon 7,c.802T>G,p.(Cys268Gly),<1,-,-,,Severe,-,Ketterling et al (1999B),United States
434,1487,Point,Missense,802,268,222,Serine Protease,Exon 7,c.802T>A,p.(Cys268Ser),2,-,-,,Moderate,-,Saad et al (1994),United Kingdom
438,1492,Point,Missense,803,268,222,Serine Protease,Exon 7,c.803G>T,p.(Cys268Phe),-,-,-,,,-,Centre B27 (unpublished),
439,1493,Point,Missense,804,268,222,Serine Protease,Exon 7,c.804T>G,p.(Cys268Trp),-,-,-,,,-,Centre B30 (unpublished),
439,1494,Point,Missense,804,268,222,Serine Protease,Exon 7,c.804T>G,p.(Cys268Trp),1,-,-,,Moderate,-,Koeberl et al (1989),United States
440,1496,Point,Nonsense,808,270,224,Serine Protease,Exon 7,c.808G>T,p.(Glu270*),<1,-,-,,Severe,-,Centre B30 (unpublished),
440,1495,Point,Nonsense,808,270,224,Serine Protease,Exon 7,c.808G>T,p.(Glu270*),<1,-,-,,Severe,-,Awidi et al (2011),Jordan
445,1507,Point,Missense,829,277,231,Serine Protease,Exon 7,c.829G>T,p.(Val277Phe),<1,-,-,,Severe,-,Belvini et al (2005),Italy
1076,3544,Point,Missense,830,277,231,Serine Protease,Exon 7,c.830T>A,p.(Val277Asp),-,-,-,NO,Severe,-,Yu et al (2012),China
446,3497,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),10,-,-,NO,Mild,-,Radic et al (2013),Argentina
446,1551,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),11,14,I,NO,Mild,-,Attali et al (1999),France
446,1547,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),8,8,I,NO,Mild,-,Attali et al (1999),France
446,1548,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),4,-,-,NO,Moderate,-,Attali et al (1999),France
446,1549,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),5,16,II,NO,Moderate,-,Attali et al (1999),France
446,1554,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),15,15,I,NO,Mild,-,Attali et al (1999),France
446,1544,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),17,13,I,NO,Mild,-,Attali et al (1999),France
446,1545,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),27,-,-,NO,Mild,-,Attali et al (1999),France
446,1553,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),9,11,I,NO,Mild,-,Attali et al (1999),France
446,1546,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),11,-,-,NO,Mild,-,Attali et al (1999),France
446,1556,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),14,14,I,NO,Mild,-,Attali et al (1999),France
446,1555,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),8,-,-,NO,Mild,-,Attali et al (1999),France
446,1552,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),13,-,-,NO,Mild,-,Attali et al (1999),France
446,1550,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),11,-,-,NO,Mild,-,Attali et al (1999),France
446,3438,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),0,-,-,NO,Severe,-,Belvini et al (2005),Italy
446,4118,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),7.7,,,NO,Mild,,Johnsen et al (2017),United States
446,4115,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),18,,,NO,Mild,,Johnsen et al (2017),United States
446,4114,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),6,,,NO,Mild,,Johnsen et al (2017),United States
446,4113,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),9,,,NO,Mild,,Johnsen et al (2017),United States
446,4112,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),11,,,NO,Mild,,Johnsen et al (2017),United States
446,4111,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),12,,,NO,Mild,,Johnsen et al (2017),United States
446,4110,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),8,,,NO,Mild,,Johnsen et al (2017),United States
446,4109,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),7,,,NO,Mild,,Johnsen et al (2017),United States
446,4107,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),8.67,,,NO,Mild,,Johnsen et al (2017),United States
446,4105,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),6,,,NO,Mild,,Johnsen et al (2017),United States
446,4108,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),6,,,NO,Mild,,Johnsen et al (2017),United States
446,1573,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),11,10,I,,Mild,-,Centre B25 (unpublished),
446,1574,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),11,-,-,,Mild,-,Centre B25 (unpublished),
446,1575,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),13,-,-,,Mild,-,Centre B25 (unpublished),
446,1577,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),-,-,-,,,-,Centre B25 (unpublished),
446,1578,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),20,-,-,,Mild,-,Centre B25 (unpublished),
446,1512,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),12,12,I,,Mild,-,Centre B23 (unpublished),
446,1561,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),10,-,-,,Mild,-,Centre B25 (unpublished),
446,1519,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),9,-,-,,Mild,-,Centre B30 (unpublished),
446,1520,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),13,-,-,,Mild,-,Aguilar-Martinez et al (1994B),
446,1527,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),-,-,-,,,-,Centre B30 (unpublished),
446,1528,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),18,-,-,,Mild,-,Centre B30 (unpublished),
446,1529,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),21,-,-,,Mild,-,Centre B1 (unpublished),
446,1530,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),13,-,-,,Mild,-,Centre B35 (unpublished),
446,1531,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),16,-,-,,Mild,-,Centre B30 (unpublished),
446,1532,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),-,-,-,,,-,Centre B30 (unpublished),
446,1534,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),-,-,-,,,-,Centre B30 (unpublished),
446,1535,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),10,-,-,,Mild,-,Centre B12 (unpublished),
446,1537,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),5,-,-,,Moderate,-,Centre B13 (unpublished),
446,1541,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),-,22,-,,,-,Centre B38 (unpublished),
446,1542,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),5,9,II,,Moderate,-,Centre B38 (unpublished),
446,1543,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),10,-,-,,Mild,-,Centre B13 (unpublished),
446,1576,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),13,-,-,,Mild,-,Centre B25 (unpublished),
446,1558,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),13,14,I,,Mild,-,Centre B25 (unpublished),
446,1559,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),17,-,-,,Mild,-,Centre B25 (unpublished),
446,1560,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),10 to 14,-,-,,Mild,-,Centre B25 (unpublished),
446,1562,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),21,-,-,,Mild,-,Centre B25 (unpublished),
446,1563,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),13,-,-,,Mild,-,Centre B25 (unpublished),
446,1564,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),11,-,-,,Mild,-,Centre B25 (unpublished),
446,1565,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),15,25,II,,Mild,-,Centre B25 (unpublished),
446,1566,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),14,-,-,,Mild,-,Centre B25 (unpublished),
446,1567,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),11,-,-,,Mild,-,Centre B25 (unpublished),
446,1568,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),15,-,-,,Mild,-,Centre B25 (unpublished),
446,1569,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),18,-,-,,Mild,-,Centre B25 (unpublished),
446,1572,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),10,-,-,,Mild,-,Centre B25 (unpublished),
446,1513,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),15,-,-,,Mild,-,Tam et al (1991),Canada
446,1522,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),20,3,I,,Mild,-,Tartary et al (1993),France
446,1521,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),11,-,-,,Mild,-,Tartary et al (1993),France
446,1540,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),-,-,-,,,-,Wulff and Herrmann (1999),Germany
446,1525,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),8.5,-,-,,Mild,-,Jayandharan et al (2005),India
446,1526,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),6.5,-,-,,Mild,-,Jayandharan et al (2005),India
446,1533,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),1.5,-,-,,Moderate,-,Belvini et al (2005),Italy
446,1523,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),7,-,-,,Mild,-,Van de Water et al (1996),New Zealand
446,1539,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),11,-,-,,Mild,-,Montejo et al (1999),Spain
446,1538,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),13,10,I,,Mild,-,Montejo et al (1999),Spain
446,1536,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),<1,<1,-,,Severe,-,Ljung et al (2001),Sweden
446,1516,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),16,-,-,,Mild,-,Ljung et al (2001),Sweden
446,1518,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),12,-,-,,Mild,-,Saad et al (1994),United Kingdom
446,1517,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),15,-,-,,Mild,-,Saad et al (1994),United Kingdom
446,1511,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),11,15,I,,Mild,-,Green et al (1991),United Kingdom
446,1510,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),8 to 15,-,-,,Mild,-,Green et al (1991),United Kingdom
446,1509,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),5 to 22,12,-,,Mild,-,Green et al (1991),United Kingdom
446,1508,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),22,-,-,,Mild,-,Green et al (1991),United Kingdom
446,1557,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),7,-,-,,Mild,-,Li et al (2000),United States
446,1524,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),9,15,II,,Mild,-,Chen et al (1995),United States
446,4106,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),11,,,,Mild,,Johnsen et al (2017),United States
446,1514,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),10,11,I,,Mild,-,Chen et al (1991a),United States
446,1515,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),15,15,I,,Mild,-,Chen et al (1991a),United States
446,1579,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),12,-,-,,Mild,-,Koeberl et al (1989),United States
446,4116,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),15,,,,Mild,,Johnsen et al (2017),United States
446,4117,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),8,,,,Mild,,Johnsen et al (2017),United States
446,4119,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),11,,,,Mild,,Johnsen et al (2017),United States
446,3781,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),14,-,-,,Mild,-,Montejo et al (1999),Spain
446,3780,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),-,-,-,,-,-,Montejo et al (1999),Spain
446,3782,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),6,16,II,,Mild,-,Montejo et al (1999),Spain
446,3741,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),5-22,12,I,,Mild,,Green et al (1990) ,United Kingdom
446,3742,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),12,,,,Mild,,Green et al (1990) ,United Kingdom
446,3744,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),22,,,,Mild,,Green et al (1990) ,United Kingdom
446,3743,Point,Missense,835,279,233,Serine Protease,Exon 7,c.835G>A,p.(Ala279Thr),11,15,I,,Mild,,Green et al (1990) ,United Kingdom
1030,3364,Point,Splice,838,,,-,Intron 7,c.838+1G>A,N/A,1,1,I,,Moderate,-,Tartary et al (1993),France
1030,3363,Point,Splice,838,,,-,Intron 7,c.838+1G>A,N/A,-,-,-,,,-,Wulff et al (1999),Germany
1031,3365,Point,Splice,838,,,-,Intron 7,c.838+1G>C,N/A,<1,-,-,,Severe,-,Ketterling et al (1999A),United States
1032,3366,Point,Splice,838,,,-,Intron 7,c.838+2T>G,N/A,-,-,-,,,-,Ketterling et al (1999A),United States
448,3439,Point,Missense,838,280,234,Serine Protease,Exon 7,c.838G>C,p.(Gly280Arg),0,-,-,NO,Severe,-,Belvini et al (2005),Italy
448,1583,Point,Missense,838,280,234,Serine Protease,Exon 7,c.838G>C,p.(Gly280Arg),<1,<1,-,,Severe,-,Centre B20 (unpublished),
448,1584,Point,Missense,838,280,234,Serine Protease,Exon 7,c.838G>C,p.(Gly280Arg),2,-,-,,Moderate,-,Centre B13 (unpublished),
1077,3545,Point,Missense,838,280,234,Serine Protease,Exon 7,c.838G>T,p.(Gly280Cys),-,-,-,NO,Severe,-,Yu et al (2012),China
447,1580,Point,Missense,838,280,234,Serine Protease,Exon 7,c.838G>A,p.(Gly280Ser),-,-,-,,Severe,-,Belvini et al (2005),Italy
1033,3371,Point,Splice,839,,,-,Intron 7,c.839-1G>A,N/A,<1,<1,-,YES,Severe,-,Matsushita et al (1990),Japan
1033,4662,Point,Splice,839,,,-,Intron 7,c.839-1G>A,N/A,<1,,,YES,Severe,,Johnsen et al (2017),United States
1033,4663,Point,Splice,839,,,-,Intron 7,c.839-1G>A,N/A,<1,,,NO,Severe,,Johnsen et al (2017),United States
1033,3369,Point,Splice,839,,,-,Intron 7,c.839-1G>A,N/A,6 to 10,-,-,,Mild,-,Saad et al (1994),
1033,3370,Point,Splice,839,,,-,Intron 7,c.839-1G>A,N/A,-,-,-,,,-,Centre B21 (unpublished),
1033,3367,Point,Splice,839,,,-,Intron 7,c.839-1G>A,N/A,<1,<1,-,,Severe,-,Chen et al (1991b),United States
1033,3368,Point,Splice,839,,,-,Intron 7,c.839-1G>A,N/A,<1,-,-,,Severe,-,Bottema et al (1991),United States
1034,3372,Point,Splice,839,,,-,Intron 7,c.839-2A>C,N/A,<1,<1,-,YES,Severe,-,Centre B38 (unpublished),
1034,4664,Point,Splice,839,,,-,Intron 7,c.839-2A>C,N/A,<1,,,YES,Severe,,Johnsen et al (2017),United States
1034,4665,Point,Splice,839,,,-,Intron 7,c.839-2A>C,N/A,<1,,,NO,Severe,,Johnsen et al (2017),United States
1034,4666,Point,Splice,839,,,-,Intron 7,c.839-2A>C,N/A,<1,,,NO,Severe,,Johnsen et al (2017),United States
1035,3373,Point,Splice,839,,,-,Intron 7,c.839-4A>G,N/A,<1,-,-,,Severe,-,Centre B20 (unpublished),
1035,3374,Point,Splice,839,,,-,Intron 7,c.839-4A>G,N/A,5,-,-,,Moderate,-,Centre B13 (unpublished),
1035,3375,Point,Splice,839,,,-,Intron 7,c.839-4A>G,N/A,2,4,II,,Moderate,-,Centre B20 (unpublished),
1120,1585,Point,Missense,839,280,234,Serine Protease,Exon 8,c.839G>C,p.(Gly280Ala),17,-,-,,Mild,-,Centre B30 (unpublished),
450,3674,Point,Missense,839,280,234,Serine Protease,Exon 8,c.839G>A,p.(Gly280Asp),-,-,-,NO,Moderate,-,Miller et al (2012),United States
450,1589,Point,Missense,839,280,234,Serine Protease,Exon 8,c.839G>A,p.(Gly280Asp),-,-,-,,Severe,-,Jenkins et al (2008),Ireland
449,4120,Point,Missense,839,280,234,Serine Protease,Exon 8,c.839G>T,p.(Gly280Val),<1,,,NO,Severe,,Johnsen et al (2017),United States
449,1586,Point,Missense,839,280,234,Serine Protease,Exon 8,c.839G>T,p.(Gly280Val),<1,-,-,,Severe,-,Centre B39 (unpublished),
449,1587,Point,Missense,839,280,234,Serine Protease,Exon 8,c.839G>T,p.(Gly280Val),2,-,-,,Moderate,-,Centre B39 (unpublished),
449,1588,Point,Missense,839,280,234,Serine Protease,Exon 8,c.839G>T,p.(Gly280Val),<1,<1,-,,Severe,-,Weinmann et al (1998),United States
451,1590,Point,Missense,844,282,236,Serine Protease,Exon 8,c.844T>A,p.(His282Gln),<1,-,-,,Severe,-,Mahajan et al (2004),India
452,4121,Point,Missense,845,282,236,Serine Protease,Exon 8,c.845A>G,p.(His282Arg),45,,,NO,Mild,,Johnsen et al (2017),United States
452,1591,Point,Missense,845,282,236,Serine Protease,Exon 8,c.845A>G,p.(His282Arg),32,-,-,,Mild,-,Centre B30 (unpublished),
452,4122,Point,Missense,845,282,236,Serine Protease,Exon 8,c.845A>G,p.(His282Arg),40,,,,Mild,,Johnsen et al (2017),United States
1157,1592,Point,Missense,847,283,237,Serine Protease,Exon 8,c.847A>G,p.(Asn283Asp),-,-,-,,,-,Wulff et al (1995),Germany
453,1593,Point,Missense,851,284,238,Serine Protease,Exon 8,c.851T>A,p.(Ile284Asn),20,-,-,,Mild,-,Centre B30 (unpublished),
1212,4789,Point,Nonsense,853,285,239,Serine Protease,Exon 8,c.853G>T,p.(Glu285*),<1,,,NO,Severe,,Johnsen et al (2017),United States
1212,4790,Point,Nonsense,853,285,239,Serine Protease,Exon 8,c.853G>T,p.(Glu285*),<1,,,NO,Severe,,Johnsen et al (2017),United States
1212,4791,Point,Nonsense,853,285,239,Serine Protease,Exon 8,c.853G>T,p.(Glu285*),<1,,,NO,Severe,,Johnsen et al (2017),United States
455,1595,Point,Nonsense,862,288,242,Serine Protease,Exon 8,c.862G>T,p.(Glu288*),<1,<1,-,,Severe,-,"Quadros et al, (2009)",India
455,1596,Point,Nonsense,862,288,242,Serine Protease,Exon 8,c.862G>T,p.(Glu288*),-,-,-,,,-,Onay et al (2003),Turkey
456,1597,Point,Missense,865,289,243,Serine Protease,Exon 8,c.865C>T,p.(His289Tyr),<1,75,II,,Severe,-,"Quadros et al, (2009)",India
1190,4759,Point,Missense,869,290,244,Serine Protease,Exon 8,c.869C>T,p.(Thr290Ile),28,,,NO,Mild,,Johnsen et al (2017),United States
1190,4760,Point,Missense,869,290,244,Serine Protease,Exon 8,c.869C>T,p.(Thr290Ile),24,,,NO,Mild,,Johnsen et al (2017),United States
1190,4761,Point,Missense,869,290,244,Serine Protease,Exon 8,c.869C>T,p.(Thr290Ile),24,,,NO,Mild,,Johnsen et al (2017),United States
460,1607,Point,Nonsense,871,291,245,Serine Protease,Exon 8,c.871G>T,p.(Glu291*),-,-,-,,,-,Centre B13 (unpublished),
459,1605,Point,Missense,871,291,245,Serine Protease,Exon 8,c.871G>A,p.(Glu291Lys),-,-,-,,,-,Centre B39 (unpublished),
459,1606,Point,Missense,871,291,245,Serine Protease,Exon 8,c.871G>A,p.(Glu291Lys),2,74,II,,Moderate,-,Centre B27 (unpublished),
459,1602,Point,Missense,871,291,245,Serine Protease,Exon 8,c.871G>A,p.(Glu291Lys),-,-,-,,,-,Wulff et al (2001),Germany
459,1603,Point,Missense,871,291,245,Serine Protease,Exon 8,c.871G>A,p.(Glu291Lys),<1,-,-,,Severe,-,Belvini et al (2005),Italy
461,3441,Point,Missense,872,291,245,Serine Protease,Exon 8,c.872A>G,p.(Glu291Gly),4.2,-,-,NO,Moderate,-,Belvini et al (2005),Italy
461,1611,Point,Missense,872,291,245,Serine Protease,Exon 8,c.872A>G,p.(Glu291Gly),3,110,II,,Moderate,-,Centre B14 (unpublished),
461,1608,Point,Missense,872,291,245,Serine Protease,Exon 8,c.872A>G,p.(Glu291Gly),12,-,-,,Mild,-,Belvini et al (2005),Italy
462,1612,Point,Missense,872,291,245,Serine Protease,Exon 8,c.872A>T,p.(Glu291Val),3,39,II,,Moderate,-,Ludwig et al (1992B),Germany
463,1613,Point,Missense,873,291,245,Serine Protease,Exon 8,c.873G>T,p.(Glu291Asp),6,-,-,,Mild,-,Centre B39 (unpublished),
465,4123,Point,Missense,874,292,246,Serine Protease,Exon 8,c.874C>A,p.(Gln292Lys),<1,,,NO,Severe,,Johnsen et al (2017),United States
465,1615,Point,Missense,874,292,246,Serine Protease,Exon 8,c.874C>A,p.(Gln292Lys),<1,-,-,,Severe,-,Centre B9 (unpublished),
466,1633,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<1,-,YES,Severe,-,Tartary et al (1993),France
466,1660,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<10,-,YES,Severe,-,Attali et al (1999),France
466,1642,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,YES,Severe,-,Belvini et al (2005),Italy
466,1663,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,YES,Severe,-,Belvini et al (2005),Italy
466,1616,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<0.1,-,YES,Severe,-,Green et al (1989),United Kingdom
466,4594,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,YES,Severe,,Johnsen et al (2017),United States
466,4612,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,YES,Severe,,Johnsen et al (2017),United States
466,4598,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,YES,Severe,,Johnsen et al (2017),United States
466,3595,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,NO,Moderate,-,Yu et al (2012),China
466,3632,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,NO,Moderate,-,Yu et al (2012),China
466,3631,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,NO,Moderate,-,Yu et al (2012),China
466,1659,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,9,II,NO,Severe,-,Attali et al (1999),France
466,1658,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<1,-,NO,Severe,-,Attali et al (1999),France
466,3464,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,NO,Severe,-,Jayandharan et al (2009),India
466,3461,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,NO,Severe,-,Belvini et al (2005),Italy
466,3460,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),0,-,-,NO,Severe,-,Belvini et al (2005),Italy
466,3700,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,NO,Moderate,-,Miller et al (2012),United States
466,3699,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,NO,Severe,-,Miller et al (2012),United States
466,4595,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,NO,Severe,,Johnsen et al (2017),United States
466,4599,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,NO,Severe,,Johnsen et al (2017),United States
466,4600,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,NO,Severe,,Johnsen et al (2017),United States
466,4602,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),1,,,NO,Moderate,,Johnsen et al (2017),United States
466,4601,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,NO,Severe,,Johnsen et al (2017),United States
466,4603,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,NO,Severe,,Johnsen et al (2017),United States
466,4604,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,NO,Severe,,Johnsen et al (2017),United States
466,4606,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,NO,Severe,,Johnsen et al (2017),United States
466,4608,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,NO,Severe,,Johnsen et al (2017),United States
466,4609,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,NO,Severe,,Johnsen et al (2017),United States
466,4610,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,NO,Severe,,Johnsen et al (2017),United States
466,4611,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,NO,Severe,,Johnsen et al (2017),United States
466,4613,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,NO,Severe,,Johnsen et al (2017),United States
466,4605,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,NO,Severe,,Johnsen et al (2017),United States
466,4596,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,NO,Severe,,Johnsen et al (2017),United States
466,4597,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,NO,Severe,,Johnsen et al (2017),United States
466,1673,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,,,-,Centre B39 (unpublished),
466,1672,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,,,-,Centre B39 (unpublished),
466,1665,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Centre B39 (unpublished),
466,1624,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<1,-,,Severe,-,Centre B23 (unpublished),
466,3458,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,,severe,-,Centre B38 (unpublished),
466,1674,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),2.9,-,-,,Moderate,-,Centre B36 (unpublished),
466,1647,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Centre B12 (unpublished),
466,1648,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),1,-,-,,Moderate,-,Centre B30 (unpublished),
466,1669,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Centre B9 (unpublished),
466,1645,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Centre B30 (unpublished),
466,1650,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,,,-,Centre B17 (unpublished),
466,1653,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Centre B35 (unpublished),
466,1646,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Centre B37 (unpublished),
466,1655,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Centre B38 (unpublished),
466,1656,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<10,-,,Severe,-,Centre B14 (unpublished),
466,1667,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Centre B21 (unpublished),
466,1670,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Centre B38 (unpublished),
466,1668,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),1.3,-,-,,Moderate,-,Centre B21 (unpublished),
466,1625,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<1,-,,Severe,-,Poon et al (1993),Canada
466,1661,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),1.6,-,-,,Moderate,-,Liu et al (2000),China
466,1631,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<1,-,,Severe,-,Tartary et al (1993),France
466,1632,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Tartary et al (1993),France
466,1654,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Costa et al (2000),France
466,1671,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Wulff et al (1999),Germany
466,1652,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<1,-,,Severe,-,Wulff et al (1999),Germany
466,1657,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,,,-,Wulff and Herrmann (1999),Germany
466,1629,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Mahajan et al (2004),India
466,1636,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Jayandharan et al (2005),India
466,1676,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,,Severe,-,Jenkins et al (2008),Ireland
466,1619,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),4,-,-,,Moderate,-,Elmahmoudi et al (2011),Tunisia
466,1635,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,,,-,Onay et al (2003),Turkey
466,1630,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,,,-,Caglayan et al (1994),Turkey
466,1620,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Green et al (1992),United Kingdom
466,1618,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,4,II,,Severe,-,Green et al (1990),United Kingdom
466,1644,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
466,1643,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,,,-,Saad et al (1994),United Kingdom
466,3459,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<1,-,,Severe,-,Green et al (1991),United Kingdom
466,1628,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Bottema et al (1991),United States
466,1627,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<1,-,,Severe,-,Tarnower and Smith (1991),United States
466,1623,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<1,-,,Severe,-,Tarnower and Smith (1991),United States
466,1622,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<1,-,,Severe,-,Tarnower and Smith (1991),United States
466,1621,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<1,-,,Severe,-,Wang et al (1990),United States
466,4593,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,,Severe,,Johnsen et al (2017),United States
466,1626,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,,Severe,-,Bottema et al (1991),United States
466,1649,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),2,-,-,,Moderate,-,Thorland et al (1995),United States
466,1641,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),-,-,-,,Severe,-,Bottema et al (1993),United States
466,1640,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),3,1.1,I,,Moderate,-,Gostout et al (1993),United States
466,1639,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,1,-,,Severe,-,Bottema et al (1993),United States
466,1637,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<1,-,,Severe,-,Bottema et al (1993),United States
466,1638,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),2,<1,I,,Moderate,-,Bottema et al (1993),United States
466,1634,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<1,-,,Severe,-,Bottema et al (1993),United States
466,4607,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,,Severe,,Johnsen et al (2017),United States
466,1662,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,-,-,,Severe,-,Ketterling et al (1999B),United States
466,1678,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<1,-,,Severe,-,Bottema et al (1990A),United States
466,3746,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<1,,,Severe,,Green et al (1990) ,United Kingdom
466,3745,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,<1,,,Severe,,Green et al (1990) ,United Kingdom
466,3753,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),<1,,,,Severe,,Green et al (1992),United Kingdom
466,3735,Point,Nonsense,880,294,248,Serine Protease,Exon 8,c.880C>T,p.(Arg294*),,,,,,,Gostout et al (1993),United States
467,1677,Point,Missense,880,294,248,Serine Protease,Exon 8,c.880C>G,p.(Arg294Gly),<1,-,-,,Severe,-,Wulff et al (1995),Germany
469,3498,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3.5,-,-,NO,Moderate,-,Radic et al (2013),Argentina
469,3499,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),12,-,-,NO,Mild,-,Radic et al (2013),Argentina
469,3596,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,NO,Moderate,-,Yu et al (2012),China
469,3633,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,NO,Moderate,-,Yu et al (2012),China
469,3634,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,NO,Moderate,-,Yu et al (2012),China
469,1739,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,-,-,NO,Moderate,-,Attali et al (1999),France
469,1740,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),6,<10,-,NO,Mild,-,Attali et al (1999),France
469,1741,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),11,5,I,NO,Mild,-,Attali et al (1999),France
469,1690,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),<1,<1,-,NO,Severe,-,Bicocchi et al (2006),Italy
469,3675,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,NO,Moderate,-,Miller et al (2012),United States
469,4124,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,,,NO,Moderate,,Johnsen et al (2017),United States
469,4125,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),1,,,NO,Moderate,,Johnsen et al (2017),United States
469,4127,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,,,NO,Moderate,,Johnsen et al (2017),United States
469,4128,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,,,NO,Moderate,,Johnsen et al (2017),United States
469,4129,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),7,,,NO,Mild,,Johnsen et al (2017),United States
469,4130,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
469,4132,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,,,NO,Moderate,,Johnsen et al (2017),United States
469,4134,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,,,NO,Moderate,,Johnsen et al (2017),United States
469,4135,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),7,,,NO,Mild,,Johnsen et al (2017),United States
469,4136,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,,,NO,Moderate,,Johnsen et al (2017),United States
469,4137,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,,,NO,Moderate,,Johnsen et al (2017),United States
469,4138,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),4.5,,,NO,Moderate,,Johnsen et al (2017),United States
469,4139,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,,,NO,Moderate,,Johnsen et al (2017),United States
469,4140,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,,,NO,Moderate,,Johnsen et al (2017),United States
469,4141,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,,,NO,Moderate,,Johnsen et al (2017),United States
469,4142,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),4.5,,,NO,Moderate,,Johnsen et al (2017),United States
469,4143,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,,,NO,Moderate,,Johnsen et al (2017),United States
469,4144,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,,,NO,Moderate,,Johnsen et al (2017),United States
469,4145,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
469,4147,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,,,NO,Moderate,,Johnsen et al (2017),United States
469,4148,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,,,NO,Moderate,,Johnsen et al (2017),United States
469,4149,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,,,NO,Moderate,,Johnsen et al (2017),United States
469,4150,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),4,,,NO,Moderate,,Johnsen et al (2017),United States
469,4151,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2.8,,,NO,Moderate,,Johnsen et al (2017),United States
469,4152,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,,,NO,Moderate,,Johnsen et al (2017),United States
469,4153,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,,,NO,Moderate,,Johnsen et al (2017),United States
469,4154,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),4.7,,,NO,Moderate,,Johnsen et al (2017),United States
469,4155,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,,,NO,Moderate,,Johnsen et al (2017),United States
469,4156,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,,,NO,Moderate,,Johnsen et al (2017),United States
469,4157,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3.7,,,NO,Moderate,,Johnsen et al (2017),United States
469,4158,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
469,4159,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),4,,,NO,Moderate,,Johnsen et al (2017),United States
469,4160,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,,,NO,Moderate,,Johnsen et al (2017),United States
469,4161,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),4,,,NO,Moderate,,Johnsen et al (2017),United States
469,4162,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,,,NO,Moderate,,Johnsen et al (2017),United States
469,4163,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,,,NO,Moderate,,Johnsen et al (2017),United States
469,4165,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),4,,,NO,Moderate,,Johnsen et al (2017),United States
469,4166,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,,,NO,Moderate,,Johnsen et al (2017),United States
469,4168,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
469,1742,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),5,-,-,,Moderate,-,Centre B39 (unpublished),
469,1753,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,,,-,Centre B39 (unpublished),
469,1754,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,,,-,Centre B39 (unpublished),
469,1755,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,,,-,Centre B39 (unpublished),
469,1756,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,,,-,Centre B39 (unpublished),
469,1757,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,,,-,Centre B39 (unpublished),
469,1711,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,-,-,,Moderate,-,Centre B30 (unpublished),
469,1713,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),4,-,-,,Moderate,-,Centre B30 (unpublished),
469,1714,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),5,-,-,,Moderate,-,Centre B30 (unpublished),
469,1715,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),<1,-,-,,Severe,-,Centre B12 (unpublished),
469,1717,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,,,-,Centre B30 (unpublished),
469,1718,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,-,-,,Moderate,-,Centre B35 (unpublished),
469,1722,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),1,-,-,,Moderate,-,Centre B30 (unpublished),
469,1724,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,,,-,Centre B17 (unpublished),
469,1725,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),9,-,-,,Mild,-,Centre B30 (unpublished),
469,1726,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),1,-,-,,Moderate,-,Centre B12 (unpublished),
469,1727,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,<6,-,,Moderate,-,Centre B22 (unpublished),
469,1730,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,,,-,Centre B30 (unpublished),
469,1731,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),7,-,-,,Mild,-,Centre B35 (unpublished),
469,1732,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),7,-,-,,Mild,-,Centre B35 (unpublished),
469,1733,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,,,-,Centre B8 (unpublished),
469,1735,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),4,<10,-,,Moderate,-,Centre B14 (unpublished),
469,1737,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,4,I,,Moderate,-,Centre B14 (unpublished),
469,1738,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3.5,-,-,,Moderate,-,Centre B13 (unpublished),
469,1744,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),<1,-,-,,Severe,-,Centre B36 (unpublished),
469,1745,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),<1,-,-,,Severe,-,Centre B36 (unpublished),
469,1746,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),<1,-,-,,Severe,-,Centre B36 (unpublished),
469,1747,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),<1,-,-,,Severe,-,Centre B36 (unpublished),
469,1748,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,-,-,,Moderate,-,Centre B13 (unpublished),
469,1749,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,,,-,Centre B21 (unpublished),
469,1750,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),4.5,-,-,,Moderate,-,Centre B21 (unpublished),
469,1751,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,2,-,,,-,Centre B38 (unpublished),
469,1752,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,-,-,,Moderate,-,Centre B38 (unpublished),
469,1758,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),6.1,-,-,,Mild,-,Centre B36 (unpublished),
469,1759,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),0,-,-,,Severe,-,Centre B36 (unpublished),
469,1761,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,,,-,Centre B36 (unpublished),
469,1763,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),1.3,-,-,,Moderate,-,Centre B36 (unpublished),
469,1764,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),1.8,-,-,,Moderate,-,Centre B36 (unpublished),
469,1765,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2 to 5,-,-,,Moderate,-,Centre B13 (unpublished),
469,1766,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2.5,2,I,,Moderate,-,Centre B13 (unpublished),
469,1767,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,-,-,,Moderate,-,Centre B38 (unpublished),
469,1768,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2.4,-,-,,Moderate,-,Centre B5 (unpublished),
469,1691,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,<10,-,,Moderate,-,Poon et al (1993),Canada
469,1692,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),6,9,II,,Mild,-,Poon et al (1993),Canada
469,1704,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,,,-,Nielsen et al (1995),Denmark
469,1703,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),5.5,-,-,,Moderate,-,Ghanem et al (1993),France
469,1723,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,-,-,,Moderate,-,Costa et al (2000),France
469,1685,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,4,I,,Moderate,-,Ludwig et al (1992B),Germany
469,1705,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,,Moderate,-,Wulff et al (1995),Germany
469,1721,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),5,-,-,,Moderate,-,Wulff et al (2001),Germany
469,1729,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),<1,<1,-,,Severe,-,Wulff et al (1999),Germany
469,1688,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,-,-,,Moderate,-,Belvini et al (2005),Italy
469,1699,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),10,-,-,,Mild,-,David et al (1993),Portugal
469,1736,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,,,-,Montejo et al (1999),Spain
469,1743,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),4,-,-,,Moderate,-,Vidal et al (2000),Spain
469,1734,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),<1,<1,-,,Severe,-,Ljung et al (2001),Sweden
469,1694,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),4,-,-,,Moderate,-,Onay et al (2003),Turkey
469,1695,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),0.2,-,-,,Severe,-,Onay et al (2003),Turkey
469,1698,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,,,-,Caglayan et al (1994),Turkey
469,1687,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
469,1689,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,,,-,Saad et al (1994),United Kingdom
469,1700,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,-,-,,Moderate,-,Saad et al (1994),United Kingdom
469,1701,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),7,-,-,,Mild,-,Saad et al (1994),United Kingdom
469,1702,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),4,19,II,,Moderate,-,Saad et al (1994),United Kingdom
469,1769,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),<1,-,-,,Severe,-,Enayat et al (2004),United Kingdom
469,1679,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,3,II,,Moderate,-,Koeberl et al (1990B),United States
469,1680,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,4,I,,Moderate,-,Chen et al (1989b),United States
469,1681,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),1,1,I,,Moderate,-,Chen et al (1991a),United States
469,1682,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),4,3,I,,Moderate,-,Chen et al (1989b),United States
469,1683,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,2,I,,Moderate,-,Chen et al (1995),United States
469,1684,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,2,I,,Moderate,-,Chen et al (1995),United States
469,1686,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,2,I,,Moderate,-,Koeberl et al (1990B),United States
469,1693,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),6,3,I,,Mild,-,Bottema et al (1991),United States
469,1696,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),15,-,-,,Mild,-,Bottema et al (1991),United States
469,1697,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,3,I,,Moderate,-,Thompson and Chen (1992),United States
469,1706,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,1.7,I,,Moderate,-,Bottema et al (1993),United States
469,1707,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),6,<6,I,,Mild,-,Bottema et al (1993),United States
469,1708,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),5,1.7,I,,Moderate,-,Bottema et al (1993),United States
469,1709,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),-,-,-,,Moderate,-,Bottema et al (1993),United States
469,1710,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,1.5,I,,Moderate,-,Bottema et al (1993),United States
469,1712,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,-,-,,Moderate,-,Thorland et al (1995),United States
469,1716,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,-,-,,Moderate,-,Thorland et al (1995),United States
469,1719,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,-,-,,Moderate,-,Thorland et al (1995),United States
469,1720,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,-,-,,Moderate,-,Thorland et al (1995),United States
469,1728,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),1,1,I,,Moderate,-,Weinmann et al (1998),United States
469,4126,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,,,,Moderate,,Johnsen et al (2017),United States
469,4131,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),6,,,,Mild,,Johnsen et al (2017),United States
469,4133,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),4.6,,,,Moderate,,Johnsen et al (2017),United States
469,4146,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),3,,,,Moderate,,Johnsen et al (2017),United States
469,4164,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),2,,,,Moderate,,Johnsen et al (2017),United States
469,4167,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>A,p.(Arg294Gln),4,,,,Moderate,,Johnsen et al (2017),United States
1096,3676,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>T,p.(Arg294Leu),-,-,-,NO,Moderate,-,Miller et al (2012),United States
1096,4169,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>T,p.(Arg294Leu),3,,,NO,Moderate,,Johnsen et al (2017),United States
1096,4170,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>T,p.(Arg294Leu),1,,,NO,Moderate,,Johnsen et al (2017),United States
1096,4171,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>T,p.(Arg294Leu),1.9,,,NO,Moderate,,Johnsen et al (2017),United States
1096,4172,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>T,p.(Arg294Leu),2,,,NO,Moderate,,Johnsen et al (2017),United States
1096,4173,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>T,p.(Arg294Leu),<1,,,NO,Severe,,Johnsen et al (2017),United States
1096,4174,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>T,p.(Arg294Leu),3,,,NO,Moderate,,Johnsen et al (2017),United States
1096,4176,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>T,p.(Arg294Leu),2,,,NO,Moderate,,Johnsen et al (2017),United States
1096,4179,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>T,p.(Arg294Leu),2,,,NO,Moderate,,Johnsen et al (2017),United States
1096,4175,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>T,p.(Arg294Leu),1.8,,,,Moderate,,Johnsen et al (2017),United States
1096,4177,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>T,p.(Arg294Leu),1.6,,,,Moderate,,Johnsen et al (2017),United States
1096,4178,Point,Missense,881,294,248,Serine Protease,Exon 8,c.881G>T,p.(Arg294Leu),3,,,,Moderate,,Johnsen et al (2017),United States
470,4180,Point,Missense,886,296,250,Serine Protease,Exon 8,c.886G>A,p.(Val296Met),5,,,NO,Moderate,,Johnsen et al (2017),United States
470,1770,Point,Missense,886,296,250,Serine Protease,Exon 8,c.886G>A,p.(Val296Met),-,-,-,,,-,Centre B12 (unpublished),
470,1771,Point,Missense,886,296,250,Serine Protease,Exon 8,c.886G>A,p.(Val296Met),4,-,-,,Moderate,-,Centre B30 (unpublished),
470,1772,Point,Missense,886,296,250,Serine Protease,Exon 8,c.886G>A,p.(Val296Met),3,-,-,,Moderate,-,Centre B12 (unpublished),
471,4181,Point,Missense,887,296,250,Serine Protease,Exon 8,c.887T>A,p.(Val296Glu),<1,,,NO,Severe,,Johnsen et al (2017),United States
471,1773,Point,Missense,887,296,250,Serine Protease,Exon 8,c.887T>A,p.(Val296Glu),-,-,-,,Severe,-,Belvini et al (2005),Italy
1151,1774,Point,Missense,890,297,251,Serine Protease,Exon 8,c.890T>A,p.(Ile297Asn),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
472,1821,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),-,-,-,YES,Severe,-,Belvini et al (2005),Italy
472,4618,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,,,YES,Severe,,Johnsen et al (2017),United States
472,3527,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
472,3526,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
472,3598,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),-,-,-,NO,Severe,-,Yu et al (2012),China
472,3597,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),-,-,-,NO,Moderate,-,Yu et al (2012),China
472,3467,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,NO,Severe,-,Jayandharan et al (2009),India
472,3466,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,NO,Severe,-,Jayandharan et al (2009),India
472,3465,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,NO,Severe,-,Jayandharan et al (2009),India
472,3454,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,NO,Severe,-,Belvini et al (2005),Italy
472,3442,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),-,-,-,NO,Severe,-,Belvini et al (2005),Italy
472,3455,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,NO,Severe,-,Belvini et al (2005),Italy
472,4615,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),2,,,NO,Moderate,,Johnsen et al (2017),United States
472,4614,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,,,NO,Severe,,Johnsen et al (2017),United States
472,3701,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),-,-,-,NO,Moderate,-,Miller et al (2012),United States
472,4617,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,,,NO,Severe,,Johnsen et al (2017),United States
472,1824,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),-,-,-,,,-,Centre B39 (unpublished),
472,1823,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),-,-,-,,,-,Centre B39 (unpublished),
472,1822,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),-,-,-,,,-,Centre B39 (unpublished),
472,1795,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,,Severe,-,Centre B30 (unpublished),
472,1778,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),3,-,-,,Moderate,-,Centre B21 (unpublished),
472,1807,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,<6,-,,Severe,-,Centre B14 (unpublished),
472,1780,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,<1,-,,Severe,,Centre B4 (unpublished),
472,1791,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,4,II,,Severe,-,Aguilar-Martinez et al (1994B),
472,1802,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),-,-,-,,,-,Centre B30 (unpublished),
472,1803,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,<1,-,,Severe,-,Centre B13 (unpublished),
472,1820,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),-,-,-,,,-,Centre B21 (unpublished),
472,1805,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,<1,-,,Severe,-,Centre B24 (unpublished),
472,1819,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),1,-,-,,Moderate,-,Centre B13 (unpublished),
472,1792,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,,Severe,-,Centre B18 (unpublished),
472,1825,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),1,-,-,,Moderate,-,Centre B36 (unpublished),
472,1796,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,,Severe,-,Meireles et al (2017),Brazil
472,1786,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,,Severe,-,Figueiredo et al (1993),Brazil
472,1779,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,<1,-,,Severe,also Fraser et al (1992),Poon et al (1987),Canada
472,1815,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),-,-,-,,Severe,-,Liu et al (2000),China
472,1813,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),-,-,-,,Severe,-,Liu et al (2000),China
472,1808,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,<1,-,,Severe,-,Costa et al (2000),France
472,1798,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,<1,-,,Severe,-,Costa et al (2000),France
472,1787,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,,Severe,-,Ghanem et al (1993),France
472,1775,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,<1,-,,Severe,-,Siguret et al (1988),France
472,1811,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),-,-,-,,,-,Wulff and Herrmann (1999),Germany
472,1812,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),-,-,-,,,-,Wulff and Herrmann (1999),Germany
472,1804,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,,Severe,-,Wulff et al (2001),Germany
472,1797,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),2,-,-,,Moderate,-,Wulff et al (2001),Germany
472,1793,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,,Severe,-,Wulff et al (1995),Germany
472,1810,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,<1,-,,Severe,-,Wulff et al (1999),Germany
472,1789,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,,Severe,-,Jayandharan et al (2005),India
472,1788,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,,Severe,-,Jayandharan et al (2005),India
472,1790,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,,Severe,-,Jayandharan et al (2005),India
472,1794,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),1,-,-,,Moderate,-,David et al (1998),Portugal
472,1816,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,,Severe,-,Vidal et al (2000),Spain
472,1806,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),-,-,-,,,-,Montejo et al (1999),Spain
472,1809,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),-,-,-,,,-,Montejo et al (1999),Spain
472,1800,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,<1,-,,Severe,-,Ljung et al (2001),Sweden
472,1783,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),1,-,-,,Moderate,-,Onay et al (2003),Turkey
472,1782,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),-,-,-,,,-,Saad et al (1994),United Kingdom
472,1781,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,,Severe,-,Green et al (1992),United Kingdom
472,1776,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,6,II,,Severe,-,Green et al (1991),United Kingdom
472,1814,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,,Severe,-,Li et al (2000),United States
472,1799,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,,Severe,-,Driscoll et al (1996),United States
472,1785,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,-,-,,Severe,-,Ketterling et al (1993A),United States
472,1784,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),3,<1,I,,Moderate,-,Bottema et al (1991),United States
472,1777,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,<1,-,,Severe,-,Chen et al (1989a),United States
472,4616,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),2,,,,Moderate,,Johnsen et al (2017),United States
472,3747,Point,Nonsense,892,298,252,Serine Protease,Exon 8,c.892C>T,p.(Arg298*),<1,6,II,,Severe,,Green et al (1990) ,United Kingdom
473,1827,Point,Missense,893,298,252,Serine Protease,Exon 8,c.893G>T,p.(Arg298Leu),13,-,-,,Mild,-,Saad et al (1994),United Kingdom
474,1829,Point,Missense,905,302,256,Serine Protease,Exon 8,c.905A>G,p.(His302Arg),9,-,-,,Mild,-,Meireles et al (2017),Brazil
474,1828,Point,Missense,905,302,256,Serine Protease,Exon 8,c.905A>G,p.(His302Arg),7,-,-,,Mild,-,Montejo et al (1999),Spain
476,1832,Point,Missense,907,303,257,Serine Protease,Exon 8,c.907C>T,p.(His303Tyr),-,-,-,,,-,Centre B38 (unpublished),
476,1831,Point,Missense,907,303,257,Serine Protease,Exon 8,c.907C>T,p.(His303Tyr),30,-,-,,Mild,-,Wulff et al (2001),Germany
476,1833,Point,Missense,907,303,257,Serine Protease,Exon 8,c.907C>T,p.(His303Tyr),<1,<0.1,-,,Severe,Also has p.Arg162* Causative,Montandon et al (1990A),United Kingdom
478,1835,Point,Missense,913,305,259,Serine Protease,Exon 8,c.913T>A,p.(Tyr305Asn),-,-,-,,,-,Liu et al (2000),China
1191,4762,Point,Missense,914,305,259,Serine Protease,Exon 8,c.914A>G,p.(Tyr305Cys),2,,,NO,Moderate,,Johnsen et al (2017),United States
479,1837,Point,Missense,915,305,259,Serine Protease,Exon 8,c.915A>G,p.(Tyr305Cys),1,-,-,,Moderate,-,Centre B30 (unpublished),
479,1841,Point,Missense,915,305,259,Serine Protease,Exon 8,c.915A>G,p.(Tyr305Cys),2,-,-,,Moderate,-,Mukherjee et al (2004),India
479,1838,Point,Missense,915,305,259,Serine Protease,Exon 8,c.915A>G,p.(Tyr305Cys),-,-,-,,Severe,-,Belvini et al (2005),Italy
479,1836,Point,Missense,915,305,259,Serine Protease,Exon 8,c.915A>G,p.(Tyr305Cys),3,-,-,,Moderate,-,Van de Water et al (1996),New Zealand
479,1839,Point,Missense,915,305,259,Serine Protease,Exon 8,c.915A>G,p.(Tyr305Cys),-,-,-,,,-,Li et al (2000),United States
479,1842,Point,Missense,915,305,259,Serine Protease,Exon 8,c.915A>G,p.(Tyr305Cys),<1,<1,-,,Severe,-,Bottema et al (1991),United States
1135,1844,Point,Missense,917,306,260,Serine Protease,Exon 8,c.917A>G,p.(Asn306Ser),9,-,-,,Mild,-,Van de Water et al (1996),New Zealand
1135,1843,Point,Missense,917,306,260,Serine Protease,Exon 8,c.917A>G,p.(Asn306Ser),24,-,-,,Mild,-,Koeberl et al (1989),United States
1192,4763,Point,Missense,917,306,260,Serine Protease,Exon 8,c.917A>C,p.(Asn306Thr),5,,,NO,Moderate,,Johnsen et al (2017),United States
481,1846,Point,Missense,928,310,264,Serine Protease,Exon 8,c.928A>T,p.(Asn310Tyr),25,25,I,,Mild,-,Weinmann et al (1998),United States
484,4619,Point,Nonsense,936,312,266,Serine Protease,Exon 8,c.936C>A,p.(Tyr312*),<1,,,NO,Severe,,Johnsen et al (2017),United States
484,1849,Point,Nonsense,936,312,266,Serine Protease,Exon 8,c.936C>A,p.(Tyr312*),<1,<1,-,,Severe,-,Wulff et al (1999),Germany
484,1855,Point,Nonsense,936,312,266,Serine Protease,Exon 8,c.936C>A,p.(Tyr312*),<1,-,-,,Severe,-,Wulff et al (2001),Germany
485,1851,Point,Nonsense,936,312,266,Serine Protease,Exon 8,c.936C>G,p.(Tyr312*),<1,-,-,,Severe,-,Centre B12 (unpublished),
485,1853,Point,Nonsense,936,312,266,Serine Protease,Exon 8,c.936C>G,p.(Tyr312*),<1,-,-,,Severe,-,Centre B25 (unpublished),
485,1852,Point,Nonsense,936,312,266,Serine Protease,Exon 8,c.936C>G,p.(Tyr312*),0,-,-,,Severe,-,Belvini et al (2005),Italy
487,1857,Point,Missense,941,314,268,Serine Protease,Exon 8,c.941A>G,p.(His314Arg),6,-,-,,Mild,-,Centre B30 (unpublished),
487,1859,Point,Missense,941,314,268,Serine Protease,Exon 8,c.941A>G,p.(His314Arg),11,-,-,,Mild,-,Centre B30 (unpublished),
487,1858,Point,Missense,941,314,268,Serine Protease,Exon 8,c.941A>G,p.(His314Arg),6,2,I,,Mild,-,Costa et al (2000),France
487,1856,Point,Missense,941,314,268,Serine Protease,Exon 8,c.941A>G,p.(His314Arg),7,-,-,,Mild,-,Saad et al (1994),United Kingdom
488,1861,Point,Missense,942,314,268,Serine Protease,Exon 8,c.942T>G,p.(His314Gln),25,-,-,,Mild,-,Centre B13 (unpublished),
488,1860,Point,Missense,942,314,268,Serine Protease,Exon 8,c.942T>G,p.(His314Gln),8,2,I,,Mild,-,Tartary et al (1993),France
488,1862,Point,Missense,942,314,268,Serine Protease,Exon 8,c.942T>G,p.(His314Gln),<1,-,-,,Severe,-,Mahajan et al (2004),India
489,4182,Point,Missense,943,315,269,Serine Protease,Exon 8,c.943G>A,p.(Asp315Asn),<1,,,NO,Severe,,Johnsen et al (2017),United States
489,1863,Point,Missense,943,315,269,Serine Protease,Exon 8,c.943G>A,p.(Asp315Asn),-,-,-,,,-,Centre B17 (unpublished),
489,1864,Point,Missense,943,315,269,Serine Protease,Exon 8,c.943G>A,p.(Asp315Asn),1.5,-,-,,Moderate,-,Knobloch et al (1993),Germany
490,3599,Point,Missense,944,315,269,Serine Protease,Exon 8,c.944A>G,p.(Asp315Gly),-,-,-,NO,Severe,-,Yu et al (2012),China
490,4183,Point,Missense,944,315,269,Serine Protease,Exon 8,c.944A>G,p.(Asp315Gly),2.5,,,NO,Moderate,,Johnsen et al (2017),United States
490,1865,Point,Missense,944,315,269,Serine Protease,Exon 8,c.944A>G,p.(Asp315Gly),<1,-,-,,Severe,-,Ghanem et al (1993),France
490,1866,Point,Missense,944,315,269,Serine Protease,Exon 8,c.944A>G,p.(Asp315Gly),<1,-,-,,Severe,-,Costa et al (2000),France
490,1867,Point,Missense,944,315,269,Serine Protease,Exon 8,c.944A>G,p.(Asp315Gly),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
491,1868,Point,Missense,944,315,269,Serine Protease,Exon 8,c.944A>T,p.(Asp315Val),<1,<1,-,,Severe,-,Wulff et al (1999),Germany
491,1869,Point,Missense,944,315,269,Serine Protease,Exon 8,c.944A>T,p.(Asp315Val),<1,-,-,,Severe,-,Ljung et al (2001),Sweden
492,1870,Point,Missense,945,315,269,Serine Protease,Exon 8,c.945C>A,p.(Asp315Glu),<1,5,II,,Severe,-,Ketterling et al (1993A),United States
493,3600,Point,Missense,946,316,270,Serine Protease,Exon 8,c.946A>T,p.(Ile316Phe),-,-,-,NO,Moderate,-,Yu et al (2012),China
493,3677,Point,Missense,946,316,270,Serine Protease,Exon 8,c.946A>T,p.(Ile316Phe),-,-,-,NO,Severe,-,Miller et al (2012),United States
493,1874,Point,Missense,946,316,270,Serine Protease,Exon 8,c.946A>T,p.(Ile316Phe),-,-,-,,,-,Centre B38 (unpublished),
493,1871,Point,Missense,946,316,270,Serine Protease,Exon 8,c.946A>T,p.(Ile316Phe),-,-,-,,,-,Onay et al (2003),Turkey
493,1875,Point,Missense,946,316,270,Serine Protease,Exon 8,c.946A>T,p.(Ile316Phe),2,2,I,,Moderate,-,Saad et al (1994),United Kingdom
493,1872,Point,Missense,946,316,270,Serine Protease,Exon 8,c.946A>T,p.(Ile316Phe),<1,<1,-,,Severe,-,Gostout et al (1993),United States
493,1873,Point,Missense,946,316,270,Serine Protease,Exon 8,c.946A>T,p.(Ile316Phe),1,-,-,,Moderate,-,Thorland et al (1995),United States
493,3784,Point,Missense,946,316,270,Serine Protease,Exon 8,c.946A>T,p.(Ile316Phe),<1,36,II,,Severe,-,Montejo et al (1999),Spain
493,3783,Point,Missense,946,316,270,Serine Protease,Exon 8,c.946A>T,p.(Ile316Phe),<1,-,-,,Severe,-,Montejo et al (1999),Spain
493,3785,Point,Missense,946,316,270,Serine Protease,Exon 8,c.946A>T,p.(Ile316Phe),<1,-,-,,Severe,-,Montejo et al (1999),Spain
494,4184,Point,Missense,947,316,270,Serine Protease,Exon 8,c.947T>C,p.(Ile316Thr),1,,,NO,Moderate,,Johnsen et al (2017),United States
494,1878,Point,Missense,947,316,270,Serine Protease,Exon 8,c.947T>C,p.(Ile316Thr),-,-,-,,,-,Centre B39 (unpublished),
494,1876,Point,Missense,947,316,270,Serine Protease,Exon 8,c.947T>C,p.(Ile316Thr),<1,<1,-,,Severe,-,Centre B23 (unpublished),
494,1877,Point,Missense,947,316,270,Serine Protease,Exon 8,c.947T>C,p.(Ile316Thr),<1,<1,-,,Severe,-,Bottema et al (1991),United States
495,1879,Point,Missense,949,317,271,Serine Protease,Exon 8,c.949G>A,p.(Ala317Thr),30,-,-,,Mild,-,Elmahmoudi et al (2011),Tunisia
496,1880,Point,Missense,950,317,271,Serine Protease,Exon 8,c.950C>A,p.(Ala317Asp),<1,-,-,,Severe,-,Wulff et al (2001),Germany
497,1885,Point,Missense,950,317,271,Serine Protease,Exon 8,c.950C>T,p.(Ala317Val),-,-,-,,,-,Centre B39 (unpublished),
497,1886,Point,Missense,950,317,271,Serine Protease,Exon 8,c.950C>T,p.(Ala317Val),-,-,-,,,-,Centre B39 (unpublished),
497,1884,Point,Missense,950,317,271,Serine Protease,Exon 8,c.950C>T,p.(Ala317Val),26,-,-,,Mild,-,Centre B30 (unpublished),
497,1881,Point,Missense,950,317,271,Serine Protease,Exon 8,c.950C>T,p.(Ala317Val),16,-,-,,Mild,-,Saad et al (1994),United Kingdom
497,1882,Point,Missense,950,317,271,Serine Protease,Exon 8,c.950C>T,p.(Ala317Val),20,-,-,,Mild,-,Saad et al (1994),United Kingdom
497,1883,Point,Missense,950,317,271,Serine Protease,Exon 8,c.950C>T,p.(Ala317Val),-,-,-,,,-,Saad et al (1994),United Kingdom
497,1887,Point,Missense,950,317,271,Serine Protease,Exon 8,c.950C>T,p.(Ala317Val),1,4,II,,Moderate,-,Koeberl et al (1990B),United States
497,1889,Point,Missense,950,317,271,Serine Protease,Exon 8,c.950C>T,p.(Ala317Val),<1,-,-,,Severe,-,Driscoll et al (1996),United States
497,3767,Point,Missense,950,317,271,Serine Protease,Exon 8,c.950C>T,p.(Ala317Val),20,,,,Mild," 
24 cases in 10 families (FIX:C range 17-23) ",Jenkins et al (2008),Ireland
1128,1888,Point,Missense,952,318,272,Serine Protease,Exon 8,c.952C>T,p.(Leu318Phe),<1,-,-,,Severe,-,Driscoll et al (1996),United States
498,4185,Point,Missense,953,318,272,Serine Protease,Exon 8,c.953T>G,p.(Leu318Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
498,1890,Point,Missense,953,318,272,Serine Protease,Exon 8,c.953T>G,p.(Leu318Arg),-,-,-,,,-,Onay et al (2003),Turkey
498,1892,Point,Missense,953,318,272,Serine Protease,Exon 8,c.953T>G,p.(Leu318Arg),<1,2,II,,Severe,-,Bottema et al (1991),United States
499,1891,Point,Missense,953,318,272,Serine Protease,Exon 8,c.953T>A,p.(Leu318His),-,-,-,,,-,Centre B30 (unpublished),
502,1894,Point,Missense,956,319,273,Serine Protease,Exon 8,c.956T>G,p.(Leu319Arg),<1,-,-,,Severe,-,Centre B9 (unpublished),
502,1895,Point,Missense,956,319,273,Serine Protease,Exon 8,c.956T>G,p.(Leu319Arg),<1,<8,-,,Severe,-,Centre B38 (unpublished),
1087,3602,Point,Missense,956,319,273,Serine Protease,Exon 8,c.956T>A,p.(Leu319Gln),-,-,-,NO,Moderate,-,Yu et al (2012),China
501,3601,Point,Missense,956,319,273,Serine Protease,Exon 8,c.956T>C,p.(Leu319Pro),-,-,-,NO,Moderate,-,Yu et al (2012),China
501,3630,Point,Missense,956,319,273,Serine Protease,Exon 8,c.956T>C,p.(Leu319Pro),-,-,-,NO,Moderate,-,Yu et al (2012),China
501,1893,Point,Missense,956,319,273,Serine Protease,Exon 8,c.956T>C,p.(Leu319Pro),<1,-,-,,Severe,-,Odom et al (1994),United States
501,4186,Point,Missense,956,319,273,Serine Protease,Exon 8,c.956T>C,p.(Leu319Pro),<1,,,,Severe,,Johnsen et al (2017),United States
503,1896,Point,Nonsense,958,320,274,Serine Protease,Exon 8,c.958G>T,p.(Glu320*),<1,-,-,,Severe,-,Centre B30 (unpublished),
504,1897,Point,Missense,959,320,274,Serine Protease,Exon 8,c.959A>G,p.(Glu320Gly),18,-,-,,Mild,-,Centre B13 (unpublished),
1193,4764,Point,Missense,960,320,274,Serine Protease,Exon 8,c.960A>C,p.(Glu320Asp),<1,,,NO,Severe,,Johnsen et al (2017),United States
1193,4765,Point,Missense,960,320,274,Serine Protease,Exon 8,c.960A>C,p.(Glu320Asp),<1,,,NO,Severe,,Johnsen et al (2017),United States
508,1904,Point,Missense,962,321,275,Serine Protease,Exon 8,c.962T>G,p.(Leu321Arg),<1,<10,-,,Severe,-,Centre B14 (unpublished),
506,1899,Point,Missense,962,321,275,Serine Protease,Exon 8,c.962T>A,p.(Leu321Gln),<1,-,-,,Severe,-,Wulff et al (1995),Germany
507,1900,Point,Missense,962,321,275,Serine Protease,Exon 8,c.962T>C,p.(Leu321Pro),<1,14,II,,Severe,-,Centre B16 (unpublished),
507,1903,Point,Missense,962,321,275,Serine Protease,Exon 8,c.962T>C,p.(Leu321Pro),<1,1,-,,Severe,-,Centre B25 (unpublished),
507,1902,Point,Missense,962,321,275,Serine Protease,Exon 8,c.962T>C,p.(Leu321Pro),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
507,1901,Point,Missense,962,321,275,Serine Protease,Exon 8,c.962T>C,p.(Leu321Pro),<1,<1,-,,Severe,-,Bottema et al (1991),United States
509,1905,Point,Missense,964,322,276,Serine Protease,Exon 8,c.964G>T,p.(Asp322Tyr),-,9,-,,,-,Centre B38 (unpublished),
1079,4620,Point,Nonsense,967,323,277,Serine Protease,Exon 8,c.967G>T,p.(Glu323*),<1,,,YES,Severe,,Johnsen et al (2017),United States
1079,3547,Point,Nonsense,967,323,277,Serine Protease,Exon 8,c.967G>T,p.(Glu323*),-,-,-,NO,Severe,-,Yu et al (2012),China
510,1906,Point,Missense,967,323,277,Serine Protease,Exon 8,c.967G>A,p.(Glu323Lys),12,-,-,,Mild,-,Centre B13 (unpublished),
511,4187,Point,Missense,971,324,278,Serine Protease,Exon 8,c.971C>A,p.(Pro324His),29,,,NO,Mild,,Johnsen et al (2017),United States
511,1907,Point,Missense,971,324,278,Serine Protease,Exon 8,c.971C>A,p.(Pro324His),30,-,-,,Mild,-,Centre B30 (unpublished),
511,4188,Point,Missense,971,324,278,Serine Protease,Exon 8,c.971C>A,p.(Pro324His),48,,,,Mild,,Johnsen et al (2017),United States
1194,4766,Point,Missense,971,324,278,Serine Protease,Exon 8,c.971C>T,p.(Pro324Leu),18,,,NO,Mild,,Johnsen et al (2017),United States
512,1908,Point,Missense,973,325,279,Serine Protease,Exon 8,c.973T>A,p.(Leu325Ile),13,13,I,,Mild,-,Centre B27 (unpublished),
513,1909,Point,Missense,973,325,279,Serine Protease,Exon 8,c.973T>G,p.(Leu325Val),12,-,-,,Mild,-,Centre B20 (unpublished),
515,1912,Point,Nonsense,974,325,279,Serine Protease,Exon 8,c.974T>G,p.(Leu325*),<1,-,-,,Severe,-,Mukherjee et al (2004),India
514,1910,Point,Missense,974,325,279,Serine Protease,Exon 8,c.974T>C,p.(Leu325Ser),<1,-,-,,Severe,-,Ghanem et al (1993),France
514,1911,Point,Missense,974,325,279,Serine Protease,Exon 8,c.974T>C,p.(Leu325Ser),<1,-,-,,Severe,-,Costa et al (2000),France
1104,3720,Point,Missense,982,328,282,Serine Protease,Exon 8,c.982A>T,p.(Asn328Tyr),4,50,II,NO,Moderate,,Bicocchi et al (2006),Italy
516,1913,Point,Missense,983,328,282,Serine Protease,Exon 8,c.983A>T,p.(Asn328Ile),-,-,-,,Mild,-,Centre B38 (unpublished),
517,1914,Point,Missense,984,328,282,Serine Protease,Exon 8,c.984C>G,p.(Asn328Lys),3,<10,-,,Moderate,-,Centre B14 (unpublished),
519,1919,Point,Missense,987,329,283,Serine Protease,Exon 8,c.987C>G,p.(Ser329Arg),6,-,-,,Mild,-,Centre B39 (unpublished),
519,1918,Point,Missense,987,329,283,Serine Protease,Exon 8,c.987C>G,p.(Ser329Arg),5,-,-,,Moderate,-,Centre B9 (unpublished),
519,1920,Point,Missense,987,329,283,Serine Protease,Exon 8,c.987C>G,p.(Ser329Arg),<1,-,-,,Severe,-,Centre B13 (unpublished),
520,1921,Point,Missense,989,330,284,Serine Protease,Exon 8,c.989A>G,p.(Tyr330Cys),-,-,-,,,-,Centre B34 (unpublished),
520,1922,Point,Missense,989,330,284,Serine Protease,Exon 8,c.989A>G,p.(Tyr330Cys),<5,-,-,,Moderate,-,Ketterling et al (1999B),United States
521,1926,Point,Nonsense,990,330,284,Serine Protease,Exon 8,c.990C>A,p.(Tyr330*),1,-,-,,Moderate,-,Centre B13 (unpublished),
521,1923,Point,Nonsense,990,330,284,Serine Protease,Exon 8,c.990C>A,p.(Tyr330*),<1,2,II,,Severe,-,Tartary et al (1993),France
521,1925,Point,Nonsense,990,330,284,Serine Protease,Exon 8,c.990C>A,p.(Tyr330*),-,-,-,,Severe,-,Belvini et al (2005),Italy
521,1924,Point,Nonsense,990,330,284,Serine Protease,Exon 8,c.990C>A,p.(Tyr330*),1,<1,I,,Moderate,-,Ketterling et al (1993B),United States
522,1927,Point,Missense,991,331,285,Serine Protease,Exon 8,c.991G>T,p.(Val331Phe),<1,<1,-,,Severe,-,"Quadros et al, (2009)",India
524,1931,Point,Missense,997,333,287,Serine Protease,Exon 8,c.997C>T,p.(Pro333Leu),-,-,-,,,-,Centre B39 (unpublished),
524,1932,Point,Missense,997,333,287,Serine Protease,Exon 8,c.997C>T,p.(Pro333Leu),<1,<1,-,,Severe,-,Chen et al (1991a),United States
523,1928,Point,Missense,997,333,287,Serine Protease,Exon 8,c.997C>A,p.(Pro333Thr),14,-,-,,Mild,-,Vidal et al (2000),Spain
1143,1929,Point,Missense,998,333,287,Serine Protease,Exon 8,c.998C>A,p.(Pro333His),-,-,-,,Mild,-,Wulff et al (1995),Germany
1143,1930,Point,Missense,998,333,287,Serine Protease,Exon 8,c.998C>A,p.(Pro333His),3,3,I,,Moderate,-,Montejo et al (1999),Spain
1143,3786,Point,Missense,998,333,287,Serine Protease,Exon 8,c.998C>A,p.(Pro333His),-,-,-,,-,-,Montejo et al (1999),Spain
525,3678,Point,Missense,1001,334,288,Serine Protease,Exon 8,c.1001T>C,p.(Ile334Thr),-,-,-,NO,Mild,-,Miller et al (2012),United States
525,4189,Point,Missense,1001,334,288,Serine Protease,Exon 8,c.1001T>C,p.(Ile334Thr),3,,,NO,Moderate,,Johnsen et al (2017),United States
525,1933,Point,Missense,1001,334,288,Serine Protease,Exon 8,c.1001T>C,p.(Ile334Thr),6,2,I,,Mild,-,Centre B38 (unpublished),
526,3679,Point,Missense,1002,334,288,Serine Protease,Exon 8,c.1002T>G,p.(Ile334Met),-,-,-,NO,Moderate,-,Miller et al (2012),United States
526,1934,Point,Missense,1002,334,288,Serine Protease,Exon 8,c.1002T>G,p.(Ile334Met),<1,<1,-,,Severe,-,Bottema et al (1991),United States
527,1935,Point,Missense,1003,335,289,Serine Protease,Exon 8,c.1003T>C,p.(Cys335Arg),-,-,-,,,-,Wulff and Herrmann (1999),Germany
528,1936,Point,Missense,1003,335,289,Serine Protease,Exon 8,c.1003T>A,p.(Cys335Ser),<1,-,-,,Severe,-,Jayandharan et al (2005),India
531,1942,Point,Missense,1004,335,289,Serine Protease,Exon 8,c.1004G>T,p.(Cys335Phe),<1,-,-,,Severe,-,Centre B13 (unpublished),
531,1943,Point,Missense,1004,335,289,Serine Protease,Exon 8,c.1004G>T,p.(Cys335Phe),2,-,-,,Moderate,-,Saad et al (1994),United Kingdom
531,1939,Point,Missense,1004,335,289,Serine Protease,Exon 8,c.1004G>T,p.(Cys335Phe),-,-,-,,,-,Gostout et al (1993),United States
531,1940,Point,Missense,1004,335,289,Serine Protease,Exon 8,c.1004G>T,p.(Cys335Phe),<1,-,-,,Severe,-,Driscoll et al (1996),United States
532,1944,Point,Missense,1004,335,289,Serine Protease,Exon 8,c.1004G>C,p.(Cys335Ser),4,-,-,,Moderate,-,Centre B11 (unpublished),
529,3603,Point,Missense,1004,335,289,Serine Protease,Exon 8,c.1004G>A,p.(Cys335Tyr),-,-,-,NO,Moderate,-,Yu et al (2012),China
529,1937,Point,Missense,1004,335,289,Serine Protease,Exon 8,c.1004G>A,p.(Cys335Tyr),<1,-,-,,Severe,-,Centre B25 (unpublished),
529,1938,Point,Missense,1004,335,289,Serine Protease,Exon 8,c.1004G>A,p.(Cys335Tyr),<1,-,-,,Severe,-,Belvini et al (2005),Italy
534,1954,Point,Missense,1009,337,291,Serine Protease,Exon 8,c.1009G>C,p.(Ala337Pro),<1,-,-,,Severe,-,Centre B13 (unpublished),
534,1955,Point,Missense,1009,337,291,Serine Protease,Exon 8,c.1009G>C,p.(Ala337Pro),2,3,II,,Moderate,-,Winship and Dragon (1991),United Kingdom
533,1950,Point,Missense,1009,337,291,Serine Protease,Exon 8,c.1009G>A,p.(Ala337Thr),-,-,-,,,-,Centre B30 (unpublished),
533,1945,Point,Missense,1009,337,291,Serine Protease,Exon 8,c.1009G>A,p.(Ala337Thr),7,9,I,,Mild,-,Green et al (1992),United Kingdom
533,1946,Point,Missense,1009,337,291,Serine Protease,Exon 8,c.1009G>A,p.(Ala337Thr),9,11,I,,Mild,-,Green et al (1992),United Kingdom
533,1947,Point,Missense,1009,337,291,Serine Protease,Exon 8,c.1009G>A,p.(Ala337Thr),7,10,-,,Mild,-,Saad et al (1994),United Kingdom
533,1948,Point,Missense,1009,337,291,Serine Protease,Exon 8,c.1009G>A,p.(Ala337Thr),10,-,-,,Mild,-,Saad et al (1994),United Kingdom
533,1949,Point,Missense,1009,337,291,Serine Protease,Exon 8,c.1009G>A,p.(Ala337Thr),6,-,-,,Mild,-,Saad et al (1994),United Kingdom
533,1953,Point,Missense,1009,337,291,Serine Protease,Exon 8,c.1009G>A,p.(Ala337Thr),10,-,-,,Mild,-,Montandon et al (1989),United Kingdom
533,1951,Point,Missense,1009,337,291,Serine Protease,Exon 8,c.1009G>A,p.(Ala337Thr),<1,-,-,,Severe,-,Li et al (2000),United States
533,1952,Point,Missense,1009,337,291,Serine Protease,Exon 8,c.1009G>A,p.(Ala337Thr),1,-,-,,Moderate,-,Li et al (2000),United States
533,3754,Point,Missense,1009,337,291,Serine Protease,Exon 8,c.1009G>A,p.(Ala337Thr),4-16,,,,Mild,,Green et al (1992),United Kingdom
535,4192,Point,Missense,1010,337,291,Serine Protease,Exon 8,c.1010C>T,p.(Ala337Val),7,,,NO,Mild,,Johnsen et al (2017),United States
535,1957,Point,Missense,1010,337,291,Serine Protease,Exon 8,c.1010C>T,p.(Ala337Val),8,-,-,,Mild,-,Centre B25 (unpublished),
535,1956,Point,Missense,1010,337,291,Serine Protease,Exon 8,c.1010C>T,p.(Ala337Val),9,-,-,,Mild,-,Weinmann et al (1998),United States
535,4190,Point,Missense,1010,337,291,Serine Protease,Exon 8,c.1010C>T,p.(Ala337Val),6,,,,Mild,,Johnsen et al (2017),United States
535,4191,Point,Missense,1010,337,291,Serine Protease,Exon 8,c.1010C>T,p.(Ala337Val),7,,,,Mild,,Johnsen et al (2017),United States
536,1958,Point,Missense,1015,339,293,Serine Protease,Exon 8,c.1015A>G,p.(Lys339Glu),17,80,II,NO,Mild,-,Attali et al (1999),France
536,1959,Point,Missense,1015,339,293,Serine Protease,Exon 8,c.1015A>G,p.(Lys339Glu),19,80,II,NO,Mild,-,Attali et al (1999),France
536,1960,Point,Missense,1015,339,293,Serine Protease,Exon 8,c.1015A>G,p.(Lys339Glu),30,-,-,,Mild,-,Centre B25 (unpublished),
537,4621,Point,Nonsense,1018,340,294,Serine Protease,Exon 8,c.1018G>T,p.(Glu340*),<1,,,NO,Severe,,Johnsen et al (2017),United States
537,1961,Point,Nonsense,1018,340,294,Serine Protease,Exon 8,c.1018G>T,p.(Glu340*),<1,<1,-,,Severe,-,Bottema et al (1991),United States
538,1962,Point,Missense,1022,341,295,Serine Protease,Exon 8,c.1022A>G,p.(Tyr341Cys),<1,-,-,,Severe,-,Ghanem et al (1993),France
540,1966,Point,Nonsense,1023,341,295,Serine Protease,Exon 8,c.1023C>G,p.(Tyr341*),-,-,-,,Severe,-,Liu et al (2000),China
540,1963,Point,Nonsense,1023,341,295,Serine Protease,Exon 8,c.1023C>G,p.(Tyr341*),<1,-,-,,Severe,-,Wulff et al (2001),Germany
540,1965,Point,Nonsense,1023,341,295,Serine Protease,Exon 8,c.1023C>G,p.(Tyr341*),<1,<1,-,,Severe,-,Wulff et al (1999),Germany
539,1964,Point,Nonsense,1023,341,295,Serine Protease,Exon 8,c.1023C>A,p.(Tyr341*),<1,-,-,,Severe,-,Centre B39 (unpublished),
542,4193,Point,Missense,1024,342,296,Serine Protease,Exon 8,c.1024A>G,p.(Thr342Ala),16,,,NO,Mild,,Johnsen et al (2017),United States
542,4194,Point,Missense,1024,342,296,Serine Protease,Exon 8,c.1024A>G,p.(Thr342Ala),25,,,NO,Mild,,Johnsen et al (2017),United States
542,1968,Point,Missense,1024,342,296,Serine Protease,Exon 8,c.1024A>G,p.(Thr342Ala),18,-,-,,Mild,-,Centre B12 (unpublished),
542,1969,Point,Missense,1024,342,296,Serine Protease,Exon 8,c.1024A>G,p.(Thr342Ala),20,-,-,,Mild,-,Centre B13 (unpublished),
542,1970,Point,Missense,1024,342,296,Serine Protease,Exon 8,c.1024A>G,p.(Thr342Ala),30,-,-,,Mild,-,Belvini et al (2005),Italy
543,1972,Point,Missense,1024,342,296,Serine Protease,Exon 8,c.1024A>C,p.(Thr342Arg),<1,-,-,,Severe,-,Jayandharan et al (2003),India
1195,4767,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>G,p.(Thr342Arg),1,,,NO,Moderate,,Johnsen et al (2017),United States
544,4195,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>A,p.(Thr342Lys),3,,,YES,Moderate,,Johnsen et al (2017),United States
544,1973,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>A,p.(Thr342Lys),-,-,-,,,-,Centre B30 (unpublished),
544,1974,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>A,p.(Thr342Lys),-,-,-,,Mild,-,Wulff et al (1995),Germany
545,3500,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,-,-,NO,Moderate,-,Radic et al (2013),Argentina
545,1982,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),<1,4 to 14,-,NO,Severe,-,Bicocchi et al (2006),Italy
545,3680,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,NO,Moderate,-,Miller et al (2012),United States
545,3681,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,NO,Mild,-,Miller et al (2012),United States
545,4196,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4197,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4198,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4199,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4200,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4202,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4203,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),<1,,,NO,Severe,,Johnsen et al (2017),United States
545,4204,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4205,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),1,,,NO,Moderate,,Johnsen et al (2017),United States
545,4206,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4207,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4208,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),6,,,NO,Mild,,Johnsen et al (2017),United States
545,4209,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4210,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4212,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4213,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4214,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),11,,,NO,Mild,,Johnsen et al (2017),United States
545,4215,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4217,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4218,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4219,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,,,NO,Moderate,,Johnsen et al (2017),United States
545,4220,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,,,NO,Moderate,,Johnsen et al (2017),United States
545,4221,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4222,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4224,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),6,,,NO,Mild,,Johnsen et al (2017),United States
545,4225,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4226,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,,,NO,Moderate,,Johnsen et al (2017),United States
545,4233,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4234,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),9,,,NO,Mild,,Johnsen et al (2017),United States
545,4235,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4236,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4237,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4238,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4239,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4241,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4242,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4243,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4244,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4245,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4246,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4247,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4248,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),1,,,NO,Moderate,,Johnsen et al (2017),United States
545,4249,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4250,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4251,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4252,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4253,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),8,,,NO,Mild,,Johnsen et al (2017),United States
545,4254,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3.33,,,NO,Moderate,,Johnsen et al (2017),United States
545,4255,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),<1,,,NO,Severe,,Johnsen et al (2017),United States
545,4257,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4258,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),9,,,NO,Mild,,Johnsen et al (2017),United States
545,4259,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4260,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4261,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4262,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4263,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4264,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4265,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4266,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4267,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4268,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4269,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,,,NO,Moderate,,Johnsen et al (2017),United States
545,4270,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),12,,,NO,Mild,,Johnsen et al (2017),United States
545,4271,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),8,,,NO,Mild,,Johnsen et al (2017),United States
545,4272,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),8.6,,,NO,Mild,,Johnsen et al (2017),United States
545,4274,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4275,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4276,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),6,,,NO,Mild,,Johnsen et al (2017),United States
545,4278,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4279,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4280,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4281,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4282,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4283,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3.5,,,NO,Moderate,,Johnsen et al (2017),United States
545,4284,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4285,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4286,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4.4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4287,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),1.2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4288,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),1,,,NO,Moderate,,Johnsen et al (2017),United States
545,4289,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),1.3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4290,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2.6,,,NO,Moderate,,Johnsen et al (2017),United States
545,4291,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,,,NO,Moderate,,Johnsen et al (2017),United States
545,4292,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4293,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4294,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4296,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2.5,,,NO,Moderate,,Johnsen et al (2017),United States
545,4297,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4298,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4299,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4300,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4301,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,,,NO,Moderate,,Johnsen et al (2017),United States
545,4302,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5.3,,,NO,Mild,,Johnsen et al (2017),United States
545,4303,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4304,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4305,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4306,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4307,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4308,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),8,,,NO,Mild,,Johnsen et al (2017),United States
545,4309,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),6.6,,,NO,Mild,,Johnsen et al (2017),United States
545,4310,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,,,NO,Moderate,,Johnsen et al (2017),United States
545,4311,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),13,,,NO,Mild,,Johnsen et al (2017),United States
545,4313,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),10,,,NO,Mild,,Johnsen et al (2017),United States
545,4314,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4315,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4316,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4317,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4318,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),7,,,NO,Mild,,Johnsen et al (2017),United States
545,4319,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4320,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4321,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,,,NO,Moderate,,Johnsen et al (2017),United States
545,4322,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4324,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4325,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4326,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2.5,,,NO,Moderate,,Johnsen et al (2017),United States
545,4328,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),6.7,,,NO,Mild,,Johnsen et al (2017),United States
545,4330,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4331,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4333,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),6,,,NO,Mild,,Johnsen et al (2017),United States
545,4334,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4336,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4337,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),6,,,NO,Mild,,Johnsen et al (2017),United States
545,4338,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),7,,,NO,Mild,,Johnsen et al (2017),United States
545,4339,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4340,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4341,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4342,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),1,,,NO,Moderate,,Johnsen et al (2017),United States
545,4343,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4344,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4345,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4346,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4347,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4348,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4349,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4350,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),20,,,NO,Mild,,Johnsen et al (2017),United States
545,4351,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4352,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),6,,,NO,Mild,,Johnsen et al (2017),United States
545,4353,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4354,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),6,,,NO,Mild,,Johnsen et al (2017),United States
545,4355,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4358,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4360,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4364,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),9,,,NO,Mild,,Johnsen et al (2017),United States
545,4368,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4369,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4370,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,,,NO,Moderate,,Johnsen et al (2017),United States
545,4371,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4372,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4375,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4376,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4377,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),8,,,NO,Mild,,Johnsen et al (2017),United States
545,4378,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,,,NO,Moderate,,Johnsen et al (2017),United States
545,4379,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4380,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4381,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,NO,Moderate,,Johnsen et al (2017),United States
545,4382,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4383,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),10,,,NO,Mild,,Johnsen et al (2017),United States
545,4384,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4385,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,4386,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,NO,Moderate,,Johnsen et al (2017),United States
545,4387,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,NO,Moderate,,Johnsen et al (2017),United States
545,2065,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Centre B39 (unpublished),
545,2067,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,-,-,,Moderate,-,Centre B39 (unpublished),
545,2078,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Centre B39 (unpublished),
545,2079,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4 to 12,-,-,,Mild,-,Centre B39 (unpublished),
545,2088,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Centre B39 (unpublished),
545,2089,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Centre B39 (unpublished),
545,2090,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Centre B39 (unpublished),
545,2091,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Centre B39 (unpublished),
545,2092,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Centre B39 (unpublished),
545,1990,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),9,8,I,,Mild,-,Centre B29 (unpublished),
545,2006,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,-,-,,Moderate,-,Centre B41 (unpublished),
545,2016,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),9,9,I,,Mild,-,Centre B20 (unpublished),
545,2034,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Centre B30 (unpublished),
545,2035,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2.5,-,-,,Moderate,-,Centre B30 (unpublished),
545,2037,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),6,-,-,,Mild,-,Centre B30 (unpublished),
545,2038,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),9,-,-,,Mild,-,Centre B37 (unpublished),
545,2040,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),7,-,-,,Mild,-,Centre B30 (unpublished),
545,2042,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,-,-,,Moderate,-,Centre B30 (unpublished),
545,2043,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),8,-,-,,Mild,-,Centre B1 (unpublished),
545,2044,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Centre B30 (unpublished),
545,2045,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),16,-,-,,Mild,-,Centre B30 (unpublished),
545,2047,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,-,-,,Moderate,-,Centre B11 (unpublished),
545,2048,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,-,-,,Moderate,-,Centre B1 (unpublished),
545,2049,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,-,-,,Moderate,-,Centre B11 (unpublished),
545,2050,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,-,-,,Moderate,-,Centre B30 (unpublished),
545,2051,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,-,-,,Moderate,-,Centre B30 (unpublished),
545,2052,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Centre B30 (unpublished),
545,2053,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Centre B30 (unpublished),
545,2059,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,-,-,,Moderate,-,Centre B11 (unpublished),
545,2060,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,-,-,,Moderate,-,Centre B11 (unpublished),
545,2062,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Centre B9 (unpublished),
545,2064,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),15,10,I,,Mild,-,Centre B13 (unpublished),
545,2072,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Centre B38 (unpublished),
545,2073,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),12,-,-,,Mild,-,Centre B38 (unpublished),
545,2074,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,8,II,,Moderate,-,Centre B38 (unpublished),
545,2075,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,8,II,,Moderate,-,Centre B38 (unpublished),
545,2077,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,-,-,,Moderate,-,Centre B38 (unpublished),
545,2080,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,-,-,,Moderate,-,Centre B9 (unpublished),
545,2083,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),<1,-,-,,Severe,-,Centre B36 (unpublished),
545,2084,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Centre B21 (unpublished),
545,2085,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),11,5,I,,Mild,-,Centre B38 (unpublished),
545,2086,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,-,-,,Moderate,-,Centre B25 (unpublished),
545,2087,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,8,-,,,-,Centre B38 (unpublished),
545,2093,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,-,-,,Moderate,-,Centre B13 (unpublished),
545,2094,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Centre B20 (unpublished),
545,2095,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,-,-,,Moderate,-,Centre B38 (unpublished),
545,2096,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,-,-,,Moderate,-,Centre B38 (unpublished),
545,2097,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,Mild,-,Centre B38 (unpublished),
545,2098,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Centre B38 (unpublished),
545,2011,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,3,II,,Moderate,-,Poon et al (1993),Canada
545,2020,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),10,-,-,,Mild,-,Nielsen et al (1992),Denmark
545,2017,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),8,7,I,,Mild,-,Tartary et al (1993),France
545,2054,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),<1,-,-,,Severe,-,Costa et al (2000),France
545,2057,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,10,II,,Moderate,-,Costa et al (2000),France
545,2066,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),<1,-,-,,Severe,-,Costa et al (2000),France
545,1975,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,7,II,,Moderate,-,Knobloch et al (1993),Germany
545,1976,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),6,7,I,,Mild,-,Knobloch et al (1993),Germany
545,1979,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,9,II,,Moderate,-,Knobloch et al (1993),Germany
545,2007,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),8,-,-,,Mild,-,Knobloch et al (1993),Germany
545,2021,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,Moderate,-,Wulff et al (1995),Germany
545,2055,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),6,9,II,,Mild,-,Wulff et al (1999),Germany
545,2070,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Wulff and Herrmann (1999),Germany
545,2071,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Wulff and Herrmann (1999),Germany
545,2081,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Wulff and Herrmann (1999),Germany
545,2099,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Mukherjee et al (2004),India
545,1992,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,-,-,,Moderate,-,Belvini et al (2005),Italy
545,2012,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,-,-,,Moderate,-,Van de Water et al (1996),New Zealand
545,2018,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,-,-,,Moderate,-,Van de Water et al (1996),New Zealand
545,2019,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,-,-,,Moderate,-,Van de Water et al (1996),New Zealand
545,2063,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),12,-,-,,Mild,-,Montejo et al (1999),Spain
545,2069,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),28,-,-,,Mild,-,Montejo et al (1999),Spain
545,2015,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),7,-,-,,Mild,-,Ljung et al (2001),Sweden
545,2068,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),11,-,-,,Mild,-,Caglayan et al (1997),Turkey
545,1978,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,15,II,,Moderate,-,Green et al (1991),United Kingdom
545,1980,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),6,5,I,,Mild,-,Green et al (1990),United Kingdom
545,1991,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Green et al (1992),United Kingdom
545,1993,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,,-,Winship and Dragon (1991),United Kingdom
545,1994,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,10,II,,Moderate,-,Green et al (1992),United Kingdom
545,2013,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),15,-,-,,Mild,-,Saad et al (1994),United Kingdom
545,2014,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),8,-,-,,Mild,-,Saad et al (1994),United Kingdom
545,2033,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,-,-,,Moderate,-,Saad et al (1994),United Kingdom
545,2036,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),7,-,-,,Mild,-,Saad et al (1994),United Kingdom
545,1977,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,7,I,,Moderate,-,Koeberl et al (1989),United States
545,1981,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,6,II,,Moderate,-,Chen et al (1991a),United States
545,1983,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,6,-,,,-,Chen et al (1991a),United States
545,1984,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,10,II,,Moderate,-,Chen et al (1991a),United States
545,1985,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,11,II,,Moderate,-,Chen et al (1991a),United States
545,1986,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,6,II,,Moderate,-,Tarnower and Smith (1991),United States
545,1987,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),1,23,II,,Moderate,-,Ketterling et al (1991A),United States
545,1988,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),6,7,I,,Mild,-,Ketterling et al (1991A),United States
545,1989,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,7,I,,Moderate,-,Ketterling et al (1991A),United States
545,1995,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),6,6,I,,Mild,-,Koeberl et al (1990B),United States
545,1996,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,8,II,,Moderate,-,Koeberl et al (1990B),United States
545,1997,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,8,II,,Moderate,-,Thompson and Chen (1992),United States
545,1998,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,10,II,,Moderate,-,Thompson and Chen (1992),United States
545,1999,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),7,-,-,,Mild,-,Ketterling et al (1991B),United States
545,2000,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,11,II,,Moderate,-,Thompson et al (1992A),United States
545,2001,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,17,II,,Moderate,-,Thompson et al (1992A),United States
545,2002,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),15,-,-,,Mild,-,Ketterling et al (1991B),United States
545,2003,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,-,-,,Moderate,-,Ketterling et al (1991B),United States
545,2004,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,-,-,,Moderate,-,Ketterling et al (1991B),United States
545,2005,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,4,I,,Moderate,-,Ketterling et al (1991B),United States
545,2008,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,5,II,,Moderate,-,Thompson and Chen (1992),United States
545,2009,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,6,-,,,-,Thompson and Chen (1992),United States
545,2010,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,7,II,,Moderate,-,Thompson and Chen (1992),United States
545,2022,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,13,II,,Moderate,-,Chen et al (1995),United States
545,2023,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,Mild,-,Bottema et al (1993),United States
545,2024,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),6,9,II,,Mild,-,Bottema et al (1993),United States
545,2025,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,5.5,II,,Moderate,-,Bottema et al (1993),United States
545,2026,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),7,6,I,,Mild,-,Bottema et al (1993),United States
545,2027,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,Mild,-,Bottema et al (1993),United States
545,2028,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3.5,4.4,I,,Moderate,-,Bottema et al (1993),United States
545,2029,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),9,12,I,,Mild,-,Bottema et al (1993),United States
545,2030,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,7,I,,Moderate,-,Bottema et al (1993),United States
545,2031,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,7.8,II,,Moderate,-,Bottema et al (1993),United States
545,2032,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2.9,7.5,II,,Moderate,-,Bottema et al (1993),United States
545,2039,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,-,-,,Moderate,-,Thorland et al (1995),United States
545,2041,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,-,-,,Moderate,-,Thorland et al (1995),United States
545,2046,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,-,-,,Moderate,-,Thorland et al (1995),United States
545,2056,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,4,-,,,-,Weinmann et al (1998),United States
545,2058,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),7,11,II,,Mild,-,Weinmann et al (1998),United States
545,2061,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,-,-,,Moderate,-,Weinmann et al (1998),United States
545,2076,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),<1,-,-,,Severe,-,Li et al (2000),United States
545,4201,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,,,,Moderate,,Johnsen et al (2017),United States
545,4211,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,,Moderate,,Johnsen et al (2017),United States
545,4216,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,,Moderate,,Johnsen et al (2017),United States
545,4223,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,,Moderate,,Johnsen et al (2017),United States
545,4227,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),8,,,,Mild,,Johnsen et al (2017),United States
545,4228,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),8,,,,Mild,,Johnsen et al (2017),United States
545,4229,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,,,,Moderate,,Johnsen et al (2017),United States
545,4230,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),8,,,,Mild,,Johnsen et al (2017),United States
545,4231,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),1,,,,Moderate,,Johnsen et al (2017),United States
545,4232,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),7,,,,Mild,,Johnsen et al (2017),United States
545,4240,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,,Moderate,,Johnsen et al (2017),United States
545,4256,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,,Moderate,,Johnsen et al (2017),United States
545,4273,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,,Moderate,,Johnsen et al (2017),United States
545,4277,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,,Moderate,,Johnsen et al (2017),United States
545,4295,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,,Moderate,,Johnsen et al (2017),United States
545,4312,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,,,,Moderate,,Johnsen et al (2017),United States
545,4323,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4.7,,,,Moderate,,Johnsen et al (2017),United States
545,4327,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4.7,,,,Moderate,,Johnsen et al (2017),United States
545,4329,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2.3,,,,Moderate,,Johnsen et al (2017),United States
545,4332,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,,Moderate,,Johnsen et al (2017),United States
545,4335,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),10,,,,Mild,,Johnsen et al (2017),United States
545,4356,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,,Moderate,,Johnsen et al (2017),United States
545,4357,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,,Moderate,,Johnsen et al (2017),United States
545,4359,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),5,,,,Moderate,,Johnsen et al (2017),United States
545,4361,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,,Moderate,,Johnsen et al (2017),United States
545,4362,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,,Moderate,,Johnsen et al (2017),United States
545,4363,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,,Moderate,,Johnsen et al (2017),United States
545,4365,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,,,,Moderate,,Johnsen et al (2017),United States
545,4366,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),7,,,,Mild,,Johnsen et al (2017),United States
545,4367,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),6,,,,Mild,,Johnsen et al (2017),United States
545,4373,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),3,,,,Moderate,,Johnsen et al (2017),United States
545,4374,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),2,,,,Moderate,,Johnsen et al (2017),United States
545,3817,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),,,,,,,Wulff et al (2001),Germany
545,3787,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),-,-,-,,-,-,Montejo et al (1999),Spain
545,3748,Point,Missense,1025,342,296,Serine Protease,Exon 8,c.1025C>T,p.(Thr342Met),4,15,II,,Moderate,,Green et al (1990) ,United Kingdom
547,2101,Point,Missense,1031,344,298,Serine Protease,Exon 8,c.1031T>A,p.(Ile344Asn),45,69,II,,Mild,-,Centre B25 (unpublished),
548,2102,Point,Missense,1033,345,299,Serine Protease,Exon 8,c.1033T>G,p.(Phe345Val),8,-,-,,Mild,-,Centre B25 (unpublished),
548,2103,Point,Missense,1033,345,299,Serine Protease,Exon 8,c.1033T>G,p.(Phe345Val),15,-,-,,Mild,-,Centre B25 (unpublished),
548,2104,Point,Missense,1033,345,299,Serine Protease,Exon 8,c.1033T>G,p.(Phe345Val),11,-,-,,Mild,-,Centre B25 (unpublished),
1080,3548,Point,Missense,1034,345,299,Serine Protease,Exon 8,c.1033T>C,p.(Phe345Ser),-,-,-,NO,Moderate,-,Yu et al (2012),China
549,2105,Point,Missense,1036,346,300,Serine Protease,Exon 8,c.1036C>T,p.(Leu346Phe),-,-,-,,,-,Centre B12 (unpublished),
550,2106,Point,Missense,1040,347,301,Serine Protease,Exon 8,c.1040A>T,p.(Lys347Ile),-,-,-,,Mild,-,Belvini et al (2005),Italy
551,2108,Point,Nonsense,1045,349,303,Serine Protease,Exon 8,c.1045G>T,p.(Gly349*),-,-,-,,Mild,-,Belvini et al (2005),Italy
551,2107,Point,Nonsense,1045,349,303,Serine Protease,Exon 8,c.1045G>T,p.(Gly349*),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
551,2109,Point,Nonsense,1045,349,303,Serine Protease,Exon 8,c.1045G>T,p.(Gly349*),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
553,2112,Point,Missense,1046,349,303,Serine Protease,Exon 8,c.1046G>A,p.(Gly349Glu),-,-,-,,,-,Centre B39 (unpublished),
552,4388,Point,Missense,1046,349,303,Serine Protease,Exon 8,c.1046G>T,p.(Gly349Val),2,,,NO,Moderate,,Johnsen et al (2017),United States
552,2110,Point,Missense,1046,349,303,Serine Protease,Exon 8,c.1046G>T,p.(Gly349Val),3,-,-,,Moderate,-,Centre B30 (unpublished),
552,2111,Point,Missense,1046,349,303,Serine Protease,Exon 8,c.1046G>T,p.(Gly349Val),2,5,II,,Moderate,-,Centre B38 (unpublished),
554,2114,Point,Missense,1052,351,305,Serine Protease,Exon 8,c.1052G>A,p.(Gly351Asp),-,-,-,,,-,Centre B39 (unpublished),
554,2113,Point,Missense,1052,351,305,Serine Protease,Exon 8,c.1052G>A,p.(Gly351Asp),<1,-,-,,Severe,-,Montejo et al (1999),Spain
554,2115,Point,Missense,1052,351,305,Serine Protease,Exon 8,c.1052G>A,p.(Gly351Asp),<1,0.3,-,,Severe,-,Green et al (1991),United Kingdom
554,4389,Point,Missense,1052,351,305,Serine Protease,Exon 8,c.1052G>A,p.(Gly351Asp),<1,,,,Severe,,Johnsen et al (2017),United States
555,2116,Point,Missense,1052,351,305,Serine Protease,Exon 8,c.1052G>T,p.(Gly351Val),<1,-,-,,Severe,-,Belvini et al (2005),Italy
556,3604,Point,Nonsense,1056,352,306,Serine Protease,Exon 8,c.1056T>A,p.(Tyr352*),-,-,-,NO,Severe,-,Yu et al (2012),China
556,2117,Point,Nonsense,1056,352,306,Serine Protease,Exon 8,c.1056T>A,p.(Tyr352*),<1,<1,-,,Severe,-,Thompson et al (1992A),United States
557,2118,Point,Nonsense,1056,352,306,Serine Protease,Exon 8,c.1056T>G,p.(Tyr352*),<1,-,-,,Severe,-,Centre B30 (unpublished),
558,2119,Point,Missense,1057,353,307,Serine Protease,Exon 8,c.1057G>C,p.(Val353Leu),-,-,-,,,-,Centre B13 (unpublished),
559,2123,Point,Missense,1058,353,307,Serine Protease,Exon 8,c.1058T>C,p.(Val353Ala),12,35,II,,Mild,-,Centre B38 (unpublished),
559,2124,Point,Missense,1058,353,307,Serine Protease,Exon 8,c.1058T>C,p.(Val353Ala),-,-,-,,Mild,-,Centre B38 (unpublished),
559,2125,Point,Missense,1058,353,307,Serine Protease,Exon 8,c.1058T>C,p.(Val353Ala),14,-,-,,Mild,-,Centre B38 (unpublished),
559,2120,Point,Missense,1058,353,307,Serine Protease,Exon 8,c.1058T>C,p.(Val353Ala),15,40,II,,Mild,-,Chen et al (1991a),United States
559,2121,Point,Missense,1058,353,307,Serine Protease,Exon 8,c.1058T>C,p.(Val353Ala),14,50,II,,Mild,-,Thompson et al (1992A),United States
559,2122,Point,Missense,1058,353,307,Serine Protease,Exon 8,c.1058T>C,p.(Val353Ala),10,62,II,,Mild,-,Weinmann et al (1998),United States
559,2126,Point,Missense,1058,353,307,Serine Protease,Exon 8,c.1058T>C,p.(Val353Ala),18,46,II,,Mild,-,Bottema et al (1989A),United States
561,2128,Point,Missense,1058,353,307,Serine Protease,Exon 8,c.1058T>A,p.(Val353Glu),<1,<1,-,,Severe,-,"Quadros et al, (2009)",India
560,3468,Point,Missense,1058,353,307,Serine Protease,Exon 8,c.1058T>G,p.(Val353Gly),<1,-,-,NO,Severe,-,Jayandharan et al (2009),India
560,3469,Point,Missense,1058,353,307,Serine Protease,Exon 8,c.1058T>G,p.(Val353Gly),<1,-,-,NO,Severe,-,Jayandharan et al (2009),India
560,2127,Point,Missense,1058,353,307,Serine Protease,Exon 8,c.1058T>G,p.(Val353Gly),3,4,I,,Moderate,-,Green et al (1991),United Kingdom
562,2129,Point,Missense,1060,354,308,Serine Protease,Exon 8,c.1060A>C,p.(Ser354Arg),2,-,-,,Moderate,-,Centre B18 (unpublished),
562,4390,Point,Missense,1060,354,308,Serine Protease,Exon 8,c.1060A>C,p.(Ser354Arg),<1,,,,Severe,,Johnsen et al (2017),United States
563,2130,Point,Missense,1061,354,308,Serine Protease,Exon 8,c.1061G>A,p.(Ser354Asn),5,26,II,,Moderate,-,Tartary et al (1993),France
563,2131,Point,Missense,1061,354,308,Serine Protease,Exon 8,c.1061G>A,p.(Ser354Asn),5,-,-,,Moderate,-,Saad et al (1994),United Kingdom
564,2132,Point,Missense,1062,354,308,Serine Protease,Exon 8,c.1062T>G,p.(Ser354Arg),<1,-,-,,Severe,-,Centre B23 (unpublished),
565,2133,Point,Missense,1063,355,309,Serine Protease,Exon 8,c.1063G>A,p.(Gly355Ser),<1,65,II,,Severe,-,Winship and Dragon (1991),United Kingdom
1129,4392,Point,Missense,1064,355,309,Serine Protease,Exon 8,c.1064G>A,p.(Gly355Asp),<1,,,NO,Severe,,Johnsen et al (2017),United States
1129,2134,Point,Missense,1064,355,309,Serine Protease,Exon 8,c.1064G>A,p.(Gly355Asp),<1,-,-,,Severe,-,Ghanem et al (1993),France
1129,2135,Point,Missense,1064,355,309,Serine Protease,Exon 8,c.1064G>A,p.(Gly355Asp),<1,-,-,,Severe,-,Gostout et al (1993),United States
566,4391,Point,Missense,1064,355,309,Serine Protease,Exon 8,c.1064G>T,p.(Gly355Val),2.5,,,NO,Moderate,,Johnsen et al (2017),United States
566,2136,Point,Missense,1064,355,309,Serine Protease,Exon 8,c.1064G>T,p.(Gly355Val),<1,58,II,,Severe,-,Thompson et al (1989),United States
567,2137,Point,Missense,1066,356,310,Serine Protease,Exon 8,c.1066T>A,p.(Trp356Arg),<1,<1,-,,Severe,-,Wulff et al (1999),Germany
567,2138,Point,Missense,1066,356,310,Serine Protease,Exon 8,c.1066T>A,p.(Trp356Arg),-,-,-,,,-,Wulff and Herrmann (1999),Germany
567,2139,Point,Missense,1066,356,310,Serine Protease,Exon 8,c.1066T>A,p.(Trp356Arg),<1,-,-,,Severe,-,Wulff et al (2001),Germany
568,2140,Point,Missense,1066,356,310,Serine Protease,Exon 8,c.1066T>C,p.(Trp356Arg),<1,86,II,,Severe,-,Centre B21 (unpublished),
569,2143,Point,Missense,1066,356,310,Serine Protease,Exon 8,c.1066T>G,p.(Trp356Gly),<1,-,-,,Severe,-,Centre B36 (unpublished),
569,2141,Point,Missense,1066,356,310,Serine Protease,Exon 8,c.1066T>G,p.(Trp356Gly),<1,-,-,,Severe,-,Belvini et al (2005),Italy
571,3696,Point,Nonsense,1067,356,310,Serine Protease,Exon 8,c.1067G>A,p.(Trp356*),-,-,-,NO,Severe,-,Miller et al (2012),United States
571,4623,Point,Nonsense,1067,356,310,Serine Protease,Exon 8,c.1067G>A,p.(Trp356*),<1,,,NO,Severe,,Johnsen et al (2017),United States
571,2147,Point,Nonsense,1067,356,310,Serine Protease,Exon 8,c.1067G>A,p.(Trp356*),<1,-,-,,Severe,-,Montejo et al (1999),Spain
571,2145,Point,Nonsense,1067,356,310,Serine Protease,Exon 8,c.1067G>A,p.(Trp356*),<1,-,-,,Severe,-,Li et al (2000),United States
571,2146,Point,Nonsense,1067,356,310,Serine Protease,Exon 8,c.1067G>A,p.(Trp356*),<1,-,-,,Severe,-,Li et al (2000),United States
571,4622,Point,Nonsense,1067,356,310,Serine Protease,Exon 8,c.1067G>A,p.(Trp356*),2,,,,Moderate,,Johnsen et al (2017),United States
571,3788,Point,Nonsense,1067,356,310,Serine Protease,Exon 8,c.1067G>A,p.(Trp356*),<1,-,-,,Severe,-,Montejo et al (1999),Spain
571,3789,Point,Nonsense,1067,356,310,Serine Protease,Exon 8,c.1067G>A,p.(Trp356*),<1,-,-,,Severe,-,Montejo et al (1999),Spain
572,4393,Point,Missense,1067,356,310,Serine Protease,Exon 8,c.1067G>T,p.(Trp356Leu),8,,,NO,Mild,,Johnsen et al (2017),United States
572,2148,Point,Missense,1067,356,310,Serine Protease,Exon 8,c.1067G>T,p.(Trp356Leu),14,-,-,,Mild,-,Centre B9 (unpublished),
572,2149,Point,Missense,1067,356,310,Serine Protease,Exon 8,c.1067G>T,p.(Trp356Leu),7,-,-,,Mild,-,Centre B13 (unpublished),
572,2151,Point,Missense,1067,356,310,Serine Protease,Exon 8,c.1067G>T,p.(Trp356Leu),4,90,II,,Moderate,-,Centre B14 (unpublished),
572,2154,Point,Missense,1067,356,310,Serine Protease,Exon 8,c.1067G>T,p.(Trp356Leu),4,-,-,,Moderate,-,Centre B18 (unpublished),
572,2150,Point,Missense,1067,356,310,Serine Protease,Exon 8,c.1067G>T,p.(Trp356Leu),7,-,-,,Mild,-,Wulff et al (2001),Germany
572,2152,Point,Missense,1067,356,310,Serine Protease,Exon 8,c.1067G>T,p.(Trp356Leu),-,-,-,,,-,Wulff et al (2001),Germany
572,2153,Point,Missense,1067,356,310,Serine Protease,Exon 8,c.1067G>T,p.(Trp356Leu),-,-,-,,,-,Wulff and Herrmann (1999),Germany
573,2155,Point,Missense,1067,356,310,Serine Protease,Exon 8,c.1067G>C,p.(Trp356Ser),<1,12,II,,Severe,-,"Quadros et al, (2009)",India
574,2157,Point,Nonsense,1068,356,310,Serine Protease,Exon 8,c.1068G>A,p.(Trp356*),<1,-,-,,Severe,-,Van de Water et al (1996),New Zealand
574,2156,Point,Nonsense,1068,356,310,Serine Protease,Exon 8,c.1068G>A,p.(Trp356*),<1,<1,-,,Severe,-,Tarnower and Smith (1991),United States
574,2158,Point,Nonsense,1068,356,310,Serine Protease,Exon 8,c.1068G>A,p.(Trp356*),<1,<1,-,,Severe,-,Wang et al (1990),United States
575,2160,Point,Missense,1068,356,310,Serine Protease,Exon 8,c.1068G>C,p.(Trp356Cys),3,-,-,,Moderate,-,Knobloch et al (1993),Germany
575,2159,Point,Missense,1068,356,310,Serine Protease,Exon 8,c.1068G>C,p.(Trp356Cys),<1,5,II,,Severe,-,Ketterling et al (1993A),United States
576,3501,Point,Missense,1068,356,310,Serine Protease,Exon 8,c.1068G>T,p.(Trp356Cys),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
576,2161,Point,Missense,1068,356,310,Serine Protease,Exon 8,c.1068G>T,p.(Trp356Cys),<1,-,-,,Severe,-,Wulff et al (1995),Germany
578,2168,Point,Nonsense,1069,357,311,Serine Protease,Exon 8,c.1069G>T,p.(Gly357*),<1,<1,-,,Severe,-,Wulff et al (1999),Germany
577,4394,Point,Missense,1069,357,311,Serine Protease,Exon 8,c.1069G>A,p.(Gly357Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
577,4395,Point,Missense,1069,357,311,Serine Protease,Exon 8,c.1069G>A,p.(Gly357Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
577,2163,Point,Missense,1069,357,311,Serine Protease,Exon 8,c.1069G>A,p.(Gly357Arg),<1,-,-,,Severe,-,Centre B39 (unpublished),
577,2165,Point,Missense,1069,357,311,Serine Protease,Exon 8,c.1069G>A,p.(Gly357Arg),<1,-,-,,Severe,-,Costa et al (2000),France
577,2164,Point,Missense,1069,357,311,Serine Protease,Exon 8,c.1069G>A,p.(Gly357Arg),<1,-,-,,Severe,-,Wulff et al (2001),Germany
577,2166,Point,Missense,1069,357,311,Serine Protease,Exon 8,c.1069G>A,p.(Gly357Arg),<1,118,II,,Severe,-,Wulff et al (1999),Germany
577,2162,Point,Missense,1069,357,311,Serine Protease,Exon 8,c.1069G>A,p.(Gly357Arg),2,100,II,,Moderate,-,Bottema et al (1991),United States
577,2167,Point,Missense,1069,357,311,Serine Protease,Exon 8,c.1069G>A,p.(Gly357Arg),3,-,-,,Moderate,-,Koeberl et al (1989),United States
579,2175,Point,Missense,1070,357,311,Serine Protease,Exon 8,c.1070G>A,p.(Gly357Glu),<1,100,II,NO,Severe,-,Bicocchi et al (2006),Italy
579,2172,Point,Missense,1070,357,311,Serine Protease,Exon 8,c.1070G>A,p.(Gly357Glu),1,84,II,,Moderate,-,Centre B14 (unpublished),
579,2174,Point,Missense,1070,357,311,Serine Protease,Exon 8,c.1070G>A,p.(Gly357Glu),<1,-,-,,Severe,-,Centre B36 (unpublished),
579,2176,Point,Missense,1070,357,311,Serine Protease,Exon 8,c.1070G>A,p.(Gly357Glu),-,-,-,,,-,Centre B21 (unpublished),
579,2178,Point,Missense,1070,357,311,Serine Protease,Exon 8,c.1070G>A,p.(Gly357Glu),<1,-,-,,Severe,-,Centre B13 (unpublished),
579,2177,Point,Missense,1070,357,311,Serine Protease,Exon 8,c.1070G>A,p.(Gly357Glu),<1,-,-,,Severe,-,Belvini et al (2005),Italy
579,2170,Point,Missense,1070,357,311,Serine Protease,Exon 8,c.1070G>A,p.(Gly357Glu),<1,100,II,,Severe,-,Miyata et al (1991),Japan
579,2171,Point,Missense,1070,357,311,Serine Protease,Exon 8,c.1070G>A,p.(Gly357Glu),1,-,-,,Moderate,-,Thorland et al (1995),United States
580,2180,Point,Missense,1070,357,311,Serine Protease,Exon 8,c.1070G>T,p.(Gly357Val),-,-,-,,,-,Centre B39 (unpublished),
580,2179,Point,Missense,1070,357,311,Serine Protease,Exon 8,c.1070G>T,p.(Gly357Val),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
581,3682,Point,Missense,1072,358,312,Serine Protease,Exon 8,c.1072A>G,p.(Arg358Gly),-,-,-,NO,Severe,-,Miller et al (2012),United States
581,2181,Point,Missense,1072,358,312,Serine Protease,Exon 8,c.1072A>G,p.(Arg358Gly),20,-,-,,Mild,-,Belvini et al (2005),Italy
1196,4768,Point,Missense,1076,359,313,Serine Protease,Exon 8,c.1076T>C,p.(Val359Ala),6,,,NO,Mild,,Johnsen et al (2017),United States
1141,2182,Point,Missense,1076,359,313,Serine Protease,Exon 8,c.1076T>A,p.(Val359Asp),2.5,100,II,,Moderate,-,Miyata et al (1994),Japan
582,2183,Point,Missense,1076,359,313,Serine Protease,Exon 8,c.1076T>G,p.(Val359Gly),<1,100,II,,Severe,-,Saad et al (1994),United Kingdom
583,2184,Point,Missense,1078,360,314,Serine Protease,Exon 8,c.1078T>A,p.(Phe360Ile),3,-,-,,Moderate,-,Centre B38 (unpublished),
584,2187,Point,Missense,1079,360,314,Serine Protease,Exon 8,c.1079T>C,p.(Phe360Ser),-,-,-,,,-,Centre B39 (unpublished),
584,2185,Point,Missense,1079,360,314,Serine Protease,Exon 8,c.1079T>C,p.(Phe360Ser),<1,-,-,,Severe,-,Centre B30 (unpublished),
584,2186,Point,Missense,1079,360,314,Serine Protease,Exon 8,c.1079T>C,p.(Phe360Ser),8,-,-,,Mild,-,Centre B35 (unpublished),
585,2188,Point,Missense,1084,362,316,Serine Protease,Exon 8,c.1084A>G,p.(Lys362Glu),-,-,-,,Moderate,-,Wulff et al (1995),Germany
588,2191,Point,Missense,1087,363,317,Serine Protease,Exon 8,c.1087G>C,p.(Gly363Arg),<1,-,-,,Severe,-,Centre B23 (unpublished),
588,2195,Point,Missense,1087,363,317,Serine Protease,Exon 8,c.1087G>C,p.(Gly363Arg),-,-,-,,,-,Nawaz et al (2008),Pakistan
1088,3605,Point,Missense,1087,363,317,Serine Protease,Exon 8,c.1087G>A,p.(Gly363Arg),-,-,-,NO,Severe,-,Yu et al (2012),China
589,2192,Point,Missense,1087,363,317,Serine Protease,Exon 8,c.1087G>T,p.(Gly363Trp),<1,-,-,,Severe,-,Montejo et al (1999),Spain
590,3606,Point,Missense,1088,363,317,Serine Protease,Exon 8,c.1088G>A,p.(Gly363Glu),-,-,-,NO,Moderate,-,Yu et al (2012),China
590,3721,Point,Missense,1088,363,317,Serine Protease,Exon 8,c.1088G>A,p.(Gly363Glu),<1,100,,NO,Severe,,Bicocchi et al (2006),Italy
590,2194,Point,Missense,1088,363,317,Serine Protease,Exon 8,c.1088G>A,p.(Gly363Glu),-,-,-,,,-,Centre B39 (unpublished),
590,2193,Point,Missense,1088,363,317,Serine Protease,Exon 8,c.1088G>A,p.(Gly363Glu),-,-,-,,,-,Saad et al (1994),United Kingdom
592,2199,Point,Missense,1096,366,320,Serine Protease,Exon 8,c.1096G>C,p.(Ala366Pro),26,-,-,,Mild,-,Centre B25 (unpublished),
593,4397,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>A,p.(Ala366Asp),4,,,NO,Moderate,,Johnsen et al (2017),United States
593,4398,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>A,p.(Ala366Asp),4,,,NO,Moderate,,Johnsen et al (2017),United States
593,4399,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>A,p.(Ala366Asp),4,,,NO,Moderate,,Johnsen et al (2017),United States
593,4400,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>A,p.(Ala366Asp),4,,,NO,Moderate,,Johnsen et al (2017),United States
593,4401,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>A,p.(Ala366Asp),4,,,NO,Moderate,,Johnsen et al (2017),United States
593,4402,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>A,p.(Ala366Asp),3,,,NO,Moderate,,Johnsen et al (2017),United States
593,4403,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>A,p.(Ala366Asp),<1,,,NO,Severe,,Johnsen et al (2017),United States
593,2201,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>A,p.(Ala366Asp),3,-,-,,Moderate,-,Van de Water et al (1996),New Zealand
593,2202,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>A,p.(Ala366Asp),1.5,-,-,,Moderate,-,Van de Water et al (1996),New Zealand
593,2203,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>A,p.(Ala366Asp),-,-,-,,,-,Montejo et al (1999),Spain
593,2200,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>A,p.(Ala366Asp),4,-,-,,Moderate,-,Saad et al (1994),United Kingdom
593,2211,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>A,p.(Ala366Asp),<1,90,II,,Severe,-,Koeberl et al (1990B),United States
594,2205,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>G,p.(Ala366Gly),14,97,II,,Mild,-,Centre B25 (unpublished),
594,2204,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>G,p.(Ala366Gly),-,-,-,,Mild,-,Belvini et al (2005),Italy
595,4396,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>T,p.(Ala366Val),5,,,NO,Moderate,,Johnsen et al (2017),United States
595,2208,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>T,p.(Ala366Val),3,119,II,,Moderate,-,Centre B14 (unpublished),
595,2209,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>T,p.(Ala366Val),1,62,II,,Moderate,-,Centre B20 (unpublished),
595,2210,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>T,p.(Ala366Val),50,-,-,,Mild,-,Centre B13 (unpublished),
595,2206,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>T,p.(Ala366Val),-,-,-,,,-,Ghanem et al (1993),France
595,2207,Point,Missense,1097,366,320,Serine Protease,Exon 8,c.1097C>T,p.(Ala366Val),15,62,II,,Mild,-,Costa et al (2000),France
598,2213,Point,Missense,1105,369,323,Serine Protease,Exon 8,c.1105C>T,p.(Leu369Phe),3,-,-,,Moderate,-,Belvini et al (2005),Italy
599,2214,Point,Missense,1106,369,323,Serine Protease,Exon 8,c.1106T>C,p.(Leu369Pro),5 to 8,-,-,,Mild,-,Centre B13 (unpublished),
599,2215,Point,Missense,1106,369,323,Serine Protease,Exon 8,c.1106T>C,p.(Leu369Pro),15,-,-,,Mild,-,Centre B13 (unpublished),
601,4624,Point,Nonsense,1108,370,324,Serine Protease,Exon 8,c.1108C>T,p.(Gln370*),2,,,NO,Moderate,,Johnsen et al (2017),United States
601,2218,Point,Nonsense,1108,370,324,Serine Protease,Exon 8,c.1108C>T,p.(Gln370*),<1,0.5,I,,Severe,-,Centre B36 (unpublished),
601,2219,Point,Nonsense,1108,370,324,Serine Protease,Exon 8,c.1108C>T,p.(Gln370*),<1,-,-,,Severe,-,Belvini et al (2005),Italy
601,2217,Point,Nonsense,1108,370,324,Serine Protease,Exon 8,c.1108C>T,p.(Gln370*),4,4,I,,Moderate,-,Bottema et al (1991),United States
600,2216,Point,Missense,1108,370,324,Serine Protease,Exon 8,c.1108C>G,p.(Gln370Glu),1,2,I,,Moderate,-,Centre B12 (unpublished),
1197,4769,Point,Missense,1109,370,324,Serine Protease,Exon 8,c.1109A>T,p.(Gln370Leu),<1,,,NO,Severe,,Johnsen et al (2017),United States
602,3376,Point,Missense,1109,370,324,Serine Protease,Exon 8,c.1109A>C,p.(Gln370Pro),-,-,-,,Moderate,-,Centre B39 (unpublished),
602,2221,Point,Missense,1109,370,324,Serine Protease,Exon 8,c.1109A>C,p.(Gln370Pro),<1,5,II,,Severe,-,Wulff et al (1999),Germany
602,2222,Point,Missense,1109,370,324,Serine Protease,Exon 8,c.1109A>C,p.(Gln370Pro),-,-,-,,,-,Ivaskevicius et al (2001),Germany
602,2220,Point,Missense,1109,370,324,Serine Protease,Exon 8,c.1109A>C,p.(Gln370Pro),<1,<1,-,,Severe,-,Lin and Shen (1993),Taiwan
1114,2223,Point,Missense,1112,371,325,Serine Protease,Exon 8,c.1112A>C,p.(Tyr371Ser),20,-,-,,Mild,-,Centre B13 (unpublished),
603,2224,Point,Nonsense,1113,371,325,Serine Protease,Exon 8,c.1113C>A,p.(Tyr371*),<1,<1,-,,Severe,-,Wulff et al (1999),Germany
603,2225,Point,Nonsense,1113,371,325,Serine Protease,Exon 8,c.1113C>A,p.(Tyr371*),2,-,-,,Moderate,-,Montejo et al (1999),Spain
603,2226,Point,Nonsense,1113,371,325,Serine Protease,Exon 8,c.1113C>A,p.(Tyr371*),<1,<1,-,,Severe,-,Gostout et al (1993),United States
604,3607,Point,Nonsense,1113,371,325,Serine Protease,Exon 8,c.1113C>G,p.(Tyr371*),-,-,-,NO,Severe,-,Yu et al (2012),China
604,4625,Point,Nonsense,1113,371,325,Serine Protease,Exon 8,c.1113C>G,p.(Tyr371*),<1,,,NO,Severe,,Johnsen et al (2017),United States
604,2227,Point,Nonsense,1113,371,325,Serine Protease,Exon 8,c.1113C>G,p.(Tyr371*),-,-,-,,,-,Centre B39 (unpublished),
604,2228,Point,Nonsense,1113,371,325,Serine Protease,Exon 8,c.1113C>G,p.(Tyr371*),4,-,-,,Moderate,-,Bottema et al (1991),United States
1099,3710,Point,Missense,1115,372,326,Serine Protease,Exon 8,c.1115T>C,p.(Leu372Pro),-,-,-,NO,Severe,-,Miller et al (2012),United States
1099,4404,Point,Missense,1115,372,326,Serine Protease,Exon 8,c.1115T>C,p.(Leu372Pro),<1,,,,Severe,,Johnsen et al (2017),United States
1099,4405,Point,Missense,1115,372,326,Serine Protease,Exon 8,c.1115T>C,p.(Leu372Pro),<1,,,,Severe,,Johnsen et al (2017),United States
606,3453,Point,Missense,1120,374,328,Serine Protease,Exon 8,c.1120G>T,p.(Val374Phe),0.4,0.8,-,NO,Severe,-,Belvini et al (2005),Italy
606,2237,Point,Missense,1120,374,328,Serine Protease,Exon 8,c.1120G>T,p.(Val374Phe),<1,3,II,,Severe,-,Centre B39 (unpublished),
606,2238,Point,Missense,1120,374,328,Serine Protease,Exon 8,c.1120G>T,p.(Val374Phe),<1,3,II,,Severe,-,Centre B39 (unpublished),
606,2233,Point,Missense,1120,374,328,Serine Protease,Exon 8,c.1120G>T,p.(Val374Phe),<1,<1,-,,Severe,-,Centre B15 (unpublished),
606,2236,Point,Missense,1120,374,328,Serine Protease,Exon 8,c.1120G>T,p.(Val374Phe),-,-,-,,,-,Centre B17 (unpublished),
606,2234,Point,Missense,1120,374,328,Serine Protease,Exon 8,c.1120G>T,p.(Val374Phe),<1,4,II,,Severe,-,Costa et al (2000),France
606,2231,Point,Missense,1120,374,328,Serine Protease,Exon 8,c.1120G>T,p.(Val374Phe),-,-,-,,,-,Knobloch et al (1993),Germany
606,2230,Point,Missense,1120,374,328,Serine Protease,Exon 8,c.1120G>T,p.(Val374Phe),4,4,II,,Moderate,-,Winship (1990),United Kingdom
606,2232,Point,Missense,1120,374,328,Serine Protease,Exon 8,c.1120G>T,p.(Val374Phe),<1,4,II,,Severe,-,Saad et al (1994),United Kingdom
607,2240,Point,Missense,1123,375,329,Serine Protease,Exon 8,c.1123C>A,p.(Pro375Thr),6,-,-,,Mild,-,Centre B38 (unpublished),
1198,4770,Point,Missense,1124,375,329,Serine Protease,Exon 8,c.1124C>T,p.(Pro375Leu),24,,,YES,Mild,,Johnsen et al (2017),United States
1198,4771,Point,Missense,1124,375,329,Serine Protease,Exon 8,c.1124C>T,p.(Pro375Leu),20,,,NO,Mild,,Johnsen et al (2017),United States
1198,4772,Point,Missense,1124,375,329,Serine Protease,Exon 8,c.1124C>T,p.(Pro375Leu),20,,,NO,Mild,,Johnsen et al (2017),United States
608,2241,Point,Missense,1127,376,330,Serine Protease,Exon 8,c.1127T>C,p.(Leu376Pro),2,-,-,,Moderate,-,Centre B30 (unpublished),
608,2242,Point,Missense,1127,376,330,Serine Protease,Exon 8,c.1127T>C,p.(Leu376Pro),7,-,-,,Mild,-,Saad et al (1994),United Kingdom
609,3502,Point,Missense,1129,377,331,Serine Protease,Exon 8,c.1129G>T,p.(Val377Phe),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
609,2243,Point,Missense,1129,377,331,Serine Protease,Exon 8,c.1129G>T,p.(Val377Phe),<1,<10,-,NO,Severe,-,Attali et al (1999),France
611,2245,Point,Missense,1130,377,331,Serine Protease,Exon 8,c.1130T>C,p.(Val377Ala),7,96,II,,Mild,-,Winship and Dragon (1991),United Kingdom
610,2244,Point,Missense,1130,377,331,Serine Protease,Exon 8,c.1130T>A,p.(Val377Asp),<1,-,-,,Severe,-,Centre B11 (unpublished),
612,2246,Point,Missense,1132,378,332,Serine Protease,Exon 8,c.1132G>T,p.(Asp378Tyr),4,-,-,,Moderate,-,Knobloch et al (1993),Germany
612,2247,Point,Missense,1132,378,332,Serine Protease,Exon 8,c.1132G>T,p.(Asp378Tyr),-,-,-,,,-,Knobloch et al (1993),Germany
612,2248,Point,Missense,1132,378,332,Serine Protease,Exon 8,c.1132G>T,p.(Asp378Tyr),3,-,-,,Moderate,-,Van de Water et al (1996),New Zealand
614,3528,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
614,3611,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,NO,Severe,-,Yu et al (2012),China
614,3610,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,NO,Severe,-,Yu et al (2012),China
614,3609,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,NO,Severe,-,Yu et al (2012),China
614,3608,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,NO,Severe,-,Yu et al (2012),China
614,3613,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,NO,Moderate,-,Yu et al (2012),China
614,3612,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,NO,Moderate,-,Yu et al (2012),China
614,2295,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,NO,Severe,-,Attali et al (1999),France
614,4634,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,,,NO,Severe,,Johnsen et al (2017),United States
614,4633,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,,,NO,Severe,,Johnsen et al (2017),United States
614,4632,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,,,NO,Severe,,Johnsen et al (2017),United States
614,4631,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,,,NO,Severe,,Johnsen et al (2017),United States
614,4630,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,,,NO,Severe,,Johnsen et al (2017),United States
614,4629,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,,,NO,Severe,,Johnsen et al (2017),United States
614,4628,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,,,NO,Severe,,Johnsen et al (2017),United States
614,4627,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,,,NO,Severe,,Johnsen et al (2017),United States
614,4626,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),1,,,NO,Moderate,,Johnsen et al (2017),United States
614,2305,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,,-,Centre B39 (unpublished),
614,2304,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,,-,Centre B39 (unpublished),
614,2297,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,,-,Centre B39 (unpublished),
614,2306,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,,-,Centre B39 (unpublished),
614,2292,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,,-,Centre B8 (unpublished),
614,2293,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,,-,Centre B30 (unpublished),
614,2294,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,<6,-,,Severe,-,Centre B14 (unpublished),
614,2298,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Centre B36 (unpublished),
614,2299,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Centre B36 (unpublished),
614,2300,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Centre B9 (unpublished),
614,2301,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,,-,Centre B21 (unpublished),
614,2302,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),1,-,-,,Moderate,-,Centre B21 (unpublished),
614,2303,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Centre B25 (unpublished),
614,2307,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Centre B38 (unpublished),
614,2264,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,<1,-,,Severe,-,Centre B26 (unpublished),
614,2279,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,,-,Centre B30 (unpublished),
614,2280,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Centre B30 (unpublished),
614,2281,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,,-,Centre B30 (unpublished),
614,2283,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Centre B11 (unpublished),
614,2288,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,,-,Centre B17 (unpublished),
614,2289,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,,-,Centre B35 (unpublished),
614,2291,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Centre B13 (unpublished),
614,2296,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,Severe,-,Liu et al (2000),China
614,2286,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Costa et al (2000),France
614,2276,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Ghanem et al (1993),France
614,2261,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,<1,-,,Severe,-,Knobloch et al (1993),Germany
614,2262,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,<1,-,,Severe,-,Knobloch et al (1993),Germany
614,2287,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,<1,-,,Severe,-,Wulff et al (1999),Germany
614,2285,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Wulff et al (2001),Germany
614,2284,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Wulff et al (2001),Germany
614,2263,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,<1,-,,Severe,-,Knobloch et al (1993),Germany
614,2265,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Jayandharan et al (2005),India
614,2309,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Mahajan et al (2007),India
614,3482,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Jayandharan et al (2009),India
614,2266,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Jayandharan et al (2005),India
614,2270,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,Severe,-,Jenkins et al (2008),Ireland
614,2254,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,Moderate,-,Belvini et al (2005),Italy
614,2310,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Awidi et al (2011),Jordan
614,2196,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,,-,Nawaz et al (2008),Pakistan
614,2290,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,,-,Nawaz et al (2008),Pakistan
614,2272,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),1,-,-,,Moderate,-,David et al (1993),Portugal
614,2256,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
614,2257,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
614,2274,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,<1,-,,Severe,-,Ljung et al (2001),Sweden
614,2271,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,<1,-,,Severe,-,Lin and Shen (1993),Taiwan
614,2275,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,,-,Onay et al (2003),Turkey
614,2259,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),6,-,-,,Mild,-,Montandon et al (1990B),United Kingdom
614,2273,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,5,II,,Severe,-,Saad et al (1994),United Kingdom
614,2278,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
614,2255,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,<1,-,,Severe,-,Koeberl et al (1990A),United States
614,2258,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,1,-,,Severe,-,Koeberl et al (1990A),United States
614,2260,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,1,-,,Severe,-,Chen et al (1991a),United States
614,2269,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,Severe,-,Ketterling et al (1993A),United States
614,2268,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,<1,-,,Severe,-,Thompson et al (1992A),United States
614,2267,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),4,<1,I,,Moderate,-,Bottema et al (1991),United States
614,2277,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),-,-,-,,Severe,-,Gostout et al (1993),United States
614,2282,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),17,19,I,,Mild,-,Chen et al (1995),United States
614,3749,Point,Nonsense,1135,379,333,Serine Protease,Exon 8,c.1135C>T,p.(Arg379*),<1,135,II,,Severe,,Green et al (1990) ,United Kingdom
613,2250,Point,Missense,1135,379,333,Serine Protease,Exon 8,c.1135C>G,p.(Arg379Gly),-,-,-,,Moderate,-,Wulff et al (1995),Germany
613,2252,Point,Missense,1135,379,333,Serine Protease,Exon 8,c.1135C>G,p.(Arg379Gly),<1,-,-,,Severe,-,Mukherjee et al (2004),India
613,2253,Point,Missense,1135,379,333,Serine Protease,Exon 8,c.1135C>G,p.(Arg379Gly),2,-,-,,Moderate,-,Belvini et al (2005),Italy
613,2249,Point,Missense,1135,379,333,Serine Protease,Exon 8,c.1135C>G,p.(Arg379Gly),<1,63,II,,Severe,-,Bottema et al (1991),United States
613,2308,Point,Missense,1135,379,333,Serine Protease,Exon 8,c.1135C>G,p.(Arg379Gly),13,17,I,,Mild,-,Bottema et al (1990C),United States
615,2311,Point,Missense,1135,379,333,Serine Protease,Exon 8,c.1135C>A,p.(Arg379Gly),<1,-,-,,Severe,-,Jayandharan et al (2005),India
616,3504,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2,-,-,NO,Moderate,-,Radic et al (2013),Argentina
616,3503,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),6,-,-,NO,Mild,-,Radic et al (2013),Argentina
616,3614,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),-,-,-,NO,Moderate,-,Yu et al (2012),China
616,3615,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),-,-,-,NO,Moderate,-,Yu et al (2012),China
616,4409,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
616,4410,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2,,,NO,Moderate,,Johnsen et al (2017),United States
616,4412,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),3,,,NO,Moderate,,Johnsen et al (2017),United States
616,4408,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2,,,NO,Moderate,,Johnsen et al (2017),United States
616,4411,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1,,,NO,Moderate,,Johnsen et al (2017),United States
616,4413,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),3,,,NO,Moderate,,Johnsen et al (2017),United States
616,4414,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2,,,NO,Moderate,,Johnsen et al (2017),United States
616,4415,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2,,,NO,Moderate,,Johnsen et al (2017),United States
616,4416,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1,,,NO,Moderate,,Johnsen et al (2017),United States
616,4418,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1,,,NO,Moderate,,Johnsen et al (2017),United States
616,4419,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),4,,,NO,Moderate,,Johnsen et al (2017),United States
616,2366,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),-,-,-,,,-,Centre B39 (unpublished),
616,2365,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),-,-,-,,,-,Centre B39 (unpublished),
616,2355,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),-,-,-,,,-,Centre B39 (unpublished),
616,2354,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),-,-,-,,,-,Centre B39 (unpublished),
616,2362,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1.3,-,-,,Moderate,-,Centre B21 (unpublished),
616,2347,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1,-,-,,Moderate,-,Centre B12 (unpublished),
616,2360,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),<1,-,-,,Severe,-,Centre B21 (unpublished),
616,2359,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1,-,-,,Moderate,-,Centre B21 (unpublished),
616,2358,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),<1,-,-,,Severe,-,Centre B36 (unpublished),
616,2357,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),<1,-,-,,Severe,-,Centre B36 (unpublished),
616,2332,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1,-,-,,Moderate,-,Centre B6 (unpublished),
616,2337,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1,-,-,,Moderate,-,Centre B30 (unpublished),
616,2348,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1,-,-,,Moderate,-,Centre B13 (unpublished),
616,2339,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2.5,-,-,,Moderate,-,Centre B30 (unpublished),
616,2340,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1,-,-,,Moderate,-,Centre B30 (unpublished),
616,2341,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),-,-,-,,,-,Centre B30 (unpublished),
616,2342,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),8,108,II,,Mild,-,Centre B30 (unpublished),
616,2343,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),3,-,-,,Moderate,-,Centre B30 (unpublished),
616,2349,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1,98,II,,Moderate,-,Centre B14 (unpublished),
616,2345,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1,-,-,,Moderate,-,Centre B12 (unpublished),
616,2370,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1 to 2,-,-,,Moderate,-,Centre B13 (unpublished),
616,2371,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),3,-,-,,Moderate,-,Centre B13 (unpublished),
616,2373,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),3,-,-,,Moderate,-,Centre B10 (unpublished),
616,2374,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),3,-,-,,Moderate,-,Centre B10 (unpublished),
616,2363,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),<1,-,-,,Severe,-,Centre B25 (unpublished),
616,2338,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2,-,-,,Moderate,-,Centre B11 (unpublished),
616,2368,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),3,-,-,,Moderate,-,Centre B36 (unpublished),
616,2367,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),5.2,-,-,,Moderate,-,Centre B36 (unpublished),
616,2364,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2 to 3.5,-,-,,Moderate,-,Centre B25 (unpublished),
616,2318,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),<1,87,II,,Severe,-,Centre B21 (unpublished),
616,2361,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),<1,-,-,,Severe,-,Centre B21 (unpublished),
616,2350,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2,148,II,,Moderate,-,Centre B14 (unpublished),
616,2327,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),16,140,II,,Mild,-,Poon et al (1993),Canada
616,2353,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),-,-,-,,Severe,-,Liu et al (2000),China
616,2352,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),-,-,-,,Severe,-,Liu et al (2000),China
616,2335,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2,125,II,,Moderate,-,Tartary et al (1993),France
616,2333,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2,88,II,,Moderate,-,Tartary et al (1993),France
616,2330,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),<1,-,-,,Severe,-,Ghanem et al (1993),France
616,2331,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),<1,-,-,,Severe,-,Martinez et al (1994),France
616,2322,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2,88,II,,Moderate,-,Knobloch et al (1993),Germany
616,2323,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),4,93,II,,Moderate,-,Knobloch et al (1993),Germany
616,2344,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2,-,-,,Moderate,-,Wulff et al (2001),Germany
616,2346,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),<1,-,-,,Severe,-,Wulff et al (2001),Germany
616,2321,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),4,86,II,,Moderate,-,Ludwig et al (1992A),Germany
616,2320,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2,60,II,,Moderate,-,Ludwig et al (1992A),Germany
616,2372,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1.42,-,-,,Moderate,-,Jayandharan et al (2003),India
616,2375,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),15,-,-,,Mild,-,Belvini et al (2005),Italy
616,2314,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1,122,II,,Moderate,-,Poort et al (1989),Netherlands
616,2328,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),<1,-,-,,Severe,-,David et al (1993),Portugal
616,2334,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),-,-,-,,,-,Onay et al (2003),Turkey
616,2329,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),4,-,-,,Moderate,-,Saad et al (1994),United Kingdom
616,2324,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),-,-,-,,,-,Saad et al (1994),United Kingdom
616,2316,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1,130,II,,Moderate,-,Green et al (1990),United Kingdom
616,2315,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1,75,II,,Moderate,-,Green et al (1989),United Kingdom
616,2313,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),<1,135,II,,Severe,-,Tsang et al (1988),United Kingdom
616,2312,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),3,119,II,,Moderate,-,Green et al (1992),United Kingdom
616,2326,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2,86,II,,Moderate,-,Bottema et al (1991),United States
616,2325,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2,80,II,,Moderate,-,Thompson and Chen (1992),United States
616,2319,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2,38,II,,Moderate,-,Chen et al (1991a),United States
616,2351,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),<1,-,-,,Severe,-,Heit et al (1998),United States
616,2317,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),2,32,II,,Moderate,-,Wang et al (1990),United States
616,2336,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),-,-,-,,Moderate,-,Bottema et al (1993),United States
616,4417,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),1,,,,Moderate,,Johnsen et al (2017),United States
616,4420,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),4,,,,Moderate,,Johnsen et al (2017),United States
616,3768,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>A,p.(Arg379Gln),3,,,,Moderate,,Jenkins et al (2008),Ireland
618,3616,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>T,p.(Arg379Leu),-,-,-,NO,Moderate,-,Yu et al (2012),China
618,4406,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>T,p.(Arg379Leu),1,,,NO,Moderate,,Johnsen et al (2017),United States
618,4407,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>T,p.(Arg379Leu),<1,,,NO,Severe,,Johnsen et al (2017),United States
618,2377,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>T,p.(Arg379Leu),2,150,II,,Moderate,-,Bottema et al (1991),United States
617,2376,Point,Missense,1136,379,333,Serine Protease,Exon 8,c.1136G>C,p.(Arg379Pro),1.7,-,-,,Moderate,-,Belvini et al (2005),Italy
619,2378,Point,Missense,1138,380,334,Serine Protease,Exon 8,c.1138G>A,p.(Ala380Thr),14,-,-,,Mild,-,Centre B30 (unpublished),
619,2379,Point,Missense,1138,380,334,Serine Protease,Exon 8,c.1138G>A,p.(Ala380Thr),7,-,-,,Mild,-,Centre B30 (unpublished),
620,2382,Point,Missense,1139,380,334,Serine Protease,Exon 8,c.1139C>A,p.(Ala380Asp),9,100,II,,Mild,Patient tested at Hong Kong,Chan et al (1991),China
620,2380,Point,Missense,1139,380,334,Serine Protease,Exon 8,c.1139C>A,p.(Ala380Asp),27,-,-,,Mild,-,Ljung et al (2001),Sweden
620,2381,Point,Missense,1139,380,334,Serine Protease,Exon 8,c.1139C>A,p.(Ala380Asp),-,-,-,,Mild,-,Ljung et al (2001),Sweden
621,2383,Point,Missense,1141,381,335,Serine Protease,Exon 8,c.1141A>G,p.(Thr381Ala),<1,<1,-,,Severe,-,"Quadros et al, (2009)",India
621,2384,Point,Missense,1141,381,335,Serine Protease,Exon 8,c.1141A>G,p.(Thr381Ala),<1,-,II,,Severe,-,Ghosh et al (2009),India
1199,4773,Point,Missense,1142,381,335,Serine Protease,Exon 8,c.1142C>T,p.(Thr381Ile),25,,,,Mild,,Johnsen et al (2017),United States
622,3617,Point,Missense,1144,382,336,Serine Protease,Exon 8,c.1144T>C,p.(Cys382Arg),-,-,-,NO,Severe,-,Yu et al (2012),China
622,2388,Point,Missense,1144,382,336,Serine Protease,Exon 8,c.1144T>C,p.(Cys382Arg),1,<1,I,,Moderate,-,Centre B30 (unpublished),
622,2389,Point,Missense,1144,382,336,Serine Protease,Exon 8,c.1144T>C,p.(Cys382Arg),<1,51,II,,Severe,-,Wulff et al (1999),Germany
622,2386,Point,Missense,1144,382,336,Serine Protease,Exon 8,c.1144T>C,p.(Cys382Arg),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
622,2387,Point,Missense,1144,382,336,Serine Protease,Exon 8,c.1144T>C,p.(Cys382Arg),1,-,-,,Moderate,-,Saad et al (1994),United Kingdom
622,2390,Point,Missense,1144,382,336,Serine Protease,Exon 8,c.1144T>C,p.(Cys382Arg),2,2,I,,Moderate,-,Green et al (1989),United Kingdom
622,2385,Point,Missense,1144,382,336,Serine Protease,Exon 8,c.1144T>C,p.(Cys382Arg),<1,5,II,,Severe,-,Chen et al (1991a),United States
622,4421,Point,Missense,1144,382,336,Serine Protease,Exon 8,c.1144T>C,p.(Cys382Arg),<1,,,,Severe,,Johnsen et al (2017),United States
623,2391,Point,Missense,1144,382,336,Serine Protease,Exon 8,c.1144T>G,p.(Cys382Gly),<1,-,-,,Severe,-,Centre B5 (unpublished),
624,3505,Point,Missense,1145,382,336,Serine Protease,Exon 8,c.1145G>A,p.(Cys382Tyr),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
624,3618,Point,Missense,1145,382,336,Serine Protease,Exon 8,c.1145G>A,p.(Cys382Tyr),-,-,-,NO,Severe,-,Yu et al (2012),China
624,2398,Point,Missense,1145,382,336,Serine Protease,Exon 8,c.1145G>A,p.(Cys382Tyr),<1,<1,-,NO,Severe,-,Bicocchi et al (2006),Italy
624,2396,Point,Missense,1145,382,336,Serine Protease,Exon 8,c.1145G>A,p.(Cys382Tyr),<1,-,-,,Severe,-,Belvini et al (2005),Italy
624,2394,Point,Missense,1145,382,336,Serine Protease,Exon 8,c.1145G>A,p.(Cys382Tyr),<1,-,-,,Severe,-,Montejo et al (1999),Spain
624,2397,Point,Missense,1145,382,336,Serine Protease,Exon 8,c.1145G>A,p.(Cys382Tyr),<1,<1,-,,Severe,-,Green et al (1991),United Kingdom
624,2392,Point,Missense,1145,382,336,Serine Protease,Exon 8,c.1145G>A,p.(Cys382Tyr),<1,-,-,,Severe,-,Driscoll et al (1996),United States
624,3790,Point,Missense,1145,382,336,Serine Protease,Exon 8,c.1145G>A,p.(Cys382Tyr),<1,-,-,,Severe,-,Montejo et al (1999),Spain
625,2399,Point,Nonsense,1146,382,336,Serine Protease,Exon 8,c.1146T>A,p.(Cys382*),<1,-,-,,Severe,-,Centre B18 (unpublished),
630,2401,Point,Missense,1147,383,337,Serine Protease,Exon 8,c.1147C>A,p.(Leu383Ile),4,120,II,,Moderate,-,Fraser et al (1992),Canada
630,2405,Point,Missense,1147,383,337,Serine Protease,Exon 8,c.1147C>A,p.(Leu383Ile),3.8,-,-,,Moderate,-,Onay et al (2003),Turkey
631,2402,Point,Missense,1147,383,337,Serine Protease,Exon 8,c.1147C>T,p.(Leu383Phe),<1,-,-,,Severe,-,Centre B30 (unpublished),
631,2406,Point,Missense,1147,383,337,Serine Protease,Exon 8,c.1147C>T,p.(Leu383Phe),<1,-,-,,Severe,-,Mukherjee et al (2004),India
631,2436,Point,Missense,1147,383,337,Serine Protease,Exon 8,c.1147C>T,p.(Leu383Phe),-,-,-,,Severe,-,Belvini et al (2005),Italy
631,2400,Point,Missense,1147,383,337,Serine Protease,Exon 8,c.1147C>T,p.(Leu383Phe),2,-,-,,Moderate,-,Onay et al (2003),Turkey
631,2403,Point,Missense,1147,383,337,Serine Protease,Exon 8,c.1147C>T,p.(Leu383Phe),4,72,II,,Moderate,-,Gostout et al (1993),United States
629,4422,Point,Missense,1148,383,337,Serine Protease,Exon 8,c.1148T>C,p.(Leu383Pro),<1,,,NO,Severe,,Johnsen et al (2017),United States
629,2404,Point,Missense,1148,383,337,Serine Protease,Exon 8,c.1148T>C,p.(Leu383Pro),2,-,-,,Moderate,-,Centre B30 (unpublished),
1043,3620,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),-,-,-,NO,Moderate,-,Yu et al (2012),China
1043,3619,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),-,-,-,NO,Moderate,-,Yu et al (2012),China
1043,4638,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,,,NO,Severe,,Johnsen et al (2017),United States
1043,4635,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,,,NO,Severe,,Johnsen et al (2017),United States
1043,3697,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),-,-,-,NO,Severe,-,Miller et al (2012),United States
1043,4637,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,,,NO,Severe,,Johnsen et al (2017),United States
1043,2427,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<3,-,-,,,-,Centre B39 (unpublished),
1043,2426,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,-,-,,Severe,-,Centre B13 (unpublished),
1043,2414,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,<1,-,,Severe,-,Centre B22 (unpublished),
1043,2415,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,<1,-,,Severe,-,Centre B22 (unpublished),
1043,2416,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,<1,-,,Severe,-,Aguilar-Martinez et al (1994B),
1043,2435,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),0,-,-,,Severe,-,Centre B36 (unpublished),
1043,2428,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,-,-,,Severe,-,Centre B20 (unpublished),
1043,2434,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),0.5,-,-,,Severe,-,Centre B36 (unpublished),
1043,2432,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,-,-,,Severe,-,Centre B9 (unpublished),
1043,3427,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,<1,-,,Severe,also has p.Ile7Phe polymorphism,Poon et al (1993),Canada
1043,2411,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,<1,-,,Severe,-,Tam et al (1991),Canada
1043,2412,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,<1,-,,Severe,also Fraser et al (1992),Poon et al (1987),Canada
1043,2413,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,<1,-,,Severe,-,Poon et al (1993),Canada
1043,2431,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),-,-,-,,Severe,-,Liu et al (2000),China
1043,2417,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,<1,-,,Severe,-,Tartary et al (1993),France
1043,2425,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,-,-,,Severe,-,Wulff et al (2001),Germany
1043,2439,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,<1,-,,Severe,-,Ludwig et al (1989),Germany
1043,2421,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,<1,-,,Severe,-,Wulff et al (1999),Germany
1043,2440,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,-,I,,Severe,-,Ghosh et al (2009),India
1043,683,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),0.9,-,-,,Severe,-,Belvini et al (2005),Italy
1043,2437,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
1043,2438,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
1043,2423,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),-,-,-,,,-,Onay et al (2003),Turkey
1043,2409,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,-,-,,Severe,-,Green et al (1990),United Kingdom
1043,2408,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),2,<1,I,,Moderate,-,Green et al (1990),United Kingdom
1043,2429,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,-,-,,Severe,-,Ketterling et al (1999B),United States
1043,2420,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),1,-,-,,Moderate,-,Thorland et al (1995),United States
1043,2419,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),1,-,-,,Moderate,-,Thorland et al (1995),United States
1043,2418,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,-,-,,Severe,-,Gostout et al (1993),United States
1043,2410,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,<1,-,,Severe,-,Freedenberg et al (1989),United States
1043,2422,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,-,-,,Severe,-,Driscoll et al (1996),United States
1043,4636,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,,,,Severe,,Johnsen et al (2017),United States
1043,2430,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,-,-,,Severe,-,Li et al (2000),United States
1043,2407,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),<1,<1,-,,Severe,-,Driscoll et al (1989),United States
1043,3818,Point,Nonsense,1150,384,338,Serine Protease,Exon 8,c.1150C>T,p.(Arg384*),,,,,,,Wulff et al (2001),Germany
1100,3711,Point,Missense,1151,384,338,Serine Protease,Exon 8,c.1151G>T,p.(Arg384Leu),776,92,I,NO,,Hyperactive Variant; Padua variant;,Simioni et al (2009),Italy
1100,3712,Point,Missense,1151,384,338,Serine Protease,Exon 8,c.1151G>T,p.(Arg384Leu),551,64,I,NO,,Hyperactive Variant; Padua variant;,Simioni et al (2009),Italy
632,2442,Point,Missense,1151,384,338,Serine Protease,Exon 8,c.1151G>C,p.(Arg384Pro),10,-,-,,Mild,-,Centre B18 (unpublished),
632,2441,Point,Missense,1151,384,338,Serine Protease,Exon 8,c.1151G>C,p.(Arg384Pro),16,27,II,,Mild,-,Gostout et al (1993),United States
633,2444,Point,Missense,1153,385,339,Serine Protease,Exon 8,c.1153T>C,p.(Ser385Pro),4,15,II,,Moderate,-,Wulff et al (1999),Germany
634,2445,Point,Missense,1157,386,340,Serine Protease,Exon 8,c.1157C>G,p.(Thr386Arg),<1,-,-,,Severe,-,Ketterling et al (1993A),United States
635,3683,Point,Missense,1157,386,340,Serine Protease,Exon 8,c.1157C>T,p.(Thr386Ile),-,-,-,NO,Moderate,-,Miller et al (2012),United States
635,2446,Point,Missense,1157,386,340,Serine Protease,Exon 8,c.1157C>T,p.(Thr386Ile),-,-,-,,,-,Centre B20 (unpublished),
636,2447,Point,Missense,1159,387,341,Serine Protease,Exon 8,c.1159A>G,p.(Lys387Glu),6 to 9,-,-,,Mild,-,Centre B13 (unpublished),
636,2448,Point,Missense,1159,387,341,Serine Protease,Exon 8,c.1159A>G,p.(Lys387Glu),-,-,-,,,-,Centre B20 (unpublished),
636,2450,Point,Missense,1159,387,341,Serine Protease,Exon 8,c.1159A>G,p.(Lys387Glu),<1,-,I,,Severe,-,Ghosh et al (2009),India
636,2451,Point,Missense,1159,387,341,Serine Protease,Exon 8,c.1159A>G,p.(Lys387Glu),5.6-12,-,I,,Mild,-,Ghosh et al (2009),India
636,2452,Point,Missense,1159,387,341,Serine Protease,Exon 8,c.1159A>G,p.(Lys387Glu),5.6-12,-,I,,Mild,-,Ghosh et al (2009),India
636,2453,Point,Missense,1159,387,341,Serine Protease,Exon 8,c.1159A>G,p.(Lys387Glu),<1,-,I,,Severe,-,Ghosh et al (2009),India
636,2454,Point,Missense,1159,387,341,Serine Protease,Exon 8,c.1159A>G,p.(Lys387Glu),<1,-,II,,Severe,-,Ghosh et al (2009),India
636,2449,Point,Missense,1159,387,341,Serine Protease,Exon 8,c.1159A>G,p.(Lys387Glu),17,-,-,,Mild,-,Heit et al (1998),United States
637,2455,Point,Missense,1161,387,341,Serine Protease,Exon 8,c.1161G>C,p.(Lys387Asn),37,-,-,,Mild,-,Centre B30 (unpublished),
638,2456,Point,Missense,1161,387,341,Serine Protease,Exon 8,c.1161G>T,p.(Lys387Asn),<1,55,II,,Severe,-,Centre B13 (unpublished),
639,3684,Point,Missense,1168,390,344,Serine Protease,Exon 8,c.1168A>T,p.(Ile390Phe),-,-,-,NO,Moderate,-,Miller et al (2012),United States
639,4423,Point,Missense,1168,390,344,Serine Protease,Exon 8,c.1168A>T,p.(Ile390Phe),3,,,NO,Moderate,,Johnsen et al (2017),United States
639,4424,Point,Missense,1168,390,344,Serine Protease,Exon 8,c.1168A>T,p.(Ile390Phe),8,,,NO,Mild,,Johnsen et al (2017),United States
639,2457,Point,Missense,1168,390,344,Serine Protease,Exon 8,c.1168A>T,p.(Ile390Phe),4,87,II,,Moderate,-,Centre B23 (unpublished),
639,2458,Point,Missense,1168,390,344,Serine Protease,Exon 8,c.1168A>T,p.(Ile390Phe),<1,-,-,,Severe,-,Wulff et al (1995),Germany
639,2459,Point,Missense,1168,390,344,Serine Protease,Exon 8,c.1168A>T,p.(Ile390Phe),<1,-,-,,Severe,-,Wulff et al (1995),Germany
640,2460,Point,Missense,1169,390,344,Serine Protease,Exon 8,c.1169T>A,p.(Ile390Asn),-,-,-,,Severe,-,Belvini et al (2005),Italy
642,2463,Point,Missense,1169,390,344,Serine Protease,Exon 8,c.1169T>G,p.(Ile390Ser),<1,119,II,,Severe,-,Centre B14 (unpublished),
642,2464,Point,Missense,1169,390,344,Serine Protease,Exon 8,c.1169T>G,p.(Ile390Ser),4.4,112,II,,Moderate,-,Li et al (2000),United States
642,3771,Point,Missense,1169,390,344,Serine Protease,Exon 8,c.1169T>G,p.(Ile390Ser),,,,,,,Ketterling et al (1999B),United States
641,2462,Point,Missense,1169,390,344,Serine Protease,Exon 8,c.1169T>C,p.(Ile390Thr),1.6,-,-,,Moderate,-,Centre B4 (unpublished),
641,2461,Point,Missense,1169,390,344,Serine Protease,Exon 8,c.1169T>C,p.(Ile390Thr),1,28,II,,Moderate,-,Costa et al (2000),France
641,4425,Point,Missense,1169,390,344,Serine Protease,Exon 8,c.1169T>C,p.(Ile390Thr),1,,,,Moderate,,Johnsen et al (2017),United States
643,2465,Point,Missense,1172,391,345,Serine Protease,Exon 8,c.1172A>G,p.(Tyr391Cys),-,-,-,,,-,Centre B39 (unpublished),
644,4639,Point,Nonsense,1173,391,345,Serine Protease,Exon 8,c.1173T>A,p.(Tyr391*),<1,,,NO,Severe,,Johnsen et al (2017),United States
644,2466,Point,Nonsense,1173,391,345,Serine Protease,Exon 8,c.1173T>A,p.(Tyr391*),<1,<6,-,,Severe,-,Wulff et al (1995),Germany
645,4426,Point,Missense,1174,392,346,Serine Protease,Exon 8,c.1174A>G,p.(Asn392Asp),24,,,NO,Mild,,Johnsen et al (2017),United States
645,4427,Point,Missense,1174,392,346,Serine Protease,Exon 8,c.1174A>G,p.(Asn392Asp),19,,,NO,Mild,,Johnsen et al (2017),United States
645,4428,Point,Missense,1174,392,346,Serine Protease,Exon 8,c.1174A>G,p.(Asn392Asp),14,,,NO,Mild,,Johnsen et al (2017),United States
645,4429,Point,Missense,1174,392,346,Serine Protease,Exon 8,c.1174A>G,p.(Asn392Asp),14,,,NO,Mild,,Johnsen et al (2017),United States
645,4430,Point,Missense,1174,392,346,Serine Protease,Exon 8,c.1174A>G,p.(Asn392Asp),46,,,NO,Mild,,Johnsen et al (2017),United States
645,2467,Point,Missense,1174,392,346,Serine Protease,Exon 8,c.1174A>G,p.(Asn392Asp),22,63,II,,Mild,-,Centre B38 (unpublished),
645,2468,Point,Missense,1174,392,346,Serine Protease,Exon 8,c.1174A>G,p.(Asn392Asp),<1,100,II,,Severe,-,Weinmann et al (1998),United States
645,4431,Point,Missense,1174,392,346,Serine Protease,Exon 8,c.1174A>G,p.(Asn392Asp),10,,,,Mild,,Johnsen et al (2017),United States
645,4432,Point,Missense,1174,392,346,Serine Protease,Exon 8,c.1174A>G,p.(Asn392Asp),17,,,,Mild,,Johnsen et al (2017),United States
646,2469,Point,Missense,1177,393,347,Serine Protease,Exon 8,c.1177A>C,p.(Asn393Thr),<1,<1,I,,Severe,-,"Quadros et al, (2009)",India
646,2470,Point,Missense,1177,393,347,Serine Protease,Exon 8,c.1177A>C,p.(Asn393Thr),<1,<1,I,,Severe,-,"Quadros et al, (2009)",India
647,4433,Point,Missense,1178,393,347,Serine Protease,Exon 8,c.1178A>T,p.(Asn393Ile),2,,,NO,Moderate,,Johnsen et al (2017),United States
647,2471,Point,Missense,1178,393,347,Serine Protease,Exon 8,c.1178A>T,p.(Asn393Ile),<1,2,II,,Severe,-,Bottema et al (1991),United States
649,2474,Point,Missense,1180,394,348,Serine Protease,Exon 8,c.1180A>G,p.(Met394Val),4,77,II,,Moderate,-,Centre B35 (unpublished),
649,2475,Point,Missense,1180,394,348,Serine Protease,Exon 8,c.1180A>G,p.(Met394Val),5,-,-,,Moderate,-,Centre B35 (unpublished),
649,2476,Point,Missense,1180,394,348,Serine Protease,Exon 8,c.1180A>G,p.(Met394Val),6,-,-,,Mild,-,Centre B10 (unpublished),
649,2473,Point,Missense,1180,394,348,Serine Protease,Exon 8,c.1180A>G,p.(Met394Val),3,103,II,,Moderate,-,Chen et al (1991a),United States
651,2479,Point,Missense,1181,394,348,Serine Protease,Exon 8,c.1181T>G,p.(Met394Arg),-,-,-,,Severe,-,Belvini et al (2005),Italy
650,2478,Point,Missense,1181,394,348,Serine Protease,Exon 8,c.1181T>A,p.(Met394Lys),<1,12,II,,Severe,-,Nielsen et al (1995),Denmark
650,2477,Point,Missense,1181,394,348,Serine Protease,Exon 8,c.1181T>A,p.(Met394Lys),2,-,-,,Moderate,-,Montejo et al (1999),Spain
652,4434,Point,Missense,1182,394,348,Serine Protease,Exon 8,c.1182G>A,p.(Met394Ile),<1,,,NO,Severe,,Johnsen et al (2017),United States
652,2482,Point,Missense,1182,394,348,Serine Protease,Exon 8,c.1182G>A,p.(Met394Ile),-,-,-,,,-,Centre B9 (unpublished),
652,2481,Point,Missense,1182,394,348,Serine Protease,Exon 8,c.1182G>A,p.(Met394Ile),<1,93,II,,Severe,-,Tartary et al (1993),France
652,2480,Point,Missense,1182,394,348,Serine Protease,Exon 8,c.1182G>A,p.(Met394Ile),<1,40,II,,Severe,-,Bottema et al (1991),United States
652,4435,Point,Missense,1182,394,348,Serine Protease,Exon 8,c.1182G>A,p.(Met394Ile),<1,,,,Severe,,Johnsen et al (2017),United States
1145,2483,Point,Missense,1182,394,348,Serine Protease,Exon 8,c.1182G>C,p.(Met394Ile),<1,-,-,,Severe,-,Mukherjee et al (2004),India
653,3685,Point,Missense,1183,395,349,Serine Protease,Exon 8,c.1183T>A,p.(Phe395Ile),-,-,-,NO,Severe,-,Miller et al (2012),United States
653,4436,Point,Missense,1183,395,349,Serine Protease,Exon 8,c.1183T>A,p.(Phe395Ile),<1,,,NO,Severe,,Johnsen et al (2017),United States
653,4437,Point,Missense,1183,395,349,Serine Protease,Exon 8,c.1183T>A,p.(Phe395Ile),<1,,,NO,Severe,,Johnsen et al (2017),United States
653,2484,Point,Missense,1183,395,349,Serine Protease,Exon 8,c.1183T>A,p.(Phe395Ile),-,-,-,,,-,Onay et al (2003),Turkey
655,4438,Point,Missense,1183,395,349,Serine Protease,Exon 8,c.1183T>C,p.(Phe395Leu),<1,,,NO,Severe,,Johnsen et al (2017),United States
655,2487,Point,Missense,1183,395,349,Serine Protease,Exon 8,c.1183T>C,p.(Phe395Leu),-,-,-,,,-,Centre B43 (unpublished),
655,2489,Point,Missense,1183,395,349,Serine Protease,Exon 8,c.1183T>C,p.(Phe395Leu),<1,-,-,,Severe,-,Centre B30 (unpublished),
655,2486,Point,Missense,1183,395,349,Serine Protease,Exon 8,c.1183T>C,p.(Phe395Leu),<1,-,-,,Severe,-,Costa et al (2000),France
655,2488,Point,Missense,1183,395,349,Serine Protease,Exon 8,c.1183T>C,p.(Phe395Leu),<1,-,-,,Severe,-,Mukherjee et al (2004),India
658,2490,Point,Missense,1183,395,349,Serine Protease,Exon 8,c.1183T>G,p.(Phe395Val),<1,-,-,,Severe,-,Jayandharan et al (2005),India
658,4439,Point,Missense,1183,395,349,Serine Protease,Exon 8,c.1183T>G,p.(Phe395Val),<1,,,,Severe,,Johnsen et al (2017),United States
659,2493,Point,Missense,1184,395,349,Serine Protease,Exon 8,c.1184T>A,p.(Phe395Tyr),-,-,-,,,-,Centre B39 (unpublished),
659,2492,Point,Missense,1184,395,349,Serine Protease,Exon 8,c.1184T>A,p.(Phe395Tyr),-,-,-,,,-,Wulff et al (2001),Germany
660,2494,Point,Missense,1185,395,349,Serine Protease,Exon 8,c.1185C>G,p.(Phe395Leu),2,-,-,,Moderate,-,Li et al (2000),United States
661,2496,Point,Missense,1186,396,350,Serine Protease,Exon 8,c.1186T>C,p.(Cys396Arg),<1,<1,-,,Severe,-,Wulff et al (1999),Germany
662,2499,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>T,p.(Cys396Phe),1,5,II,,Moderate,-,Tartary et al (1993),France
662,2497,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>T,p.(Cys396Phe),7.8,-,-,,Mild,-,Onay et al (2003),Turkey
662,2498,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>T,p.(Cys396Phe),-,-,-,,Severe,-,Li et al (2000),United States
664,4440,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>C,p.(Cys396Ser),<1,,,NO,Severe,,Johnsen et al (2017),United States
664,2509,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>C,p.(Cys396Ser),-,-,-,,,-,Centre B19 (unpublished),
664,2511,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>C,p.(Cys396Ser),35,45,I,,Mild,-,Taylor et al (1991),Canada
664,2508,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>C,p.(Cys396Ser),<1,45,II,,Severe,-,Wulff et al (1995),Germany
664,2510,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>C,p.(Cys396Ser),2,-,-,,Moderate,-,Montejo et al (1999),Spain
663,4441,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>A,p.(Cys396Tyr),<1,,,NO,Severe,,Johnsen et al (2017),United States
663,4442,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>A,p.(Cys396Tyr),<1,,,NO,Severe,,Johnsen et al (2017),United States
663,4443,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>A,p.(Cys396Tyr),<1,,,NO,Severe,,Johnsen et al (2017),United States
663,2506,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>A,p.(Cys396Tyr),-,-,-,,,-,Centre B39 (unpublished),
663,2501,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>A,p.(Cys396Tyr),-,-,-,,,-,Centre B18 (unpublished),
663,2502,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>A,p.(Cys396Tyr),<1,-,-,,Severe,-,Centre B30 (unpublished),
663,2505,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>A,p.(Cys396Tyr),<1,-,-,,Severe,-,Centre B13 (unpublished),
663,2504,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>A,p.(Cys396Tyr),<1,-,-,,Severe,-,Mahajan et al (2004),India
663,2500,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>A,p.(Cys396Tyr),<1,-,-,,Severe,-,Ljung et al (2001),Sweden
663,2507,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>A,p.(Cys396Tyr),<1,<1,-,,Severe,-,Saad et al (1994),United Kingdom
663,2503,Point,Missense,1187,396,350,Serine Protease,Exon 8,c.1187G>A,p.(Cys396Tyr),<1,<1,-,,Severe,-,Weinmann et al (1998),United States
665,2512,Point,Nonsense,1188,396,350,Serine Protease,Exon 8,c.1188T>A,p.(Cys396*),0.4,-,-,,Severe,-,Onay et al (2003),Turkey
666,2513,Point,Missense,1188,396,350,Serine Protease,Exon 8,c.1188T>G,p.(Cys396Trp),3.6,-,-,,Moderate,-,Centre B5 (unpublished),
667,2515,Point,Missense,1189,397,351,Serine Protease,Exon 8,c.1189G>C,p.(Ala397Pro),8,-,-,,Mild,,Chan et al (1998),
667,2514,Point,Missense,1189,397,351,Serine Protease,Exon 8,c.1189G>C,p.(Ala397Pro),-,-,-,,,-,Liu et al (2000),China
668,2516,Point,Missense,1189,397,351,Serine Protease,Exon 8,c.1189G>A,p.(Ala397Thr),<1,<1,-,,Severe,-,"Quadros et al, (2009)",India
668,2517,Point,Missense,1189,397,351,Serine Protease,Exon 8,c.1189G>A,p.(Ala397Thr),<1,<1,-,,Severe,-,"Quadros et al, (2009)",India
669,2518,Point,Missense,1190,397,351,Serine Protease,Exon 8,c.1190C>T,p.(Ala397Val),2,-,-,,Moderate,-,Kwon et al (2008),South Korea
670,4444,Point,Missense,1192,398,352,Serine Protease,Exon 8,c.1192G>A,p.(Gly398Ser),<1,,,NO,Severe,,Johnsen et al (2017),United States
670,2519,Point,Missense,1192,398,352,Serine Protease,Exon 8,c.1192G>A,p.(Gly398Ser),-,-,-,,,-,Liu et al (2000),China
671,2528,Point,Missense,1193,398,352,Serine Protease,Exon 8,c.1193G>C,p.(Gly398Ala),4,19,II,NO,Moderate,-,Attali et al (1999),France
671,2529,Point,Missense,1193,398,352,Serine Protease,Exon 8,c.1193G>C,p.(Gly398Ala),8,<10,-,NO,Mild,-,Attali et al (1999),France
671,2526,Point,Missense,1193,398,352,Serine Protease,Exon 8,c.1193G>C,p.(Gly398Ala),-,-,-,,,-,Centre B31 (unpublished),
671,2527,Point,Missense,1193,398,352,Serine Protease,Exon 8,c.1193G>C,p.(Gly398Ala),3,-,-,,Moderate,-,Centre B11 (unpublished),
1053,3540,Point,Missense,1193,398,352,Serine Protease,Exon 8,c.1193G>A,p.(Gly398Asp),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
1053,3541,Point,Missense,1193,398,352,Serine Protease,Exon 8,c.1193G>A,p.(Gly398Asp),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
1053,2524,Point,Missense,1193,398,352,Serine Protease,Exon 8,c.1193G>A,p.(Gly398Asp),<1,-,-,,Severe,-,Centre B39 (unpublished),
1053,2525,Point,Missense,1193,398,352,Serine Protease,Exon 8,c.1193G>A,p.(Gly398Asp),<1,-,-,,Severe,-,Centre B39 (unpublished),
1053,2520,Point,Missense,1193,398,352,Serine Protease,Exon 8,c.1193G>A,p.(Gly398Asp),-,-,-,,,-,Centre B18 (unpublished),
1053,2521,Point,Missense,1193,398,352,Serine Protease,Exon 8,c.1193G>A,p.(Gly398Asp),<1,-,-,,Severe,-,Centre B30 (unpublished),
1053,2523,Point,Missense,1193,398,352,Serine Protease,Exon 8,c.1193G>A,p.(Gly398Asp),<1,-,-,,Severe,-,Centre B9 (unpublished),
1053,2522,Point,Missense,1193,398,352,Serine Protease,Exon 8,c.1193G>A,p.(Gly398Asp),<1,3,II,,Severe,-,Wulff et al (1999),Germany
1213,4792,Point,Nonsense,1204,402,356,Serine Protease,Exon 8,c.1204G>T,p.(Gly402*),<1,,,,Severe,,Johnsen et al (2017),United States
672,3508,Point,Missense,1204,402,356,Serine Protease,Exon 8,c.1204G>A,p.(Gly402Arg),2,-,-,NO,Moderate,-,Radic et al (2013),Argentina
672,2532,Point,Missense,1204,402,356,Serine Protease,Exon 8,c.1204G>A,p.(Gly402Arg),-,-,-,,,-,Centre B39 (unpublished),
672,2531,Point,Missense,1204,402,356,Serine Protease,Exon 8,c.1204G>A,p.(Gly402Arg),2,-,-,,Moderate,-,Centre B20 (unpublished),
672,2533,Point,Missense,1204,402,356,Serine Protease,Exon 8,c.1204G>A,p.(Gly402Arg),1,-,-,,Moderate,-,Centre B25 (unpublished),
672,2534,Point,Missense,1204,402,356,Serine Protease,Exon 8,c.1204G>A,p.(Gly402Arg),2,-,-,,Moderate,-,Centre B32 (unpublished),
672,2535,Point,Missense,1204,402,356,Serine Protease,Exon 8,c.1204G>A,p.(Gly402Arg),2,-,-,,Moderate,-,Centre B32 (unpublished),
672,2530,Point,Missense,1204,402,356,Serine Protease,Exon 8,c.1204G>A,p.(Gly402Arg),<1,75,II,,Severe,-,Costa et al (2000),France
672,2536,Point,Missense,1204,402,356,Serine Protease,Exon 8,c.1204G>A,p.(Gly402Arg),4,-,-,,Moderate,-,Saad et al (1994),United Kingdom
673,2538,Point,Missense,1205,402,356,Serine Protease,Exon 8,c.1205G>A,p.(Gly402Glu),1,-,-,,Moderate,-,Kwon et al (2008),South Korea
1122,3727,Point,Missense,1207,403,357,Serine Protease,Exon 8,c.1207G>T,p.(Gly403Cys),,,,,,,Centre B30 (unpublished),
674,2539,Point,Missense,1208,403,357,Serine Protease,Exon 8,c.1208G>A,p.(Gly403Asp),11,70,II,,Mild,-,"Quadros et al, (2009)",India
675,2540,Point,Missense,1211,404,358,Serine Protease,Exon 8,c.1211G>C,p.(Arg404Thr),-,-,-,,,-,Montejo et al (1999),Spain
676,2542,Point,Missense,1213,405,359,Serine Protease,Exon 8,c.1213G>A,p.(Asp405Asn),<1,100,II,,Severe,-,Centre B38 (unpublished),
676,2541,Point,Missense,1213,405,359,Serine Protease,Exon 8,c.1213G>A,p.(Asp405Asn),-,-,-,,,-,Liu et al (2000),China
677,2543,Point,Missense,1214,405,359,Serine Protease,Exon 8,c.1214A>G,p.(Asp405Gly),1.5,-,-,,Moderate,-,Centre B18 (unpublished),
678,2544,Point,Nonsense,1217,406,360,Serine Protease,Exon 8,c.1217C>G,p.(Ser406*),<1,-,-,,Severe,-,Ghanem et al (1993),France
678,2545,Point,Nonsense,1217,406,360,Serine Protease,Exon 8,c.1217C>G,p.(Ser406*),<1,-,-,,Severe,-,Tartary et al (1993),France
678,2546,Point,Nonsense,1217,406,360,Serine Protease,Exon 8,c.1217C>G,p.(Ser406*),1.5,-,-,,Moderate,-,Ghanem et al (1993),France
679,2550,Point,Missense,1217,406,360,Serine Protease,Exon 8,c.1217C>T,p.(Ser406Leu),<1,95,II,NO,Severe,-,Bicocchi et al (2006),Italy
679,2549,Point,Missense,1217,406,360,Serine Protease,Exon 8,c.1217C>T,p.(Ser406Leu),-,-,-,,,-,Centre B31 (unpublished),
679,2548,Point,Missense,1217,406,360,Serine Protease,Exon 8,c.1217C>T,p.(Ser406Leu),<1,-,-,,Severe,-,Ghanem et al (1993),France
679,2552,Point,Missense,1217,406,360,Serine Protease,Exon 8,c.1217C>T,p.(Ser406Leu),<1,-,-,,Severe,-,Costa et al (2000),France
679,2547,Point,Missense,1217,406,360,Serine Protease,Exon 8,c.1217C>T,p.(Ser406Leu),1,-,-,,Moderate,-,Saad et al (1994),United Kingdom
679,2551,Point,Missense,1217,406,360,Serine Protease,Exon 8,c.1217C>T,p.(Ser406Leu),2,130,II,,Moderate,-,Chen et al (1991a),United States
681,3621,Point,Missense,1219,407,361,Serine Protease,Exon 8,c.1219T>C,p.(Cys407Arg),-,-,-,NO,Severe,-,Yu et al (2012),China
681,3686,Point,Missense,1219,407,361,Serine Protease,Exon 8,c.1219T>C,p.(Cys407Arg),-,-,-,NO,Severe,-,Miller et al (2012),United States
681,2558,Point,Missense,1219,407,361,Serine Protease,Exon 8,c.1219T>C,p.(Cys407Arg),<1,<1,-,,Severe,-,Centre B7 (unpublished),
681,2559,Point,Missense,1219,407,361,Serine Protease,Exon 8,c.1219T>C,p.(Cys407Arg),-,-,-,,Severe,-,Jenkins et al (2008),Ireland
681,2556,Point,Missense,1219,407,361,Serine Protease,Exon 8,c.1219T>C,p.(Cys407Arg),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
681,2557,Point,Missense,1219,407,361,Serine Protease,Exon 8,c.1219T>C,p.(Cys407Arg),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
681,2560,Point,Missense,1219,407,361,Serine Protease,Exon 8,c.1219T>C,p.(Cys407Arg),5,-,-,,Moderate,-,Onay et al (2003),Turkey
681,4447,Point,Missense,1219,407,361,Serine Protease,Exon 8,c.1219T>C,p.(Cys407Arg),<1,,,,Severe,,Johnsen et al (2017),United States
682,4445,Point,Missense,1219,407,361,Serine Protease,Exon 8,c.1219T>G,p.(Cys407Gly),<1,,,NO,Severe,,Johnsen et al (2017),United States
682,2561,Point,Missense,1219,407,361,Serine Protease,Exon 8,c.1219T>G,p.(Cys407Gly),<1,25,II,,Severe,-,Wulff et al (1999),Germany
680,2553,Point,Missense,1219,407,361,Serine Protease,Exon 8,c.1219T>A,p.(Cys407Ser),<1,-,-,,Severe,-,Centre B30 (unpublished),
680,2554,Point,Missense,1219,407,361,Serine Protease,Exon 8,c.1219T>A,p.(Cys407Ser),<1,-,-,,Severe,-,Centre B35 (unpublished),
680,2555,Point,Missense,1219,407,361,Serine Protease,Exon 8,c.1219T>A,p.(Cys407Ser),<1,-,-,,Severe,-,Wulff et al (1995),Germany
680,4446,Point,Missense,1219,407,361,Serine Protease,Exon 8,c.1219T>A,p.(Cys407Ser),<1,,,,Severe,,Johnsen et al (2017),United States
684,2565,Point,Missense,1220,407,361,Serine Protease,Exon 8,c.1220G>T,p.(Cys407Phe),-,-,-,,,-,Liu et al (2000),China
683,4448,Point,Missense,1220,407,361,Serine Protease,Exon 8,c.1220G>A,p.(Cys407Tyr),<1,,,NO,Severe,,Johnsen et al (2017),United States
683,4449,Point,Missense,1220,407,361,Serine Protease,Exon 8,c.1220G>A,p.(Cys407Tyr),<1,,,NO,Severe,,Johnsen et al (2017),United States
683,2564,Point,Missense,1220,407,361,Serine Protease,Exon 8,c.1220G>A,p.(Cys407Tyr),-,-,-,,,-,Centre B30 (unpublished),
683,2562,Point,Missense,1220,407,361,Serine Protease,Exon 8,c.1220G>A,p.(Cys407Tyr),0.5,-,-,,Severe,-,Belvini et al (2005),Italy
1214,4793,Point,Nonsense,1222,408,362,Serine Protease,Exon 8,c.1222C>T,p.(Gln408*),<1,,,NO,Severe,,Johnsen et al (2017),United States
686,2567,Point,Nonsense,1225,409,363,Serine Protease,Exon 8,c.1225G>T,p.(Gly409*),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
685,4450,Point,Missense,1225,409,363,Serine Protease,Exon 8,c.1225G>A,p.(Gly409Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
685,2566,Point,Missense,1225,409,363,Serine Protease,Exon 8,c.1225G>A,p.(Gly409Arg),<1,110,II,,Severe,-,Centre B41 (unpublished),
685,4451,Point,Missense,1225,409,363,Serine Protease,Exon 8,c.1225G>A,p.(Gly409Arg),<1,,,,Severe,,Johnsen et al (2017),United States
685,4452,Point,Missense,1225,409,363,Serine Protease,Exon 8,c.1225G>A,p.(Gly409Arg),<1,,,,Severe,,Johnsen et al (2017),United States
688,4453,Point,Missense,1226,409,363,Serine Protease,Exon 8,c.1226G>C,p.(Gly409Ala),4,,,NO,Moderate,,Johnsen et al (2017),United States
688,2570,Point,Missense,1226,409,363,Serine Protease,Exon 8,c.1226G>C,p.(Gly409Ala),3,100,II,,Moderate,-,Thompson et al (1992A),United States
687,2568,Point,Missense,1226,409,363,Serine Protease,Exon 8,c.1226G>A,p.(Gly409Glu),<1,-,-,,Severe,-,Van de Water et al (1996),New Zealand
687,2569,Point,Missense,1226,409,363,Serine Protease,Exon 8,c.1226G>A,p.(Gly409Glu),2,53,II,,Moderate,-,Saad et al (1994),United Kingdom
689,2571,Point,Missense,1226,409,363,Serine Protease,Exon 8,c.1226G>T,p.(Gly409Val),1 to 5,100,II,,Moderate,-,Bajaj et al (1990),United States
690,2573,Point,Missense,1228,410,364,Serine Protease,Exon 8,c.1228G>A,p.(Asp410Asn),<1,-,-,,Severe,-,Centre B21 (unpublished),
690,2572,Point,Missense,1228,410,364,Serine Protease,Exon 8,c.1228G>A,p.(Asp410Asn),2,-,-,,Moderate,-,Saad et al (1994),United Kingdom
691,2575,Point,Missense,1228,410,364,Serine Protease,Exon 8,c.1228G>C,p.(Asp410His),<1,100,II,,Severe,-,Ludwig et al (1992B),Germany
691,2574,Point,Missense,1228,410,364,Serine Protease,Exon 8,c.1228G>C,p.(Asp410His),2,95,II,,Moderate,-,Bottema et al (1990C),United States
692,3687,Point,Missense,1228,410,364,Serine Protease,Exon 8,c.1228G>T,p.(Asp410Tyr),-,-,-,NO,Severe,-,Miller et al (2012),United States
692,4454,Point,Missense,1228,410,364,Serine Protease,Exon 8,c.1228G>T,p.(Asp410Tyr),<1,,,NO,Severe,,Johnsen et al (2017),United States
692,2576,Point,Missense,1228,410,364,Serine Protease,Exon 8,c.1228G>T,p.(Asp410Tyr),<1,-,-,,Severe,-,Li et al (2000),United States
693,2578,Point,Missense,1229,410,364,Serine Protease,Exon 8,c.1229A>G,p.(Asp410Gly),1,-,-,,Moderate,-,Centre B38 (unpublished),
693,2577,Point,Missense,1229,410,364,Serine Protease,Exon 8,c.1229A>G,p.(Asp410Gly),-,-,-,,,-,Liu et al (2000),China
694,3622,Point,Missense,1229,410,364,Serine Protease,Exon 8,c.1229A>T,p.(Asp410Val),-,-,-,NO,Moderate,-,Yu et al (2012),China
694,2579,Point,Missense,1229,410,364,Serine Protease,Exon 8,c.1229A>T,p.(Asp410Val),<1,130,II,,Severe,-,Chen et al (1991a),United States
695,2580,Point,Missense,1230,410,364,Serine Protease,Exon 8,c.1230T>G,p.(Asp410Glu),<1,-,-,,Severe,-,Belvini et al (2005),Italy
697,4455,Point,Missense,1231,411,365,Serine Protease,Exon 8,c.1231A>G,p.(Ser411Gly),<1,,,NO,Severe,,Johnsen et al (2017),United States
697,2582,Point,Missense,1231,411,365,Serine Protease,Exon 8,c.1231A>G,p.(Ser411Gly),<1,12,II,,Severe,-,Centre B38 (unpublished),
697,2583,Point,Missense,1231,411,365,Serine Protease,Exon 8,c.1231A>G,p.(Ser411Gly),-,-,-,,,-,Centre B18 (unpublished),
698,2585,Point,Missense,1232,411,365,Serine Protease,Exon 8,c.1232G>A,p.(Ser411Asn),2,-,-,,Moderate,-,Nielsen et al (1995),Denmark
698,2584,Point,Missense,1232,411,365,Serine Protease,Exon 8,c.1232G>A,p.(Ser411Asn),<1,-,-,,Severe,-,Wulff et al (2001),Germany
699,4456,Point,Missense,1232,411,365,Serine Protease,Exon 8,c.1232G>T,p.(Ser411Ile),<1,,,NO,Severe,,Johnsen et al (2017),United States
699,2586,Point,Missense,1232,411,365,Serine Protease,Exon 8,c.1232G>T,p.(Ser411Ile),<1,-,-,,Severe,-,Ludwig et al (1992B),Germany
699,2671,Point,Missense,1232,411,365,Serine Protease,Exon 8,c.1232G>T,p.(Ser411Ile),1.8,-,-,,Moderate,-,Saad et al (1994),United Kingdom
700,2587,Point,Missense,1233,411,365,Serine Protease,Exon 8,c.1233T>A,p.(Ser411Arg),1,90,II,,Moderate,-,Koeberl et al (1990B),United States
701,2588,Point,Missense,1233,411,365,Serine Protease,Exon 8,c.1233T>G,p.(Ser411Arg),<1,100,II,,Severe,-,Lin and Shen (1993),
702,3509,Point,Missense,1234,412,366,Serine Protease,Exon 8,c.1234G>T,p.(Gly412Trp),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
702,2589,Point,Missense,1234,412,366,Serine Protease,Exon 8,c.1234G>T,p.(Gly412Trp),4,-,-,,Moderate,-,Centre B39 (unpublished),
704,2597,Point,Missense,1235,412,366,Serine Protease,Exon 8,c.1235G>C,p.(Gly412Ala),8,-,-,,Mild,-,Li et al (2000),United States
703,4457,Point,Missense,1235,412,366,Serine Protease,Exon 8,c.1235G>A,p.(Gly412Glu),<1,,,NO,Severe,,Johnsen et al (2017),United States
703,4458,Point,Missense,1235,412,366,Serine Protease,Exon 8,c.1235G>A,p.(Gly412Glu),<1,,,NO,Severe,,Johnsen et al (2017),United States
703,4459,Point,Missense,1235,412,366,Serine Protease,Exon 8,c.1235G>A,p.(Gly412Glu),<1,,,NO,Severe,,Johnsen et al (2017),United States
703,2593,Point,Missense,1235,412,366,Serine Protease,Exon 8,c.1235G>A,p.(Gly412Glu),<1,-,-,,Severe,-,Centre B9 (unpublished),
703,2591,Point,Missense,1235,412,366,Serine Protease,Exon 8,c.1235G>A,p.(Gly412Glu),-,-,-,,Severe,-,Liu et al (2000),China
703,2592,Point,Missense,1235,412,366,Serine Protease,Exon 8,c.1235G>A,p.(Gly412Glu),-,-,-,,Severe,-,Liu et al (2000),China
703,2590,Point,Missense,1235,412,366,Serine Protease,Exon 8,c.1235G>A,p.(Gly412Glu),6,-,-,,Mild,-,Ghanem et al (1993),France
703,2594,Point,Missense,1235,412,366,Serine Protease,Exon 8,c.1235G>A,p.(Gly412Glu),2.2,-,-,,Moderate,-,Onay et al (2003),Turkey
703,2595,Point,Missense,1235,412,366,Serine Protease,Exon 8,c.1235G>A,p.(Gly412Glu),0.5,-,-,,Severe,-,Onay et al (2003),Turkey
703,2596,Point,Missense,1235,412,366,Serine Protease,Exon 8,c.1235G>A,p.(Gly412Glu),<1,32,II,,Severe,-,Bottema et al (1991),United States
706,2605,Point,Nonsense,1237,413,367,Serine Protease,Exon 8,c.1237G>T,p.(Gly413*),-,-,-,,,-,Centre B39 (unpublished),
705,2603,Point,Missense,1237,413,367,Serine Protease,Exon 8,c.1237G>A,p.(Gly413Arg),<1,-,-,,Severe,-,Centre B21 (unpublished),
705,2600,Point,Missense,1237,413,367,Serine Protease,Exon 8,c.1237G>A,p.(Gly413Arg),<1,-,-,,Severe,-,Ghanem et al (1993),France
705,2599,Point,Missense,1237,413,367,Serine Protease,Exon 8,c.1237G>A,p.(Gly413Arg),-,-,-,,Moderate,-,Belvini et al (2005),Italy
705,2598,Point,Missense,1237,413,367,Serine Protease,Exon 8,c.1237G>A,p.(Gly413Arg),3,-,-,,Moderate,-,Caglayan et al (1994),Turkey
705,2602,Point,Missense,1237,413,367,Serine Protease,Exon 8,c.1237G>A,p.(Gly413Arg),1.5,-,-,,Moderate,-,Caglayan et al (1997),Turkey
705,2601,Point,Missense,1237,413,367,Serine Protease,Exon 8,c.1237G>A,p.(Gly413Arg),1,-,-,,Moderate,-,Thorland et al (1995),United States
705,2604,Point,Missense,1237,413,367,Serine Protease,Exon 8,c.1237G>A,p.(Gly413Arg),<1,14,II,,Severe,-,Chen et al (1991a),United States
1200,4774,Point,Missense,1237,413,367,Serine Protease,Exon 8,c.1237G>C,p.(Gly413Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
1200,4775,Point,Missense,1237,413,367,Serine Protease,Exon 8,c.1237G>C,p.(Gly413Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
708,2609,Point,Missense,1238,413,367,Serine Protease,Exon 8,c.1238G>C,p.(Gly413Ala),3,103,II,,Moderate,-,Centre B14 (unpublished),
707,2606,Point,Missense,1238,413,367,Serine Protease,Exon 8,c.1238G>A,p.(Gly413Glu),8,-,-,,Mild,-,Centre B30 (unpublished),
707,2608,Point,Missense,1238,413,367,Serine Protease,Exon 8,c.1238G>A,p.(Gly413Glu),<1,-,-,,Severe,-,Centre B6 (unpublished),
707,2607,Point,Missense,1238,413,367,Serine Protease,Exon 8,c.1238G>A,p.(Gly413Glu),<1,-,-,,Severe,-,Elmahmoudi et al (2011),Tunisia
710,2620,Point,Missense,1240,414,368,Serine Protease,Exon 8,c.1240C>T,p.(Pro414Ser),<1,-,-,,Severe,-,Centre B39 (unpublished),
709,3623,Point,Missense,1240,414,368,Serine Protease,Exon 8,c.1240C>A,p.(Pro414Thr),-,-,-,NO,Severe,-,Yu et al (2012),China
709,2615,Point,Missense,1240,414,368,Serine Protease,Exon 8,c.1240C>A,p.(Pro414Thr),<1,133,II,NO,Severe,-,Attali et al (1999),France
709,3688,Point,Missense,1240,414,368,Serine Protease,Exon 8,c.1240C>A,p.(Pro414Thr),-,-,-,NO,Severe,-,Miller et al (2012),United States
709,3689,Point,Missense,1240,414,368,Serine Protease,Exon 8,c.1240C>A,p.(Pro414Thr),-,-,-,NO,Moderate,-,Miller et al (2012),United States
709,4460,Point,Missense,1240,414,368,Serine Protease,Exon 8,c.1240C>A,p.(Pro414Thr),2,,,NO,Moderate,,Johnsen et al (2017),United States
709,4461,Point,Missense,1240,414,368,Serine Protease,Exon 8,c.1240C>A,p.(Pro414Thr),<1,,,NO,Severe,,Johnsen et al (2017),United States
709,2612,Point,Missense,1240,414,368,Serine Protease,Exon 8,c.1240C>A,p.(Pro414Thr),<1,-,-,,Severe,-,Centre B37 (unpublished),
709,2614,Point,Missense,1240,414,368,Serine Protease,Exon 8,c.1240C>A,p.(Pro414Thr),<1,-,-,,Severe,-,Centre B35 (unpublished),
709,2617,Point,Missense,1240,414,368,Serine Protease,Exon 8,c.1240C>A,p.(Pro414Thr),-,-,-,,,-,Centre B36 (unpublished),
709,2611,Point,Missense,1240,414,368,Serine Protease,Exon 8,c.1240C>A,p.(Pro414Thr),7,>100,II,,Mild,-,Poon et al (1993),Canada
709,2619,Point,Missense,1240,414,368,Serine Protease,Exon 8,c.1240C>A,p.(Pro414Thr),-,-,-,,Severe,-,Belvini et al (2005),Italy
709,2610,Point,Missense,1240,414,368,Serine Protease,Exon 8,c.1240C>A,p.(Pro414Thr),<1,156,II,,Severe,-,Bertina et al (1990),Netherlands
709,2613,Point,Missense,1240,414,368,Serine Protease,Exon 8,c.1240C>A,p.(Pro414Thr),2,115,II,,Moderate,-,Weinmann et al (1998),United States
713,2628,Point,Missense,1241,414,368,Serine Protease,Exon 8,c.1241C>G,p.(Pro414Arg),<1,-,-,,Severe,-,Mahajan et al (2007),India
711,2616,Point,Missense,1241,414,368,Serine Protease,Exon 8,c.1241C>A,p.(Pro414His),<1,-,-,,Severe,-,Centre B36 (unpublished),
711,2621,Point,Missense,1241,414,368,Serine Protease,Exon 8,c.1241C>A,p.(Pro414His),<1,102,II,,Severe,-,Wulff et al (1999),Germany
711,3819,Point,Missense,1241,414,368,Serine Protease,Exon 8,c.1241C>A,p.(Pro414His),,,,,,,Wulff et al (2001),Germany
712,2627,Point,Missense,1241,414,368,Serine Protease,Exon 8,c.1241C>T,p.(Pro414Leu),-,100,-,,,-,Centre B38 (unpublished),
712,2625,Point,Missense,1241,414,368,Serine Protease,Exon 8,c.1241C>T,p.(Pro414Leu),2,62,II,,Moderate,-,Nielsen et al (1992),Denmark
712,2626,Point,Missense,1241,414,368,Serine Protease,Exon 8,c.1241C>T,p.(Pro414Leu),-,-,-,,Severe,-,Belvini et al (2005),Italy
712,2623,Point,Missense,1241,414,368,Serine Protease,Exon 8,c.1241C>T,p.(Pro414Leu),3,-,-,,Moderate,-,Saad et al (1994),United Kingdom
712,2624,Point,Missense,1241,414,368,Serine Protease,Exon 8,c.1241C>T,p.(Pro414Leu),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
712,2622,Point,Missense,1241,414,368,Serine Protease,Exon 8,c.1241C>T,p.(Pro414Leu),-,-,-,,,-,Bottema et al (1991),United States
712,4462,Point,Missense,1241,414,368,Serine Protease,Exon 8,c.1241C>T,p.(Pro414Leu),<1,,,,Severe,,Johnsen et al (2017),United States
715,3624,Point,Missense,1243,415,369,Serine Protease,Exon 8,c.1243C>A,p.(His415Asn),-,-,-,NO,Moderate,-,Yu et al (2012),China
715,2630,Point,Missense,1243,415,369,Serine Protease,Exon 8,c.1243C>A,p.(His415Asn),<1,-,-,,Severe,-,Odom et al (1994),United States
716,3510,Point,Missense,1244,415,369,Serine Protease,Exon 8,c.1244A>G,p.(His415Arg),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
716,4464,Point,Missense,1244,415,369,Serine Protease,Exon 8,c.1244A>G,p.(His415Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
716,4465,Point,Missense,1244,415,369,Serine Protease,Exon 8,c.1244A>G,p.(His415Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
716,4466,Point,Missense,1244,415,369,Serine Protease,Exon 8,c.1244A>G,p.(His415Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
716,2631,Point,Missense,1244,415,369,Serine Protease,Exon 8,c.1244A>G,p.(His415Arg),<3,-,-,,,-,Mukherjee et al (2004),India
716,2632,Point,Missense,1244,415,369,Serine Protease,Exon 8,c.1244A>G,p.(His415Arg),<1,<1,-,,Severe,-,Bottema et al (1990C),United States
716,4463,Point,Missense,1244,415,369,Serine Protease,Exon 8,c.1244A>G,p.(His415Arg),2,,,,Moderate,,Johnsen et al (2017),United States
717,3471,Point,Missense,1245,415,369,Serine Protease,Exon 8,c.1245T>A,p.(His415Gln),<1,-,-,NO,Severe,-,Jayandharan et al (2009),India
717,4467,Point,Missense,1245,415,369,Serine Protease,Exon 8,c.1245T>A,p.(His415Gln),<1,,,NO,Severe,,Johnsen et al (2017),United States
717,2633,Point,Missense,1245,415,369,Serine Protease,Exon 8,c.1245T>A,p.(His415Gln),5,60,II,,Moderate,-,Centre B38 (unpublished),
1107,2635,Point,Missense,1256,419,373,Serine protease,Exon 8,c.1256T>A,p.(Val419Glu),<1,-,-,,Severe,-,Centre B30 (unpublished),
1107,2634,Point,Missense,1256,419,373,Serine protease,Exon 8,c.1256T>A,p.(Val419Glu),1,1,I,,Moderate,-,Aguilar-Martinez et al (1994A),France
1098,3709,Point,Missense,1256,419,373,Serine Protease,Exon 8,c.1256T>G,p.(Val419Gly),-,-,-,NO,Moderate,-,Miller et al (2012),United States
1098,4468,Point,Missense,1256,419,373,Serine Protease,Exon 8,c.1256T>G,p.(Val419Gly),<1,,,NO,Severe,,Johnsen et al (2017),United States
1098,4469,Point,Missense,1256,419,373,Serine Protease,Exon 8,c.1256T>G,p.(Val419Gly),<1,,,NO,Severe,,Johnsen et al (2017),United States
718,2637,Point,Nonsense,1258,420,374,Serine Protease,Exon 8,c.1258G>T,p.(Glu420*),-,-,-,,,-,Wulff et al (2001),Germany
718,2638,Point,Nonsense,1258,420,374,Serine Protease,Exon 8,c.1258G>T,p.(Glu420*),<1,1,-,,Severe,-,David et al (1998),Portugal
718,2636,Point,Nonsense,1258,420,374,Serine Protease,Exon 8,c.1258G>T,p.(Glu420*),1,-,-,,Moderate,-,Saad et al (1994),United Kingdom
719,2639,Point,Missense,1258,420,374,Serine Protease,Exon 8,c.1258G>A,p.(Glu420Lys),5.4,70,II,,Mild,-,"Quadros et al, (2009)",India
720,2640,Point,Missense,1265,422,376,Serine Protease,Exon 8,c.1265C>A,p.(Thr422Asn),15,13,I,,Mild,-,Green et al (1991),United Kingdom
721,3625,Point,Missense,1270,424,378,Serine Protease,Exon 8,c.1270T>C,p.(Phe424Leu),-,-,-,NO,Severe,-,Yu et al (2012),China
721,2642,Point,Missense,1270,424,378,Serine Protease,Exon 8,c.1270T>C,p.(Phe424Leu),<1,<1,-,NO,Severe,-,Bicocchi et al (2006),Italy
721,2641,Point,Missense,1270,424,378,Serine Protease,Exon 8,c.1270T>C,p.(Phe424Leu),<1,<1,-,,Severe,-,Chen et al (1991a),United States
721,4470,Point,Missense,1270,424,378,Serine Protease,Exon 8,c.1270T>C,p.(Phe424Leu),<1,,,,Severe,,Johnsen et al (2017),United States
722,2643,Point,Missense,1270,424,378,Serine Protease,Exon 8,c.1270T>G,p.(Phe424Val),<1,-,-,,Severe,-,Caglayan et al (1997),Turkey
723,4471,Point,Missense,1271,424,378,Serine Protease,Exon 8,c.1271T>C,p.(Phe424Ser),<1,,,NO,Severe,,Johnsen et al (2017),United States
723,2645,Point,Missense,1271,424,378,Serine Protease,Exon 8,c.1271T>C,p.(Phe424Ser),-,-,-,,,-,Liu et al (2000),China
723,2644,Point,Missense,1271,424,378,Serine Protease,Exon 8,c.1271T>C,p.(Phe424Ser),<1,-,-,,Severe,-,Jayandharan et al (2005),India
724,2646,Point,Nonsense,1274,425,379,Serine Protease,Exon 8,c.1274T>G,p.(Leu425*),-,-,-,,,-,Wulff and Herrmann (1999),Germany
724,2647,Point,Nonsense,1274,425,379,Serine Protease,Exon 8,c.1274T>G,p.(Leu425*),<1,-,-,,Severe,-,Knobloch et al (1993),Germany
1054,3539,Point,Missense,1274,425,379,Serine Protease,Exon 8,c.1274T>C,p.(Leu425Ser),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
725,4472,Point,Missense,1275,425,379,Serine Protease,Exon 8,c.1275A>C,p.(Leu425Phe),3,,,NO,Moderate,,Johnsen et al (2017),United States
725,4473,Point,Missense,1275,425,379,Serine Protease,Exon 8,c.1275A>C,p.(Leu425Phe),2,,,NO,Moderate,,Johnsen et al (2017),United States
725,2649,Point,Missense,1275,425,379,Serine Protease,Exon 8,c.1275A>C,p.(Leu425Phe),11,-,-,,Mild,-,Centre B21 (unpublished),
725,2648,Point,Missense,1275,425,379,Serine Protease,Exon 8,c.1275A>C,p.(Leu425Phe),5,-,-,,Moderate,-,Tam et al (1991),Canada
726,2651,Point,Missense,1276,426,380,Serine Protease,Exon 8,c.1276A>G,p.(Thr426Ala),<1,-,-,,Severe,-,Li et al (2000),United States
1127,2650,Point,Missense,1276,426,380,Serine Protease,Exon 8,c.1276A>C,p.(Thr426Pro),<1,-,-,,Severe,-,David et al (1993),Portugal
727,2652,Point,Missense,1277,426,380,Serine Protease,Exon 8,c.1277C>A,p.(Thr426Asn),1.4,-,-,,Moderate,-,Centre B30 (unpublished),
729,2655,Point,Missense,1277,426,380,Serine Protease,Exon 8,c.1277C>T,p.(Thr426Ile),0,-,-,,Severe,-,Centre B36 (unpublished),
729,2657,Point,Missense,1277,426,380,Serine Protease,Exon 8,c.1277C>T,p.(Thr426Ile),0,-,-,,Severe,-,Belvini et al (2005),Italy
729,2654,Point,Missense,1277,426,380,Serine Protease,Exon 8,c.1277C>T,p.(Thr426Ile),<1,1,-,,Severe,-,Saad et al (1994),United Kingdom
728,2653,Point,Missense,1277,426,380,Serine Protease,Exon 8,c.1277C>G,p.(Thr426Ser),7,<10,I,,Mild,Patient tested at Hong Kong,Chan et al (1991),China
732,3512,Point,Missense,1279,427,381,Serine Protease,Exon 8,c.1279G>A,p.(Gly427Arg),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
732,3690,Point,Missense,1279,427,381,Serine Protease,Exon 8,c.1279G>A,p.(Gly427Arg),-,-,-,NO,Moderate,-,Miller et al (2012),United States
732,2661,Point,Missense,1279,427,381,Serine Protease,Exon 8,c.1279G>A,p.(Gly427Arg),2,-,-,,Moderate,-,Centre B39 (unpublished),
732,2663,Point,Missense,1279,427,381,Serine Protease,Exon 8,c.1279G>A,p.(Gly427Arg),-,-,-,,Severe,-,Belvini et al (2005),Italy
735,2666,Point,Missense,1280,427,381,Serine Protease,Exon 8,c.1280G>C,p.(Gly427Ala),2,-,-,,Moderate,-,Centre B35 (unpublished),
734,2665,Point,Missense,1280,427,381,Serine Protease,Exon 8,c.1280G>A,p.(Gly427Glu),-,-,-,,Severe,-,Belvini et al (2005),Italy
1201,4776,Point,Missense,1280,427,381,Serine Protease,Exon 8,c.1280G>T,p.(Gly427Val),2,,,NO,Moderate,,Johnsen et al (2017),United States
1201,4777,Point,Missense,1280,427,381,Serine Protease,Exon 8,c.1280G>T,p.(Gly427Val),2,,,NO,Moderate,,Johnsen et al (2017),United States
1201,4778,Point,Missense,1280,427,381,Serine Protease,Exon 8,c.1280G>T,p.(Gly427Val),3,,,NO,Moderate,,Johnsen et al (2017),United States
736,2667,Point,Missense,1282,428,382,Serine Protease,Exon 8,c.1282A>T,p.(Ile428Phe),1,-,-,,Moderate,-,Centre B13 (unpublished),
1161,2668,Point,Missense,1288,430,384,Serine Protease,Exon 8,c.1288A>T,p.(Ser430Cys),5,20,II,,Moderate,-,Wulff et al (1999),Germany
737,2669,Point,Missense,1289,430,384,Serine Protease,Exon 8,c.1289G>A,p.(Ser430Asn),-,-,-,,,-,Centre B39 (unpublished),
738,2670,Point,Missense,1289,430,384,Serine Protease,Exon 8,c.1289G>C,p.(Ser430Thr),24,-,-,,Mild,-,Montejo et al (1999),Spain
740,2672,Point,Missense,1290,430,384,Serine Protease,Exon 8,c.1290C>G,p.(Ser430Arg),-,-,-,,,-,Wulff et al (2001),Germany
1202,4779,Point,Missense,1290,430,384,Serine Protease,Exon 8,c.1290C>A,p.(Ser430Arg),1,,,NO,Moderate,,Johnsen et al (2017),United States
741,3514,Point,Missense,1291,431,385,Serine Protease,Exon 8,c.1291T>A,p.(Trp431Arg),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
741,2673,Point,Missense,1291,431,385,Serine Protease,Exon 8,c.1291T>A,p.(Trp431Arg),-,-,-,,Moderate,-,Wulff et al (1995),Germany
742,3513,Point,Missense,1291,431,385,Serine Protease,Exon 8,c.1291T>C,p.(Trp431Arg),3,-,-,NO,Moderate,-,Radic et al (2013),Argentina
742,2674,Point,Missense,1291,431,385,Serine Protease,Exon 8,c.1291T>C,p.(Trp431Arg),<1,-,-,,Severe,-,Centre B18 (unpublished),
742,2677,Point,Missense,1291,431,385,Serine Protease,Exon 8,c.1291T>C,p.(Trp431Arg),2,81,II,,Moderate,-,Centre B14 (unpublished),
742,2678,Point,Missense,1291,431,385,Serine Protease,Exon 8,c.1291T>C,p.(Trp431Arg),-,-,-,,,-,Centre B21 (unpublished),
742,2679,Point,Missense,1291,431,385,Serine Protease,Exon 8,c.1291T>C,p.(Trp431Arg),-,-,-,,,-,Centre B21 (unpublished),
742,2676,Point,Missense,1291,431,385,Serine Protease,Exon 8,c.1291T>C,p.(Trp431Arg),2,51,II,,Moderate,-,Montejo et al (1999),Spain
742,2675,Point,Missense,1291,431,385,Serine Protease,Exon 8,c.1291T>C,p.(Trp431Arg),-,-,-,,,-,Ljung et al (2001),Sweden
743,2680,Point,Missense,1291,431,385,Serine Protease,Exon 8,c.1291T>G,p.(Trp431Gly),13,80,II,,Mild,-,Montejo et al (1999),Spain
747,4640,Point,Nonsense,1293,431,385,Serine Protease,Exon 8,c.1293G>A,p.(Trp431*),<1,,,NO,Severe,,Johnsen et al (2017),United States
747,2691,Point,Nonsense,1293,431,385,Serine Protease,Exon 8,c.1293G>A,p.(Trp431*),-,-,-,,,-,Liu et al (2000),China
747,2694,Point,Nonsense,1293,431,385,Serine Protease,Exon 8,c.1293G>A,p.(Trp431*),<1,<1,-,,Severe,-,"Quadros et al, (2009)",India
747,2688,Point,Nonsense,1293,431,385,Serine Protease,Exon 8,c.1293G>A,p.(Trp431*),<1,-,-,,Severe,-,Ljung et al (2001),Sweden
747,2681,Point,Nonsense,1293,431,385,Serine Protease,Exon 8,c.1293G>A,p.(Trp431*),-,-,-,,,-,Liu et al (1997),United States
747,2682,Point,Nonsense,1293,431,385,Serine Protease,Exon 8,c.1293G>A,p.(Trp431*),-,-,-,,,-,Ketterling et al (1999B),United States
745,2683,Point,Missense,1293,431,385,Serine Protease,Exon 8,c.1293G>C,p.(Trp431Cys),11,-,-,,Mild,-,Enayat et al (2004),United Kingdom
746,2685,Point,Missense,1293,431,385,Serine Protease,Exon 8,c.1293G>T,p.(Trp431Cys),<1,96,II,NO,Severe,-,Attali et al (1999),France
746,2686,Point,Missense,1293,431,385,Serine Protease,Exon 8,c.1293G>T,p.(Trp431Cys),-,-,-,,,-,Centre B39 (unpublished),
746,2687,Point,Missense,1293,431,385,Serine Protease,Exon 8,c.1293G>T,p.(Trp431Cys),-,-,-,,Severe,-,Jenkins et al (2008),Ireland
746,2684,Point,Missense,1293,431,385,Serine Protease,Exon 8,c.1293G>T,p.(Trp431Cys),1,-,-,,Moderate,-,Saad et al (1994),United Kingdom
1203,4780,Point,Missense,1294,432,386,Serine Protease,Exon 8,c.1294G>T,p.(Gly432Cys),<1,,,NO,Severe,,Johnsen et al (2017),United States
1049,3691,Point,Missense,1294,432,386,Serine Protease,Exon 8,c.1294G>A,p.(Gly432Ser),-,-,-,NO,Severe,-,Miller et al (2012),United States
1049,4474,Point,Missense,1294,432,386,Serine Protease,Exon 8,c.1294G>A,p.(Gly432Ser),<1,,,NO,Severe,,Johnsen et al (2017),United States
1049,4475,Point,Missense,1294,432,386,Serine Protease,Exon 8,c.1294G>A,p.(Gly432Ser),<1,,,NO,Severe,,Johnsen et al (2017),United States
1049,2689,Point,Missense,1294,432,386,Serine Protease,Exon 8,c.1294G>A,p.(Gly432Ser),2,-,-,,Moderate,-,Centre B30 (unpublished),
1049,2693,Point,Missense,1294,432,386,Serine Protease,Exon 8,c.1294G>A,p.(Gly432Ser),-,-,-,,Severe,-,Wulff et al (1995),Germany
1049,2690,Point,Missense,1294,432,386,Serine Protease,Exon 8,c.1294G>A,p.(Gly432Ser),<1,-,-,,Severe,-,Jayandharan et al (2005),India
1049,3483,Point,Missense,1294,432,386,Serine Protease,Exon 8,c.1294G>A,p.(Gly432Ser),<1,-,-,,Severe,-,Jayandharan et al (2009),India
1049,2692,Point,Missense,1294,432,386,Serine Protease,Exon 8,c.1294G>A,p.(Gly432Ser),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
749,2699,Point,Missense,1295,432,386,Serine Protease,Exon 8,c.1295G>C,p.(Gly432Ala),-,-,-,,,-,Centre B18 (unpublished),
749,2700,Point,Missense,1295,432,386,Serine Protease,Exon 8,c.1295G>C,p.(Gly432Ala),-,-,-,,,-,Wulff et al (2001),Germany
749,2701,Point,Missense,1295,432,386,Serine Protease,Exon 8,c.1295G>C,p.(Gly432Ala),<5,-,-,,Moderate,-,Wulff and Herrmann (1999),Germany
749,2702,Point,Missense,1295,432,386,Serine Protease,Exon 8,c.1295G>C,p.(Gly432Ala),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
748,4476,Point,Missense,1295,432,386,Serine Protease,Exon 8,c.1295G>A,p.(Gly432Asp),<1,,,NO,Severe,,Johnsen et al (2017),United States
748,2696,Point,Missense,1295,432,386,Serine Protease,Exon 8,c.1295G>A,p.(Gly432Asp),2,119,II,,Moderate,-,Centre B14 (unpublished),
748,2698,Point,Missense,1295,432,386,Serine Protease,Exon 8,c.1295G>A,p.(Gly432Asp),<1,-,-,,Severe,-,Mukherjee et al (2004),India
748,2695,Point,Missense,1295,432,386,Serine Protease,Exon 8,c.1295G>A,p.(Gly432Asp),2,120,II,,Moderate,"publication unavailable: J Nara Med Ass 43, 503-10",Kuze et al (1992),Japan
748,2697,Point,Missense,1295,432,386,Serine Protease,Exon 8,c.1295G>A,p.(Gly432Asp),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
750,2703,Point,Missense,1295,432,386,Serine Protease,Exon 8,c.1295G>T,p.(Gly432Val),1,-,-,,Moderate,-,Montejo et al (1999),Spain
750,2704,Point,Missense,1295,432,386,Serine Protease,Exon 8,c.1295G>T,p.(Gly432Val),<1,-,-,,Severe,-,Heit et al (1998),United States
750,3791,Point,Missense,1295,432,386,Serine Protease,Exon 8,c.1295G>T,p.(Gly432Val),1,-,-,,Moderate,-,Montejo et al (1999),Spain
1204,4781,Point,Missense,1297,433,387,Serine Protease,Exon 8,c.1297G>C,p.(Glu433Gln),13,,,NO,Mild,,Johnsen et al (2017),United States
751,4477,Point,Missense,1297,433,387,Serine Protease,Exon 8,c.1297G>A,p.(Glu433Lys),<1,,,NO,Severe,,Johnsen et al (2017),United States
751,2711,Point,Missense,1297,433,387,Serine Protease,Exon 8,c.1297G>A,p.(Glu433Lys),-,-,-,,,-,Centre B39 (unpublished),
751,2714,Point,Missense,1297,433,387,Serine Protease,Exon 8,c.1297G>A,p.(Glu433Lys),-,-,-,,,-,Centre B39 (unpublished),
751,2706,Point,Missense,1297,433,387,Serine Protease,Exon 8,c.1297G>A,p.(Glu433Lys),<1,-,-,,Severe,-,Centre B13 (unpublished),
751,2713,Point,Missense,1297,433,387,Serine Protease,Exon 8,c.1297G>A,p.(Glu433Lys),1,67,II,,Moderate,-,Costa et al (2000),France
751,2705,Point,Missense,1297,433,387,Serine Protease,Exon 8,c.1297G>A,p.(Glu433Lys),2,74,II,,Moderate,-,Wulff et al (1999),Germany
751,2709,Point,Missense,1297,433,387,Serine Protease,Exon 8,c.1297G>A,p.(Glu433Lys),-,-,-,,,-,Wulff and Herrmann (1999),Germany
751,2710,Point,Missense,1297,433,387,Serine Protease,Exon 8,c.1297G>A,p.(Glu433Lys),<1,63,II,,Severe,-,Wulff et al (1999),Germany
751,2708,Point,Missense,1297,433,387,Serine Protease,Exon 8,c.1297G>A,p.(Glu433Lys),2,-,-,,Moderate,-,Belvini et al (2005),Italy
751,2707,Point,Missense,1297,433,387,Serine Protease,Exon 8,c.1297G>A,p.(Glu433Lys),<1,-,-,,Severe,-,Montejo et al (1999),Spain
752,2719,Point,Missense,1298,433,387,Serine Protease,Exon 8,c.1298A>C,p.(Glu433Ala),-,-,-,,,-,Centre B39 (unpublished),
752,2720,Point,Missense,1298,433,387,Serine Protease,Exon 8,c.1298A>C,p.(Glu433Ala),-,-,-,,,-,Centre B39 (unpublished),
752,2716,Point,Missense,1298,433,387,Serine Protease,Exon 8,c.1298A>C,p.(Glu433Ala),<1,118,II,,Severe,-,Centre B14 (unpublished),
752,2715,Point,Missense,1298,433,387,Serine Protease,Exon 8,c.1298A>C,p.(Glu433Ala),1,-,-,,Moderate,-,Wulff et al (2001),Germany
752,2718,Point,Missense,1298,433,387,Serine Protease,Exon 8,c.1298A>C,p.(Glu433Ala),-,-,-,,,-,Wulff et al (2001),Germany
752,2717,Point,Missense,1298,433,387,Serine Protease,Exon 8,c.1298A>C,p.(Glu433Ala),4,90,II,,Moderate,-,Montejo et al (1999),Spain
753,2722,Point,Missense,1298,433,387,Serine Protease,Exon 8,c.1298A>G,p.(Glu433Gly),-,-,-,,,-,Centre B17 (unpublished),
753,2721,Point,Missense,1298,433,387,Serine Protease,Exon 8,c.1298A>G,p.(Glu433Gly),2,95,II,,Moderate,-,Bottema et al (1991),United States
754,4641,Point,Nonsense,1300,434,388,Serine Protease,Exon 8,c.1300G>T,p.(Glu434*),<1,,,NO,Severe,,Johnsen et al (2017),United States
754,2724,Point,Nonsense,1300,434,388,Serine Protease,Exon 8,c.1300G>T,p.(Glu434*),-,-,-,,,-,Centre B18 (unpublished),
754,2723,Point,Nonsense,1300,434,388,Serine Protease,Exon 8,c.1300G>T,p.(Glu434*),<1,-,-,,Severe,-,Li et al (2000),United States
755,2725,Point,Missense,1300,434,388,Serine Protease,Exon 8,c.1300G>A,p.(Glu434Lys),21,62,II,NO,Mild,-,Bicocchi et al (2006),Italy
756,2726,Point,Missense,1301,434,388,Serine Protease,Exon 8,c.1301A>G,p.(Glu434Gly),24,-,-,,Mild,-,Centre B30 (unpublished),
1083,3551,Point,Missense,1303,435,389,Serine Protease,Exon 8,c.1303T>C,p.(Cys435Arg),-,-,-,NO,Severe,-,Yu et al (2012),China
758,3626,Point,Missense,1303,435,389,Serine Protease,Exon 8,c.1303T>G,p.(Cys435Gly),-,-,-,NO,Moderate,-,Yu et al (2012),China
758,2728,Point,Missense,1303,435,389,Serine Protease,Exon 8,c.1303T>G,p.(Cys435Gly),<1,-,-,,Severe,-,Centre B30 (unpublished),
757,2727,Point,Missense,1303,435,389,Serine Protease,Exon 8,c.1303T>A,p.(Cys435Ser),<1,-,-,,Severe,-,Elmahmoudi et al (2011),Tunisia
759,3692,Point,Missense,1304,435,389,Serine Protease,Exon 8,c.1304G>A,p.(Cys435Tyr),-,-,-,NO,Severe,-,Miller et al (2012),United States
759,4478,Point,Missense,1304,435,389,Serine Protease,Exon 8,c.1304G>A,p.(Cys435Tyr),<1,,,NO,Severe,,Johnsen et al (2017),United States
759,4479,Point,Missense,1304,435,389,Serine Protease,Exon 8,c.1304G>A,p.(Cys435Tyr),<1,,,NO,Severe,,Johnsen et al (2017),United States
759,2729,Point,Missense,1304,435,389,Serine Protease,Exon 8,c.1304G>A,p.(Cys435Tyr),<1,<1,-,,Severe,-,Centre B23 (unpublished),
759,2734,Point,Missense,1304,435,389,Serine Protease,Exon 8,c.1304G>A,p.(Cys435Tyr),3,-,-,,Moderate,-,Centre B30 (unpublished),
759,2732,Point,Missense,1304,435,389,Serine Protease,Exon 8,c.1304G>A,p.(Cys435Tyr),<1,<1,-,,Severe,-,Nielsen et al (1995),Denmark
759,2733,Point,Missense,1304,435,389,Serine Protease,Exon 8,c.1304G>A,p.(Cys435Tyr),<1,2,II,,Severe,-,Nielsen et al (1995),Denmark
759,2731,Point,Missense,1304,435,389,Serine Protease,Exon 8,c.1304G>A,p.(Cys435Tyr),35,-,-,,Mild,-,Tartary et al (1993),France
759,2735,Point,Missense,1304,435,389,Serine Protease,Exon 8,c.1304G>A,p.(Cys435Tyr),<1,5,II,,Severe,-,Wulff et al (1999),Germany
759,2736,Point,Missense,1304,435,389,Serine Protease,Exon 8,c.1304G>A,p.(Cys435Tyr),<1,-,-,,Severe,-,Wulff et al (2001),Germany
759,2737,Point,Missense,1304,435,389,Serine Protease,Exon 8,c.1304G>A,p.(Cys435Tyr),<1,-,-,,Severe,-,Elmahmoudi et al (2011),Tunisia
759,2738,Point,Missense,1304,435,389,Serine Protease,Exon 8,c.1304G>A,p.(Cys435Tyr),<1,-,-,,Severe,-,Elmahmoudi et al (2011),Tunisia
759,2730,Point,Missense,1304,435,389,Serine Protease,Exon 8,c.1304G>A,p.(Cys435Tyr),4,7,II,,Moderate,-,Saad et al (1994),United Kingdom
1042,3434,Point,Missense,1304,435,389,Serine Protease,Exon 8,c.1304G>T,p.(Cys435Tyr),<1,-,-,NO,Severe,-,Jayandharan et al (2009),India
1055,3538,Point,Missense,1306,436,390,Serine Protease,Exon 8,c.1306G>A,p.(Ala436Thr),<1,-,-,NO,Severe,-,Radic et al (2013),Argentina
1055,4480,Point,Missense,1306,436,390,Serine Protease,Exon 8,c.1306G>A,p.(Ala436Thr),<1,,,NO,Severe,,Johnsen et al (2017),United States
1055,2742,Point,Missense,1306,436,390,Serine Protease,Exon 8,c.1306G>A,p.(Ala436Thr),<1,-,-,,Severe,-,Centre B13 (unpublished),
1055,2743,Point,Missense,1306,436,390,Serine Protease,Exon 8,c.1306G>A,p.(Ala436Thr),1,94,II,,Moderate,-,Centre B35 (unpublished),
1055,2745,Point,Missense,1306,436,390,Serine Protease,Exon 8,c.1306G>A,p.(Ala436Thr),-,-,-,,,-,Centre B21 (unpublished),
1055,2739,Point,Missense,1306,436,390,Serine Protease,Exon 8,c.1306G>A,p.(Ala436Thr),<1,40,II,,Severe,-,Tartary et al (1993),France
1055,2740,Point,Missense,1306,436,390,Serine Protease,Exon 8,c.1306G>A,p.(Ala436Thr),1,-,-,,Moderate,-,Van de Water et al (1996),New Zealand
1055,2741,Point,Missense,1306,436,390,Serine Protease,Exon 8,c.1306G>A,p.(Ala436Thr),7,50,II,,Mild,-,Gostout et al (1993),United States
1055,2744,Point,Missense,1306,436,390,Serine Protease,Exon 8,c.1306G>A,p.(Ala436Thr),<1,-,-,,Severe,-,Li et al (2000),United States
1055,4481,Point,Missense,1306,436,390,Serine Protease,Exon 8,c.1306G>A,p.(Ala436Thr),<1,,,,Severe,,Johnsen et al (2017),United States
761,2746,Point,Missense,1307,436,390,Serine Protease,Exon 8,c.1307C>A,p.(Ala436Glu),-,-,-,,,-,Saad et al (1994),United Kingdom
761,2747,Point,Missense,1307,436,390,Serine Protease,Exon 8,c.1307C>A,p.(Ala436Glu),2,30,II,,Moderate,-,Wang et al (1990),United States
762,3627,Point,Missense,1307,436,390,Serine Protease,Exon 8,c.1307C>T,p.(Ala436Val),-,-,-,NO,Severe,-,Yu et al (2012),China
762,2754,Point,Missense,1307,436,390,Serine Protease,Exon 8,c.1307C>T,p.(Ala436Val),<1,150,II,NO,Severe,-,Attali et al (1999),France
762,4482,Point,Missense,1307,436,390,Serine Protease,Exon 8,c.1307C>T,p.(Ala436Val),<1,,,NO,Severe,,Johnsen et al (2017),United States
762,4483,Point,Missense,1307,436,390,Serine Protease,Exon 8,c.1307C>T,p.(Ala436Val),<1,,,NO,Severe,,Johnsen et al (2017),United States
762,4484,Point,Missense,1307,436,390,Serine Protease,Exon 8,c.1307C>T,p.(Ala436Val),<1,,,NO,Severe,,Johnsen et al (2017),United States
762,4485,Point,Missense,1307,436,390,Serine Protease,Exon 8,c.1307C>T,p.(Ala436Val),<1,,,NO,Severe,,Johnsen et al (2017),United States
762,2755,Point,Missense,1307,436,390,Serine Protease,Exon 8,c.1307C>T,p.(Ala436Val),<1,-,-,,Severe,-,Drost et al (2000),China
762,2749,Point,Missense,1307,436,390,Serine Protease,Exon 8,c.1307C>T,p.(Ala436Val),0,-,-,,Severe,-,Belvini et al (2005),Italy
762,2750,Point,Missense,1307,436,390,Serine Protease,Exon 8,c.1307C>T,p.(Ala436Val),1 to 4,140,II,,Moderate,-,Sugimoto et al (1988),Japan
762,2752,Point,Missense,1307,436,390,Serine Protease,Exon 8,c.1307C>T,p.(Ala436Val),<1,71,II,,Severe,-,Saad et al (1994),United Kingdom
762,2748,Point,Missense,1307,436,390,Serine Protease,Exon 8,c.1307C>T,p.(Ala436Val),<1,100,II,,Severe,-,Spitzer et al (1988),United States
762,2751,Point,Missense,1307,436,390,Serine Protease,Exon 8,c.1307C>T,p.(Ala436Val),2,48,II,,Moderate,-,Tarnower and Smith (1991),United States
762,2753,Point,Missense,1307,436,390,Serine Protease,Exon 8,c.1307C>T,p.(Ala436Val),1,-,-,,Moderate,-,Thorland et al (1995),United States
1156,2761,Point,Missense,1318,440,394,Serine Protease,Exon 8,c.1318A>C,p.(Lys440Gln),18,150,II,,Mild,-,Weinmann et al (1998),United States
763,4486,Point,Missense,1318,440,394,Serine Protease,Exon 8,c.1318A>G,p.(Lys440Glu),<1,,,NO,Severe,,Johnsen et al (2017),United States
763,4487,Point,Missense,1318,440,394,Serine Protease,Exon 8,c.1318A>G,p.(Lys440Glu),<1,,,NO,Severe,,Johnsen et al (2017),United States
763,2757,Point,Missense,1318,440,394,Serine Protease,Exon 8,c.1318A>G,p.(Lys440Glu),2,-,-,,Moderate,-,Centre B30 (unpublished),
763,2759,Point,Missense,1318,440,394,Serine Protease,Exon 8,c.1318A>G,p.(Lys440Glu),1 to 5,33,-,,Moderate,-,Centre B38 (unpublished),
763,2758,Point,Missense,1318,440,394,Serine Protease,Exon 8,c.1318A>G,p.(Lys440Glu),<1,-,-,,Severe,-,Ketterling et al (1999B),United States
764,2760,Point,Missense,1320,440,394,Serine Protease,Exon 8,c.1320A>C,p.(Lys440Asn),-,-,-,,,-,Centre B30 (unpublished),
765,2762,Point,Missense,1321,441,395,Serine Protease,Exon 8,c.1321T>C,p.(Tyr441His),4,-,-,,Moderate,-,Thorland et al (1995),United States
765,2763,Point,Missense,1321,441,395,Serine Protease,Exon 8,c.1321T>C,p.(Tyr441His),-,-,-,,,-,Liu et al (1997),United States
766,3628,Point,Missense,1322,441,395,Serine Protease,Exon 8,c.1322A>G,p.(Tyr441Cys),-,-,-,NO,Severe,-,Yu et al (2012),China
766,2765,Point,Missense,1322,441,395,Serine Protease,Exon 8,c.1322A>G,p.(Tyr441Cys),<1,-,-,,Severe,-,Jayandharan et al (2005),India
766,2766,Point,Missense,1322,441,395,Serine Protease,Exon 8,c.1322A>G,p.(Tyr441Cys),1.3,-,-,,Moderate,-,Jayandharan et al (2005),India
766,2764,Point,Missense,1322,441,395,Serine Protease,Exon 8,c.1322A>G,p.(Tyr441Cys),<1,-,-,,Severe,-,Saad et al (1994),United Kingdom
767,2767,Point,Nonsense,1323,441,395,Serine Protease,Exon 8,c.1323T>G,p.(Tyr441*),<1,<1,-,,Severe,-,Ljung et al (2001),Sweden
768,3629,Point,Missense,1324,442,396,Serine Protease,Exon 8,c.1324G>A,p.(Gly442Arg),-,-,-,NO,Moderate,-,Yu et al (2012),China
768,4488,Point,Missense,1324,442,396,Serine Protease,Exon 8,c.1324G>A,p.(Gly442Arg),<1,,,NO,Severe,,Johnsen et al (2017),United States
768,2770,Point,Missense,1324,442,396,Serine Protease,Exon 8,c.1324G>A,p.(Gly442Arg),<1,-,-,,Severe,-,Centre B13 (unpublished),
768,2768,Point,Missense,1324,442,396,Serine Protease,Exon 8,c.1324G>A,p.(Gly442Arg),<1,110,II,,Severe,-,Attree et al (1989),France
768,2769,Point,Missense,1324,442,396,Serine Protease,Exon 8,c.1324G>A,p.(Gly442Arg),1,90,II,,Moderate,-,Costa et al (2000),France
768,2771,Point,Missense,1324,442,396,Serine Protease,Exon 8,c.1324G>A,p.(Gly442Arg),<1,90,II,,Severe,-,Ghanem et al (1993),France
770,2773,Point,Missense,1325,442,396,Serine Protease,Exon 8,c.1325G>C,p.(Gly442Ala),1,112,II,,Moderate,-,Centre B41 (unpublished),
769,2772,Point,Missense,1325,442,396,Serine Protease,Exon 8,c.1325G>A,p.(Gly442Glu),<1,-,-,,Severe,-,Kwon et al (2008),South Korea
771,2775,Point,Missense,1325,442,396,Serine Protease,Exon 8,c.1325G>T,p.(Gly442Val),-,-,-,,,-,Centre B39 (unpublished),
771,2776,Point,Missense,1325,442,396,Serine Protease,Exon 8,c.1325G>T,p.(Gly442Val),-,-,-,,,-,Wulff and Herrmann (1999),Germany
771,2774,Point,Missense,1325,442,396,Serine Protease,Exon 8,c.1325G>T,p.(Gly442Val),-,-,-,,,-,Saad et al (1994),United Kingdom
772,2777,Point,Missense,1327,443,397,Serine Protease,Exon 8,c.1327A>C,p.(Ile443Leu),20,-,-,,Mild,-,Centre B8 (unpublished),
773,2814,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),6,-,-,NO,Mild,-,Attali et al (1999),France
773,2815,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),1,46,II,NO,Moderate,-,Attali et al (1999),France
773,3693,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),-,-,-,NO,Moderate,-,Miller et al (2012),United States
773,3694,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),-,-,-,NO,Mild,-,Miller et al (2012),United States
773,4489,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,,,NO,Moderate,,Johnsen et al (2017),United States
773,4490,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),5,,,NO,Moderate,,Johnsen et al (2017),United States
773,4491,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),4,,,NO,Moderate,,Johnsen et al (2017),United States
773,4492,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),6,,,NO,Mild,,Johnsen et al (2017),United States
773,4493,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,,,NO,Moderate,,Johnsen et al (2017),United States
773,4494,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),1,,,NO,Moderate,,Johnsen et al (2017),United States
773,4495,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,,,NO,Moderate,,Johnsen et al (2017),United States
773,4496,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),22,,,NO,Mild,,Johnsen et al (2017),United States
773,4497,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,,,NO,Moderate,,Johnsen et al (2017),United States
773,4498,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),1,,,NO,Moderate,,Johnsen et al (2017),United States
773,4499,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3.37,,,NO,Moderate,,Johnsen et al (2017),United States
773,4500,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),11,,,NO,Mild,,Johnsen et al (2017),United States
773,4501,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),5,,,NO,Moderate,,Johnsen et al (2017),United States
773,4502,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,,,NO,Moderate,,Johnsen et al (2017),United States
773,4503,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,,,NO,Moderate,,Johnsen et al (2017),United States
773,4504,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),1,,,NO,Moderate,,Johnsen et al (2017),United States
773,4505,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),5,,,NO,Moderate,,Johnsen et al (2017),United States
773,4508,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,,,NO,Moderate,,Johnsen et al (2017),United States
773,4509,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,,,NO,Moderate,,Johnsen et al (2017),United States
773,4512,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),12.6,,,NO,Mild,,Johnsen et al (2017),United States
773,4513,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,,,NO,Moderate,,Johnsen et al (2017),United States
773,4514,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,,,NO,Moderate,,Johnsen et al (2017),United States
773,4515,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),5,,,NO,Moderate,,Johnsen et al (2017),United States
773,4518,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,,,NO,Moderate,,Johnsen et al (2017),United States
773,4520,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3.6,,,NO,Moderate,,Johnsen et al (2017),United States
773,4521,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),4,,,NO,Moderate,,Johnsen et al (2017),United States
773,4522,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,,,NO,Moderate,,Johnsen et al (2017),United States
773,4523,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,,,NO,Moderate,,Johnsen et al (2017),United States
773,4524,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),5,,,NO,Moderate,,Johnsen et al (2017),United States
773,4525,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),<1,,,NO,Severe,,Johnsen et al (2017),United States
773,4526,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,,,NO,Moderate,,Johnsen et al (2017),United States
773,4527,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),1,,,NO,Moderate,,Johnsen et al (2017),United States
773,4528,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),1,,,NO,Moderate,,Johnsen et al (2017),United States
773,4529,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),5,,,NO,Moderate,,Johnsen et al (2017),United States
773,4530,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,,,NO,Moderate,,Johnsen et al (2017),United States
773,4531,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),11,,,NO,Mild,,Johnsen et al (2017),United States
773,4532,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,,,NO,Moderate,,Johnsen et al (2017),United States
773,4533,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),8,,,NO,Mild,,Johnsen et al (2017),United States
773,4534,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),<1,,,NO,Severe,,Johnsen et al (2017),United States
773,4535,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),10,,,NO,Mild,,Johnsen et al (2017),United States
773,4536,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,,,NO,Moderate,,Johnsen et al (2017),United States
773,4538,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),1,,,NO,Moderate,,Johnsen et al (2017),United States
773,4539,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,,,NO,Moderate,,Johnsen et al (2017),United States
773,4540,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,,,NO,Moderate,,Johnsen et al (2017),United States
773,4541,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,,,NO,Moderate,,Johnsen et al (2017),United States
773,4542,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,,,NO,Moderate,,Johnsen et al (2017),United States
773,2809,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),1.5,-,-,,Moderate,-,Centre B12 (unpublished),
773,2813,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,62,II,,Moderate,-,Centre B20 (unpublished),
773,2816,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),-,-,-,,,-,Centre B21 (unpublished),
773,2817,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),-,-,-,,,-,Centre B21 (unpublished),
773,2818,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),-,-,-,,,-,Centre B21 (unpublished),
773,2819,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),-,-,-,,,-,Centre B38 (unpublished),
773,2785,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,62,II,,Moderate,-,Geddes et al (1989),Canada
773,2806,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,80,II,,Moderate,-,Poon et al (1993),Canada
773,2807,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),12,160,II,,Mild,-,Poon et al (1993),Canada
773,2786,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,62,II,,Moderate,-,Attree et al (1989),France
773,2787,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,70,II,,Moderate,-,Attree et al (1989),France
773,2788,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),4,52,II,,Moderate,-,Attree et al (1989),France
773,2778,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),0 to 6,-,-,,Moderate,-,Koeberl et al (1989),United States
773,2779,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),<1,100,II,,Severe,-,Ware et al (1988),United States
773,2780,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),<1,100,II,,Severe,-,Spitzer et al (1990),United States
773,2781,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,55,II,,Moderate,-,Bottema et al (1990B),United States
773,2782,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,65,II,,Moderate,-,Bottema et al (1990B),United States
773,2783,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),1,73,II,,Moderate,-,Bottema et al (1990B),United States
773,2784,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),4,61,II,,Moderate,-,Bottema et al (1990B),United States
773,2789,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),1,45,II,,Moderate,-,Thompson et al (1990),United States
773,2790,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,64,II,,Moderate,-,Thompson et al (1990),United States
773,2791,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,75,II,,Moderate,-,Thompson et al (1990),United States
773,2792,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),5,96,II,,Moderate,-,Thompson et al (1990),United States
773,2793,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),4,56,II,,Moderate,-,Chen et al (1991a),United States
773,2794,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),4,88,II,,Moderate,-,Chen et al (1991a),United States
773,2795,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),<1,-,-,,Severe,-,Bottema et al (1990B),United States
773,2796,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,54,II,,Moderate,-,Bottema et al (1990B),United States
773,2797,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),8,70,II,,Mild,-,Ketterling et al (1991B),United States
773,2798,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,72,II,,Moderate,-,Thompson and Chen (1992),United States
773,2799,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),<1,27,II,,Severe,-,Ketterling et al (1991B),United States
773,2800,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),7,-,-,,Mild,-,Ketterling et al (1991B),United States
773,2801,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),8,-,-,,Mild,-,Ketterling et al (1991B),United States
773,2802,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),-,-,-,,,-,Ketterling et al (1991B),United States
773,2803,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,-,-,,Moderate,-,Ketterling et al (1991B),United States
773,2804,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,-,-,,Moderate,-,Ketterling et al (1991B),United States
773,2805,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),9,74,II,,Mild,-,Thompson and Chen (1992),United States
773,2808,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,100,II,,Moderate,-,Chen et al (1995),United States
773,2810,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),4,-,-,,Moderate,-,Weinmann et al (1998),United States
773,2811,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,-,-,,Moderate,-,Weinmann et al (1998),United States
773,2812,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),5,35,II,,Moderate,-,Weinmann et al (1998),United States
773,4506,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,,,,Moderate,,Johnsen et al (2017),United States
773,4507,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),1,,,,Moderate,,Johnsen et al (2017),United States
773,4510,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,,,,Moderate,,Johnsen et al (2017),United States
773,4511,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,,,,Moderate,,Johnsen et al (2017),United States
773,4516,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,,,,Moderate,,Johnsen et al (2017),United States
773,4517,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),2,,,,Moderate,,Johnsen et al (2017),United States
773,4519,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),4,,,,Moderate,,Johnsen et al (2017),United States
773,4537,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),3,,,,Moderate,,Johnsen et al (2017),United States
773,3799,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),,,,,,,Tam et al (1991),Canada
773,3722,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),,,,,,,Bottema et al (1989A),United States
773,3723,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),,,,,,,Bottema et al (1989A),United States
773,3724,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),,,,,,,Bottema et al (1989A),United States
773,3725,Point,Missense,1328,443,397,Serine Protease,Exon 8,c.1328T>C,p.(Ile443Thr),,,,,,,Bottema et al (1989A),United States
774,2820,Point,Missense,1330,444,398,Serine Protease,Exon 8,c.1330T>C,p.(Tyr444His),4.6,58,II,,Moderate,-,"Quadros et al, (2009)",India
775,2821,Point,Missense,1331,444,398,Serine Protease,Exon 8,c.1331A>C,p.(Tyr444Ser),-,-,-,,,-,Saad et al (1994),United Kingdom
775,2822,Point,Missense,1331,444,398,Serine Protease,Exon 8,c.1331A>C,p.(Tyr444Ser),-,-,-,,,-,Saad et al (1994),United Kingdom
776,2823,Point,Missense,1334,445,399,Serine Protease,Exon 8,c.1334C>A,p.(Thr445Asn),-,-,-,,,-,Liu et al (1997),United States
776,3769,Point,Missense,1334,445,399,Serine Protease,Exon 8,c.1334C>A,p.(Thr445Asn),15,,,,Mild,,Jenkins et al (2008),Ireland
777,2824,Point,Missense,1334,445,399,Serine Protease,Exon 8,c.1334C>T,p.(Thr445Ile),14,-,-,,Mild,-,Centre B30 (unpublished),
778,4543,Point,Missense,1338,446,400,Serine Protease,Exon 8,c.1338G>C,p.(Lys446Asn),12,,,NO,Mild,,Johnsen et al (2017),United States
778,2825,Point,Missense,1338,446,400,Serine Protease,Exon 8,c.1338G>C,p.(Lys446Asn),12,-,-,,Mild,-,Centre B13 (unpublished),
779,2826,Point,Missense,1340,447,401,Serine Protease,Exon 8,c.1340T>A,p.(Val447Glu),<1,-,-,,Severe,-,Jayandharan et al (2003),India
781,2828,Point,Missense,1343,448,402,Serine Protease,Exon 8,c.1343C>T,p.(Ser448Phe),8,-,-,,Mild,-,Vidal et al (2000),Spain
781,2829,Point,Missense,1343,448,402,Serine Protease,Exon 8,c.1343C>T,p.(Ser448Phe),8,-,-,,Mild,-,Koeberl et al (1990B),United States
782,2830,Point,Missense,1343,448,402,Serine Protease,Exon 8,c.1343C>A,p.(Ser448Tyr),7,-,-,,Mild,-,Enayat et al (2004),United Kingdom
783,4544,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),32,,,NO,Mild,,Johnsen et al (2017),United States
783,4545,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),35,,,NO,Mild,,Johnsen et al (2017),United States
783,2831,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),-,-,-,,,-,Centre B34 (unpublished),
783,2833,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),32,-,-,,Mild,-,Centre B30 (unpublished),
783,2834,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),33,-,-,,Mild,-,Centre B30 (unpublished),
783,2839,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),28,-,-,,Mild,-,Centre B25 (unpublished),
783,2840,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),35,-,-,,Mild,-,Centre B25 (unpublished),
783,2841,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),33,-,-,,Mild,-,Centre B13 (unpublished),
783,2842,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),-,-,-,,,-,Centre B13 (unpublished),
783,2843,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),25,-,-,,Mild,-,Centre B25 (unpublished),
783,2844,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),40,-,-,,Mild,-,Centre B25 (unpublished),
783,2835,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),19,-,-,,Mild,-,Costa et al (2000),France
783,2838,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),23,-,-,,Mild,-,Costa et al (2000),France
783,2832,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),-,-,-,,Mild,-,Wulff et al (1995),Germany
783,2837,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),19,-,-,,Mild,-,Montejo et al (1999),Spain
783,2836,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),-,-,-,,,-,Liu et al (1997),United States
783,3770,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),41,,,,Mild,,Jenkins et al (2008),Ireland
783,3792,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),13,-,-,,Mild,-,Montejo et al (1999),Spain
783,3793,Point,Missense,1345,449,403,Serine Protease,Exon 8,c.1345C>T,p.(Arg449Trp),34,-,-,,Mild,-,Montejo et al (1999),Spain
784,2849,Point,Missense,1346,449,403,Serine Protease,Exon 8,c.1346G>A,p.(Arg449Gln),25,132,II,,Mild,-,Centre B45 (unpublished),
784,2846,Point,Missense,1346,449,403,Serine Protease,Exon 8,c.1346G>A,p.(Arg449Gln),29,-,-,,Mild,-,Aguilar-Martinez et al (1994B),
784,2851,Point,Missense,1346,449,403,Serine Protease,Exon 8,c.1346G>A,p.(Arg449Gln),33,101,II,,Mild,-,Centre B25 (unpublished),
784,2845,Point,Missense,1346,449,403,Serine Protease,Exon 8,c.1346G>A,p.(Arg449Gln),30,60,II,,Mild,-,Poon et al (1993),Canada
784,2850,Point,Missense,1346,449,403,Serine Protease,Exon 8,c.1346G>A,p.(Arg449Gln),29,-,-,,Mild,-,Costa et al (2000),France
784,2848,Point,Missense,1346,449,403,Serine Protease,Exon 8,c.1346G>A,p.(Arg449Gln),48,185,II,,Mild,-,Wojcik et al (1995),Netherlands
784,2847,Point,Missense,1346,449,403,Serine Protease,Exon 8,c.1346G>A,p.(Arg449Gln),12,-,-,,Mild,-,Saad et al (1994),United Kingdom
1205,4782,Point,Missense,1348,450,404,Serine Protease,Exon 8,c.1348T>A,p.(Tyr450Asn),<1,,,NO,Severe,,Johnsen et al (2017),United States
786,2853,Point,Missense,1348,450,404,Serine Protease,Exon 8,c.1348T>C,p.(Tyr450His),4,-,-,,Moderate,-,Centre B23 (unpublished),
786,2854,Point,Missense,1348,450,404,Serine Protease,Exon 8,c.1348T>C,p.(Tyr450His),7,162,II,,Mild,-,Centre B14 (unpublished),
787,2857,Point,Missense,1349,450,404,Serine Protease,Exon 8,c.1349A>G,p.(Tyr450Cys),<1,<1,-,NO,Severe,-,Attali et al (1999),France
787,4546,Point,Missense,1349,450,404,Serine Protease,Exon 8,c.1349A>G,p.(Tyr450Cys),<1,,,NO,Severe,,Johnsen et al (2017),United States
787,4547,Point,Missense,1349,450,404,Serine Protease,Exon 8,c.1349A>G,p.(Tyr450Cys),<1,,,NO,Severe,,Johnsen et al (2017),United States
787,2855,Point,Missense,1349,450,404,Serine Protease,Exon 8,c.1349A>G,p.(Tyr450Cys),-,-,-,,,-,Centre B18 (unpublished),
787,2856,Point,Missense,1349,450,404,Serine Protease,Exon 8,c.1349A>G,p.(Tyr450Cys),-,-,-,,,-,Heit et al (1998),United States
1084,3552,Point,Nonsense,1350,450,404,Serine Protease,Exon 8,c.1350T>G,p.(Tyr450*),-,-,-,NO,Severe,-,Yu et al (2012),China
788,4548,Point,Missense,1351,451,405,Serine Protease,Exon 8,c.1351G>T,p.(Val451Phe),11,,,NO,Mild,,Johnsen et al (2017),United States
788,2858,Point,Missense,1351,451,405,Serine Protease,Exon 8,c.1351G>T,p.(Val451Phe),23,26,I,,Mild,-,Thompson et al (1992A),United States
789,2859,Point,Missense,1357,453,407,Serine Protease,Exon 8,c.1357T>A,p.(Trp453Arg),<1,-,-,,Severe,-,Centre B35 (unpublished),
789,2861,Point,Missense,1357,453,407,Serine Protease,Exon 8,c.1357T>A,p.(Trp453Arg),<1,-,-,,Severe,-,Centre B25 (unpublished),
789,2860,Point,Missense,1357,453,407,Serine Protease,Exon 8,c.1357T>A,p.(Trp453Arg),<1,<1,-,,Severe,-,Costa et al (2000),France
790,2862,Point,Missense,1357,453,407,Serine Protease,Exon 8,c.1357T>C,p.(Trp453Arg),1,-,-,,Moderate,-,Koeberl et al (1989),United States
790,2863,Point,Missense,1357,453,407,Serine Protease,Exon 8,c.1357T>C,p.(Trp453Arg),<1,2,II,,Severe,-,Bottema et al (1991),United States
790,2864,Point,Missense,1357,453,407,Serine Protease,Exon 8,c.1357T>C,p.(Trp453Arg),-,-,-,,,-,Liu et al (1997),United States
790,2865,Point,Missense,1357,453,407,Serine Protease,Exon 8,c.1357T>C,p.(Trp453Arg),-,-,-,,,-,Liu et al (1997),United States
790,2866,Point,Missense,1357,453,407,Serine Protease,Exon 8,c.1357T>C,p.(Trp453Arg),-,-,-,,,-,Liu et al (1997),United States
791,3698,Point,Nonsense,1358,453,407,Serine Protease,Exon 8,c.1358G>A,p.(Trp453*),-,-,-,NO,Severe,-,Miller et al (2012),United States
791,2867,Point,Nonsense,1358,453,407,Serine Protease,Exon 8,c.1358G>A,p.(Trp453*),-,-,-,,,-,Centre B17 (unpublished),
792,2868,Point,Missense,1358,453,407,Serine Protease,Exon 8,c.1358G>T,p.(Trp453Leu),-,-,-,,,-,Centre B20 (unpublished),
793,4642,Point,Nonsense,1359,453,407,Serine Protease,Exon 8,c.1359G>A,p.(Trp453*),<1,,,NO,Severe,,Johnsen et al (2017),United States
793,2871,Point,Nonsense,1359,453,407,Serine Protease,Exon 8,c.1359G>A,p.(Trp453*),51,-,-,,Mild,-,Centre B13 (unpublished),
793,2870,Point,Nonsense,1359,453,407,Serine Protease,Exon 8,c.1359G>A,p.(Trp453*),<1,<1,-,,Severe,-,Wulff et al (1999),Germany
793,2869,Point,Nonsense,1359,453,407,Serine Protease,Exon 8,c.1359G>A,p.(Trp453*),<1,<1,-,,Severe,-,Saad et al (1994),United Kingdom
793,3813,Point,Nonsense,1359,453,407,Serine Protease,Exon 8,c.1359G>A,p.(Trp453*),<1,<1,,,Severe,-,Wulff et al (1999),Germany
793,3820,Point,Nonsense,1359,453,407,Serine Protease,Exon 8,c.1359G>A,p.(Trp453*),,,,,,,Wulff et al (2001),Germany
794,2872,Point,Missense,1359,453,407,Serine Protease,Exon 8,c.1359G>C,p.(Trp453Cys),6,-,-,,Mild,-,Wulff et al (2001),Germany
795,2873,Point,Missense,1361,454,408,Serine Protease,Exon 8,c.1361T>A,p.(Ile454Asn),-,-,-,,Severe,-,Belvini et al (2005),Italy
796,2875,Point,Missense,1361,454,408,Serine Protease,Exon 8,c.1361T>C,p.(Ile454Thr),<1,-,-,,Severe,-,Centre B13 (unpublished),
796,2876,Point,Missense,1361,454,408,Serine Protease,Exon 8,c.1361T>C,p.(Ile454Thr),<1,-,-,,Severe,-,Centre B24 (unpublished),
796,2874,Point,Missense,1361,454,408,Serine Protease,Exon 8,c.1361T>C,p.(Ile454Thr),1,1,I,,Moderate,-,David et al (1998),Portugal
798,2878,Point,Nonsense,1364,456,410,Serine Protease,Exon 8,c.1364G>T,p.(Glu456*),-,-,-,,,-,Centre B39 (unpublished),
799,4643,Point,Nonsense,1369,457,411,Serine Protease,Exon 8,c.1369A>T,p.(Lys457*),<1,,,NO,Severe,,Johnsen et al (2017),United States
799,2879,Point,Nonsense,1369,457,411,Serine Protease,Exon 8,c.1369A>T,p.(Lys457*),<1,<1,-,,Severe,-,Attree et al (1989),France
800,2880,Point,Missense,1373,458,412,Serine Protease,Exon 8,c.1373C>A,p.(Thr458Lys),3,1,I,,Moderate,-,Bottema et al (1991),United States
800,2881,Point,Missense,1373,458,412,Serine Protease,Exon 8,c.1373C>A,p.(Thr458Lys),-,-,-,,,-,Liu et al (1997),United States
